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Abstract
Polymorphism is the ability of a molecule to adopt more than one crystalline form and 
the control of polymorphism is of importance to the fine chemical industry. 
Complimentary computational crystal structure prediction and experimental 
crystallisation techniques have been used to investigate the polymorphism of four 
organic molecules, none of which were previously known to be polymorphic. For each 
molecule computational crystal structure prediction produced possible crystal structures, 
which could correspond to new polymorphs. Manual crystallisation techniques were 
employed in three instances, and an automated crystallisation platform was used in the 
fourth, to discover new polymorphs. The crystal structures of all new polymorphs and 
solvates were fully determined, where possible, by single crystal X-ray diffraction for 
comparison to the predicted structures.
The 5-fluorouracil crystallisation screen produced one new polymorph which 
corresponded to a low energy predicted structure. For 5-fluorocytosine, where no 
anhydrous forms had previously been determined, two new polymorphs were 
discovered, one of which was predicted by the computational results. The study on
3-azabicyclo[3.3.1]nonane-2,4-dione aimed to find a new hydrogen bond dimer-based 
polymorph inspired by the results of earlier prediction studies. The crystallisation screen 
produced one new polymorph which was structurally related to the previously reported 
chain-based structure, along with a high temperature plastic phase. Four polymorphs of
4-hydroxycoumarin were discovered, of which two were fully characterised by single 
crystal X-ray diffraction and two were identified by powder X-ray diffraction. Many of 
the newly discovered solvates of these molecules had their hydrogen bonding 
rationalised in terms of the hydrogen bonded motifs found in the predicted structures of 
the parent molecule.
The viability of computationally predicting monohydrate structures was 
investigated, using 5-azauracil monohydrate as a test system. This proved a success, 
with the known crystal structure found by the computational method to be energetically 
competitive with the other hypothetical structures.
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Abbreviations and definitions
5FU 5-Fluorouracil
5FC 5-Fluorocytosine
API Active Pharmaceutical Ingredient
BQT 3-Azabicyclo[3.3. l]nonane-2,4-dione
CCDC Cambridge Crystallographic Database Centre
CSD Cambridge Structural Database
CSP Crystal Structure Prediction
C SP1999 CCDC international blind test of structure prediction (1999)
CSP2001 CCDC international blind test of structure prediction (2001)
CSP2004 CCDC international blind test of structure prediction (2004)
Drug Substance see API
Drug Product API formulated into the drug delivery vehicle (tablet,
suspension etc.)
DSC Differential Scanning Calorimetry
DMA Distributed Multipole Analysis
ESP Electrostatic potential
EV Solvent evaporation crystallisation method
FDA Food and Drug Administration -  oversees pharmaceutical
regulation in the United States 
Parent The neutral API (free acid or base) from which a salt is derived
Salt Reaction of the parent API in an acid/base reaction to become a
charged species, with a constituent counter-ion from the reaction 
STA Simultaneous Thermal Analysis, usually a combination of DSC
and TGA
SXRD Single crystal X-Ray Diffraction
TGA Thermogravimetric Analysis
VD Vapour diffusion crystallisation method
XRPD X-Ray Powder Diffraction
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Chapter 1 Introduction
1.1 General introduction to polymorphism and its study
The origin of the word polymorphism derives from the Greek, poly = many and morph 
= forms. Its most common usages in science are predominantly biological in context, 
such as ‘genetic polymorphism’ which refers to minor differences in the same gene 
(alleles) that can manifest themselves in physical differences such as eye colour, hair 
type or diseases. The use of the word polymorph in the organic solid state is analogous 
-  with the molecule of interest the ‘gene’, the different crystalline forms it can adopt the 
‘alleles’ and the differences between polymorphs manifesting themselves as different 
physical and chemical properties.
Polymorphism can have important implications for the development of new fine 
chemical products such as pharmaceuticals, pigments and dyes, high energy materials 
and food ingredients.1 The arrangement of the molecules in a crystal structure 
determines its physical properties, and different polymorphs can exhibit varying 
physical, chemical and mechanical properties such as solubility and bioavailability; heat 
capacity and enthalpy of melting; melting and sublimation temperatures; rates of solid 
state reactions and chemical stability. Lack of control of the identity and quantity of 
polymorphs can potentially lead to inconsistency in the performance of the product. 
This could include drug substances failing to achieve the desired therapeutic activity, 
unreliable explosion characteristics for high energy materials, inconsistency in the 
colour of a dye or pigment compound or inferior oraleptic characteristics in chocolate 
due to polymorphism of a substituent.1 To obtain reliable results, the polymorphism of 
the compound must be controlled, and to achieve this, full knowledge of the solid forms 
of the compound and their inter-relationships is required.
Polymorphism is only one aspect of the full range of solid forms in which an 
organic molecule can potentially participate (scheme 1.1) and the definition of each of 
the terms shown in scheme 1.1 will provide a framework for the study of the organic 
solid state.
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Desolvated
Solvates
Polymorphs
Molecular Adducts
Conformational Packing
Parent Molecule
Chiral Amorphous
Scheme 1.1: Possible solid state forms in which the organic molecule of interest, the 
parent molecule, can potentially participate. Not all combinations are illustrated
1.2 Definitions
1.2.1 Polymorphism
Organic solid state definitions of the term polymorphism in the scientific literature are 
dependent on the degree of inclusiveness that each author desired. The most permissive 
definition of polymorphism includes all of the solid state forms in which the neutral 
parent molecule is present, including non-crystalline forms (amorphous forms) and 
those in which the parent molecule forms a crystalline molecular adduct with another 
molecular species (solvates and co-crystals).4’5 The least permissive definition of 
polymorphism is that the only difference between polymorphs is that they exhibit 
different crystal structures due to differences in the molecular packing arrangement, 
which can include changes to the conformation of the molecules therein.6 Implicit 
within this definition are the similarities between polymorphs: polymorphs are 
crystalline and have the same chemical composition, while the molecules comprising 
the crystal exhibit the same structural- and stereo- isomerism. McCrone7 has provided a 
sound working definition, that has stood the test of time: “two polymorphs will be 
different in crystal structure but identical in the liquid and vapour states”. This 
definition succinctly excludes amorphous forms and molecular adducts. For the 
purposes of this work, the strictest definition above will be employed:
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The only difference between polymorphs is that they exhibit different crystal 
structures due to differences in the molecular packing arrangement, which can 
include changes to the conformation of the molecules therein.
Polymorphism in elements, such as that of the diamond, graphite and fullerene forms of 
carbon is usually termed allotropy. The only sub-categorisation of polymorphism is 
with regard to molecular conformational flexibility. Rigid molecules, without the 
capability of changing conformation, can only differ in the relative orientation, or 
packing, of the molecules to give alternative crystal structures, giving rise to the term 
‘packing polymorphism’. Conformational polymorphs, in addition to packing 
differences, will have significant differences between the conformations of the 
constituent molecules in the polymorphs, which requires the molecule to have at least 
one torsion angle around which it is relatively free to rotate. Thus where there are 
significant molecular conformational differences, the polymorphs are classed as 
conformational polymorphs. The differentiation between these terms is necessarily 
artificial, as even for polymorphs of rigid molecules the conformations will differ 
slightly.8
1.2.2 Amorphous forms
Amorphous forms differ from crystalline forms by the degree of order inherent in the 
form. While crystalline forms have short range interactions and long range order, 
amorphous forms have only the short range interactions with a disordered arrangement 
of the molecules,9 and can be envisaged as supercooled liquids. There have been 
suggestions of different modifications of the amorphous state for some compounds, 
though the occurrence is thought to be rare, leading to the designation ‘polyamorphism’ 
-  a direct analogy to polymorphism in the crystalline state.10 For amorphous forms there 
exists a temperature at which the amorphous material converts from a glass-like state to 
a more rubber-like state, because of increased molecular mobility above this 
temperature, known as the glass transition temperature (Tg).
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1.2.3 Molecular adducts -  solvates, co-crystals and salts
Datta and Grant have defined a crystal as a molecular adduct when its lattice 
consists of more than one chemical component”,6 and it is used here as a general term to 
encompass solvates, co-crystals and salts.
Solvates are crystal structures in which both the parent molecule and the solvent of 
crystallisation are present and have been sub-classified according to the role of the 
solvent in the crystal structure.11 In isolated lattice site solvates, each solvent molecule 
does not have close contacts with any other solvent molecules -  the solvent molecules 
are separated by molecules of the parent species. If there is no strong interaction 
between the solvent and the non-solvent molecules in the crystal, then these solvates 
can be referred to as clathrates, and the solvent can be viewed as filling voids in the 
lattice. In channel solvates the solvent is contained within channels in the crystal 
structure. Desolvation can occur where the channels meet the surface of the crystal. The 
loss of solvent from the end of a channel causes a thermodynamic gradient along the 
channel causing solvent migration and further desolvation. In some channel solvates the 
solvent content in the channels can vary with the vapour pressure of the solvent, and the 
solvent can be included in non-stoichiometric quantities. The third solvate sub-category 
contains ion associated solvates. These solvates can occur for salts, and the coordination 
can be very strong, leading to difficulties in desolvating such solvates.
Solvate crystals once removed from the mother liquor of the crystallisation are 
often unstable with respect to desolvation, or alternatively the desolvation can be 
effected by exposing the solvate crystals to elevated temperature. There are three 
possible products of desolvation: the now unsolvated lattice can collapse to a previously 
known unsolvated crystalline form, to an amorphous state, or the unsolvated compound 
can retain the crystal structure of the original solvate -  a desolvated solvate.12’13 Such 
phases are of lower density than conventional polymorphs and tend to be more 
disordered.14 Lattice collapses associated with desolvation can be advantageous in 
pharmaceutical development in a particle engineering context because it can give 
micrometer-size particles with a small size distribution.
In scheme 1.1, hydrates have been deliberately included as a subset of solvates, 
because while there is nothing inherently special about water as a solvent in solvates, 
the prevalence of hydrates15 requires their explicit inclusion, and indeed the importance
26
of hydrates is highlighted by the work presented in chapter 7 which contains some of 
the first crystal structure predictions for a monohydrate.
Co-crystals and solvates belong to a broad continuum, in which the unionised 
parent compound is present in the crystal, along with one or more other molecular 
components. The difference between solvates and co-crystals has been defined by 
Almarsson and Zaworotko: “The primary difference is the physical state of the isolated 
pure components: if one component is liquid at room temperature, then the crystals are 
referred to as solvates; if both components are solids at room temperature, the products 
are referred to as co-crystals”16 This definition is not universally accepted, with Dunitz 
defining ‘co-crystal’ as a term that encompasses solvates as a sub-category: “[a co­
crystal is] ... a crystal containing two or more components together. Thus co-crystal 
encompasses molecular compounds, molecular complexes, solvates, inclusion 
compounds, channel compounds, clathrates ...”17. While the Almarsson and Zaworotko 
delineation is artificial, in most circumstances it provides a clear distinction and will be 
adhered to in this work.
Salts are formed when the parent compound containing acid or base functional 
groups is ionised in an acid-base reaction and crystallises with the counter-ion from the 
acid-base reaction. The chemical composition of the parent molecule is now changed, 
and because of this and the charged nature of the molecular components of the resultant 
crystal, these crystalline products are salts rather than co-crystals.
1.2.4 Chiral forms
For a chiral compound in solution, comprised of R and S enantiomers, two 
crystallisation outcomes are possible. Both enantiomers can crystallise together to yield 
one crystalline form containing both R and S enantiomers, to give a racemic crystalline 
product. Alternatively each enantiomer can crystallise separately, giving crystals of pure 
R and crystals of pure S, the process of optical resolution. In each of these three forms, 
the racemate, pure R and pure S, the steroisomerism is different and this inequality 
between their constituent molecules precludes them from being designated polymorphs.
Chiral molecules which exhibit dynamic isomerism and rapid equilibration in 
the liquid state have been used as an argument, in conjunction with McCrone’s 
definition of polymorphism that the two different crystal forms become equivalent in
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the liquid state, to assign crystals of the same molecule but with different chirality (pure 
R, pure S and RS) as polymorphs.18'20 At the same time it has been acknowledged that 
for such systems where the interconversion is slow, then such crystal forms do not 
qualify as polymorphically related. The two optically resolved crystal forms and the 
racemate, even when they show rapid equilibration upon melting or dissolution, are not 
polymorphs in the strictest sense because of the molecular stereo-isomeric 
inequivalence in the crystalline state. For such crystal structures the qualification ‘chiral 
polymorph’ can be used to connote the same molecular connectivity but stereo-isomeric 
inequivalence.
1.2.5 Phenomena related to polymorphism
The terms defined in sections 1.2.1-1.2.4 provides a framework within which to classify 
the different solid state forms of a compound, however there are related phenomena that 
require further interpretation. Highlighted below are some phenomena whose 
classification is ambiguous using the conceptual framework outline above.
Molecules that can tautomerise can potentially crystallise into different crystal 
structures containing the different tautomeric forms.19 Strictly tautomerism is a form of 
structural isomerism, and crystal structures containing different isomers are not 
polymorphs. Similar confusion can surround molecules that can crystallise in either 
neutral or zwitterionic forms. In both of these cases the isomerism is caused by a facile 
proton transfer and, according to McCrone’s definition of polymorphism, such forms 
would be identical in the liquid state soon after melting or dissolution due to rapid 
equilibration. So while neither of these phenomena can be assigned as true 
polymorphism they can be defined with qualification as tautomeric polymorphism and 
zwitterionic polymorphism respectively.
Polytypism is a feature of some layer structures, in which the repeat stacking of 
the layers is not well defined. In a set of polytypes the constitution of the fundamental 
layer will be identical but the individual polytypes will exhibit different stacking of the 
layers. In such cases the two crystallographic axes that lie in the plane of the layer are 
well defined and constant between the different polytypes, while the third axis length 
will vary depending on the stacking present in each particular polytype.
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The term ‘pseudopolymorph’ is a historical term that has been used for various 
phenomena similar to polymorphism, usually, but not exclusively, referring to
IQ 91 9 9solvates. Both Seddon and Bernstein have argued against the use of this term 
because there is ambiguity in both the use of the prefix pseudo- and the precise 
definition of the term pseudopolymorph. The term adds little to the language of the 
organic solid state that is not covered more precisely by other terms, and for this reason 
it will be avoided.
1.3 The prevalence of polymorphism
The prevalence of polymorphism in the organic solid state is a factor in determining its 
potential importance to the fine chemicals industry. McCrone stated that “every 
compound has different polymorphic forms, and that, in general, the number of forms 
known for a particular compound is proportional to the time and money spent in 
research on that compound”,7 suggesting that the more a molecule is investigated for 
polymorphism, the more instances of polymorphism will be found.
An accurate quantification of the proportion of organic molecules that exhibit 
polymorphism based on existing data is difficult because, to arrive at an accurate 
statistic, only the relatively small set of systems for which polymorphism has been 
thoroughly investigated can be considered. An analysis of the Cambridge Structural 
Database (CSD) for polymorphs in 1999 yielded only 321 polymorphic systems in the 
subset of organic molecules.24 Of this 321, 291 were dimorphic, 27 were trimorphic and 
three had four polymorphs. By 2004, the prevalence of multi-polymorphic instances had 
increased to 50 trimorphic systems, 5 tetramorphic, one pentamorphic and one 
hexamorphic system.25 Such numbers are a very small percentage of the structures 
present in the CSD because the vast majority of crystal structures present in the CSD 
were determined only to elucidate the structure of the molecule in the crystal -  in such 
cases the first crystal structure obtained was published, with no further investigation of 
the solid state diversity. For such molecules upon which no solid state investigation has 
been done, no comment can be made about their possible polymorphism. The Innsbruck 
School of Pharmacognoscy have investigated the polymorphism of a large number of 
organic molecules over the past 50 years using hot stage microscopy as their principal 
characterisation technique and conclude that approximately one third of organic
29
molecules can form polymorphs, with a further third capable of forming solvates. If 
this figure is approximately accurate, the potential for polymorphism (and solvate 
formation) for any individual organic molecule is significant and will warrant 
investigation if it is to be used as a fine chemical.
1.4 Polymorphism in the pharmaceutical industry
The pharmaceutical industry in particular focuses significant resources in discovering 
and controlling the solid state forms of newly developed active pharmaceutical 
ingredients (APIs). It is critical to discover all solid state forms to select the form for 
drug product development that has optimal physical and chemical characteristics, and to 
specify that single form to the regulatory authorities who will only licence that one form 
for use in the final drug product, and to maximise intellectual property protection. In 
this context the solid state diversity of two widely used pharmaceuticals, 5-fluorouracil 
and 5-fluorocytosine, is investigated (chapters 3 & 4).
1.4.1 Optimisation of the solid state form
The optimal form of an API is defined in terms of a small range of criteria, fulfilment of 
which are pre-requisite before the form of the API can be considered for use in a drug 
product. These criteria include how the physical properties of each of the available 
forms impacts the physical and chemical stability of the API, its solubility, 
bioavailability and manufacturability.14 The chosen form must be suitably physically 
and chemically stable, have sufficient solubility/bioavailability to be effective, have 
favourable physical properties such as flowability, compactability/tabletting, 
morphology, hygroscopicity27 and if there is the possibility of phase transitions under 
manufacturing conditions they should be well understood and easily controlled. 
Potentially the optimal form could be a polymorph (either stable or metastable), an 
amorphous form, a hydrate, or a salt of the parent API. Choice of the optimal form for 
development ideally happens early in the development of the API prior to the first 
clinical trials, and a change of form later in the development process will prove costly 
(in terms of both time and money).
Ideally the thermodynamically most stable polymorphic form of the API is 
chosen for development which aids the formulation of a robust method of manufacture 
and imparts confidence in the manufacturing specification submitted to regulatory
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bodies such as the Food and Drug Administration (FDA). The choice of the 
thermodynamically most stable form minimises the possibility of unplanned phase 
changes due to variations in the manufacturing process or during storage of the drug 
product. In the case of highly soluble APIs, often the variation in solubility between 
different polymorphic forms is not sufficient to affect the bioavailability of the API and 
a less stringent specification is allowed that may lead to any one of the known 
polymorphs (though even in this scenario it is best practice to specify a single 
polymorph). It is estimated that the variability in solubility between polymorphs is 
commonly less than a factor of 10.30 In the most usual case, where the polymorphic 
form of the API critically determines the efficacy of the drug product (through either 
solubility or stability considerations), it is required that only a single form is 
manufactured and included in the drug product, and that controls are developed and put 
in place to monitor amounts of other polymorphic forms.4,14 Commonly a range of 
experiments, including slurrying and thermal cycling experiments, is carried out on 
what is thought to be the most stable form to ensure that there is not a more stable form 
possible.
When the stable form does not have the required physical properties, especially 
low solubility and thus poor bioavailability, alternative solid state forms can be 
considered. Both metastable crystalline forms and the amorphous form are unstable 
with respect to the thermodynamically most stable form which leads to them having 
greater solubility, though there is the danger that a metastable form could convert to a 
more stable form or that an amorphous formulation could crystallise. Use of either as 
the selected form of an API in the drug product requires proof that it is suitably 
kinetically stable, and detailed consideration of the manufacturing specification is 
required including monitoring that the chosen form is being produced reliably and 
monitoring for the possible production of other forms. The choice of either a metastable 
polymorph or amorphous form that subsequently underwent an unexpected phase 
change during either drug manufacture or drug product storage would infer that there 
was inadequate control of the manufacturing process and would lead to the withdrawal 
of approval for the drug product. Examples of the use of an amorphous form include 
novobiocin, where the crystalline form is not readily absorbed, but the amorphous form 
is and is therefore therapeutically active, and cefuroxime axetil (Ceftin®), which is
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formulated as a fully amorphous form, but which is very unstable to the presence of the
-3 1
crystalline form. In solid suspensions of novobiocin additives are required to suppress
the inherent tendency for the amorphous form to crystallise, and some formulations of
 ^1cefuroxime axetil are wax coated to prevent crystallisation.
A thorough knowledge of the polymorph and solvate profile of the API is 
essential, even in cases where the most stable form is chosen for development. The 
manufacturing process must be fully controlled at each stage with respect to the solid 
form of the API. Processes used in pharmaceutical manufacture such as temperature 
variation, relative humidity changes, milling, wet granulation and drying processes can 
cause phase conversions within or between any of the following categories:
o
polymorphs, solvates, desolvated solvates and amorphous forms. Environmental 
conditions under which either the bulk API or the drug product may be stored must be 
considered because of their potential impact on the solid form of the API. For example, 
the hygroscopicity of the chosen form of the API must be well understood -  if it has the 
potential to absorb water and convert to a hydrate, this may not cause a problem in low 
humidity areas, but production at, or shipping to, more humid regions may cause a 
phase transition to the hydrate. A form that undergoes a hydration phase change below 
60% relative humidity will require all water to be excluded from manufacture and upon 
storage of the final drug product.14
A salt version of an API is often used in circumstances where it has desirable 
physical properties that the parent API does not possess. For a selected salt form such 
properties can include greater solubility, and hence bioavailability or circumstances 
where the salt may be crystalline while the parent API can only be produced as an 
amorphous form, allowing structural characterisation by single crystal X-ray diffraction. 
The parent API may have a complex polymorphic profile that is difficult to control, 
whereas the salt may only have one form or the parent API may be hygroscopic whereas 
the salt may not. In a similar analogy to optimisation of the polymorphic form, a salt 
screen would be carried out to determine the optimal salt form based on its physical 
solid state properties. It should be noted that because each salt produced is chemically 
distinct from the parent API, each would have its own polymorph and solvate profile 
and if a salt was chosen for development, a polymorph and solvate screen would have to 
be performed upon that version.
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The classic example of a drug substance for which the solid state characterisation was 
crucially incomplete is the anti-HIV drug ritonavir (Norvir ©) developed and marketed 
by Abbott Laboratories. The form chosen (Form I) for development was assumed to be 
the thermodynamically most stable form and the drug product was formulated as both a 
liquid and as a semi-solid capsule. Almost two years after the drug was released to 
market, the semi-solid formulation started to fail the quality control dissolution test, 
with a large proportion of the drug substance unexpectedly precipitating out. The semi­
solid capsule contained a near saturated solution of Form I, but this was super-saturated 
with respect to a new, more stable form, Form II. This new polymorph was the cause of 
the failure of the dissolution tests and resulted in withdrawal of the drug from the 
market. It was viewed as desirable to reformulate Form I, even though metastable with 
respect to Form II and that potential for seeding by Form I will always be a risk, as it 
had more favourable manufacturing properties and indeed the reformulated product 
released, after a delay of 18 months, contained Form I.34
1.4.2 Intellectual property protection
A fundamental reason to thoroughly research the polymorphism of pharmaceutical 
ingredients is for robust intellectual property protection. A patent granted on an 
invention bestows upon the holder of the patent a limited term of exclusivity to exploit 
the invention, in return for its public disclosure and the freedom for anyone to employ 
the invention upon expiration of the patent. The substantial expenditure on research and 
design, of both the products brought to market and those that fail the development 
process and never get to market, is recovered by the premium that can be charged for 
the marketed products due to the exclusivity afforded by the patent for the lifetime of 
the patent. To ensure recovery of the initial investment, the patent protection must cover 
all eventualities. Alternative newly discovered polymorphs to the form marketed or 
those covered by the company’s original patent could be used by a rival company to 
circumvent the original patent, and produce the drug in the new polymorphic form. For 
a pharmaceutical, the rival company would only have to establish bioequivalence of 
their new form with the original form before submitting an Abbreviated New Drug 
Application (ANDA) which would draw on the clinical trial data contained in the 
original company’s New Drug Application (NDA) for proof of safety and efficacy
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against the disease in question. The ANDA would be considerably less expensive for 
the rival company compared to the cost of the original NDA, as it does not have to take 
on the expense of the clinical trials, or the risk that the drug may fail in the clinical trial 
stage. A key example is the case of the GlaxoSmithKline drug ranitidine hydrochloride 
(Zantac ®), one of the first attempts to exploit polymorphism to extend the patent 
protection on a blockbuster pharmaceutical. During the pre-clinical development 
process, two forms were discovered and patented, though Form 1 was prepared and 
patented approximately three years prior to Form 2. Form 2 was the form used in 
manufacture of the drug product. At the expiration of the patent on Form 1 Novopharm 
attempted to manufacture a generic version of Form 1 of ranitidine hydrochloride. 
Manufacture according to the original Form 1 patent only yielded Form 2, and 
Novopharm argued that Form 1 had never been produced using the patented route and 
that this invalidated the Form 2 patent, which would have allowed it to produce either 
form without restriction three years prior to the expiry of the Form 2 patent. 
GlaxoSmithKline successfully defended the validity of the Form 2 patent, though their 
attempts to stop Novopharm and others from marketing Form 1 with small amounts of 
Form 2 (present as an impurity) by arguing that it violated their Form 2 patent were 
ultimately unsuccessful.1
1.5 Thermodynamics of polymorphism
At a given temperature and pressure usually only one polymorph is stable, and all other 
polymorphs are metastable. Metastable forms can be short lived or kinetically stabilised 
and longer lived. The relative stability of two polymorphs is determined by the free 
energy difference:
AG = AH -TAS
The enthalpy difference, AH , is the lattice energy difference between the two forms, 
which occurs because the intermolecular interactions are different in the two 
polymorphs. The entropy difference, AS , is due to differences in the lattice vibrations 
and any disorder present in the polymorphs.5 The enthalpy of a crystal form at constant 
pressure is a sum of the internal energy, U, due to all of the intermolecular interactions 
in the crystal plus a PV term, with P usually the atmospheric pressure:3
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H = U + PV
The difference in the PV term between two polymorphs, PA V , is so small that it is 
negligible in the calculation of the free energy difference. Over the full range of 
temperature in which a crystalline form can exist, the enthalpy of the crystal increases 
with rising temperature due to increasing molar volume and weakening of the 
intermolecular interactions. The entropy, initially zero at 0 K, increases due to the 
increasing population of higher energy levels of lattice vibrations. The increase in the 
T.S term outweighs the increase in the enthalpy term, leading to a net decrease in the 
free energy with increasing temperature (figure 1.1).
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Figure 1.1: Variation in enthalpy, entropy and free energy with temperature for a 
crystalline phase. At 0 K the entropy So = 0, so Go = Ho
A pair of polymorphs can be thermodynamically related in one of two ways. One 
polymorph can be metastable with respect to the other at all temperatures below their 
melting points, in which case the relationship is monotropic. If each of the polymorphs 
has a temperature range in which it is stable with respect to the other, and consequently 
there is a transition temperature at which the order of stability crosses, the two forms are 
said to be enantiotropically related. In figure 1.2 polymorphs A and B are 
monotropically related with A more stable than B. In figure 1.3 A and B are 
enantiotropically related with A more stable than B at lower temperatures. Included in 
both figures are the free energy and enthalpy curves for the liquid.
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Figure 1.2: Free energy relationship between monotropically related polymorphs
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Figure 1.3: Free energy relationship between enantiotropically related polymorphs
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These diagrams have provided the basis for two thermodynamic rules -  the Burger and 
Ramberger rules -  used to determine the thermodynamic relationship between two 
polymorphs from thermal data. The heat of transition rule states that if the enthalpy of 
transition (AHt) between the two polymorphs is endothermic then they are 
enantiotropes, and if exothermic the two are monotropes. The heat of fusion rule states 
that if the higher melting polymorph has the higher heat of fusion then the two 
polymorphs are monotropes, and if the higher melting polymorph has the lower heat of 
fusion then they are enantiotropes. In both cases it is assumed that the appropriate data 
can be collected: in the case of the transition rule the phase transition must be observed 
and for the fusion rule the phase transition must not occur. The thermodynamic stability 
difference between polymorphs is the fundamental basis for many of the physical 
property differences, such as the exhibition of different saturated vapour pressures and 
different solubilities in a given solvent:
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where p\ and pi are the saturated vapour pressures and s\ and si are the equilibrium 
solubilities of the two polymorphs.3 The more stable polymorph has the lower solubility 
and saturated vapour pressure.
1.6 Crystallisation
The process of crystallisation is comprised of two steps -  a nucleation step followed by 
crystal growth. While thermodynamics defines the stability domains for different 
polymorphs, kinetics controls the crystallisation pathway and consequently can lead to 
the formation of metastable crystal structures.37
1.6.1 Nucleation
•38Gavezzotti has postulated the steps that may constitute crystal growth from solution:
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• A. When super-saturation is reached the solute de-mixes in the form of minute 
droplets with liquid structure
• B. As super-saturation increases, the size of the droplets increases, up to a point 
where the transition to a semi-ordered structure starts; there is a long period 
during which the droplet structure is fluxional
• C. Due to as yet largely unknown reasons (which might be related with kinetic
factors such as cracks in the container walls or impurities, rather than
thermodynamics) there are transitions to a pre-crystalline structure, which then 
starts its way to growth
• D. In solution steps A-C are largely influenced by interaction with the solvent
• E. Growth of different crystalline nuclei proceeds at different rates, in a
competition regime, and the appearance of a given crystal structure depends on
the stability of the structure itself, but also very much on the growth speed
Each of the steps A-E will be addressed in more detail below to outline the theory of 
nucleation.
A. When super-saturation is reached the solute de-mixes in the form of minute droplets 
with liquid structure
A saturated solution is one in which the solution state is in equilibrium with the solute 
in a specified solid state. The specified solid state can be the thermodynamically most 
stable polymorph or a metastable polymorph, in which case the equilibrium is a 
metastable equilibrium. The condition of super-saturation is required for nucleation to 
commence, and this is commonly achieved by either solvent evaporation or cooling of a 
solution saturated at elevated temperature. The super-saturation, a, is defined as the 
difference in chemical potential between a molecule in the super-saturated state and the 
equilibrium state, but is commonly expressed in terms of activities (a). Where solubility
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(x) can approximate for the activity, this substitution is also made. For small values of
A solution that is saturated can commonly be cooled into the super-saturated region 
before crystallisation occurs. The difference between the onset of super-saturation and 
crystallisation is known as the metastable zone (figure 1.4) and its presence is related to 
the activation energy required for nucleation. Within this zone if seeds of a polymorph 
are introduced, the super-saturation is relieved and the product will be the same 
polymorph as that of the seeds.
Figure 1.4: Metastable zone width. The metastable zone limit defines the super­
saturation limit beyond which spontaneous nucleation can occur
B. As super-saturation increases, the size of the droplets increases, up to a point where 
the transition to a semi-ordered structure starts; there is a long period during which the 
droplet structure is fluxional. C. Due to as yet largely unknown reasons (which might be 
related with kinetic factors like cracks in the container walls or impurities, rather than 
thermodynamics) there are transitions to a pre-crystalline structure, which then starts 
its way to growth
(jcm -  xeq) the final approximation can be made below39
S u p e rsa tu ra te d
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The super-saturation provides the driving force for crystallisation, and the available 
energy, upon which it acts, must overcome the interfacial tension, that is the energy 
required to form the new solid-solution interface:39 40
AG = -zk  Tin + Pyz2 /3
where z is the number of molecules in the nucleus, /? is a nucleus shape factor and y is 
the interfacial tension. Plotting the free energy difference for different super-saturations, 
shows that the energy barrier is lower at higher super-saturations and that the nucleus 
size (zc -  the critical nucleus size) required to overcome the barrier is smaller (figure
1.5). When the available energy can overcome this energy barrier, nucleation occurs.
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Figure 1.5: Barrier to nucleation at different super-saturations. At higher super­
saturation the energy barrier to nucleation is lower and the critical nucleus size is 
smaller39
The above consideration of nucleation assumes that the nucleation is spontaneous from 
solution, known as primary homogeneous nucleation. Primary heterogeneous nucleation 
is where the nucleation event is induced by foreign particles, such as dust or insoluble 
impurities in the solution. Secondary nucleation occurs when the nucleation event is 
induced by crystals of the crystallising solute that are either unintentionally present in 
the crystallisation vessel, or have been intentionally added to ensure a predictable 
crystallisation outcome, known as seeding.41
40
D. In solution steps A-C are largely influenced by interaction with the solvent
The solvent used for the crystallisation is of critical importance in determining the 
outcome of the crystallisation. During the pre-nucleus stage self-assembled units are 
thought to exist in solution, usually associated through strong intermolecular 
interactions such as hydrogen bonds, and it is these units that aggregate to form the 
critical nuclei and the final macroscopic crystalline product.40 The solute when 
dissolved in solvents with different properties such as polarity or proton-donating 
ability, may form different self-assembled units which can lead to different polymorph 
or solvate outcomes.42 For this reason solvent is the primary variable parameter 
exploited in crystallisation screens. The nucleation process can hence be envisaged, 
from a supramolecular viewpoint, as including a step involving self-assembled units in 
solution prior to nucleation:43
Molecules in solution <-» Self-assembled units in solution <-> Crystallisation
It should be noted, however, that solvent is not the only variable that can change the 
polymorphic outcome of a crystallisation; other factors to consider include, but are not 
limited to, temperature, initial concentration of solution, seeding (intentional or 
unintentional), impurities in solution, agitation and cooling rate.44
E. Growth of different crystalline nuclei proceeds at different rates, in a competition 
regime, and the appearance of a given crystal structure depends on the stability of the 
structure itself, but also very much on the growth speed
At the pre-critical nucleus stage nuclei of several different polymorphic forms may be 
present in the crystallisation. These nuclei are all at the fluxional stage where 
dissolution is more energetically favoured than growth, and as the crystallisation 
proceeds the continued growth of one of the forms present is favoured over all others, 
while the others re-dissolve and their constituent molecules attach to the nuclei of the 
favoured form.3 The favoured form will be the one that grows most quickly to its unique 
critical nucleus size and its further growth is then energetically advantageous (figure
1.5). This form will be observed at the expense of all others, even those that could result 
in more stable crystal structures -  the favoured form may be the thermodynamically
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most stable form or a metastable form. From this it can be appreciated that the process 
of nucleation is not thermodynamically controlled, and that kinetic factors influence the 
crystallisation outcome.45 A crystallisation pathway that leads to a metastable 
polymorph may have a lower energy barrier to nucleation compared to the 
thermodynamic crystallisation pathway and the kinetic drive to relieve the imposed 
super-saturation of the system dominates the thermodynamic drive to attain the lowest 
point of free energy (figure 1.6).46 The initial formation of a metastable form will only 
yield that form as the final crystallisation product if the crystallisation process is 
completely kinetically controlled and not allowed to enter a regime where 
thermodynamic control can take over: if the metastable form is left in contact with its 
mother liquor for a period of time after the kinetic driving force has been extinguished, 
there is a thermodynamic driving force for a reconstructive phase transition to the 
thermodynamically more stable form.
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Figure 1.6: Kinetic versus thermodynamic control of crystallisation. The kinetic 
pathway has a lower nucleation activation energy ( ^  ^ 110)? leads to the less
stable crystal structure (AGkinetic). The thermodynamic pathway has a higher
barrier to nucleation ( ^ tthemDdynmc) ^ut lea^s to the more stable crystal structure
(  ^^therm odyn Bic )
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1.6.2 Nucleation of solvates
The crystallisation of a solvate rather than a non-solvated form can be seen as an 
‘interruption’ to the above model of nucleation. Self-assembled units that include 
solvent can form in solution, co-ordinated to solute molecules via multi-point hydrogen 
bond contacts.47 The energy barrier for removal of the strongly co-ordinated solvent to 
enable the solute species to crystallise into a non-solvated crystal structure, the 
demixing step, can be high enough that the alternative crystallisation pathway where the 
solvent is incorporated into the crystal structure is followed instead. The enthalpic gain 
from the strong multi-point interactions between solvent and solute outweighs the 
entropic gain that would be achieved from the demixing process.47 A statistical 
analysis15 of the CSD in 2000 showed that 15% of the organic crystal structures therein 
were solvates, though again the inherent bias of the structures present in the CSD must 
be appreciated: the CSD is a database of single crystal structures that in the main were 
determined for the purpose of providing definitive proof of molecular structure. As 
discussed above in reference to the prevalence of polymorphism, for many of the 85% 
of molecules whose reported crystal structures are not solvates it cannot be concluded 
that they don’t form solvates, but rather that for each of these systems no information is 
available beyond the fact that the single crystallisation experiment carried out yielded an 
unsolvated crystal structure rather than a solvate. It has been suggested that a third of 
molecules may form solvates19 and McCrone’s provocative statement on the prevalence
n
of polymorphism will also hold true for solvated crystal forms, leading to perhaps even 
this being an underestimate.
1.6.3 Crystal growth and morphology
For the crystal form that wins out at the competitive pre-nucleation stage and whose 
crystallites have passed their critical nucleus size, the crystal growth regime is entered. 
At this stage the nuclei have a crystalline internal structure and are bounded by faces, 
with the planes of these faces usually having low Miller indices.
48A step growth mechanism for crystal surfaces has been proposed by Kossel. 
The crystal can be envisaged as comprised of a three dimensional array of cubes, with 
each cube representing a molecule or growth unit in the case of self-assembled units in 
solution. Upon a face an island monolayer of several cubes can spontaneously form,
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which constitutes the beginning of the next new layer on the face.49 The edges of the 
island monolayer are steps in which kinks can occur, and these kinks are the primary 
attachment site for growth of the face. A molecule in the bulk solution will diffuse 
through the solution to the surface of the crystal and is adsorbed onto the face; it then 
diffuses along the plane until it encounters the step and diffuses along the step until a 
kink is found; the molecule joins the crystal by adding to the step at the point of the 
kink (figure 1.7). The kink moves along the step as further growth units attach to it until 
it reaches the edge of the face and grows out. At this point a new step is formed, in 
which a new kink occurs and this kink subsequently grows out. This process occurs 
until the steps themselves reach the edge of the face and an entire new layer has been 
deposited on the face. For further growth a new island monolayer must form. The 
higher the temperature the more surface imperfections, such as steps, kinks, surface- 
adsorbed growth units and surface vacancies occur in a face, enabling the step growth 
mechanism 49 The surface nucleation step is the rate-limiting step in the Kossel model 
and the model has proved unrepresentative of true crystal growth because crystals can 
grow at levels of super-saturation lower than that required to induce surface nucleation.
Figure 1.7: Kossel model of crystal growth on a surface. Key: brown = surface 
vacancy; purple = surface adsorbed growth unit; blue = surface adsorbed unit 
diffusing towards step; green = step unit; red = unit joining the step at kink
Burton, Cabrera and Frank50 proposed a dislocation model, proposing that crystal faces 
grow via lattice defects such as screw dislocations (figure 1.8). Molecules can attach to 
the step formed by the dislocation and layers add to the face by growing in spirals 
around the epicentre of the dislocation. As the dislocation never grows out, the surface 
nucleation step of the Kossel model is avoided and the rate of growth of the face can 
occur close to the maximum theoretical rate for the level of super-saturation of the 
solution.41
44
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Figure 1.8: Screw dislocation on a crystal surface
Gibbs51 showed that for a crystal in equilibrium with its environment, the faces are 
exhibited to minimise the surface free energy, minimising
l o j  Fi
where a* is the specific surface free energy and F j  is the area of the ith face. This is 
known as the equilibrium morphology and it is distinct from the growth morphology, 
where the relative growth rates of faces dictates which faces have greatest 
morphological importance. The growth morphology was explained by Wulff49 as 
deriving from “the velocities of growth of different faces in the directions of their 
normals are proportional to the appropriate specific surface free energies.” The relative 
growth rates of faces are dependent on the surface free energy of the faces. Faces with a 
lower (greater negative) surface free energy per unit area grow more quickly than higher 
energy faces, and after sufficient growth of the crystal, the rapidly growing faces can 
‘grow out’ and are no longer exhibited by the crystal as faces. The slow growing crystal 
faces are the morphologically important faces as it is these faces that are observed as the 
bounding faces in macroscopic crystals. The surface free energy is dictated by the 
different orientation of the growth units at the surface of each face and the functional 
groups presented at the face to the solution. The stronger the interactions that can be 
formed between the surface molecules and solute molecules joining from solution, the 
lower the surface free energy and the faster the growth rate. For the crystal to grow, 
solute molecules from solution must attach to the faces of the crystal. The process of 
mass deposition on to a crystal body grown from solution is comprised of several 
processes, some of which may occur at the same time: diffusion of solvated solute
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molecules to the surface of the crystal, diffusion through the adsorption layer, surface 
diffusion of solvated or desolvated molecules, desolvation of molecules, integration of 
molecules into the lattice followed by counter diffusion of released solvent molecules 
away from the crystal surface.41
The influence of the internal crystalline structure on the growth rates of different 
faces and the determination of which faces have greatest morphological importance has 
been investigated by Hartmann and Perdok.51 In their model, again using cubes to 
represent molecules, each face can be classified as belonging to one of three general 
types: K (kinked) faces are parallel to no strong intermolecular bond directions, periodic 
bond vectors, and a growth unit joining a K face can form the maximum three strong 
bonds upon integration onto the surface; S (stepped) faces are parallel to one periodic 
bond vector, and a growth unit will form two strong bonds upon joining an S surface; F 
(flat) faces are parallel to two periodic bond vectors, and a growth unit will only form 
one strong bond upon joining an F surface. K faces have a lower surface free energy and 
faster growth rate than S faces, and in turn S faces have lower surface free energy and 
faster growth rate than F faces. They note that initially, due to the driving force to 
relieve the super-saturation the nuclei grow with approximately isometric shape and 
only when the saturation condition becomes closer to ‘equilibrium’ does the differential 
energies of the faces start to determine the rate at which different faces grow. They also 
define ‘attachment energy’ as “the bond energy released when one building unit is 
attached to the surface of the crystal”51 as a replacement for the surface free energy that 
has an entropic component, related to the solvent.
After the different attachment energies of the faces of the crystal, the second 
important factor that can affect the morphology of the crystal is the solvent used in the
c r n
crystallisation. ’ When in contact with the solution the faces of the crystal will be 
solvated. Different faces present different orientations of the molecules that constitute 
the crystal, so each different face has a different functional group composition and the 
different faces will be solvated to different degrees in a given solvent. A face containing 
polar groups is going to be more strongly solvated by polar solvents than by non-polar 
solvents, and vice versa for a non-polar face. The differential solvation of the faces of 
the same crystal structure in two different solvents can cause the relative rates of growth 
of equivalent faces to be altered, giving different observed morphologies from the two
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solvents. Stronger solvation of a particular face will require more energy for the 
diffusion of solute molecules to the surface through the adsorption layer, and for 
counter-diffusion of solvent molecules away from the face to allow the solute molecules 
to integrate into the crystal surface. This causes the face to grow more slowly than it 
would in a solvent that provides weaker solvation of the face.
1.6.4 Concomitant crystallisation and disappearing polymorphs
The simultaneous crystallisation of two (or more) polymorphs of a single compound 
from the same crystallisation experiment is known as concomitant polymorphism. Two 
crystallisation pathways that have very similar activation energies of crystallisation 
could lead to concomitant crystallisation, as both pathways will relieve the initial super­
saturation at the same rate for the same available energy. It should be noted, however 
there will be an inherent tendency for the more stable crystal structure to form in this 
situation, as it releases more energy to compensate for the energy required to form the 
phase boundary between the solution and the new crystalline state.46 In this case, there 
will be a thermodynamic tendency for the metastable form to convert to the stable form 
after the initial crystallisation. An example of a compound that can exhibit concomitant 
polymorphism is 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile (or ROY, 
after the observation that the different polymorphs exhibit various shades of red, orange 
and yellow), a pharmaceutical precursor produced at Lilly Research Laboratories.24 This 
compound was initially reported to crystallise in 6 different solvent free forms from 
methanol, occasionally showing mixtures of polymorphs in single crystallisation 
experiments. This effect, if present in a drug substance, would complicate attempts to 
formulate a robust procedure to manufacture a single form of the drug substance.
The discovery of a new thermodynamically stable polymorph of a compound 
may change the crystallisation result of a previously reliable method for growing a 
known crystal form, giving the new polymorph in preference to the original metastable 
one. The mere occurrence of the new polymorph in the same laboratory may cause 
crystals of the original polymorph to convert to the new form by seeding of the 
atmosphere, and may greatly increase the difficulty of regaining the original polymorph 
or even completely stop it from being grown again in that locality.54 In such a situation, 
the now elusive metastable polymorph is an example of a disappearing polymorph.
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Intentional seeding has been used for many years as an important method for promoting 
crystallisation in a solution, and is useful for reliably preparing one crystal form over 
another.54 Once a sample of the new more stable polymorph is opened to the laboratory 
space, small crystalline particles seeds can be unintentionally spread throughout the 
laboratory; these particles can find their way into new crystallisation experiments, by 
contamination of apparatus, or by airborne diffusion if small enough. This unintentional 
seeding with the new more stable polymorph may suppress the growth of the metastable 
form in crystallisation experiments. The presence of these seeds circumvents the rate- 
limiting homogeneous nucleation step of the crystallisation process -  crystals grow out 
rapidly from the seed nuclei of the more stable form, giving only this form as the 
crystallisation product.55 Once a more stable polymorph is discovered and displaces the 
original polymorph as the usual crystallisation result, it is always in principle possible to 
recover the ‘disappeared’ form -  however the caveat must be included that it may 
require extensive time and effort to discover the experimental conditions required to 
yield the disappeared form.56
1.7 Crystallisation methods
1.7.1 Classic crystallisation methods
The super-saturation required to induce crystallisation is commonly achieved in one of 
three ways: by cooling a saturated solution, by allowing solvent to evaporate from a 
solution, or by the addition of a miscible anti-solvent to reduce the overall solubility.
The parameter most usually varied in a crystallisation screen to attempt to find 
polymorphs is the solvent used for the crystallisation experiments, though other factors 
that can be varied combinatorially with solvent include rate of cooling, rate of solvent 
evaporation, initial level of solution saturation and the presence or absence of agitation 
of the solution during crystallisation.
A recent invention in the field of crystallisation screening has been the advent of 
high through-put screens, that use traditional crystallisation methods, but in an 
automated, parallelised platform to increase the rate of crystallisation conditions that 
can be investigated.57'59
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1.7.2 Novel crystallisation methods
Much research has been carried out on designing tailor made impurities, whose 
presence in small quantities in a crystallisation can alter the polymorphic outcome.52’53 
The mode of action of the impurity is selective adsorption onto some of the faces of the 
nuclei of one potential polymorph at the pre-critical nucleus stage, with this adsorption 
inhibiting further growth of this form, allowing nuclei of a different form to reach the 
critical nucleus stage and become the crystallisation product.60 For some systems the 
additive does not work at the nucleation stage, but upon formation of an initial 
metastable form, preventing its subsequent inter-conversion to a more stable form: 
crystallisation from solutions with no additive yields the stable form, but solutions with 
additive present will yield the metastable form.61;62
Polymers have been employed as heteronucleation surfaces, with different 
polymers yielding different polymorphs. Using this method new polymorphs of the 
pharmaceuticals carbamazepine63 and sulfamethoxazole25 have been discovered, which 
have proved inaccessible by traditional crystallisation routes.
High pressure crystallisation has also been a rich source of new polymorphs. 
Most polymorphism studies are carried out at ambient pressure, and by introducing 
variation in the applied pressure, occurrence domains of high pressure phases can be 
found and the new forms characterised. High pressure crystallisations have been 
performed both on pure samples from the liquid phase, such as for acetone,64 and from 
solutions, such as for piracetam65 and acetamide.66 Direct crystallisation of high 
pressure phases has been observed as well as solid-solid phase transitions upon 
application of pressure.
1.8 Intermolecular interactions
1.8.1 The origin of intermolecular interactions
Implicit so far has been the assumption that for a particular compound, the crystalline 
solid state is favoured below its melting point -  raising the question as to why the 
crystalline solid state forms. Upon cooling through the melting point of the compound 
and crystallisation, the enthalpy gain from ordering the molecules into the crystal and 
the thermal randomisation of the surroundings outweighs the loss of entropy caused by 
the ordering of the molecules.67 The enthalpy gain comes from attractive intermolecular
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forces producing an inherent drive for the molecules to form a close packed
arrangement, to minimise empty space in the crystal structure, as defined by
68Kitaigorodski’s principle of close packing. A crystalline product maximises the 
enthalpy gain from formation of intermolecular interactions, while minimising the 
repulsive interactions and produces a close packed structure.
The attractive intermolecular interactions that hold crystals together arise from 
the non-uniform electronic distribution in the molecules. These forces are an order of 
magnitude weaker than the intramolecular covalent bonds that join the atoms of the 
molecule together. The strongest intermolecular interactions between uncharged 
molecules usually have energies of 16-60 kJ mol'1,69 with a typical covalent bond 
having a dissociation energy at least 200 kJ mol'1. The intermolecular interaction 
between two spherical molecules can be graphically represented as a Morse curve
70(figure 1.9). At very close intermolecular distances there is a strong repulsive 
interaction between the molecules due to the overlap of the electron clouds of the two 
molecules, which would eventually lead to electrons with the same quantum numbers
7 1occupying the same space, violating the Pauli exclusion principle. At longer 
intermolecular separations the interactions between the molecules are attractive, and are 
the result of mutually advantageous electron arrangements in the two molecules, such as 
attractive electrostatic interactions, where partially negatively and positively charged 
groups on the two molecules are orientated towards one another, or polarisation, where 
the charge distribution in one molecule distorts the charge density in the other to lower 
the overall energy, or dispersion forces which are a quantum mechanical effect deriving 
from correlation of the instantaneous dipolar fluctuations in the charge distribution of
70*77the two molecules. ’ Some of the attractive forces are directional in nature, and 
consequently have been defined beyond their general role as an attractive intermolecular 
force -  these include dipole-dipole interactions (the tendency for dipolar molecules to 
pack in a head-to-tail arrangement), k-k interactions between aromatic ring sub-units, 
and hydrogen bonds.
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Figure 1.9: Morse potential curve for the intermolecular interaction of two 
spherical molecules. The energy minimum occurs at intermolecular separation Rm, 
of magnitude £
1.8.2 Intermolecular potentials
The ideal potential to model intermolecular interactions and calculate the free energy of 
crystal structures at a defined temperature would have to use an accurate methodology 
that addressed all of the following terms:73
G = U °+  Uia„ + UiMa -  T(Siaa + SimJ + PV
Currently employed methods used in crystal structure prediction usually only calculate 
the £/interterm at 0 K, neglecting the zero point energy, U ° , the vibrational energy a 
molecule retains even at 0 K. The intramolecular term £/intra is assumed to be constant
between structures when the rigid body approximation is employed and the difference 
in thePV  term is negligible between structures. The entropy based terms are neglected 
due to the 0 K nature of the calculation. This reduces the requirement, for rigid 
molecules, to that of an accurate description of the intermolecular interactions within 
the crystal to rank the structures at 0 K. This is modelled by partitioning the 
intermolecular potential into its constituent contributions and modelling each of these.
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Long range forces include the electrostatic contribution, polarisation and dispersion,
79while the short range terms include repulsion, exchange and charge transfer.
The repulsion term is a short range interaction that occurs when molecules are 
brought closer together than their van der Waals contact distance. The Pauli Exclusion 
Principle prevents the overlap because it would cause electrons with the same quantum 
numbers (but from two different molecules) to attempt to occupy the same space. At 
short range this is a steeply rising repulsive interaction usually modelled as an 
exponential term.
The dispersion term is a long range term that is universally attractive, is always 
present and is a purely quantum mechanical effect. It arises from the instantaneous
70correlation of induced dipoles, or electronic motion, in the molecules.
The electrostatic forces derive from the distribution of the valence electrons in a 
molecule. Coulombic interactions occur between molecules, between the undistorted 
charge distributions of the molecules. These forces can be either attractive or repulsive 
and persist over the longest range of any of the contributions to the intermolecular 
potential. For all species except spherical ions the electrostatic forces have an 
orientational dependence, and the electrostatic forces between two molecules can be 
either attractive or repulsive depending on this orientation. These forces are responsible 
for important features such as hydrogen bonding and n-n stacking, which have strong 
orientational dependence.72
Polarisation forces (or induction) are attractive and arise from the distortion of a 
molecule’s charge distribution in the field of the undistorted charge distribution of 
another molecule. A similar term occurs for the reverse action -  the distortion of the 
second molecule’s charge distribution by the first molecule. These distortions only 
occur if they lower the overall energy, and hence are always attractive. Structures that 
have strong hydrogen bonding, with electron clouds in close contact in the hydrogen
72bonding region, may exhibit polarisation effects that could be significant. The 
exchange interaction is an attractive force that is caused by the ability of the electron 
density of two individual molecules, at short range, to extend over the whole of the 
molecular pair. This is usually included with the repulsion term, which is the dominant 
contribution.72 Charge transfer can occur when molecules are at close range with 
overlapping charge distributions. Electron density can be transferred from the occupied
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orbitals of one molecule to the unoccupied orbitals of the other can occur giving rise to
the attractive charge transfer term. This is an attractive term and it is usually responsible
11for part of the short-range modification of the polarisation.
Two approximations are used to sum the intermolecular forces to give the lattice 
energy of the crystal structure. The first is the atom-atom approximation which assumes 
that the intermolecular potential between two molecules is the sum of all of the 
interactions between all atoms in the first molecule with all of the atoms in the second:72
U(R,Q(R= J U ,k(Rik)
ieA,keB
where atoms i belongs to molecule A and atoms k belongs to molecule B with each pair 
of atoms, i and k separated by distance The second is the pairwise additivity 
approximation, where the lattice energy of the crystal is equal to the sum of the
interactions between every pair of molecules in the crystal, with no treatment of many-
11body terms. The validity of the pairwise approximation differs between the terms that 
make up the overall intermolecular potential. Electrostatic interactions are strictly 
pairwise additive, dispersion is approximately pairwise additive and repulsion is 
approximately pairwise additive at common molecular separations in the crystal.70 
Summation of every molecule with every other molecule in the crystal is impracticable 
and a cutoff radial limit is usually chosen, in conjunction with Ewald summation to 
accelerate the convergence of the electrostatic term.
Commonly the electrostatic, dispersion and repulsion parts of the intermolecular 
potential are the only ones specifically modelled for use in lattice energy minimisation. 
The dispersion and repulsion contributions are modelled together using empirical 
models, using parameterisations for each type of atom that are assumed to be 
transferable between molecules. The electrostatic contribution is usually calculated 
specifically for the molecule under investigation, from a more sound theoretical basis. 
Truly ab initio potentials, with no empirical contribution to the calculation are currently 
too expensive for the large number of energy minimisations required for crystal 
structure prediction,74 though attempts have been made to refine the lowest energy
*JC
structures of a search using an ab initio derived potential.
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1.8.3 Dispersion-repulsion models
The dispersion and repulsion terms are commonly modelled together and are modelled 
for each atom type using an empirical description which has been parameterised against 
appropriate physical data, usually for CSP crystal structures and heats of sublimation. 
Usually the parameters for each atom type are assumed to be transferable between 
molecules. The most well-known dispersion-repulsion model is the ‘12-6’ Lennard-
76Jones potential:
the interatomic separation; e is the depth of the energy well; o = 2'mRm where Rm is the 
separation at which the energy minimum occurs and a  is the position where the
parameters that can be varied to fit the experimental data.
Buckingham modified the Lennard-Jones potential to combine an exponential- 
based model for the repulsive term with the same term for the dispersion to produce an 
‘exp-6’ model:
where R is the interatomic separation, and A, B and C are parameters that can be fitted 
according to experimental data. Once the Buckingham potential is fitted for each atomic 
type of interest, the isotropic atom-atom approximation is employed -  the molecule is 
assumed to be comprised of a superposition of spherical atoms. The dispersion- 
repulsion part of the intermolecular potential is the summation of the interaction of each 
atom in each molecule with all other atoms in all other molecules, within the cutoff, 
with a Buckingham potential centred on each atom with parameters specific to that 
atom’s type.
where the 12th power term models the repulsion which quickly decays with increasing 
interatomic separation and the 6th power term models the longer range dispersion. R is
repulsive arm crosses the zero of the energy scale (figure 1.9).70 Both e and a are
Ubuck^ R) ~ Ae
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Williams and co-workers developed a self-consistent potential based on the 
Buckingham potential and parameterised against sets of crystal structures for each atom 
type. Initially parameters for carbon and hydrogen were developed against hydrocarbon
77*78crystal structures ’ and once these parameters were optimised they were held constant
7 Q *70 OA Q |
for optimisation of the parameters for oxygen , nitrogen, fluorine and chlorine. 
Coombes et al. reparameterised Williams’ original hydrogen potential to give separate
87parameters for polar hydrogen. For each atom type the homoatomic terms were 
derived and the heteroatomic cross terms were calculated using well-known geometric 
combining rules:
A , = U a J  b " = \ {B“+ c„ = (c„cji
where i  and k  are different atom types. The sets of crystal structures used by Williams 
were small, less than 10 structures, each containing just C, H and the atom type to be 
parameterised, with no hydrogen bonding in any of the structures, and the crystal 
structures were all determined at room temperature. The electrostatic part of the 
intermolecular potential was modelled using point charges.
Williams later revisited the parameterisations, developing parameters not only 
for atom types but for structural sub-classes of atom types, such as differently 
hybridised carbons, and based on larger crystal structure sets and sublimation 
enthalpies, while using more sophisticated electrostatic models.83'85
Many other force fields have been developed based on either liquids or
macromolecular systems, but do not provide sufficiently accurate modelling of the
18crystalline solid state.
1.8.4 Electrostatic models
The most commonly adopted method used to represent the electrostatic part of the 
intermolecular potential for a molecule is to calculate the electrostatic potential for the 
isolated molecule from the ab initio calculated wavefunction using an affordable basis 
set and a high level calculation, such as SCF, with or without the MP2 electron 
correlation correction. From the wavefunction of the molecule the electrostatic potential 
at a grid of points in space outside the van der Waals radius of the molecule can be
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calculated and atomic point charges fitted to optimally reproduce the electrostatic 
potential at the grid points. The resultant charges, known as electrostatic potential (ESP) 
fitted atomic point charges, have no physical meaning -  their values simply optimise the 
fit to the grid of points, giving the best description possible of the electrostatic potential 
at these points.
The simple nuclear site electrostatic model is limited as it assumes that the 
charge on a particular atom is spherical. Extra non-atomic charge sites can be included 
at physically realistic sites to model effects such as lone pairs, known as the ESP 
extended site point charge model. These methods have been compared to the original 
nuclear-site charge model and have been shown to be appreciably more accurate. 8 5 ’8 6  
More recently a similar method has been developed with point charges placed not only 
on nuclear sites, but also at satellite positions that do not necessarily correlate with 
physical features such as lone pairs, but are sited to further optimise the fit of the whole 
set of point charges to the ab initio calculated charge density. 8 7
Distributed multipole analysis (DMA) 8 8  is a more sophisticated method that still 
relies on the calculation of the electrostatic potential of the molecule using ab initio 
methods, but instead of fitting only point charges to the nuclear positions, it calculates a 
series of multipoles at each nuclear site comprising charge, dipole, quadrupole, 
octopole, and hexadecapole, directly from the wavefunction of the molecule. The higher 
terms model non-spherical features and has been shown to successfully model 
interactions such as n-n interactions and hydrogen bonds . 8 9 ’9 0  Several studies have 
investigated the effect of different electrostatic models on crystal structure lattice energy 
minimisation, predominantly concluding that multipole-based models are superior to 
ESP fitted atomic charges. 8 2 ’9 1 ’9 2
Filippini and Gavezzotti have developed a Buckingham-based potential in 
which they have no explicit electrostatic model, but include electrostatic contributions 
within the Buckingham parameters. They parameterised all of the homoatomic 
potentials for C, H, N, O, Cl and S and also parameterised the heteroatomic cross-terms 
separately rather than using geometric combining rules. Only non-hydrogen bonded 
crystal structures were included in the training sets used for parameter fitting and the 
potential was shown to reproduce many crystals properties for a range of non-hydrogen 
bonding molecules.
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1.8.5 Hydrogen bonds
In many organic molecules the functional groups required to produce hydrogen bonds 
are present. Hydrogen bonding is the most important structure directing determinant, 
and the most useful interaction for assessing the packing modes present in crystal 
structures. Pauling gave an early definition of hydrogen bonding: “A hydrogen bond is 
an interaction that directs the association of a covalently bound hydrogen atom with one 
or more other atoms, groups of atoms or molecules into an aggregate structure that is 
sufficiently stable to make it convenient for the chemist to consider it as an independent 
chemical species. ” 9 4  An alternative definition is possible defining the hydrogen bond in 
terms of the types of atoms that are required to participate: a hydrogen bond is an 
attractive intermolecular interaction between a hydrogen atom that is covalently bonded 
to an electronegative atom, and an electron rich atom on another molecule 
(intermolecular hydrogen bond), or to an electron rich atom that is part of a different 
functional group on the same molecule (intramolecular hydrogen bond) (scheme 1 .2 ).
D 5- -  H s+  • • • A s -
Scheme 1.2: Schematic representation of a hydrogen bond. D is the hydrogen 
donor electronegative atom; A is the electronegative acceptor atom
The principal components of the intermolecular potential that contribute to hydrogen 
bonding are the electrostatic and polarisation terms, with dispersion, repulsion and 
charge-transfer components being less influential on both the strength and directionality
71of hydrogen bonding. The electronegative nature of the donor atom withdraws 
electron density from the D-H bond, leaving a partial positive charge on the hydrogen 
atom. This partial positive charge interacts with the electron rich acceptor atom, such as 
the lone pairs on oxygen, to form the hydrogen bond. Hydrogen bonds have been 
classed according to their strength, ease of attainment and reliability of formation (table
1 95;96
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Very strong
[F -H -F f [N -H -N  ]' P -0 -H 0 = P
Strong
O -H -O C N-H 0=C O- HO- H
Weak
C-H 0 N-H-F-C O -H -ti
Table 1.1: Hydrogen bond classification
Hydrogen bonds that contain ionic groups are beyond the scope of this work. Strong 
hydrogen bonds occur when the hydrogen is polarisable and is covalently bonded to an 
electron-withdrawing donor atom, oxygen or nitrogen, and interacts with a partially
71negatively charged and comparatively less polarisable acceptor atom, such as oxygen.
In the examples of weak hydrogen bonds, carbon acts as a weak hydrogen bond donor 
as it is not particularly electronegative producing a less positively charged hydrogen 
atom, fluorine as a hydrogen bond acceptor is not sufficiently polarisable to produce a 
strong interaction and the ^-electron cloud formed by aromatic groups do not have a 
focus of electron density to act as a strong hydrogen bond acceptor.
The strong hydrogen bonds defined in table 1.1 have D—A lengths that are less 
than the sum of the van der Waals radii of the donor and acceptor atoms, with the 
hydrogen atom completely subsumed into the van der Waals sphere of these two 
atoms. 7 0  The formation of a strong hydrogen bond lengthens the D-H distance, by 
0.01-0.05 A.96 The sum of the van der Waals radii9 7  gives an upper limit to 0 -H --0  
hydrogen bonds of 3.04 A (with 2.75 A a common average98) and 3.07 A for N-H—O 
hydrogen bonds (with 2.85 A a common average98). It should be stressed that such 
upper limits should not be construed as absolute, as in many cases hydrogen bonds 
longer than the sum of the van der Waals radii can be identified that, while weak in 
nature, may well have a role in the production of the structure observed. This is most 
particularly true with hydrogen bonds of the form C-H- O, because of their inherent 
weakness, which have 0 * 0  distances in the range 3.0 to 4.0 A98 (with 3.56 A the mean 
distance calculated in a recent study99). Strong hydrogen bonds exhibit preferred 
directionality, associating with the regions of electron density on the acceptor molecule, 
such as lone pairs. The angle D-H—A can be assumed to adopt a near linear disposition 
in the absence other forces. However, in crystal structures deviation from linearity
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commonly occurs because of the adoption of the optimal compromise between all 
intermolecular interactions in the crystal structure, with distortion of a particular 
hydrogen bond contact repaid by a more favourable interaction elsewhere in the 
structure. Weaker hydrogen bonds are more easily distortable from the ideal geometry 
that strong hydrogen bonds.
Etter1 0 0 produced a set of general rules to determine the likely hydrogen bonding 
that a molecule will adopt in the crystalline state:
• 1. All good proton donors and acceptors are used in hydrogen bonding
• 2. Six-membered-ring intramolecular hydrogen bonds form in preference to 
intermolecular hydrogen bonds
• 3. The best proton donors and acceptors remaining after intramolecular 
hydrogen bond formation form intermolecular hydrogen bonds to one another
Exceptions to these rules are known such as alloxan1 0 1 ;1 0 2  where, even though hydrogen 
bond donors and acceptors are present, they are unused in the crystal structure. While 
these rules pertain to the strong hydrogen bonds that can potentially be formed, the 
influence of weaker interactions, especially C-H—O , 1 0 3 ' 1 0 5 should not be discounted. 
Where strong hydrogen bonds are absent, weaker hydrogen bonds determine the crystal 
structure adopted and C-H "O interactions can be structure directing in some cases even 
when strong hydrogen bonds are present. 9 8
The reliability of formation of strong hydrogen bonds and their directional 
nature enables crystallographers to describe the packing of the crystal structure in terms 
of the hydrogen bond pattern. Graph set analysis1 0 6 ’ 1 0 7 has been employed in a 
systematic method developed for this purpose, based on the general scheme shown in 
scheme 1.3.
Scheme 1.3: Graph set descriptor
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G is the descriptor of the hydrogen bond pattern: C designates the pattern as an infinite 
chain, S an intramolecular hydrogen bond pattern, R a ring pattern and D other finite 
patterns. The superscript a is the number of acceptors in the repeat unit and the 
subscript d is the number of donors in the repeat unit, n is the degree of the pattern and 
is the number of atoms in the repeat unit. All graph set descriptors that include only one 
unique hydrogen bond are termed first order (scheme 1.4A), while those that include 
two hydrogen bonds are second order, and this continues to higher order (scheme 1.4B). 
Higher order graph sets can contain the most descriptively useful graph sets. First order 
graph sets are also defined as hydrogen bonded motifs, though this term will be used 
more permissively in this work for the most descriptive hydrogen bonded feature in the 
structure.
H
A B
Scheme 1.4: Graph set examples. A -  dimerisation of a carboxylic acid with first 
order graph set R ^ ) ;  B -  dimerisation of an amide and a carboxylic acid with 
two first order D)(2) graph sets and one R ^ )  second order graph set
The identification or rejection of weak hydrogen bonds in a crystal structure can have a 
critical influence on the calculated graph set.
1.9 C rystal structure prediction
The ab initio prediction of the crystal structure, or structures, that a molecule will adopt, 
prior to the possibly expensive and time consuming synthesis of that molecule, would 
be a powerful tool to those interested in developing organic materials with specific 
physical properties as the correctly predicted crystal structure(s) would contain all the 
necessary molecular packing information to be able to subsequently predict the physical 
and chemical properties of the crystalline form(s). In the cases where the crystal 
structure(s) exhibit undesirable properties then an alternative course of action can be 
considered.
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Crystal structure prediction (CSP) is related to crystal engineering, though distinct from 
it. Crystal engineering seeks to design and control the way that molecules crystallise5 5  
by exploiting intermolecular interactions that have been proven to occur reliably in 
other crystal structures. These intermolecular interactions are usually strong hydrogen
bonds such as O-H—O, N - H - 0  and these well defined hydrogen bonds, when present
1 08in crystal structures, are the building blocks of ‘supramolecular synthons’, defining 
the structure in terms of intermolecular interactions. Crystal engineering comprises the 
analysis of already known crystal structures to draw conclusions about the 
intermolecular interactions that direct the assembly of the crystals, and the 
computational analysis of intermolecular interactions using quantum mechanical 
methods and empirical potentials, to design new molecules which exhibit predicted 
intermolecular interactions. 1 0 9  The ability to determine the intermolecular interactions 
that a designed molecule will exhibit leads to the ability to design the crystal 
supermolecule with specific desirable properties. 1 1 0  Moulton and Zaworotko111 provide 
delineation between crystal structure prediction and crystal engineering -  crystal 
engineering deals with less precise design, concentrating on network prediction, while 
crystal structure prediction is more precise, aiming to predict space group, unit cell and 
the precise packing details.
In a Nature editorial in 1988, Maddox1 1 2 proclaimed that the inability to predict 
crystal structures from the molecular structure was a “continuing scandal” in physical 
science. The question “Are crystal structures predictable?” is a prudent question to 
ask1 1 3 ’ 1 1 4 prior to attempting to develop a methodology to do so. In the first instance the 
problem seems relatively simple, usually dominated by strong directional interactions 
such as hydrogen bonding to provide the principal molecular associations and the close 
packing principle requiring dense structures. However, for a particular compound, there 
is often more than one way to pack the molecules into a crystal structure to satisfy the 
hydrogen bonding rules and produce a dense structure -  it is the more subtle 
interactions that can be the key determinant of which of the possible structures is 
observed. Indeed the implicit assumption that it is thermodynamic stability that drives 
the outcome is not completely correct -  nucleation kinetics (section 1 .6 ) can determine 
the outcome of a crystallisation, requiring more than just lattice energy to be used as a
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1 n
structure discriminator between possible crystal structures. Gavezzotti has 
summarised the steps required for successful crystal structure prediction:
• 1. Generation of a set of polymorphs
• 2. Unequivocal detection of the most stable one at a given temperature
• 3. Modelling of the nucleation kinetics to determine which phase[s] which 
actually appear under given conditions
He concluded his account by summarising that this was not yet achievable (in 1994). 
Success in step 1, the generation of a set of energetically feasible potential polymorphs 
(the crystal energy landscape), depends upon the method used, its inherent limitations 
and the computational power available to thoroughly explore the lattice energy surface 
to locate all possible minima thereon. Upon generation of a set of hypothetical crystal 
structures by a CSP method, each structure must be energy minimised using an 
intermolecular potential to rank the structures by stability. Step 2, the identification of 
the most stable phase, is dependent upon the intermolecular potential employed to 
calculate the lattice energies of the structures generated in step 1 , and the errors in the 
potential versus the energy gap between potential polymorphs. Step 3, the modelling of 
nucleation kinetics, is far from achievable in the near future, and yet is identified as the 
crucial aspect missing from current attempts to predict crystal structures. 4 5  Current 
methods usually rely on satisfying the first two of the three criteria above -  the 
generation of a set of potential polymorphs, the reliable ranking of these structures 
using available intermolecular potentials and the identification of the subset of these 
structures within the usual energy window for polymorphism (usually up to 10 kJ m ol1 
above the global energy minimum structure1).
The possible outcomes of crystal structure prediction have been schematically 
summarised in figure 1.10. 9 0  Figure 1.10a shows the most favourable situation where 
the known structure has been found by the crystal structure prediction method and is 
significantly more stable than all other hypothetical structures. It is desirable for the 
known structure to have the lowest lattice energy and to be the densest structure, to
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satisfy the close packing principle. Figure 1.10b shows an outcome where crystal 
structure prediction indicates that there may well be a single thermodynamically more 
stable crystal structure. Figure 1.10c is the most common result of crystal structure 
prediction where the known structure is low in energy, but there are many other distinct 
structures within the same energy window.
Density Density Density
Figure 1.10: Possible crystal structure prediction outcomes; left to right a) ideal 
scenario, with no further low energy structures; b) the known structure may not 
be the thermodynamically most stable; c) the known structure is among a range of 
low energy structures. In all cases the experimental structure is shown in red 9 0
1.9.1 Crystal structure generation methods
A reliable crystal structure generation method has to produce dense crystal structures in 
a range of space groups including all of the common space groups that organic 
molecules crystallise in. The exploration of the crystal packing energy surface has to 
locate as many of the low energy minima as possible, including the true global energy 
minimum. The degrees of freedom that can be varied, for a Z' = 1 system, to produce 
different hypothetical structures include: the unit cell constants, a, b, c, a, p, y, ranging 
from one variable (cubic symmetry) to six (triclinic symmetry); the rotations of the 
molecule within the asymmetric unit, the Eulerian angles; the translations of the 
molecule within the asymmetric unit; the internal degrees of freedom within the 
molecule. 1 15 For molecules without any flexible torsion angles, the assumption that the 
molecular conformation is rigid is commonly employed -  the isolated gas phase 
quantum mechanically optimised molecular structure is usually used as the search input. 
Internal rotational degrees of freedom introduce extra complexity into the crystal 
structure prediction of flexible systems, requiring not only a more expensive search 
procedure to address the extra intramolecular freedom, but also quantification of the
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intramolecular energy differences between conformations to correct the lattice energy 
for the energy required to bring about the conformational differences. 7 5 ’ 1 1 6
Verwer and Leusen have categorised the different methods that have been used
117to generate crystal structures:
• 1. Construction of low energy clusters of 10-50 molecules, which can be viewed 
as the nucleus from which the crystal will eventually grow. The centre of such a 
cluster is assumed to be similar to the final crystal structure. [...]
• 2. Construction of configurations containing 1-10 molecules, related by the 
desired symmetry elements, which are then subjected to lattice symmetry to 
form crystals. [...] non-periodic clusters are generated first [and] translational 
symmetry is introduced to simulate a bulk environment.
• 3. Generation of a large set of crude molecular packings, subject to the desired 
space group symmetry, which are then energy minimised. Periodicity is assumed 
at all stages [...].”
Programs in current use include Polymorph Predictor which uses a simulated annealing 
algorithm, (category 3) , 1 1 5 PROMET which generates small clusters exploiting 
inversion centre, glide, screw symmetry operators which are translated to produce
1 1 Q
crystal structures (category 2), UPACK which uses systematic or random methods to 
vary molecular orientation and unit cell parameters within fixed space groups (category 
3) 1 1 9 and MOLPAK which uses common coordination environments in common space 
groups as the basis for crystal structure generation (category 3) . 1 2 0
1.9.2 International blind tests of crystal structure prediction
On three occasions in the past seven years, 1999, 2001 and 2004, the Cambridge 
Crystallographic Data Centre (CCDC) has organised an international blind test of 
crystal structure prediction, 1 2 1 ' 1 2 3 open to academic groups and commercial companies 
involved in the field. In each blind test an independent referee chose three molecules 
whose crystal structures had been determined, but unreleased. The molecular structures
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were passed to the participating groups and three predictions for each molecule were 
requested. The three structures were chosen to present different degrees of difficulty to 
the CSP algorithms. The degrees of complexity of the three molecules used during the 
first blind test (CSP 1999) were defined to aid participants: 121
“the maximum size of the molecule was restricted to 30 atoms, including hydrogen, and 
the space group was stipulated to be one of the more commonly observed ones with one 
molecule per asymmetric unit, i.e. Z -1.0, although no defined list of allowed space 
groups was provided. It was also specified that submissions should belong to three 
categories of perceived difficulty for prediction:
(i) a small, rigid molecule with only C,H,N,0 atoms allowed and less than 20 atoms
(ii) a small, rigid molecule with some less common elements
(iii) a molecule with some small amount of conformational freedom”
For the second blind test (CSP2001) the number of atoms allowed was increased to 40
122and the flexible molecule test (iii) was increased to two flexible torsion angles. The 
third blind test (CSP2004) lifted the restriction on space groups and allowed Z' = 2 
structures as well as Z' = 1 structures. 1 2 3 In none of the tests were disordered structures, 
co-crystals or solvates included. Comparison of the submitted predictions with the 
experimental structures, which were released upon the expiration of the submission 
deadline, was by coordination sphere overlay, allowing predictions that lay within a 
defined root mean square overlay tolerance of the corresponding experimental structure, 
but in an incorrect space group, to be classified as successful. 1 2 4
The results of the three blind tests are summarised in table 1.2. The overall 
success rate is low, but with more success for the smaller rigid systems. The flexible 
systems, group (iii), showed only one success from a total of 1 1 1  predictions, indicating 
that the CSP methods currently employed cannot thoroughly search the crystal packing 
energy surface when extra degrees of intramolecular freedom are introduced. The 
smallest molecule included in any of the blind tests, the CSP2004 category (i) molecule 
azetidine, was the only test subject used that crystallised with two independent 
molecules in the asymmetric unit, and this was a major contributory factor to the lack of
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success for this molecule. The Z' = 1 limitation is still a very real constraint for CSP
methods -  only 8  of the 18 participating groups explicitly addressed the possibility of
Z' = 2 crystal structures in their structure generation method for azetidine.
The least successful blind test has been the most recent one, CSP2004, and
suggests that the pace of methodological development has not proceeded as fast as the
test subject constraints have been lifted -  indeed the original flexible molecule
constraints as defined in 1999 are still as much of a challenge today. The problems of
thoroughly searching the crystal packing energy surface, ranking the generated
structures using a reliable intermolecular (and potentially intramolecular) potential, and
then choosing which three of the myriad low energy structures to submit are as evident
in the last blind test as the first -  from Gavezzotti’s requirements for successful crystal 
1 1^structure prediction the third step still proves to be the decisive hurdle yet be 
addressed.
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CSP1999 CSP2001 CSP2004
(i) Rigid
0
H
H
H2c ----------c h 2
0
^ 2 ^  1 N r l
Designator I IV VIII XI
Participants/
Success
11/[0/4] * 15/2 15/4 t 18/0
(ii) Atom 
types
H j C ^ /  / \
/ — *  
HjC \ J  /
A  
0  0
0
0
Designator II V IX
Participants/
Success
8/1 15/4 15/1
(iii) Flexible
NH
-L/°/A
0 , N  h , c
_K>0 2 N ---------d  h--------- N H
c h 3
Designator III VI X
Participants/
Success
1 1 / 1 1 1 / 0 15/0
Table 1.2: Summary of results from the three CCDC international blind tests; * 
two polymorphs were characterised -  one was not predicted, while the other was 
predicted by four groups;f molecule was only partially blind
1.10 O utline o f  project o f  study
The aim of using crystal structure prediction to identify the potential motifs present in 
crystal structures, and especially those that pack to give low energy predicted structures, 
and then use this to influence the crystallisation strategy is an important goal for the 
pharmaceutical industry for compounds where only a small amount of material is
• 1 0 ^ *  1 O Aavailable in early development. ’ The studies presented in this work combine 
extensive experimental crystallisation screening to discover new polymorphs of the
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subject molecules in conjunction with crystal structure prediction studies. For each 
molecule studied the low energy predicted structures could be classified according to a 
small range of principal hydrogen bonded synthons, and the experimental structures 
discovered in the course of the crystallisation screens were rationalised in terms of these 
motifs to lead to further understanding of the origin of the polymorphism of these 
molecules.
Two related fluorinated molecules, 5-fluorouracil and 5-fluorocytosine, both 
widely used in medicine, were studied using CSP and manual crystallisation techniques 
(chapters 3 & 4). In each case neither of these molecules was previously known to be 
polymorphic, and both were also chosen because they were capable of forming a range 
of strong hydrogen bonds. CSP studies were carried out on coumarin and its derivatives, 
4-hydroxycoumarin, 7-hydroxycoumarin, 6 -methoxycoumarin (chapter 5), none of 
which were known conclusively to be polymorphic. Coumarins are a class of 
compounds many of which are used as laser dyes, with some having applications as 
pharmaceutical precursors and as fine chemicals. A manual crystallisation screen was 
performed on 4-hydroxycoumarin and an abbreviated screen on 6 -methoxycoumarin. 
The rigid test molecule from CSP2001, 3-azabicyclo[3.3.1]nonane-2,4-dione, was 
subjected to a state-of-the-art automated high throughput crystallisation screen to 
attempt to discover a hydrogen-bonded dimer based polymorph, the possibility of which 
is strongly suggested by the results of the blind test (chapter 6 ). The prevalence of 
hydrates of pharmaceutical molecules led to an investigation into the viability of 
extending the CSP method to predicting the crystal structures of monohydrates using 5- 
azauracil monohydrate as a test system (chapter 7).
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Chapter 2 Experimental and computational methods
2.1 Introduction
This chapter describes the manual experimental polymorph screening undertaken in this 
thesis, along with the analytical techniques used, and the computational crystal structure 
prediction method.
Section 2.2 outlines the manual crystallisation screening methods used in this 
work and provides an introduction to high through-put crystallisation techniques. 
Details of the two manual crystallisation techniques, solvent evaporation and vapour 
diffusion, are given.
Section 2.3 details the analytical methods used during this work including single 
crystal X-ray diffraction, powder X-ray diffraction and simultaneous thermal analysis.
The workflow of the specific crystal structure prediction used in this thesis is 
presented at the beginning of section 2.4 along with an outline of each of the steps in the 
workflow. The principal programs and the intermolecular potential used in the method 
are then presented in greater detail in separate sub-sections.
2.2 C rystallisation screening m ethod
2.2.1 Manual crystal screening
The manual crystallisation screening carried out in this work used solvent evaporation 
and vapour diffusion crystallisation methods, changing the crystallisation conditions by 
varying the solvent. Each crystallisation used between 2-10 ml of solvent in which the 
target compound was dissolved. Crystallisations were controlled to attempt to yield 
single crystals of sufficient size (approximately 0.2 mm ) for single crystal X-ray 
diffraction. The production of single crystals allowed relatively quick determination of 
the unit cell dimensions and full structure determinations were undertaken each time a 
new unit cell was encountered. The weakness in using single crystal X-ray diffraction as 
the principal characterisation method is that only one crystal is checked, but the 
resulting crystal structure may not be representative of the bulk sample. Indeed the 
common practice of choosing the ‘best’ crystal from a sample for structure 
determination may aggravate this weakness: the chosen crystal may be a minor
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crystallisation product, whereas the remaining, more microcrystalline, material may be 
the predominant crystallisation result. To address this weakness, crystals of ‘typical’ 
morphology were chosen whenever possible. The strength of this technique is that only 
one crystal need grow for a full structure determination. X-ray powder diffraction was 
used to characterise all commercially supplied samples and also for cases where single 
crystal X-ray diffraction was unsuitable, such as characterising the products of 
desolvation or where a crystallisation product was microcrystalline. In many 
circumstances, however, insufficient quantities of microcrystalline precipitate were 
produced for analysis by X-ray powder diffraction. Manual crystallisation screens are 
part of the studies presented in chapters 3, 4 and 5.
2.2.2 High throughput polymorph screening techniques
The number of experiments that can set up in a defined period of time, and the number 
of crystallisation products that can be analysed by a single scientist will practically limit 
the range of experiments in a manual crystallisation screen. The advantage of high 
through-put crystallisation methods is that a larger matrix of crystallisation conditions 
can be addressed in the same period of time. Such methods have been developed in the 
pharmaceutical industry on a micro scale, usually because in the development phase of a 
drug substance a very limited quantity is available for solid form screening. At the same 
time the screen must identify as many forms as possible in order to advance the optimal 
form to the clinical stage of development and as a consequence of this constraint on the 
quantity of crystallised sample, the ‘gold standard’ of phase identification, powder X- 
ray diffraction, 2 8  is unsuitable and Raman spectroscopy is more commonly employed. 
Upon identification of distinct forms, the crystallisation is scaled up from the micro 
scale to give a sufficient quantity of each form for full phase characterisation by X-ray 
powder diffraction, thermal methods and optical microscopy. Another consideration 
specific to automated screening is that the data generated from the increased matrix of 
crystallisations requires more powerful correlation and analysis techniques, usually 
requiring a custom designed computer database. 3 3 ’5 8  Several proof-of-concept studies 
have been published, applying high through-put screening to a small number of high
1 7 7  “2 ”^  C7profile APIs: paracetamol, carbemazepine and ritonavir. Each of these screens 
found at least all of the known forms of the API targeted plus either difficult to
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characterise forms (paracetamol) or new forms (carbemazepine and ritonavir). Chapter 
6  details the application of a high through-put crystallisation screen, and the specific 
method is described therein.
2.2.3 Solvent evaporation
Crystallisation through solvent evaporation (EV) from a saturated solution is a common 
method used to grow crystals. A solvent containing the target compound in solution is 
placed in a crystallisation vessel and the solvent is allowed to evaporate steadily through 
the top of the open vessel. As solvent evaporates the solute is forced out of solution and 
crystallisation occurs (figure 2.1). The rate of evaporation of volatile solvents can 
controlled using a pierced lid to slow the rate of solvent evaporation and this control 
generally leads to fewer, larger crystals as the crystallisation product.
Figure 2.1: Solvent evaporation. Upon evaporation of solvent the solution becomes 
supersaturated, followed by crystallisation
Super-saturated solutions are more likely to lead to a kinetic crystallisation product -  
once a crystalline phase nucleates this phase will grow out rapidly relieving the super­
saturation. Equilibration between solution and crystalline phase is not reached so there 
is less opportunity for phase changes to give successively more stable phases. 
Conversely sub-saturated solutions are more likely to lead to the thermodynamic 
crystalline form, as the slower crystallisation provides more opportunity to 
accommodate a series of phase changes via solution mediated phase tranformations.
Saturated solutions were made by standing solvent over an excess of the target 
compound for 24-48 hours followed by filtration. Sub-saturated solutions were made by 
diluting filtered saturated solutions with the appropriate amount of fresh solvent to give 
25% and 50% saturated solutions. With all crystallisation methods the possibility of 
unintentional seeding, with either foreign particles or seeds of a known form of the
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target molecule, must be addressed because of its potential to suppress polymorphism. 
In an attempt to remove all seeds, solutions were filtered through fine grained 
compacted Celite clay prior to use in crystallisations. In this work two different types of 
flat-bottomed straight-sided sample tubes were used for solvent evaporation. These 
sample tubes could be sealed with snap-on plastic lids. The large sample tubes (LCO) 
were 25 mm in diameter, 75 mm in height and could contain a maximum volume of 
32.5 ml. The smaller sample tubes (SCO) were 15 mm in diameter, 50 mm in height and 
could contain up to 5 ml of solvent. All crystallisations were set up in virgin glassware 
to prevent possible cross-contamination that could occur with the use of washed vials.
2.2.4 Vapour diffusion
In crystallisation by vapour diffusion (VD) a saturated solution of the target compound 
is placed in a small open vial, which is placed upright in a larger closed vial in which a 
small quantity of anti-solvent has been added. The outer vial is sealed to produce a 
closed system in which anti-solvent diffuses into the inner vial and solvent diffuses 
from the inner vial (figure 2 .2 ).
Figure 2.2: Vapour diffusion. Anti-solvent diffuses into the inner vial and solvent 
counter-diffuses out of the inner vial
The anti-solvent is required be more volatile than the solvent, to give a net increase in 
the amount of solvent in the inner vial. When the solvent/anti-solvent mixture in the 
inner vial reaches the point where it can no longer contain all of the solute, 
crystallisation occurs. The solvent must initially be saturated, otherwise the vapour 
diffusion may not induce crystallisation. If crystallisation occurs late in the diffusion 
process, it could be either solvent/solute or anti-solvent/solute interactions that are 
predominant, which could potentially influence the polymorph produced. An advantage
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of this crystallisation method is that the crystals are grown in an increasing volume of 
solvent, usually yielding better quality crystals than solvent evaporation. Both the 
solvent and the anti-solvent can be varied, as long as they have the correct relative 
volatilities and miscibilities.
In this work vapour diffusions were carried out using SCO vials as the inner vial 
and LCO vials as the outer, closed vial. The choice of anti-solvent was dictated by 
initial solubility tests and solvent volatility considerations.
2.2.5 Solvent range
For each of the three manual screens a core range of 26 solvents were used (table 2.1). 
For each individual screen further solvents were also included, depending on their 
availability at the time of the screen. In total 51 different solvents were used in at least 
one manual screen. Of these 26 solvents 20 were included within the 67 solvents used in 
the high through-put screen described in chapter 6 . This solvent range samples alcohols, 
saturated and aromatic hydrocarbons, chlorinated and fluorinated solvents, solvents 
containing oxygen in ketone, ether and ester functional groups, solvents containing 
nitrogen in cyano, amido and nitro functional groups as well as those with distinct 
properties such as water and dimethylsulfoxide. A range of solvent polarities is 
sampled. The solubility of each target molecule in each solvent was tested, and those 
solvents in which it was insoluble were discounted and the remaining solvents used in 
the crystallisation screen.
Solvents
2,2,2-T rifluoroethanol Chloroform Methylbenzoate*
1,2-Dichloroethane Cyclohexane n-hexane
1,4-Dioxane Dichloromethane* Nitromethane
2-Butanol Diethylether* o-xylene
2-Chloroethanol* Dimethylformamide T etrachloroethylene*
2-Propanol Dimethylsulfoxide Tetrahydrofuran
Acetone Ethanol Toluene
Acetonitrile Ethylacetate Water
Benzonitrile* Methanol
Table 2.1: The core range of 26 solvents used in all three manual crystallisation 
screens. * not included in the high through put screen solvent range
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2.3 Analytical techniques
2.3.1 Single crystal X-ray diffraction
Single crystal X-ray diffraction (SXRD) data were collected on a Bruker AXS SMART 
APEX diffractometer with a charge coupled device (CCD) detector. The X-ray source 
was a molybdenum anode, Mo Ka X = 0.71073 A, with a graphite monochromator. The 
diffractometer was fitted with a Bruker AXS Kryoflex open flow cryostat. Unit cell 
determinations and data sets were collected at either 298 K or 150 K. The Bruker 
SMART1 2 8 diffraction suite was used to control data collection. Data for unit cell 
determination were generated by taking 20, 30, or 50 frames with 5, 10 or 20 second 
exposures at three separate crystal orientations, scanning co in 0.3° steps. A full sphere 
of data was collected for all crystal structure determinations. The data was integrated 
using the software package SAINT+ 1 2 9  and a semi-empirical absorption correction 
applied using SADABS. 1 3 0 Structure solution by direct methods and subsequent 
structural refinement were carried out using the SHELXTL suite. Full matrix least 
squares refinements were based on F . Friedel opposites were not merged for structures 
where the space group contained an inversion centre, but were merged for structures in 
non-centrosymmetric space groups (light-atom structures). All non-hydrogen atom 
positions were refined anisotropically. Hydrogen positions were usually found from the 
electron density map and freely refined. In some circumstances methyl hydrogens were 
placed on the carbon atom using a rigid rotor model and refined using a riding model. 
At the end of the refinement process the maximum shift/parameter ratio was less than 
0.001. The final electron density map was usually featureless with a maximum electron 
density of less than 0.5 e A'3. Tables are provided at the end of each chapter 
summarising the crystal structure determinations presented in that chapter.
131In this work, asymmetric unit figures were produced using the SHELXTL 
package, with thermal ellipsoids for all non-hydrogen atoms plotted at the 50% 
probability level, and hydrogen atoms shown as spheres of arbitrary radius. Where 
hydrogen bonds (O-H- O, N-H—O, N-H—N) occur in the asymmetric unit they are 
shown as solid dashed lines. Figures showing crystal packing were produced using
1 'X'y 1 3 3either Mercury (wireframe and overlay figures) or CAMERON (ball-and-stick 
figures). In all crystal packing figures hydrogen bonds are shown as dotted lines.
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2.3.2 X-ray powder diffraction
X-ray powder diffraction (XRPD) data were collected on a Siemens D500 
diffractometer, in a 0-20 Bragg-Brentano geometry. The X-ray source was a copper 
anode, Cu Ka X = 1.54056 A, with a quartz pre-sample monochromator. Samples were 
mounted on a silicon monolith, cut slightly offset from the 1 1 1  plane to give zero 
background, in either a 0.3mm recess, or no recess. Samples were rotated in the X-ray 
beam to improve counting statistics. A typical scan measured from 5-40° in 20, with
0.05° stepping and 10 seconds exposure per step.
Two crystal structures determined from capillary XRPD data, by Dr. P. 
Fernandes and Dr. A. J. Florence (Strathclyde University), are presented in Chapter 6 , 
and the general method used is described therein.
2.3.3 Simultaneous thermal analysis
Simultaneous thermal analysis (STA) comprising combined differential scanning 
calorimetry (DSC) and thermogravimetric analysis (TGA) was carried out using a 
Netzsch STA 449-C Jupiter instrument. Samples were placed in open or pierced-lid 10 
pi aluminium pans and heated from room temperature until melting or decomposition, 
at 10 K min'1. All samples were heated under a flow of nitrogen at 10 ml min"1.
2.4 Crystal structure prediction method
2.4.1 The MOLPAK-DMAREL crystal structure prediction workflow
The MOLPAK1 3 4-DMAREL1 3 5 crystal structure prediction method used in this thesis 
can be summarised in seven steps (scheme 2.1). This methodology refers to the case 
where at least one crystal structure is already available to use as a basis for the crystal 
structure prediction, but where no crystal structure is available energy minimisation of 
experimental crystal structures can be carried out upon their discovery.
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CSP workflow Programs
5. Analysis to ensure all structures have 
energy minimised to a true minimum
Analysis
DMAREL
6. Clustering of duplicate structures to give energy 
landscape of thermodynamically feasible structures
Cluster
1. Energy minimisation of known crystal structure 
using experimental molecular conformation
DMAREL + GDMA
2. Ab initio optimisation of molecular conformation Gaussian03
4. Generation and energy minimisation 
of possible crystal structures
MOLPAK
DMAREL
3. Energy minimisation of known crystal structure 
using ab initio molecular conformation
OptimalPaste 
DMAREL + GDMA
7. Comparison of predicted structures with 
experimental structure(s)
Mercury
PLUTO
Scheme 2.1: Crystal structure prediction workflow and programs used at each step
1. Energy minimisation of known crystal structure using experimental molecular 
conformation (ExptMinExpt)
Initially the experimental crystal structure, containing the experimental molecular 
conformation from this crystal structure, is lattice energy minimised using DMAREL 
(section 2.4.1) . 1 3 5 Prior to energy minimisation, the bond lengths to hydrogen atoms in 
the crystal structure are standardised to counteract the foreshortening introduced during 
structure determination by single crystal X-ray diffraction. Bonds to hydrogen are
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standardised to average values derived from neutron data136: C-H = 1.08 A; N-H =1.01 
A; O-H = 0.97 A. The intermolecular potential used for this step comprises a distributed 
multipole electrostatic model (section 2.4.3), analysing the MP2/6-31G(d,p) charge 
density, unless otherwise specified, and the FIT dispersion-repulsion potential (section
2.4.4). The result of this step is the energy minimised structure using the experimental 
molecular conformation -  the ExptMinExpt structure. This step tests the accuracy with 
which the intermolecular potential reproduces the experimental crystal structure.
2. Ab initio optimisation of molecular conformation
The second step is the ab initio optimisation of the molecular conformation from the 
experimental crystal structure to obtain the energy minimised gas phase molecular 
conformation. This molecular conformation is used as the search input because using an 
experimental molecular conformation from a known polymorph could unfairly bias the 
search results in favour of that polymorph to the detriment of other potential (or real) 
polymorphs. The optimisation is performed using the quantum mechanics package
1 T7Gaussian03, using the 6-31G(d,p) basis set and MP2 level calculations (section
2.4.5).
3. Energy minimisation of known crystal structure using ab initio molecular 
conformation (ExptMinOpt)
The third step is closely analogous to the first step, but with ab initio optimised 
molecular conformation pasted into the experimental crystal structure in place of the 
experimental molecular conformation. The computer program OptimalPaste1 3 8  
substitutes the ab initio optimised conformation for the experimental conformation in 
the crystal structure by minimising the root mean square discrepancy between all 
corresponding non-hydrogen atomic positions of one molecule. This crystal structure is 
energy minimised to give the ExptMinOpt structure. Due to the use of the optimised 
molecular conformation, the reproduction of the experimental crystal structure in this 
step is generally inferior to that of the first step as it ignores any genuine effect of 
crystal packing on the molecular conformation. However the difference should not be 
large if the rigid body approximation is appropriate, and the reproduction should be 
within the usual tolerance of under 5% error in the cell parameters. This step tests the
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ability of the potential to reproduce the crystal structure, using the ab initio optimised 
molecular structure. It allows direct comparison of the resultant ExptMinOpt version of 
the experimental structure with the hypothetical crystal structures generated in step 4. 
The ExptMinOpt structure is the closest that any predicted structure can come to 
reproducing the experimental structure. It should be noted that while MOLPAK limits 
the CSP procedure to only generating structures with Z' = 1, DMAREL does not have 
this limitation and experimental structures can be lattice energy minimised regardless of 
the number of symmetry independent molecules.
4. Generation and energy minimisation of possible crystal structures
The fourth step is the computational crystal structure search procedure, using the 
program MOLPAK (section 2.4.6) . 1 3 4 This program uses predefined packing types in a 
range of the most common space groups, but with a Z' = 1 limitation, to generate 
hypothetical crystal structures for organic molecules. The ab initio optimised molecular 
conformation is input and different packing arrangements are used to define the relative 
positions of the molecules. A systematic search places different molecular orientations 
in these packing arrangements to generate dense crystal structures by condensation 
using a pseudo-hard sphere repulsion potential. This produces the initial hypothetical 
crystal structures. For each packing type up to 200 of the most dense structures are 
passed to DMAREL for full energy minimisation, with its more sophisticated 
intermolecular potential.
5. Analysis to ensure all structures have energy minimised to a true minimum
The fifth step is the analysis of the hypothetical crystal structures generated to ensure 
that all structures have reached a true energy minimum. Any structure that energy 
minimises to a saddle point rather than a true minimum in its initial space group is re­
minimised without the symmetry element that led to the saddle point, producing a 
structure in a sub-group of the original space group with two molecules in the
1 T8asymmetric unit. This procedure is carried out by the program Analysis and it is 
usually defined that up to two symmetry operators can be removed serially for each 
saddle point structure. This leads to a small number of Z' = 2 structures being present in
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the search results. Reduced cell parameters1 3 9 are then calculated for each structure and 
they are ranked according to lattice energy.
6. Clustering of duplicate structures to give energy landscape of thermodynamically 
feasible structures
The sixth step is to cluster duplicate predicted structures -  each minimum on the crystal 
packing surface may be reached by DMAREL minimisation of more than one of the 
MOLPAK generated structures, and these duplicate structures must be discarded to 
leave only the lowest energy example of each of these clusters. The program Cluster1 3 8  
uses both peak profile matching of simulated powder patterns1 4 0  and the co-ordination 
environment1 2 4 around a central molecule in each structure to find hypothetical crystal 
structures that are effectively equivalent. The co-ordination environment comparison 
commonly used the 18 molecules with centres of mass closest to the central molecule. 
All of the distinct structures are ranked according to their lattice energy and volume and 
the dense, low energy structures are regarded as those most likely to correspond to 
experimental polymorphs. These structures are usually plotted on a scatter graph of 
lattice energy against cell volume per molecule (density) to give the crystal energy 
landscape.
7. Comparison of low energy structures with experimental structure
The accuracy with which the experimental crystal structure is reproduced by the 
ExptMinExpt and ExptMinOpt energy minimisations can be quantified by calculation 
of the F-value, which takes into account the differences introduced in the cell 
parameters, and molecular positions and orientations (section 2.4.7).
The ExptMinOpt energy minimised crystal structure is the only version of the 
experimental crystal structure that can be directly compared with the hypothetical 
structures generated by the CSP search because it has been energy minimised using the 
same intermolecular potential and with the same molecular conformation as that used in 
the search. The ExptMinOpt structure can be compared to computed structures using the 
visualisation program Mercury, 1 3 2 which has a structure overlay function. Graph sets for 
all low energy generated structures and discovered polymorphs were calculated using 
PLUTO. 141
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2.4.2 Energy minimisation by DMAREL135
DMAREL is used for energy minimisation of both MOLPAK-generated and 
experimental crystal structures, using the FIT dispersion-repulsion potential and 
electrostatic distributed multipole analysis of the charge density calculated by Gaussian. 
For a crystal structure the parameters that are varied in the process of arriving at an 
energy minimum are three translational and three rotational components for each 
molecule in the unit cell plus six strain vectors to describe the changes in the cell 
dimensions. The energy is minimised as a function of these 6 Z+ 6  where Z is the number 
of molecules in the unit cell. 1 3 5 No kinetic energy factors are calculated such as zero- 
point energy or lattice vibrational effects, meaning that the energy surface upon which 
the energy of the crystal structure is calculated is a ‘0 K surface with neglect of zero-
, 142point energy .
An iterative procedure using a modified Newton-Raphson method is used for the 
energy minimisation. An unmodified Newton-Raphson calculation has the form:
S , = - t l (W-')vGJ
j
where <2, is the step direction, G is the initial position first derivative vector and W is the 
second derivative matrix (Hessian) . 1 4 3 The second derivative matrix, the second partial 
derivative of the internal energy with respect to each pair of variables, defines whether 
the point is a saddle point or a true minimum:
W = - ^ —
’ Sq.dq,
70where qj and qj are variables that the minimisation is being carried out with respect to.
Each iteration of the minimisation includes a choice of the step direction and the 
size of that step. The step direction is provided by the Newton-Raphson equation: G is 
the gradient vector that includes the partial derivative of the lattice energy with respect 
to all coordinates of a point and gives the direction of greatest downward slope. 1 4 4 A 
series of line searches are carried out to find the optimal step size in the direction <2,, 
though a user-defined maximum step size is imposed to prevent the step from taking the
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minimisation beyond the region in which the second order Taylor expansion, upon 
which the Newton-Raphson method is based, is valid. 1 4 5
Energy minimisations are carried out with space group constraints imposed. If 
the eigenvalues calculated from the components of the Hessian matrix are all positive 
then the point is a true minimum. If one of the eigenvalues is negative then the point is a 
transition state, a saddle point, and the eigenvector corresponding to this eigenvalue will
70lead the minimisation procedure to a true minimum. In the case of a saddle point 
minimisation result a lower symmetry sub-group will have a lower energy, and the 
minimisation can be repeated with the symmetry operator corresponding to the most 
negative eigenvalue removed. This will increase the number of molecules in the 
asymmetric unit by a factor of two for each symmetry operator removed.
The atom-atom approximation is used to sum the interaction energy for each 
pair of molecules and pairwise additivity approximation is used to sum of these two 
molecule interactions over all of the molecules in the crystal. The lattice energy could 
be summed for each molecule with every other molecule in the crystal structure, 
however this would be computationally expensive, and therefore summation limits are 
employed. Charge-charge (R 1), charge-dipole (R'2) and dipole-dipole (R'3) electrostatic 
terms converge slowly and a direct cutoff would not give reliable result. Consequently 
for these terms the Ewald accelerated summation technique is used . 1 4 6 ,1 4 7  The higher 
multipole terms of the electrostatic interactions converge more rapidly and are cut off 
using a direct cutoff at 15 A. The 15 A limit refers to the maximum distance between 
the centres of mass of two molecules and all of the site-site interactions in molecules
135within this distance are calculated, regardless of the actual site-site separation. 
Dispersion-repulsion terms are summed with a direct cutoff of 15 A between atoms.
2.4.3 Calculation of distributed multipoles using GDMA88
GDMA derives a series of point multipoles to represent the charge distribution around 
the molecule, from the wavefimction calculated using ab initio methods. Atomic 
multipoles are particularly useful for the modelling of electrostatic effects such as 
hydrogen bonding and n-n interactions, 8 9  producing a more accurate electrostatic model 
than potential derived nuclear point charges for a slight increase in computational 
expense.
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GDMA calculates the distributed multipoles directly from the wavefimction of the 
molecule -  with only the exponents of the gaussian functions in the basis set used and 
the nuclear charges and positions required. The products of the primitive gaussian 
functions that comprise the basis set are calculated, with the product of two gaussians a 
further gaussian function for the overlap of the two functions. The charge density, x¥*x¥, 
can be expressed in terms of these gaussian products. A multipole expansion about the 
point of overlap of two gaussians can be calculated exactly and then moved to a nearest 
chosen site and incorporated into a multipole expansion at this site.88 The distributed 
multipoles are calculated at nuclear sites and are calculated up to hexadecapole. Nuclear 
sites are generally sufficient to ensure good convergence of the electrostatic potential 
and interaction energies, as calculated from the distributed multipole analysis.
Multipole expansions do not give a correct potential inside the charge 
distribution, because they neglect penetration effects.88 They also exhibit basis set 
dependence: a particular part of a wavefunction may be described by basis functions on 
different atoms between different basis sets, leading to differences in how the
QO
electrostatic potential is modelled using multipoles. However this is not seen as a 
particularly important effect because outside the molecule the electrostatic potential 
should only vary with the quality of the wavefunction used, provided the expansion is 
converged.
2.4.4 The FIT dispersion-repulsion potential
The dispersion and repulsion terms for each atomic type are modelled together, using an 
empirical method and, unlike the electrostatic model which is not transferable and must 
be generated specifically for each different molecule, they are assumed to be 
transferable for each atomic type. The Buckingham potential form, used by DMAREL 
to model the dispersion and repulsion contributions to the intermolecular potential, 
combines an exponential-based repulsive term with the London dispersion term.
During the 1970s and 1980s, Williams and co-workers produced a consistent set 
of values for the homoatomic Buckingham parameters for a number of elements, 
deriving the Buckingham parameters for each by optimisation against a range of 
experimental crystal structures. The isotropic atom-atom approximation was employed,
1ARwhere the molecule is assumed to be an overlay of spherical atoms, and the
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interactions between two molecules were assumed to be equal to the sum of the 
interactions between each atom in the first molecule with each of the atoms in the 
second molecule. This allowed the parameters for each atomic type to be transferable.
77*78 77*78 70Optimised parameters were generated for carbon, ’ hydrogen, ’ oxygen,
78 80 81nitrogen, fluorine and chlorine. Their method employed the general expression for 
the intermolecular potential:
= A„ exP(-BIKr:t) - C lKr^  + qiqkr~1
where i is an atom of type i on one molecule, k is an atom of type k  on a second 
molecule and r  is the distance between atoms i and k  and where the three parameters A, 
B, and C were those to be derived for each atomic type. The modelling of the 
electrostatic term for each molecule used nuclear-site, extended-site or bond-site 
potential derived point charges. The extended- and bond- site models were used when 
the nuclear site point potential derived point charge model did not give a satisfactory 
representation of the electrostatic potential. It should be noted that while the functional 
form of the Buckingham potential principally models the dispersion and repulsion, the 
empirical fitting partially absorbs other effects (such as exchange and polarisation) and 
differences between the true charge density and the electrostatic model.
For each atomic type a range of crystal structures was chosen as a training set 
against which the Buckingham potential parameters were optimised for that atomic 
type. Initially parameters for carbon and hydrogen were developed,77 by optimising the 
A and C parameters, while fixing the B parameter for both atomic types to values 
obtained from previous work using different methods. Once C and H parameters were 
derived they were held constant for optimisation of the parameters for oxygen,79
• 78 80 81nitrogen, fluorine and chlorine. The carbon and hydrogen A and C parameters were 
slightly reparameterised at the same time as the nitrogen parameters were derived.78 For 
each atomic type the homoatomic parameters were calculated and the heteroatomic 
cross terms were calculated using the well-known geometric combining rules (section 
1.8.3). Uncertainty in the validity of the calculated heteroatomic values led, in two 
chapters, to further validation for specific cases -  for fluorine (chapter 3) and for the 
interactions of water with organic molecules (chapter 7).
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The structures in the training sets were chosen so that they did not include hydrogen 
bonding, to minimise the effect of the electrostatic term and maximise the effect of the 
dispersion-repulsion terms on the experimental crystal structures. Carbon and hydrogen 
were originally parameterised against the crystal structures of a small number of 
hydrocarbons, and then slightly reparameterised during the nitrogen parameter 
development; parameters for oxygen were found from the crystal structures of P- 
oxygen, carbon dioxide, trioxane, tetraoxocane and succinic anhydride; nitrogen 
parameters were developed against a-nitrogen and aza- and cyano- containing 
hydrocarbons and fluorine against a small range of perfluorocarbon crystal structures. 
Williams only produced terms for non-polar hydrogen atoms attached to carbon (and 
hereafter denoted non-polar, Hnp). A separate model was desirable for polar hydrogen 
atoms, those attached to oxygen and nitrogen. Coombes et al.82 further optimised 
Williams’ hydrogen parameters against the crystal structures of a range of N-H 
containing molecules to produce optimised parameters for polar hydrogens (Hp). An 
SCF DMA electrostatic model was used. Williams’ optimised parameters for carbon, 
non-polar hydrogen, nitrogen, oxygen, along with Coombes’ polar hydrogen 
parameters, are used with the Buckingham potential as the dispersion-repulsion model 
for DMAREL, and known as the FIT potential. These parameterisations were each 
based on a limited number of crystal structures and sample each atomic type in a limited 
number of environments. The environment around a particular atom in a particular 
crystal structure may be very different to the average environment sampled during the 
empirical parameterisation for that atomic type, potentially causing this particular atom 
to be poorly represented by the dispersion-repulsion parameters optimised for its 
generic atomic type.
2.4.5 Calculation of molecular wavefunctions and ab initio optimisations of 
molecular structures
The program Gaussian (98 or 03)137 is used for two tasks in the CSP method: it is used 
to calculate the wavefunction and charge density of the molecule prior to calculation of 
the distributed multipoles, and it is used to produce the ab initio gas phase optimised 
molecular conformation, usually starting from the molecular conformation from a 
known crystal structure, by minimising the total energy of the conformation.
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In this thesis both tasks were always carried out using the 6-31G(d,p) basis set and 
using, for the most part, MP2 (Moller-Plesset 2nd order) level calculations. This is a 
split-valence double-zeta basis set, with two basis functions representing each valence 
orbital, but only a single basis function represents each core orbital. The 6-31G(d,p) 
basis sets represents the core Is atomic orbitals of second row atoms with a contracted 
basis function made up of a fixed linear combination of 6 primitive Gaussian functions. 
The valence 2s and 2p atomic orbitals are represented by two basis functions -  the inner 
part of each valence orbital is represented by a contraction of 3 primitive Gaussian 
functions and the outer part of the orbital by a single Gaussian function. This basis set 
includes d-type polarisation on non-hydrogen atoms and p-type polarisation on 
hydrogen atoms.145
MP2 calculations provide a correction to the corresponding Hartree-Fock self- 
consistent field (HF-SCF) calculation to account for electron correlation effects. The 
MP2 level calculation provides an extra term to the Hartree-Fock term to better 
approach the true electronic energy.144
2.4.6 Crystal structure generation by MOLPAK134
The MOLPAK method for generation of crystal structures is based on the observation 
by Kitaigorodsky149 that all organic molecules show close packing in their crystal 
structures. He defined the packing coefficient as the ratio of the molecular volume to the 
unit cell volume per molecule.149 It has been noted that virtually all crystal structures of 
organic molecules have a packing coefficient between 0.65 and 0.75, close to the hard 
sphere packing coefficient of 0.74.150
MOLPAK uses a rigid molecular conformation, most usually the ab initio 
optimised conformation, as the input for the generation of hypothetical crystal 
structures. This is known as the rigid body approximation, and while it is not significant 
for molecules that do not have degrees of torsional freedom, it is a limitation for flexible 
molecules, where a series of molecular conformations must be used as the input for 
separate MOLPAK searches to compensate.116 MOLPAK is also limited to producing 
structures with only one molecule in the asymmetric unit. The symmetry operations 
used to generate hypothetical crystal structures are: inversion through a point; mirror 
plane; glide plane; two-fold rotation axis and two-fold screw axis. A central molecule is
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taken and the application of the symmetry operations of a space group is used, along 
with a simple repulsion potential, to generate a crystal structure. Most of the space 
groups employed in MOLPAK can generate more than one arrangement of molecules in 
the coordination sphere around a single molecule, and for these space groups more than 
one packing type is defined. The process for building the crystal structure in a packing 
type can be summarised:
• 1. A molecule is placed in an orthogonal axis system and a second molecule is 
placed on axis-1 an arbitrary distance from the central molecule. The distance 
between the central molecule and this neighbour is reduced until the repulsion 
potential dictates that the molecules are as close as they can be without incurring 
significant repulsion. This intermolecular separation is applied to produce a row 
of translationally related molecules.
• 2. A second row, identical to the first, is placed in the axis-1 /axis-2 plane 
parallel to the first row, and moved towards it until a similar repulsion criterion 
is met. In the case of packing types in triclinic and monoclinic space groups, the 
two rows are moved parallel to one another (parallel to axis-1) until the 
repulsion is minimised. For orthorhombic space groups the relation of the first 
row to the second is fixed by the space group and only the separation of the two 
rows is determined by the repulsion potential. A plane is produced from this 
condensation of rows of molecules.
• 3. Step 3 is the three-dimensional analogue of the first two steps: a second plane 
is generated parallel to the first plane and moved towards the first plane, in the 
direction of axis-3 until the repulsion criterion is again met. For triclinic space 
groups the relative positioning of the planes with respect to axis-1 and axis-2 is 
varied until the repulsion is minimised. In this case for both monoclinic and 
orthorhombic space groups the relative positioning of the two planes is dictated 
by the space group symmetry and only the separation of the planes need be 
determined.
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The intermolecular potential used is a pseudo-hard sphere potential using the atom-atom 
pairwise approximation. The level of restriction of positioning of packing units (for 
example 2 generated planes) depends on the number of symmetry operators in the space 
group. This was explained by Holden and Ammon134 “For monoclinic and 
orthorhombic space groups, the positions of the molecules of the 2D grid, relative to its 
intersection with axis-3 [adjacent 2D grids] are restricted, and procedure 3 determines 
only the length of a unit cell axis. However for the two triclinic space groups the grid 
must be shifted in both the axis-1 and axis-2 directions to determine two angles in 
addition to the length of an axis.” Hence if the packing units are not restricted by 
symmetry operations, then their positioning has one (step 2) or two (step 3) extra 
degrees of freedom associated and this positioning is dictated solely by the repulsion 
potential.
Different orientations of the molecules with respect to the global co-ordinate 
system are systematically sampled. The rigid molecular probe is used in different 
orientations in different iterations in each packing type, by varying the Euler angles in 
10° steps over a 180° range around each of the three axes. 5 to 10 of the most densely 
packed volume arrangements are subjected to a more detailed search over a ±10° 
Eulerian range, with a 2° step size.
Two different MOLPAK searches were used in this thesis: the standard search 
used 37 packing types covering the most common 18 space groups with the 125 most 
dense structures from each packing type passed to DMAREL for further energy 
minimisation; the extended search used 47 packing types covering the most common 22 
space groups and passed the 200 most dense structures in each packing type to 
DMAREL.
2.4.7 Comparison of experimental and energy minimised structures
All polymorphs of the target compound known prior to a crystal structure prediction 
search, or found during subsequent crystallisation screening, had to be energy 
minimised using the same potential and molecular conformation as that used in the 
search, to give the ExptMinOpt energy minimised structure, as this allows direct 
comparison between the predicted structures and the ExptMinOpt energy minimised 
experimental structure.
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The reproduction of the experimental crystal structure by its ExptMinExpt or 
ExptMinOpt energy minimised structures is quantified by the calculation of the F- 
value:151
F = (A 0/2)2 + (10Ax)2 +(100Atf/a)2 +(100A b ib )2 +(100Ac/c)2 + A a 2 +Aj32 +A y 2
where AO is the rotational displacement of the rigid molecule after minimisation (°), Ax 
is the translational displacement (A) and the remaining terms are the changes in the cell 
parameters (A and °). The multiplication factors in the first five terms bring the errors 
onto a comparable scale.152 This so-called ‘figure-of-shame’ quantifies the accuracy of 
the reproduction of the crystal structure by the intermolecular potential and the 
approximations applied in the method. For comparisons between experimental and 
ExptMinOpt structures this also includes variation due to the modified molecular 
conformation used. As a guide, an ExptMinOpt structure with an F-value under 
approximately 50 and with all cell parameters reproduced to within 5% is viewed as a 
successful energy minimisation.
Qualitative comparison of the ExptMinOpt version of the experimental structure 
with the experimental structure or with structures generated by the CSP search can be
1 'X'Jmade using the root mean square overlay function in Mercury, which allows the user 
to define the atoms or molecules upon which to match the two structures. PLUTO141 can 
be used to calculate graph sets for both experimental and hypothetical crystal structures, 
and the user can define which hydrogen bond types are included in the calculation and 
the distance and angle criteria for these hydrogen bonds.
2.5 Supporting inform ation
The compact disc that accompanies this thesis contains all supporting information. This 
includes detailed results for all experimental crystallisation screens, summaries of all 
crystal structure predictions carried out, and crystallographic information files (.cif) and 
a summary of crystallisation conditions for all newly determined crystal structures.
Chapter 3 5-Fluorouracil
3.1 Introduction
3.1.1 Historical and medicinal background
5-Fluorouracil (5-fluoropyrimidine-2,4-dione, 5FU, figure 3.1) was originally
1synthesised in 1957 specifically because it was thought to be a potential anti-cancer 
agent, based on observations that cancerous tissue incorporates the nucleobase uracil 
faster than non-malignant tissue and it was thought that the fluorinated analogue could 
have an inhibitory effect.154 Preliminary studies in rats and mice proved this supposition 
correct.155 5FU has been shown to have both DNA and RNA modes of action.156 In 
DNA it inhibits the thymidylate enzyme that readies thymine for DNA incorporation, 
and can be incorporated itself into DNA in place of thymine. In RNA, 5FU substitution 
for uracil leads to both enzyme inhibition and changes in protein expression. In the 
intervening 50 years since its discovery 5FU has become widely used to treat a range of 
solid tumours,157 usually in combination therapies with other anti-cancer 
pharmaceuticals or ionising radiation.156 As a side-effect 5FU is known to be a powerful 
immunosuppressant.158
0 7
Figure 3.1: Chemical structure of 5-fluorouracil (5FU) with its crystallographic 
numbering scheme
3.1.2 Previously published crystal structures
The CSD contains one crystal structure of 5FU (FURACL159) hereafter referred to as 
form 1. Form 1 crystallises in the triclinic space group P 1, and unusually it contains
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four molecules in the asymmetric unit. An analysis160 of Z' > 1 structures in the CSD in 
2001 found that only 600 structures were reported to have Z' = 4, though this may be an 
under-representation of its true occurrence in nature. The unit cell of form 1 was 
originally reported in an unconventional setting with p = 43.9(3)°. The unit cell and the 
conventional setting are summarised in table 3.1.
5-Fluorouracil Form 1159 Conventional unit cell
Empirical formula C4 H3 N2 O2 F
Crystal system Triclinic Triclinic
Space group P i PI
a, b, c (A) 9.22(3), 12.66(3), 12.67(3) 8.79(5), 9.22(3), 12.66(3)
a, Pi Y (°) 89.7(3), 43.9(3), 98.6(3) 98.6(3), 99.5(5), 89.4(4)
V (A3) 998 998
z \ z 4 ,8 4 ,8
Table 3.1: Unit cell parameters for the published structure of 5FU form 1. The 
conventional unit cell was calculated using PLATON139
The form 1 crystal structure is also unusual in that it contains four fluorine atoms in 
close proximity forming a tetramer (figure 3.2). Each of the four close F—F 
intermolecular distances are less than 3.2 A, which when compared to the van der Waals 
radius of fluorine 1.47 A,97 suggests that the fluorine atoms are almost in van der Waals 
contact. All four crystallographically independent molecules are present in the tetramer 
unit. Interactions involving fluorine, such as F—F, C-H - F and C-F"-7i are not 
commonly used as structure directing synthons in crystal engineering as they are very 
weak, and are easily overwhelmed by stronger interactions, though it has been noted 
that these interactions can act in a stabilising supporting role.161’162 In the crystal 
structure each 5FU molecule forms a R 2(8) hydrogen bonded ring comprised of two N- 
H *0 hydrogen bonds and two single N - H - 0  hydrogen bonds. These hydrogen bonds 
produce a hydrogen bonded sheet with no strong interactions between adjacent sheets. 
Each sheet is comprised of three different hydrogen bonded rings: the R ^ )  
association, a R ^ lb ) ring and a Rjj(40) ring with the F—F tetramer at its centre (figure 
3.2).
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Figure 3.2: Hydrogen bonded sheet present in 5FU form 1. The F—F tetramer and 
the three different hydrogen bonded rings can be observed
The crystal structures of several co-crystals containing 5FU have also been published; 
with cytosine as a monohydrate,163 in a 2:1 ratio with theophylline as a monohydrate164 
(both co-crystal solvates), with 1-methylcytosine,165 and with 9-ethylhypoxanthine.166
It was postulated, in light of the unusual features exhibited by the 5FU form 1 
crystal structure, that there may be a more stable and ‘conventional’ polymorph 
awaiting discovery, possibly with only one independent molecule in the asymmetric 
unit in a higher symmetry space group without close contacts between the fluorine 
atoms. To investigate this proposition, both computational crystal structure prediction 
and an experimental crystallisation screen were carried out.
3.2 C ry sta l s tru c tu re  p red ic tio n
3.2.1 Validation of the fluorine dispersion-repulsion potential
The FIT dispersion-repulsion parameters for C, Hnp, Hp, N, O have been used 
extensively in the past to energy minimise crystal structures and, within the inherent 
limitations of their empirical derivation and the Buckingham potential form, have been
found to be fit for purpose. The fluorine dispersion-repulsion potential was derived by
80Williams and co-workers at the same time as the other atom types, but prior to this
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study had not been used in the energy minimisation of any fluorine-containing crystal 
structures with DMAREL. The fluorine potential parameters were originally fitted to a 
training set of perfluorohydrocarbons, containing only C, Hnp and F atoms. The 
heteroatomic cross-terms between fluorine and the other FIT atom types were derived 
using the geometric combining rules and the uncertainty in the performance of the 
cross-terms required potential validation prior to the use of the fluorine potential during 
CSP. The FIT potential augmented with the fluorine potential was tested for its ability 
to energy minimise a small number of fluorinated crystal structures containing other 
atom types and other functional groups.
A series of six fluorine-containing crystal structures (figure 3.3) were energy 
minimised using DMAREL. The six crystal structures were chosen from the CSD, with 
the atom types limited to C, H, N, O and F, with only one molecule in the asymmetric 
unit, and with all hydrogen atom positions determined in the crystal structure. Four of 
the molecules in the test set included other atom types beyond C, H and F, and were 
capable of hydrogen bonding, hence providing a more demanding test of the fluorine 
potential’s ability to reproduce heteroatomic interactions. None of the molecules in the 
test set included flexible torsion angles, and it was expected that the ab initio 
optimisation of their molecular conformations would not lead to significant changes 
compared to the experimental conformations for any of the molecules. Each crystal 
structure was energy minimised using both the experimental molecular conformation 
(ExptMinExpt) and the ab initio optimised molecular conformation (ExptMinOpt), and 
then compared to the corresponding experimental structure (table 3.2). For all molecules 
the electrostatic potential was modelled using a distributed multipole analysis of the 
MP2/6-31G(d,p) wavefunction, and the molecular conformations were optimised using 
the same level of theory.
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Figure 3.3: Molecules used to test the fluorine potential. FACFOE
(1,2-difluorobenzene); NECMUD (4-fluoroethynylbenzene); LAKJEM 
(3-methyl-5-fluorouracil); TAGQOH (5,6-difluoro-2-benzimidazolone); 
WOCGOK (5-fluoroindoline-2,3-dione); FPYRMO (5-fluoropyrimidine-2-one)
FACFOE Experimental ExptMinExpt % error ExptMinOpt % error
Space group F2Jn
a (A) 7.481 7.737 3.42 7.706 3.02
b(A) 5.961 6.063 1.72 6.072 1.86
c(A) 11.725 11.600 -1.06 11.701 -0.20
p n 103.815 102.644 -1.13 102.316 -1.44
Vol. (A3) 507.70 530.95 4.58 534.92 5.36
Density (g/cm3) 1.493 1.427 -4.38 1.417 -5.09
F 25.30 22.41
FPYRMO
Space group P2^lc
a (A) 11.118 11.198 0.72 11.305 1.68
b (A) 6.012 6.175 2.72 6.225 3.55
c (A) 7.147 7.232 1.19 7.243 1.34
P (°) 104.310 107.156 2.73 107.047 2.62
Vol. (A3) 462.89 477.85 3.23 487.33 5.28
Density (g/cm3) 1.637 1.586 -3.13 1.555 -5.01
F 32.050 34.29
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LAKJEM E x p er im en ta l E xptM inE xpt % error E xptM inO pt % error
S p a c e  g ro u p P2Jn
a (A) 4 .6 7 4 .5 4 -2 .7 9 4 .681 0 .2 3
b (A) 1 1 .4 3 9 1 1 .2 4 9 -1 .6 6 1 1 .1 7 4 -2 .31
c  (A) 1 1 .5 0 7 1 2 .1 1 5 5 .2 9 1 1 .9 9 9 4 .2 7
p n 1 0 1 .0 8 1 0 1 .0 4 7 -0 .0 3 1 0 3 .0 7 1 .97
V ol. (A3) 6 0 3 .2 5 6 0 7 .2 5 0 .6 6 6 1 1 .3 6 1 .34
D e n s ity  (g /c m 3) 1 .5 8 7 1 .5 7 6 -0 .6 6 1 .5 6 6 -1 .3 3
F 5 9 .4 6 4 1 .2 2
NECMUD
S p a c e  g ro u p P2jlc
a (A) 7 .0 6 5 7 .2 1 6 2 .1 4 7 .2 9 4 3 .2 4
b (A) 6 .5 8 7 6 .7 9 4 3 .1 5 6 .7 6 6 2 .71
c  (A) 13 .241 1 3 .2 8 6 0 .3 4 1 3 .3 7 6 1 .02
P (°) 9 9 .6 4 0 100 .931 1 .3 0 1 02 .061 2 .4 3
V ol. (A 3) 6 0 7 .5 0 6 3 9 .5 6 5 .2 8 6 4 5 .5 0 6 .2 6
D e n s ity  (g /c m 3) 1 .3 1 3 1 .2 4 8 -5 .01 1 .2 3 6 -5 .8 9
F 1 8 .2 0 4 2 7 .7 8
TAGQOH
S p a c e  g ro u p P2-\lc
a (A) 8 .2 3 2 8 .0 8 0 -1 .8 5 8 .0 9 8 -1 .6 3
b (A) 7 .341 7 .3 8 7 0 .6 4 7 .5 2 2 2 .4 8
c ( A ) 1 1 .3 0 9 1 1 .6 3 9 2 .9 2 1 1 .6 4 9 3.01
P (°) 9 0 .5 3 0 9 1 .6 8 4 1 .27 9 1 .6 8 1 1 .27
V ol. (A 3) 683 .31 6 9 4 .3 7 1 .62 7 0 9 .2 9 3 .8
D e n s ity  (g /c m 3) 1 .6 5 4 1 .6 2 7 -1 .5 9 1 .5 9 3 -3 .6 6
F 2 0 .9 7 4 2 7 .1 5
W OCGO K
S p a c e  g ro u p P2-\lc
a (A) 3 .7 8 9 3 .9 4 0 3 .9 8 3 .9 5 3 4 .3 2
b (A) 1 2 .2 0 0 1 2 .3 4 3 1 .17 1 2 .4 3 4 1 .92
c  (A) 14 .9 9 1 4 .3 8 0 -4 .0 7 14 .381 -4 .0 7
p  n 94.41 8 9 .3 3 8 -5 .3 7 8 9 .2 8 2 -5 .4 3
V ol. (A 3) 6 9 0 .8 7 6 9 9 .21 1.21 7 0 6 .7 1 2 .2 9
D e n s ity  (g /c m 3) 1 .5 8 8 1 .5 6 9 -1 .1 9 1 .5 5 2 -2 .2 4
F 8 9 .2 6 0 9 6 .3 6
Table 3.2: Summary of energy minimisations from fluorine potential testing
All six of the structures were successfully reproduced by the FIT potential augmented 
with the fluorine homo- and hetero- atomic terms. The largest error in reproduction of a 
cell parameter in the energy minimisation of the six structures was a - 5 . 4 2 %  error in the 
p angle in the ExptMinOpt minimisation of 5 - f l u o r o i n d o l i n e - 2 , 3 - d i o n e  (WOCGOK), 
and this structure proved to be the most poorly reproduced structure. The F-value for the 
ExptMinExpt minimisation was 89 and this rose to 96 when the optimised conformation 
was used in the minimisation. Qualitatively an overlay of the experimental and
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ExptMinOpt structures showed that the structure had not significantly changed during 
the minimisation procedure. The structure of 3-methyl-5-fluorouracil also had an F 
value greater than 50, though only for the ExptMinExpt reproduction. The reproduction 
of this structure is of particular interest, as it is obviously closely related to 5- 
fluorouracil, though the methyl group on N l, rather than a hydrogen atom leads to very 
different hydrogen bonding. An overlay of the experimental and ExptMinOpt structures 
showed that the structure had not been significantly altered. The other four structures in 
the test set were well reproduced.
While this six molecule test set may not explore all possible fluorine hetero­
interactions thoroughly, the success in their reproduction does indicate that the fluorine 
potential is as reliable as can be expected in light of the limitations of the empirical 
method, and is suitable for use in the crystal structure prediction of 5FU.
In the course of this study a new polymorph was discovered (form 2) and both 
polymorphs were energy minimised, further testing the potential.
3.2.2 Energy minimisation of 5-fluorouracil polymorphs
In the course of the experimental screen, the crystal structure of 5FU form 1 was 
redetermined at 150 K. This structure was significantly more accurate than the literature 
structure159 and a superior starting point for energy minimisation. The experimental 
crystallisation screen also yielded a second polymorph of 5FU and the crystal structures 
of both forms as determined at 150 K were energy minimised using both the 
experimental and ab initio optimised molecular conformations.
The minimisation of 5FU form 1 proved successful, with the largest 
ExptMinOpt cell parameter error only 3.72%. The ExptMinOpt minimisation of form 2 
showed an error of 6.09% in the a axial length, greater than the maximum 5% error 
normally assumed to be attributable to thermal effects, but upon visual inspection it was 
evident that the structure was not significantly altered by the energy minimisation 
process, with the hydrogen bonded ribbons still intact in the energy minimised structure. 
ExptMinExpt and ExptMinOpt energy minimisations of both structures are summarised 
in table 3.3.
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5 -F lu o r o u r a c il
F orm  1 F orm  2
E xpt.* E xp tM in E xp t
%
error E xp tM in O p t
%
error E xpt. E xp tM in E xp t
%
error
E xp tM in O p t %
error
a (A) 8 .6 3 2 9 8 .7 2 9 1.11 8 .8 4 5 2 .4 6 5 .0 4 3 5 .2 4 4 3 .9 8 5 .351 6 .0 9
b (A) 9 .1 5 6 9 .3 2 9 1 .89 9 .2 7 4 1 .2 9 1 4 .9 3 5 1 5 .2 4 5 2 .0 8 1 5 .2 6 2 2 .1 8
c  (A) 1 2 .5 7 9 6 1 2 .9 7 2 3 .1 2 1 3 .0 4 7 3 .7 2 6 .6 0 5 6 .5 0 6 -1 .4 9 6 .5 0 7 -1 .4 7
a ( ° ) 9 9 .1 2 9 7 .3 8 -1 .7 6 9 6 .6 2 -2 .5 3 - - -
P (° ) 1 0 0 .0 2 9 8 .1 0 -1 .9 2 9 7 .1 4 -2 .8 8 1 0 8 .8 8 1 0 9 .8 4 0 .8 8 1 1 0 .2 9 1 .29
Y (°) 9 0 .0 2 9 1 .3 0 1 .42 9 1 .6 9 1 .86 - - -
V o lu m e  (A 3) 9 6 6 .4 1 0 3 6 .3 7 .2 3 1 0 5 3 .8 9 .0 5 4 7 0 .7 4 8 9 .3 3 .9 4 4 9 8 .4 5 .8 9
D e n s ity  (g  c m '3) 1 .7 8 8 1 .6 6 7 -6 .7 5 1 .6 4 0 -8 .3 1 .8 3 5 1 .7 6 6 -3 .7 9 1 .7 3 3 -5 .5 6
F inal E n e r g y  
(kJ m o l'1)
-1 0 2 .9 8 -9 6 .5 8 -1 0 9 .2 9 -1 0 2 .4 9
F 3 6 .2 6 6 2 .6 3 2 8 .9 6 5 3 .0 0
Table 3.3: Energy minimisation of the crystal structures of 5FU. * Low temperature redetermination obtained during this study
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3.2.3 Crystal s tructure  prediction -  results
The MP2/6-31G(d,p) ab initio optimised molecular conformation of 5FU was used as 
the imput for the MOLPAK search. The search generated structures in 37 MOLPAK
138packing types spanning 18 different space groups. The programs Analysis and
1 IQCluster were not used in this study, so all structures that minimised to saddle points 
were discarded and the resultant list was clustered by hand by comparing reduced cells, 
with the lowest energy member of each cluster retained. All remaining structures within 
8 kJ mol'1 of the global energy minimum structure were examined visually and by graph 
set analysis and similar structures that were not close enough to cluster by comparing 
reduced cells were identified and only the most stable retained. The resulting scatter plot 
containing 61 distinct hypothetical crystal structures (figure 3.4). A summary table of 
these structures is provided in the supporting information along with the atom 
numbering scheme used during the CSP search.
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Figure 3.4: Scatter plot of all CSP generated structures for 5FU within 8 kJ mol'1 
of the global energy minimum
Comparison of the ExptMinOpt energy minimised structures of the two experimental 
polymorphs with the list of low energy hypothetical structures showed that the form 2 
structure corresponded exactly to the global energy minimum structure, which was
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nearly 6 kJ mol'1 more stable than form 1. Form 1 proved both higher in energy and less 
dense than many of the predicted structures.
5FU has two hydrogen bond donors and two hydrogen bond acceptors and it was 
expected that the computed structures would all show hydrogen bonding, and because 
of the equal number of donors and acceptors that all donors and acceptors would be 
satisfied. The set of structures within 8 kJ mol'1 of the global minimum showed a 
variety of hydrogen bond patterns so the structures were classified by their most 
defining hydrogen bonded feature, as identified by graph set analysis using the default 
graph set parameters in PLUTO.141 Three recurring hydrogen bonded motifs were 
identified -  two ribbon motifs and one sheet motif. Figure 3.5 shows the scatter plot of 
predicted structures classified by hydrogen bond motif.
120
-94
-95
-97
Volume per Molecule (cubic Angstroms)
126 128 130 132
£-100
♦  ♦
♦ ♦♦
♦ ♦ ♦
♦
V  ♦
o
♦  ♦  
♦
\  
♦  ♦
♦
♦ ♦
♦ Ribbon 2
♦ Ribbon 1
♦ 3D  1
♦ O ther 
O Form 1 
O Form  2
-103
Figure 3.5: CSP scatter plot classified by hydrogen bonded motif
In eight structures, including four of five lowest energy structures, each molecule forms 
two R ^ )  hydrogen bonds rings to produce a ribbon motif, 5FU ribbon 1 (figure 3.6). 
The two R ^ )  interactions on each molecule do not share hydrogen bond donors.
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Figure 3.6: Hydrogen bonded ribbon motif 1. Two independent hydrogen bonded 
R ^ )  rings propagate the ribbon. The alternate numbering scheme that was used 
in the CSP search and supporting information tables is shown
In 24 structures each molecule forms two R ^ )  dimers, each to an adjacent molecule, 
but the two hydrogen bonded rings share the same acceptor, 5FU ribbon 2 (figure 3.7).
Figure 3.7: Hydrogen bonded ribbon 2. The two R ^ )  rings share the same 
carbonyl acceptor
Eight structures have a hydrogen bonded sheet motif, comprised of 5FU ribbon 2 sub­
units within the sheet, and with further single hydrogen bonds linking these ribbons into 
the sheet structure, 5FU sheet 1. The sheets have a thickness of approximately 9 A in 
the third dimension. Figure 3.8 shows two views of the sheet, both parallel to the plane 
of the sheet, and perpendicular to the 9 A direction. The outer surfaces of the sheets are 
mainly made up of fluorine atoms.
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Figure 3.8: Hydrogen bonded sheet 1. Two views parallel to the plane of the sheet 
are shown. The first view shows the 5FU ribbon 2 sub-unit and the second view 
shows the single hydrogen bonds linking the ribbon 2 sub-units together to make 
the sheet
The other 21 structures show a variety of other hydrogen bonded motifs based on chains 
and R ^ )  rings. Graph set analysis and hydrogen bond details for all 61 low energy 
structures are provided in the supporting information. None of the hypothetical 
structures produced a hydrogen bonded sheet similar to the sheet observed in the form 1 
crystal structure with regions containing fluorine close contacts.
Both 5FU ribbons 1 and 2 have been observed in other 5-substituted uracils. 
5FU ribbon 1 is observed in two of the three known polymorphs of 5-nitrouracil167’168 
and 5FU ribbon 2 is found in 5-chlorouracil,169 5-bromouracil,170 5-methyluracil 
(thymine)171 and 5-eniluracil.172
3.3. E x p erim en ta l cry sta llisa tio n  screen
3.3.1 Crystallisation screen
5-Fluorouracil was purchased from Aldrich Chemical Company (Poole, UK, 99% 
purity) and was used as purchased in the crystallisation screen, and was confirmed to be 
form 1 by XRPD. 5FU proved to be soluble in 26 solvents from the available library of 
35. It was found to be insoluble in diethylether, cyclohexane, hexane, toluene, o-xylene, 
chloroform, dichloromethane, 1,2-dichloroethane and tetrachloroethylene. 5FU was 
slightly soluble in 11 solvents where the solubility was approximately 1-2 mg/ml at 
room temperature. It proved to be soluble in 15 solvents, where the solubility was 
greater than 1-2 mg/ml at room temperature. The 5FU crystallisation screen is
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summarised in table 3.9. Solvent evaporation from saturated solutions were carried out 
over the full range of 26 solvents. Vapour diffusions with toluene anti-solvent and 
vapour diffusions with diethylether anti-solvent were also carried out over a smaller 
solvent range of 17 solvents. 12 mixed solvent recrystallisations were also set up, with 
approximately 50:50 solvent: toluene anti-solvent ratios. All of the solvents chosen for 
the mixed solvent crystallisations were more volatile than toluene, with evaporation of 
the solvent leading to precipitation of 5FU within the toluene anti-solvent. Solvent 
evaporation from sub-saturated solutions were set up over a range of eight solvents and 
both 25% and 50% saturation levels were used.
Of the 149 experiments summarised in table 3.9, 58 produced crystals that were 
large enough and of sufficient quality for characterisation by SXRD. In the other 
crystallisations either the crystallisation failed to give a precipitate, which was a 
common result for the vapour diffusion experiments, or the crystallisation gave a small 
amount of microcrystalline precipitate. For all crystallisations which produced single 
crystals the unit cell of a crystal of typical morphology was determined, and in seven 
cases new unit cells were observed and full data sets collected, yielding new crystal 
structures. Of the seven new forms six were solvates, and one was a new polymorph, 
form 2. The crystal structure of form 1 was also redetermined at 150 K, giving a more 
accurate determination of the crystal structure than the literature structure.
A crystallisation database, summarising all crystallisations and results, is 
provided on the supporting information CD (in Chapter_3_5Fluorouracil) and a 
summary spreadsheet detailing crystallisation conditions for all of the forms of 
5-fluororacil is also given (Crystallisation_Summary.xls).
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Solvent
A ceton itrile
A c e to n e
1-butan ol
E thanol
M ethanol
1-prop an ol
N itrom eth an e
W ater
2 -b u tan o l
2 -p rop an o l
T etrahydrofuran
1 ,4 -d io x a n e
E th y la ce ta te
A niline
F orm am id e
2 ,2 ,2 ,-tr iflu oroeth an o l
D im eth ylform am id e
D im eth y lsu lfox id e
A c e ta ld e h y d e
B enzon itrile
2 -ch lo ro eth a n o l
E th y len e  g lyco l
M eth y lb en zo a te
M eth y leth y lk eton e
1 -m eth yl-2-p yrrolid in on e
tert-bu ty lm ethyleth er
Solubility (RT)
Slightly  S o lu b le
S lightly  S o lu b le
S o lu b le
S o lu b le
S o lu b le
S o lu b le
Sligh tly  S o lu b le
S o lu b le
S o lu b le
S o lu b le
S o lu b le
S o lu b le
Sligh tly  S o lu b le
Sligh tly  S o lu b le
Sligh tly  S o lu b le
S o lu b le
S o lu b le
S o lu b le
Slightly  S o lu b le
S o lu b le
Sligh tly  S o lu b le
S o lu b le
Slightly  S o lu b le
S ligh tly  S o lu b le
S o lu b le
S ligh tly  S o lu b le
EV 100 EV 50 EV 25 VDether
VD
toluene
MX
toluene
Table 3.9: Crystallisation screen summary
Key: EV = solvent evaporation at saturation of 100%, 
50% or 25%; VD = vapour diffusion with diethylether or 
toluene anti-solvent; all crystallisations were carried out 
at room temperature (RT). MX = mixed solvent; * = 
immiscible; f  = solvent too involatile. The values in the 
table denote the number of repeat experiments
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3.3.2 Redeterm ination of the crystal structure of form  1
5-Fluorouracil form 1
Crystals of 5-fluorouracil form 1 could be grown from many different solvents, with 
good quality crystals easily grown from ethanol and methanol. While different solvents 
were capable of giving a variety of different crystal morphologies, a recurring crystal 
habit was identified, that of a square based pyramid truncated before the apex (figure 
3.9). The crystals proved prone to delamination on manipulation, with the delamination 
occurring parallel to the base of the pyramid and usually splitting the crystal into a 
multitude of very thin plate crystallites that themselves were usually twinned. This is 
consistent with the non-hydrogen bonded sheet composition of the crystal structure, 
with the sheets parallel to the 1 1 0 Miller planes. Single crystals of suitable quality for 
a high quality SXRD determination were grown by slow cooling a saturated solution of 
5FU in nitromethane using a domestic refrigerator. The asymmetric unit is shown in 
figure 3.10 and the crystal structure is summarised in table 3.7. The F—F distances in 
this redetermined structure are F9--F29 = 3.046(2) A, F29 - F19 = 3.045(2) A, F19—F39 
= 3.091(2) A, F9—F29 = 3.046(2) A, confirming the close contacts in the fluorine 
tetramer.
Figure 3.9: Common habit of 5FU form 1. In this example along with the four 
dominant side faces of the square based pyramid, a fifth smaller face is observed. 
The apex of the pyramid has not grown out. Lines have been added to the picture 
to highlight the different faces
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Figure 3.10: Asymmetric unit of 5FU form 1
3.3.3 5-Fluorouracil form 2
5-Fluorouracil form 2
A second polymorph of 5-fluorouracil was discovered by slow evaporation of a 
saturated solution of nitromethane at room temperature over a period of four months. 
This crystallisation method proved extremely unreliable for growing further samples of 
form 2 -  only three of approximately 40 further repeated recrystallisations produced 
form 2, with all others giving form 1. Form 2 crystallises in the monoclinic space group 
P2\/c with one molecule in the asymmetric unit (figure 3.11 and table 3.7).
Figure 3.11: Asymmetric unit of 5FU form 2
The hydrogen bonded motif present in the crystal structure of 5FU form 2 is the ribbon 
1 motif. The ribbons lie side-by-side to form rippled sheets with no strong hydrogen 
bond interactions between the ribbons in a sheet, or between adjacent sheets (figure 
3.12). The sheets stack as the -1 0 2 Miller planes and stack directly upon one another 
when viewed parallel to the c crystallographic axis. There are no short F—F contacts in 
the crystal structure. The two hydrogen bonds, each of which is present once in each of 
the R ^ )  rings, are N3-H3--08 andNl-Hl---07.
Figure 3.12: Three ribbons comprising part of one sheet in the 5FU form 2 crystal 
structure
Despite the unreliability of the crystallisation method, a sufficient quantity of form 2 
was grown for thermal analysis. DSC experiments on both polymorphs were performed 
by Dr. Andrea Johnston (Strathclyde University) (figure 3.13). From these experiments 
it can be seen that form 2 melts at a lower temperature than form 1 and also has a 
smaller heat of melting (the area of the melt event).
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Figure 3.13: DSC results for 5FU forms 1 and 2. Form 1 is shown in green and 
form 2 in olive. Form 2 melts at lower temperature and has a lower heat of melting 
than form 1
3.3.4 5-Fluorouracil solvates
The crystallisation screen produced six new solvates, some of which show hydrogen 
bond features that can be related to the computed structures or the experimental 
polymorphs and the solvates are discussed emphasising these features. Also reported is 
the crystal structure of a solid solution of 5-fluorouracil and thymine.
3.3.5 2,2,2-TrifIuoroethanol and benzonitrile solvates
These two solvates are reported together because both contain 5FU ribbon 2 sub-units in 
their hydrogen bonding patterns. In both of these crystal structures the carbonyl 
hydrogen bond acceptor that is left unused in the 5FU ribbon 2 structure is satisfied by 
interactions with solvent molecules -  in the case of the 2,2,2-trifluoroethanol solvate it 
forms a strong hydrogen bond to the hydroxyl group of the solvent molecule and in the 
case of the benzonitrile solvate it forms a weak C-H---0 interaction with the benzonitrile 
solvent, which does not contain any strong hydrogen bond donating groups.
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5-Fluorouracil 2,2,2-trifluoroethanol (7 /7 /73
5FU 2,2,2-trifluoroethanol solvate crystals were grown by solvent evaporation from a 
saturated solution of 5FU in 2,2,2-trifluoroethanol crystallising in the monoclinic space 
group P21 with one molecule of 5FU and one molecule of 2,2,2-trifluoroethanol in the 
asymmetric unit (figure 3.14 and table 3.7).
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Figure 3.14: Asymmetric unit of 5FU 2,2,2-trifluoroethanol solvate
The principal hydrogen bonded motif in the structure is the 5FU ribbon 2. Each 5FU 
molecule participates in two R 7(8) rings, each being comprised of one N l-H l * 0 7  
hydrogen bond and one N3-H3- 0 7  hydrogen bond. The carbonyl oxygen atom in the 
5FU molecule not used in the ribbon hydrogen bonding is hydrogen bonded to a 2,2,2- 
trifluoroethanol molecule. The 2,2,2-trifluoroethanol molecules form the outer edge of 
the ribbon, with the 5FU molecules forming the inside of the ribbon (figure 3.15). There 
is also a F—F (2.891(2) A) close contact between one of the trifluoromethyl fluorine 
atoms from the solvent and the 5FU fluorine atom, thus further stabilising the ribbon. 
The ribbons stack parallel to the ab plane with the 2,2,2-trifluoroethanol molecules from 
adjacent stacks of ribbons in van der Waals contact.
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Figure 3.15: The hydrogen bonded ribbon motif and the stacking of the ribbons in 
the 5FU 2,2,2-trifluoroethanol solvate structure. A: Strong hydrogen bonds and 
short F***F contacts in the ribbon; B: Stacking of the ribbons
5-Fluorouracil benzonitrile (1/1)
Small block crystals of a 5FU benzonitrile solvate were grown by solvent evaporation 
from a saturated solution over a period of nearly a year. This solvate crystallises in the 
space group P2\lc with one molecule of 5FU and one molecule of benzonitrile in the 
asymmetric unit (figure 3.16 and table 3.7).
Figure 3.16: Asymmetric unit of the 5FU benzonitrile solvate
The 5FU ribbon 2 motif is present in the crystal structure, alternating with ribbons of 
benzonitrile molecules to form sheets (figure 3.17). The sheets lie parallel to the be
plane, stacking as the 2 0 0 plane. Each 5FU molecule participates in two R ^ )  rings to 
form 5FU ribbon 2, with each ring comprised of one N l-H l—07 hydrogen bond and 
one N3-H3—07 hydrogen bond. The benzonitrile molecules form a ribbon using two 
weak C-H--N interactions bifurcated at N il:  C16-H16-N11 (D -A  = 3.503(1) A, D- 
H -A  angle = 149(1) °) and C12-H12-N11 (D -A  = 3.379(2) A, D -H -A  angle = 
152(1) °). These interactions are comparable with the C -H -N  interaction found in the 
crystal structure of benzonitrile174 which is linear and of length 3.676 A. The C-H -N 
contacts in the solvate structure are short enough to be classified as interactions, and the 
distortion of the hydrogen bonding angles away from the expected linear disposition can 
be explained by the bifurcation at N il. Two C-H -F and one C -H -0  weak hydrogen 
bonds are the only interactions between the 5FU ribbons and the benzonitrile ribbons. 
The intermolecular interactions present in the crystal structure are summarised in table 
3.4.
H -A  (A) D -A  (A) <(D-H—A) n
5FU hydrogen bonds
N1-H1-07 1.91(2) 2.799(1) 172(1)
N3-H3-07 1.91(2) 2.769(1) 175(1)
5FU benzonitrile interactions
C14-H14—08 2.52(2) 3.441(1) 159(1)
C13-H13-F9 2.45(2) 3.368(1) 150(1)
C15-H15—F9 2.59(2) 3.451(1) 150(1)
Benzonitrile benzonitrile interactions
C12-H12-N11 2.51(1) 3.379(2) 152(1)
C16-H16—N11 2.63(1) 3.503(1) 149(1)
Table 3.4: Intermolecular interactions present in the 5FU  benzonitrile solvate
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Figure 3.17: The hydrogen bonding present in a single sheet of the 5FU 
benzonitrile solvate. 5FU ribbon 2 sub-units can be observed forming weak 
hydrogen bonded interactions with benzonitrile molecules. Adjacent benzonitrile 
molecules interact by weak C-H***0 interactions
3.3.6 1,4-Dioxane solvate
5-Fluorouracil 1,4-dioxane (4/I)115
The crystal structure of this solvate is comprised of hydrogen bonded sheets which 
include hydrogen bonded rings that resemble the largest ring found in the 5FU form 1 
crystal structure. 5FU crystallises with 1,4-dioxane in a 4:1 ratio in the triclinic space 
group P I . Block crystals were grown by solvent evaporation from a saturated solution 
of 5FU in 1,4-dioxane. The 1,4-dioxane molecule is located on the inversion centre at 
origin of the unit cell and consequently there is half of a 1,4-dioxane molecule and two 
5FU molecules in the asymmetric unit (figure 3.18 and table 3.7).
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Figure 3.18: Asymmetric unit of the 5FU 1,4-dioxane solvate
This crystal structure is made up of hydrogen bonded sheets which lie parallel to the 
2 -1  1 Miller planes and, considering only strong hydrogen bonds, each sheet is 
comprised of R ^ )  rings formed between two 5FU molecules and large R}2(54) rings 
that contain both 5FU and 1,4-dioxane molecules (figure 3.19). At the centre of the 
large ring a tetramer of F—F close contacts is present, and this ring is related to the 
Rg(40) rings present in 5FU form 1, with the F -F  tetramer and six central 5FU
molecules (those overlaid in figure 3.20) common to both rings. Instead of the two 
further 5FU molecules that complete the form 1 ring, in the solvate two 1,4-dioxane 
molecules and four further 5FU molecules are incorporated to form the larger ring.
H y d ro g en  b o n d H - A  (A) D - A  (A) <(D -H —A) n
N 1 - H 1 - 0 1 7 1 .98 (3 ) 2 .7 9 8 (2 ) 1 6 7 (2 )
N 3 - H 3 - 0 7 1 .95 (2 ) 2 .8 5 7 (2 ) 1 7 6 (2 )
N 11-H 11 —0 2 1 1 .84 (2 ) 2 .7 4 6 (2 ) 1 7 1 (2 )
N 1 3 - H 1 3 - 0 1 8 1 .98 (2 ) 2 .8 2 4 (2 ) 1 7 5 (2 )
F - F s h o r t  c o n ta c t s
F 9 - F 1 9 n/a 3 .1 8 3 (2 ) n/a
F 9—F19 n/a 3 .0 3 4 (2 ) n/a
Table 3.5: Hydrogen bonds and short F—F contacts in the 5FU 1,4-dioxane solvate
Figure 3.19: The hydrogen bonded sheet present in the 5FU 1,4-dioxane solvate
Figure 3.20: Overlay of 5FU 1,4-dioxane solvate ring (coloured by
element) and 5FU form 1 Rg(40) ring (coloured blue). The overlay was matched
on the six central 5FU molecules that are seen to match closely, while at the left 
and right of the figure the differences in the two rings can be observed
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3.3.7 Form am ide, DM F and DMSO solvates
None of these three solvates show any similarities to either the hydrogen bonded motifs 
found in the predicted structures or to the non-solvated crystal structures or indeed to 
one another.
5-Fluorouracil formamide (1/1)
Crystals of this solvate were grown by solvent evaporation of the resultant solution from 
a failed vapour diffusion of diethyl ether into a saturated solution of 5FU in formamide. 
The crystal structure adopts the monoclinic space group P2\/m with both the 5FU 
molecule and the formamide molecule lying on the mirror plane (figure 3.21 and table 
3.7). The metric symmetry is almost orthorhombic, higher than the actual symmetry of 
the crystal structure, and in this case the crystal proved to be a pseudo-merohedral twin, 
which was treated during the refinement by the application of the twin law ( 1 0 0  0 - 1 0  
0 0-1) and refined with a scale factor of 0.34.
Figure 3.21: Asymmetric unit of the 5FU formamide solvate. Each atom has half 
occupancy as both molecules lie on the mirror plane
In this crystal structure each 5FU molecule does not hydrogen bond to any other 5FU 
molecules, but hydrogen bonds to three formamide molecules, figure 3.22.
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Figure 3.22: Hydrogen bonded sheet present in the 5FU formamide solvate
5-Fluorouracil dimethylformamide (2/1 ) 176
5FU forms a hemisolvate with dimethylformamide (DMF), crystallising in P2\/c with 
two 5FU molecules and one DMF molecule in the asymmetric unit (figure 3.23 and 
table 3.7). The crystals were grown by vapour diffusion of diethyl ether into a saturated 
solution of 5FU in DMF.
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Figure 3.23: Asymmetric unit of the 5FU DMF solvate
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The structure contains hydrogen bonded sheets built out of smaller sub-units comprising 
four 5FU molecules and two DMF molecules (figure 3.24). The sub-units do not lie flat 
in the sheet, but lie parallel to two different planes: half of the sub-units are parallel to 
the 2 -1 -4 Miller plane and the other half are parallel to 2 1 -4. These two groups are 
cross linked by hydrogen bonds to form the sheet (figure 3.25) and the sheet has a 
thickness in the third dimension of approximately 14 A. In figure 3.25 the molecules are 
coloured by symmetry and the view has been chosen to be parallel to the two planes in 
which the sub-units lie. The blue and green molecules are the symmetry independent 
5FU molecules and the DMF molecule is coloured red. The DMF molecules are present 
on both surfaces of the sheets, with the 5FU molecules contained within the sheet.
Figure 3.24: Hydrogen bonded sub-unit present in the 5FU DMF solvate. The four 
points of contact with adjacent sub-units used to build the hydrogen bonded sheet 
are shown
Figure 3.25: View of the 5FU DMF solvate hydrogen bonded sheet parallel to the 
plane of the sheet
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5-Fluorouracil dimethylsulfoxide ( l / l ) 111
5FU forms a 1:1 solvate with dimethylsulfoxide (DMSO), crystallising in P2\!c (table 
3.7). Crystals were grown by vapour diffusion of diethyl ether into a saturated solution 
of 5FU in DMSO. The DMSO molecule is disordered with the sulfur atom split over 
two sites with the two components showing opposite pyrimidisation. Only the sulfur 
atom and the methyl hydrogen atoms were modelled as disordered. The ratio of the 
major to minor component refined to 0.94, and only the major component is shown in 
the asymmetric unit in figure 3.26. The following bond lengths were restrained to be 
equivalent in the two components, to within 0.01 A: S20-020 and S20’-020; S20-C20 
and S20’-C20; S20-C21 and S20’-C21.
Figure 3.26: Asymmetric unit of the 5FU DMSO solvate. Only the major 
component of the DMSO disorder is shown
The DMSO oxygen atom forms strong hydrogen bonds to two 5FU molecules to give a 
hydrogen bonded chain (figure 3.27). Neither of the 5FU carbonyl oxygen atoms forms 
strong hydrogen bonds due to the stronger hydrogen bond acceptor capability of the 
sulfoxide oxygen which, according to the hydrogen bond rules,100 will form the 
dominant association with the N-H hydrogen bond donors from the 5FU molecules. The 
ribbons propagate parallel to the b axis and they stack to form layers parallel to the be 
plane. A similar hydrogen bonding pattern is found in the DMSO solvate of 
5-nitrouracil.167
0 7
■
■
■
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Figure 3.27: Hydrogen bonded ribbon present in the 5FU DMSO solvate. DMSO 
molecules and 5FU molecules alternate in the ribbon
3.3.8 Co-crystallisation of 5-fluorouracil with thymine
1785-Fluorouracil thymine solid solution
The presence in the CSD of several co-crystals containing 5FU led to attempts to co- 
crystallise it with thymine (5-methyluracil), based on the premise that the fluorine atom 
and the methyl group are often interchangeable to give isomorphic crystal structures.179 
5FU and thymine were mixed in a 1:1 molar ratio and sub-saturated solutions in 
methanol, nitromethane, tetrahydrofuran, DMSO, DMF, water, benzonitrile and 2,2,2- 
trifluoroethanol were prepared. Sub-saturated solutions were used so that the 1:1 molar 
ratio prior to dissolution was retained in solution.
Crystallisation from 2,2,2-trifluoroethanol produced a new unit cell, a full data
1 7 8set was collected and a new crystal structure determined. This proved to be a solid 
solution of 5FU and thymine (table 3.7). Solid solutions are conceptually distinct from 
co-crystals. Solid solutions have been defined as "a homogeneous crystalline phase in 
which some of the constituent molecules are substituted by foreign molecules that 
possess sufficient similarity that the lattice dimensions are changed only slightly".6 The 
asymmetric unit (figure 3.28) contains two independent sites and both of these sites 
have non-integer occupancies of both 5FU and thymine. At each site the 5FU and 
thymine occupancies sum to one, so each site is fully occupied. Because the only 
molecular difference between 5FU and thymine is the functional group bonded to the 5- 
position, it is only this that differentiates the presence of 5FU from thymine in the 
crystal structure.
117
09
Figure 3.28: Asymmetric unit of the 5FU/thymine solid solution crystal structure. 
Positions 9 and 19 have non-integer occupancies of fluorine atoms and methyl 
groups and both are shown
Three separate crystal structure determinations using three different crystals were 
recorded. Two of the crystals were grown from a 1:1 ratio of 5FU : thymine and one 
crystal was grown from a 2:1 ratio. The ratio in the crystallisation solution influenced 
the relative ratios of 5FU : thymine at positions 9 and 19 in the crystal structure with the 
higher ratio crystallisation solution giving a higher proportion of 5FU at both sites (table 
3.6, position 19 in all three structures preferentially incorporates 5FU rather than 
thymine). Solid solution crystals with this structure could not be grown from 3:1 or 1:2 
5FU : thymine ratios -  suggesting that 5FU and thymine have limited solubility in this 
solid solution.
R atio  5 F U :T h y m in e  in s o lu t io n
% 5FU  in c r y s ta l s tr u c tu r e
p o s it io n  9 p o s i t io n  19
1:1 0 .5 2 (1 ) 0 .7 0 (1 )
1:1 0 .5 5 (1 ) 0 .6 9 (2 )
2:1 0 .6 6 (1 ) 0 .7 6 (1 )
Table 3.6: 5FU : thymine occupancies in the three determinations of the 
5FU:thymine solid solution crystal structure. The ratios at crystallographic 
positions 9 and 19 are given separately
In the crystal structure each 5FU/thymine forms four hydrogen bonds, giving a R ^ )  
ring and two single hydrogen bonds, and these interactions then form hydrogen bonded 
nets (figure 3.29). The nets in the crystal structure interpenetrate, and hydrogen bond 
together at the points of interpenetration. None of the hypothetical 5FU crystal 
structures corresponds to this crystal structure.
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Figure 3.29: A single hydrogen bonded net present in the 5FU/thymine solid 
solution crystal structure. Four ring sub-units are shown
3.4 Discussion
3.4.1 The prediction of polymorphs of 5-fluorouracil
From the CSP search it was found that 5FU ribbon 1 was present in four of the five 
lowest energy hypothetical structures, showing that the close packing ability and 
intermolecular interactions available with this motif leads to lower energy crystal 
structures than those available based on the other observed motifs. Consequently on a 
calculated thermodynamic basis, the 5FU ribbon 1 motif was most likely to be found in 
a new polymorph. The experimental discovery of the new polymorph, form 2, that did 
indeed exhibit this motif confirmed the hypothesis.
The calculated energy difference from the energy minimisation of both 
polymorphs is almost 6 kJ mol'1 with form 2 most stable. It should be remembered that 
the energy minimisation process is carried out in effect at 0 K. The density of forms 1 
and 2 from the single crystal structures determined in this study were compared. The 
density rule36 states that, for a pair of polymorphs, the more dense structure is the more 
stable structure at 0 K. Form 2 is denser than form 1 at 150 K and so the density rule
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indicates that form 2 is more stable than form 1 at absolute zero, assuming that the 
density order doesn’t change between 150 K and absolute zero. This correlates with the 
calculated energy order. The results of the DSC experiments contradict the density rule 
and the calculated energy difference. Form 2 melts at a lower temperature than form 1, 
with a melt onset of 278° C vs. 283° C for form 1, and form 2 also has a lower heat of 
fusion, AHFonn2_>Uqujd= 200 J g ' compared to AHFoml^ liquld = 296 J g '1 for form 1. Form
2 is less stable close to the melting point of the two forms, as it melts first, and by 
applying the heat of fusion rule the two forms are found to be monotropically related, 
with form 2 less stable at all temperatures. The heat of fusion rule result may well be 
invalid due to the very high temperature at which the melt occurred -  it is likely that this 
was a decomposition event and indeed when the sample was recovered to room 
temperature it was no longer 5-fluorouracil.
Uncertainty in the applicability of the fluorine potential led to two further 
minimisations of the form 1 ExptMinOpt structure with modified fluorine potential 
parameters. The fluorine dispersion term was increased by 20% in one minimisation and 
the repulsion pre-exponential factor was decreased by 25% in the other. In neither case 
was the reproduction of the form 1 structure significantly altered and the lattice energy 
in both cases decreased by less than 1.5 kJ mol'1. It can be concluded that the 
reproduction of the form 1 structure by the unmodified FIT potential is satisfactory.
The method of crystallising form 2 from nitromethane proved unreliable, with 
form 1 returned more often than form 2. To gain an understanding of the crystallisation
processes that could lead to either form 1 or form 2 from nitromethane solutions, Said
• 180Hamad (the Royal Institution) undertook molecular dynamics studies of 
supersaturated 5FU solutions in pure nitromethane, pure water and nitromethane doped 
with 0.1% water. The simulation of 5FU molecules in water showed that the N-H and 
C=0 groups were strongly hydrogen bonded by water molecules leading to strong 
solvation of this part of the molecule, while the fluorine atom was more hydrophobic. 
This relative lack of fluorine solvation led by default to F -F interactions in the 
simulation, because the conventional hydrogen bonds were interrupted by the strongly 
bound water. In nitromethane the solvation of the 5FU molecules was generally weaker 
and lead to a greater number of strong N-H -0=C  hydrogen bonds compared to the 
water simulation and even the formation of R ^ )  5FU dimer and trimer self-
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associations. In the water-doped nitromethane simulation, with four water molecules per 
5FU molecule, the water molecules generally formed hydrogen bonds with the 5FU 
molecules again blocking the formation of strong hydrogen bonds, or in the case where 
one single hydrogen bond did occur, prevented the formation of the R-2 OO dimer. 
Nitromethane is a hygroscopic solvent and the simulations show that even 0.1% 
contamination with water could be sufficient to disrupt the form 2 crystallisation 
pathway, yielding form 1 by default. This concurs with the experimental evidence, and 
suggests that even initially dry nitromethane could collect sufficient atmospheric water 
to alter the crystallisation pathway in favour of form 1.
3.4.2 Relationship between CSP structures and solvate crystal structures
The 5FU ribbon 2 motif was the most popular motif present in the set of low energy 
hypothetical structures and this, along with its presence in the crystal structures of 
several other 5-substituted uracils, indicated that it was a motif that could be expected to 
be observed in a new polymorph. However 5FU ribbon 2 has a significant disadvantage 
compared to 5FU ribbon 1 that could account for its lowest energy structures not being 
as low in energy as the lowest energy structures based on 5FU ribbon 1. In 5FU ribbon 
2 the two R ^ )  rings share the same carbonyl acceptor and the second carbonyl 
oxygen present in the 5FU molecule is not hydrogen bonded. There are no strong 
hydrogen bond donors that are not involved in the two R ^ )  rings in 5FU ribbon 2 and 
consequently the second 5FU carbonyl oxygen does not form a strong hydrogen bond in 
crystal structures that exhibit 5FU ribbon 2. Two of the six solvates discovered in the 
course of the crystallisation screen show the 5FU ribbon 2 motif, with the solvent 
providing the extra hydrogen bonding capability to enable the second 5FU carbonyl 
oxygen to be hydrogen bonded. In the case of the 2,2,2-trifluoroethanol solvate the 
hydroxyl group from the solvent hydrogen bonds to the second 5FU carbonyl oxygen 
and in the benzonitrile solvate it forms a weak C-H - 0  hydrogen bond to the 
benzonitrile molecule, which is not capable of forming strong hydrogen bonds.
The 5FU form 1 structure is not observed in the low energy hypothetical 
structures because of a limitation of the CSP procedure which can only generate 
structures with one molecule in the asymmetric unit and the most unique aspect of the 
form 1 structure, the F—F tetramer, is not observed in any of the low energy structures.
121
The fluorine tetramer was observed, however, in the crystal structure of the 1,4-dioxane 
solvate. This solvate structure could be viewed as the result of an interruption to the 
form 1 crystallisation pathway, with the F -F  tetramer feature formed, but the formation 
of the ring around the tetramer interrupted by the strongly hydrogen bonded 1,4-dioxane 
molecules, leading to the solvate rather than form 1.
The three other solvates did not show any similarities to the predicted motifs.
3.5 C onclusion
The crystal structure prediction of 5-fluorouracil generated a large range of low energy 
hypothetical structures, but only a small number of recurrent hydrogen bonded motifs. 
The discovery during this study of one new polymorph, six solvates and one solid- 
solution co-crystal containing 5-fluorouracil highlights the versatility of crystallisation 
of 5-fluorouracil, both with itself and other species.
The hydrogen bonded motif present in the lowest energy predicted structures 
proved to be the motif observed in the new polymorph discovered during the 
experimental crystallisation screen and upon energy minimisation this new polymorph 
corresponded exactly to the lowest energy predicted structure. This crystal structure
prediction would be judged a success by the criteria of the CCDC international blind
1^1 1tests, ' as the global energy minimum structure would be submitted as one of the 
three predicted structures most likely to correspond to an observed crystal structure. 
Attempts to elucidate which polymorph was thermodynamically most stable proved 
inconclusive.
The most prevalent hydrogen bonded ribbon motif found in the search structure 
was experimentally observed in two solvates, and its discovery in these crystal 
structures proved that this ribbon was indeed a realistic and experimentally realisable 
hydrogen bonded motif, that required the further hydrogen bonding functionality of the 
solvent in these crystal structures before it could crystallise. The hydrogen bonded motif 
found in 5-fluorouracil form 1 was not observed in any of the hypothetical structures, 
and even its most salient feature, the tetramer of F -F close contacts, was not found. 
This feature was observed however in one of the solvates, which may be an example of 
an interruption to the form 1 crystallisation pathway.
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Crystal Data
Compound name 5-Fluorouracil
form 1
Empirical formula C4H3N20 2F
Formula weight 130.1
Crystal system, space group Triclinic, P  1
a (A) 8.6329(12)
b (A) 9.1560(13)
c (A) 12.5796(18)
a (°) 99.119(2)
(3 0 100.021(3)
Y(°) 90.017(2)
v  (A3) 966.4(2)
Z',Z 4 ,8
D(calc (g cm'3)) 1.788
Data Collection
Crystal size (mm) 0 .2 2 x 0 .2 0 x 0 .1 9
Temperature (K) 150(2)
hkl range (h, k, 1) -11—>11, -12—>11, -16
Reflections measured, Rint 8688, 0.0252
Independent reflections 4489
Reflections I>2o(I) 3470
Refinement
Parameters refined 373
R(F) (I>2o(I)) 0.049
wR(F2) (all reflections) 0.122
Residual electron density 0.34, -0.29
(min, max (e A'3))
5-Fluorouracil 
form 2 
C4H3N20 2F 
130.1
Monoclinic, P2\!c 
5.0433(12) 
14.935(3) 
6.6049(15)
90
108.884(4)
90
470.7(2)
1,4
1.836
0 .3 0 x 0 .1 7 x 0 .1 3
150(2)
16 -6—>6, -19—>19, -8 
3956, 0.0198 
1127 
1020
94
0.054 
0.153 
0.42, -0.26
5-Fluorouracil 5-Fluorouracil
2,2,2-trifluoroethanol benzonitrile
c 4h 3n 2o 2f , c 2h 3o f 3 c 4h 3n 2o 2f , c 7h 5n
230.1 233.2
Monoclinic, P 2X Monoclinic, P 2 x/c
5.3976(6) 7.0460(7)
6.7062(8) 24.035(2)
12.1098(14) 6.8640(7)
90 90
102.807(2) 116.554(2)
90 90
427.44(9) 1039.8(2)
1,2 1,4
1.788 1.490
1 .4 9 x 0 .3 4 x 0 .1 7 0.61 x 0 .37 x 0 .2 0
150(2) 150(2)
-7-*4, -8—>8, -15—>-15 -8-*9, -31—>-27, -8—>9
2621,0.0159 6296, 0.0158
1090 2458
1060 2120
160 186
0.027 0.037
0.073 0.112
0.30, -0.25 0.27, -0.24
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Crystal Data
Compound name
Empirical formula 
Formula weight 
Crystal system, space group 
a (A) 
b (A) 
c (A) 
a (°)
P(°) 
y(°) 
v  (A3)
Z',Z
D(calc (g cm'3))
Data Collection
Crystal size (mm) 
Temperature (K) 
hkl range (h, k, 1) 
Reflections measured, Rin, 
Independent reflections 
Reflections I>2o(I) 
Refinement 
Parameters refined 
R(F) (I>2o(I)) 
wR(F2) (all reflections) 
Residual electron density 
(min, max (e A'3))
5-Fluorouracil 
1,4-dioxane
C4H3N20 2F, >/4(C4H80 2)
152.1
Triclinic, P  1 
7.0847(11)
8.4733(13)
10.2291(15)
98.128(3)
96.913(3)
99.785(3)
592.5(2)
2 ,4
1.705
0.35 x 0.24 x 0.03 
150(2)
-9—>9, -11—>11, -13—>13
5320, 0.0291
2741
2131
230 
0.052 
0.114 
0.33, -0.33
5-Fluorouracil 
formamide 
C4H3N20 2F, CH3NO
175.1
Monoclinic, P 2x/m 
6.827(4)
6.111(3)
8.424(4)
90
90.313(8)
90
351.4(3)
0 .5 ,2
1.655
0.33 x 0 .26x0 .15  
150(2)
-8—>8, -7—>7, -1 0 ^ 1 0  
2892, 0.0243 
866 
765
92
0.041
0.111
0.43, -0.28
5-Fluorouracil 
dimethylformamide 
C4H3N20 2F, VKQHrNO) 
166.6
Monoclinic, P 2x/n 
14.7361(18)
5.8693(7)
16.397(2)
90
100.524(2)
90
1394.3(3)
2 , 8
1.588
0.42x0.21  x 0.11 
150(2)
-19—>19, -7—>7, -21—>20
11701,0.0315
3331
2768
238 
0.049 
0.108 
0.29, -0.22
5-Fluorouracil 
dimethylsulfoxide 
C4H3N20 2F, C2H6OS
208.2
Monoclinic, P 2 x/c 
9.8831(10)
10.8128(11)
8.6842(9)
90
107.397(2)
90
885.58(16)
1,4
1.562
0 .29x0.21  x 0.11 
298(2)
-13—>12, -14—>14, -11—>11
7666, 0.0220
2127
1921
140 
0.036 
0.090 
0.40, -0.54
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Crystal Data
Compound name
Empirical formula 
Formula weight 
Crystal system, space group 
a (A) 
b (A) 
c (A)
CL(°)
P(°)
y(°) 
v  (A3)
Z', z
D(calc (g cm'3))
Data Collection
Crystal size (mm) 
Temperature (K) 
hkl range (h, k, 1) 
Reflections measured, Rint 
Independent reflections 
Reflections I>2a(I) 
Refinement 
Parameters refined 
R(F) (I>2g(I)) 
wR(F2) (all reflections)
Residual electron density 
(min, max (e A'3))
5-Fluorouracil
thymine
0.61(C4H3N2O2F), 0.39(C5H6N2O2) 
257.1
Monoclinic, C ite  
19.3785(15)
5.9918(5)
20.0293(15)
90
117.813(1)
90
2057.0(3)
2 , 8
1.660
0 .7 9 x 0 .2 2 x 0 .2 0
150(2)
-25—>25, -7—>7, -26-
8568,0.0155
2459
2232
207 
0.037 
0.096 
0.35, -0.19
►26
Table 3.7: Crystal structure summary for all 5FU crystal structures included in this chapter
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Chapter 4 -  5-Fluorocytosine
4.1 Introduction
5-Fluorocytosine (4-amino-5-fluoropyrimidin-2-one, 5FC, figure 4.1) is the 
5-fluorinated analogue of the DNA nucleobase cytosine, and has important medical 
applications. The first reported medical use of 5-fluorocytosine,181 in 1968, was in the 
treatment of systemic fungal infections. Since then it has commonly been used in 
combination with amphotericin B as an anti-fungal treatment.182 A more recent 
application is its use as a pro-drug for the delivery of 5-fluorouracil to tumour cells in 
patients. Delivered in combination with cytosine deaminase, this enzyme converts the 
5-fluorocytosine to 5-fluorouracil in vivo which is then subsequently converted to 
pyrimidine anti-metabolites by cellular enzymes. In the intervening 37 years between its 
first medical use and this study184 no anhydrous crystal structure has been published; the 
only structure containing 5-fluorocytosine present in the CSD23 is that of a 
monohydrate.185
Figure 4.1: Molecular structure and crystallographic numbering of
5-fluorocytosine
5FC was investigated using computational crystal structure prediction to predict 
possible anhydrous crystal structures, and a simultaneous manual crystallisation screen 
to discover whether any of these predicted crystal structures could be found 
experimentally.
02
H4
H1
C5 N4
F5 H3
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4.2 Crystal structure prediction
4.2.1 Energy minimisation o f the polymorphs of 5-fluorocytosine
Two polymorphs of 5FC were discovered in the course of the crystallisation screen. The 
molecular conformation of the 5FC molecule was ab initio optimised and the resultant 
conformation was found to exhibit significant pyrimidisation of the NH2 group, more 
pronounced than in any of the molecular conformations found in 5FC experimental 
crystal structures. This observation, combined with the known uncertainty concerning 
the degree of pyrimidisation induced into amino groups by ab initio optimisation
1 RAmethods, led to a further, constrained, molecular optimisation in which the amino 
group was constrained to be planar. The crystal structures of both polymorphs were 
energy minimised with their experimental molecular conformations, the ab initio 
optimised molecular conformer, and the planar constrained conformer.
In all DMAREL135 energy minimisations a distributed multipole analysis88 of 
the MP2/6-31G(d,p) charge distribution was used to model the electrostatic contribution 
to the intermolecular potential and the dispersion and repulsion contributions were
7 7  7Qmodelled using the FIT ‘ parameters for C H N O atoms and additional parameters 
for the fluorine atoms.80
For both polymorphs the energy minimisations with the experimental molecular 
conformations led to excellent reproductions, with F-values under 5 and very small 
errors in all the lattice parameters. The energy minimisations of form 2 with both ab 
initio and planar molecular conformations produced satisfactory reproductions of the 
experimental crystal structure, with the largest variation in a cell parameter of 2.9% 
(table 4.1). The energy minimisation of form 1 with the planar conformation was also 
successful, returning an F-value of 11 and with a largest cell parameter error of 1.6% 
(table 4.1).
The energy minimisation of form 1 with the ab initio molecular conformation 
led to significant rearrangement of the molecules, resulting in a poor reproduction of the 
experimental crystal structure and breaking of the tetragonal symmetry. The differences 
between the experimental and optimised conformations were small and it was 
concluded that the reproduction of this crystal structure must be critically dependent on 
very minor conformational change. A series of constrained ab initio optimisations was
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performed in an attempt to find the critical difference that caused the lattice energy 
minimisation with the fully ab initio optimised molecular conformation to give such a 
poor reproduction of the experimental crystal structure. A successful minimisation was 
achieved by fixing the relative positions of the six atoms in the ring of the molecule, 
while allowing the peripheral groups (NH2 , F5, 02, HI, H4) to optimise. The lattice 
energy minimisation using this partially optimised molecular structure (form 1 ring- 
fixed ExptMinConOpt) led to a satisfactory reproduction with an F-value of 7 and 
largest cell parameter error of 1.1% (table 4.1). This ring-fixed constrained 
conformation was as close to the fully ab initio optimised conformation as could be 
found without producing the drastic structural changes detailed above upon energy 
minimisation.
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5 -F lu o r o c y t o s in e
F orm  1 F orm  2
E x p e r im e n ta l
E xp tM in C o n O p t
r in g -fix e d
%
error
E xp tM in C o n O p t
P la n a r
%
error E x p er im en ta l
E xp tM in O p t  
ab  initio
%
error
E x p tM in C o n O p t
P la n a r
%
error
a (A) 6.639 6.702 0.96 6.743 1.57 4.063 4.120 1.40 4.083 0.50
b (A) 6.639 6.702 0.96 6.743 1.57 9.521 9.600 0.84 9.555 0.36
c(A) 23.471 23.72 1.06 23.709 1.02 12.739 12.844 0.83 13.112 2.93
P(°) - - - 92.99 92.17 -0.87 92.75 -0.25
V o lu m e  (A3) 1034.3 1065.5 3.00 1078.09 4.22 492.1 507.66 3.16 510.93 3.83
D e n s ity  (g  c m 3) 1.658 1.610 -2.88 1.591 -4.05 1.742 1.689 -3.06 1.678 -3.69
F inal E n e r g y  
(kJ m o l'1)
-123.87 -115.85 -117.12 -116.99
F 7.00 10.90 10.64 17.28
Table 4.1: Summary of the energy minimisation results for the polymorphs of 5FC, using different molecular models. Planar 
molecular conformations were used for both polymorphs, the fully ab initio optimised conformation was also used for form 2 and a 
conformation with the ring atoms fixed was also used for form 1
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4.2.2 Crystal structure prediction -  results
The MP2/6-31G(d,p) ab initio optimised conformation was used as the input for the
120MOLPAK search. However, because the NH2 conformation exhibited pronounced 
pyrimidisation in the ab initio conformer, a supplementary search was carried out using 
the fully planar molecular conformation. The MOLPAK searches both used 37 packing 
types that generated structures in 18 common space groups. DMAREL135 energy 
minimisation of the resultant structures was performed using the same model potential 
as used earlier: distributed multipole analysis of the MP2/6-31G(d,p) wavefunction to 
model the electrostatic term combined with the FIT plus fluorine dispersion-repulsion 
potential.
The crystal structure search with the ab initio optimised molecular conformation 
generated 33 hypothetical structures within 10 kJ mol"1 of the global energy minimum 
(figure 4.2) and the search with the planar conformation generated 46 hypothetical 
structures (figure 4.3). Structures that initially minimised to a saddle point had up to two 
symmetry operators removed sequentially, those that were associated with the most 
negative eigenvalue from the second derivative matrix. If this did not lead to a true 
energy minimum the structure was discarded. This resulted in approximately 1/6 of the 
structures from the ab initio search and 1/4 of the structures from the planar search 
having 2! > 1. Included in both scatter plots are the positions of the energy minimised 
experimental structures, with the corresponding molecular conformation. Summary 
tables of the low energy structures from both searches including reduced cell 
parameters, graph set analysis and hydrogen bond information along with the CSP 
molecular numbering scheme are included in the supporting information.
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Predicted structures that corresponded to the energy minimised 5FC form 2 structures 
were found in both searches, ranked third in the ab initio search and found at the global 
energy minimum in the planar search. In neither search was a predicted structure found 
that corresponded to the form 1 crystal structure, though this can be attributed to the 
crystallisation of form 1 in the unusual space group P4\2\2 -  a space group in which 
MOLPAK does not generate structures. More significantly the energy order of the two 
polymorphs was different depending on the conformation used -  with the planar 
conformation form 2 was calculated to be 1.1 kJ m o l1 more stable than form 1, while 
for the ab initio conformation form 1 was more stable by over 6 kJ mol'1. It must be 
appreciated that the form 1 minimisation was not carried out with the fully ab initio 
optimised conformation but was performed with the ring-fixed constrained molecular 
conformation, making a direct energy comparison to the ab initio form 2 energy 
minimised structure not strictly appropriate.
Two different ribbon structures occurred repeatedly within the hypothetical 
structures from the ab initio search. Ribbon motif 1 (RM1, figure 4.4) is the dominant 
hydrogen bonding motif, present in 30 of the 33 hypothetical structures including all of 
the structures within 8.3 kJ mol'1 of the ab initio search global energy minimum. Two 
structures exhibited an alternative ribbon motif (RM2, figure 4.5), however the lowest 
energy structure exhibiting this ribbon motif was 9 kJ mol'1 above the global energy 
minimum. A single structure showing a sheet motif, where each molecule forms one 
hydrogen bond dimer and two single hydrogen bonds, occurred 8.3 kJ mol'1 above the 
global energy minimum.
Of the 46 structures found in the planar search 27 exhibit RM1, 13 exhibit RM2 
and the remaining 6 structures show alternative hydrogen bonding motifs usually based 
on one hydrogen bond dimer and two single hydrogen bonds per molecule. The 21 
structures in the lowest 4.6 kJ mol'1 were all RM1 structures, with RM2 structures only 
present at more than 5.2 kJ m ol1 above the global energy minimum.
Ribbon RM1 is characterised by a single R ^ )  dimer interaction, with the 
hydrogen bond components N1 -HI —N3 and N4-H2--02 (figure 4.4).
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Figure 4.4: Ribbon motif 1, RM1 [first order graph set: C[(4),C[(6); second 
order: R ^ ) ]
Ribbon RM2 propagates via two different alternating R ^ )  dimers: one dimer is 
comprised of two N4-H2—N3 hydrogen bonds and the other is comprised of two N l- 
H l—02 hydrogen bonds (figure 4.5).
Figure 4.5: Ribbon motif 2, RM2 [first order graph set: R 2 (8 )a ,R 2 (8 )b ]
5FC has an unequal number of hydrogen bond donors and acceptors, with three N-H 
potential donors and only two acceptors: the carbonyl and aza groups. The three lowest 
energy structures from the ab initio search and the two lowest energy structures from 
the planar search all form a further 5FO-5FC hydrogen bond, N4-H3—02 or N4- 
H3—N3, in addition to the hydrogen bonds in the RM1 ribbon. This contrasts with the 
majority of predicted structures from both searches in which the final amino hydrogen 
on each molecule is left unused. The search results clearly show that there is an 
energetic preference for forming structures that contain RM1, and also for forming 
inter-ribbon hydrogen bonds to allow all hydrogen bonding groups present in 5FC to be 
used.
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4.3 Experimental crystallisation screen
4.3.1 Crystallisation screen
5FC was found to be insoluble in chloroform, cyclohexane, diethylether, DMF, hexane, 
and toluene. The crystallisation grid shown in table 4.2 was completed. The 
crystallisation methods employed were evaporation of saturated solutions at room 
temperature and 5° C, evaporation of 50% saturated solutions at room temperature and 
5° C, vapour diffusion with diethyl ether anti-solvent and vapour diffusion with toluene 
anti-solvent. A smaller subset of saturated solvent evaporations from aqueous two 
solvent systems was also carried out. The solvents used were acetone, benzonitrile, 
ethanol, methanol, 2-butanol and 2-propanol. 1:9, 1:3 and 1:1 water : solvent ratios were 
used.
Of the 227 crystallisations set up 53 produced crystals that were characterised by 
SXRD unit cell determination. Where new unit cells were found, full data sets were 
collected and the crystal structure determined. Two polymorphs, a new monohydrate, a 
hemipentahydrate, methanol and 2,2,2-trifluoroethanol solvates, as well as the known 
monohydrate (crystal structure redetermined) were found. A co-crystal monohydrate 
was also discovered in the course of the crystallisation screen with the minor synthetic 
by-product 5-fluoroisocytosine.
A crystallisation database, summarising all crystallisations and results, is 
provided on the supporting information CD (in Chapter_4_5Fluorocytosine) and a 
summary spreadsheet detailing crystallisation conditions for all of the forms of 
5-fluorocytosine is also given (Crystallisation_Summary.xls).
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Solvent EV 100 RT
EV 50 
RT
m
Ol
 
<
o
o EV 50
5°C
VD
toluene
VD
ether
A c e to n e X X X X
B en zon itr ile X X X X X X
E thanol X X X X X X
M eth an ol X X X X X X
2 -b u ta n o l X X X X X X
2 -p ro p a n o l X X X X X X
1 ,4 -d io x a n e X X X X X X
1 -m e-2 -p y rro lid in o n e X X X X X X
2 ,2 ,2 ,-tr iflu o ro eth a n o l X X X X X X
2 -ch lo ro e th a n o l X X X X X X
A c e ta ld e h y d e X X X X X X
A cetic  A cid X X X X X X
A ceton itrile X X X X X X
D iisoprop yl e th er X X X X X X
E th y la ce ta te X X X X X X
E th y len e  g lyco l X X X X X X
M ethyl b e n z o a te X X X X X X
N itro m eth a n e X X X X X X
o -x y le n e X X X X X X
T e tr a ch lo ro e th y len e X X X X X X
T etrahydrofuran X X X X X X
1 ,2 -d ich lo ro e th a n e X X X X
D ich lo ro m eth a n e X X X X
D im eth y lsu lfox id e X
F orm am id e X
W ater X
Table 4.2: Experimental crystallisation screen carried out on 5FC. x denotes that this crystallisation was set up; EV = solvent 
evaproration of 100% and 50% solutions at room temperature and 5°C; VD = vapour diffusion with toluene or diethyl ether
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4.3.2 5-Fluorocytosine polym orphs
Two polymorphs of 5FC were discovered in the course of the crystal structure screen. 
5-Fluorocytosine form 1
Crystals of form 1 were originally grown by vapour diffusion of diethyl ether into a 
saturated solution of 2-propanol and the structure was determined by SXRD. Form 1 
exhibits a block morphology, usually observed with well-defined faces. It crystallises in 
the tetragonal space group P4i2i2, with a single molecule in the asymmetric unit (figure 
4.6 and table 4.4).
Figure 4.6: Asymmetric unit of 5FC form 1
The structure exhibits RM1 with the ribbons stacking in an ABAB repeat pattern. The 
planes of the ribbons in adjacent stacks are parallel to different planes -  in one the 
ribbon planes are parallel to the 2-2 8 Miller planes and in the adjacent stack the ribbon 
planes are parallel to the -2 -2 8 Miller planes. An inter-ribbon hydrogen bond, N4- 
H3 02, is also present which satisfies the N-H hydrogen bond donor that was not used 
in forming the RM1 ribbon. This hydrogen bond incorporates the two dimensional RM1 
motif into a three dimensional hydrogen bond network (figure 4.7).
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Figure 4.7: Crystal packing of 5FC form 1. A single ribbon from the central stack 
is included and three from each of the adjacent stacks. View parallel to the 
diagonal of the ab plane
The powder pattern of 5FC as supplied (Fluorochem, Old Glossop, 98% purity) was 
measured over the 20 range 5-30°. This pattern closely matched the simulated powder 
pattern from the form 1 crystal structure. Three small peaks were observed in the 
commercial material sample at approximately 11.5, 16.7 and 24.8° and are assumed to 
be due to synthesis by-products in the supplied sample. Crystals of form 1 were 
reproducibly obtained by sublimation over a period of 30 hours at 200-215 °C under 
dynamic vacuum (~1 mm Hg), as confirmed by XRPD (figure 4.8).
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Figure 4.8: XRPD of commercial 5FC (red), the product of sublimation (blue) and 
the simulated pattern of the form 1 crystal structure (black)
5-Fluorocytosine form 2
A second polymorph of 5FC, form 2, was discovered by solvent evaporation from 5% 
aqueous 2-propanol. This crystallisation experiment exhibited concomitant 
polymorphism,46 with the block crystals in the crystalline product proving to be form 1 
and the plate crystals form 2. Form 2 crystallises in the space group P2\/n with one 
molecule in the asymmetric unit (figure 4.9 and table 4.4).
138
Figure 4.9: Asymmetric unit of 5FC form 2
The crystal structure contains RM1 hydrogen bonded ribbons and the additional 
hydrogen bond, N4-H3- 02, links the ribbons viaR \ (8) rings into sheets (figure 4.10). 
These sheets lie parallel to the 1 0 1 Miller planes, stack directly in the structure and 
have a stepped cross-section. The ribbons are rippled in form 2, rather than the flat 
topology exhibited by the RM1 ribbons in form 1.
Figure 4.10: The hydrogen bonded sheet structure in 5FC form 2
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Subsequent crystallisation experiments revealed that while both forms initially 
crystallise from solution, over a period of days small blocks start to grow on the surface 
of the form 2 plates, and the plates gradually dissolve at the expense of the blocks. The 
form 1 blocks from the initial crystallisation show no morphology change over the same 
period and the blocks growing on the form 2 plates are assumed to be form 1. It can be 
deduced from these observations that form 2 is metastable at room temperature with 
respect to form 1. The three crystals in figure 4.11 were photographed in situ in the 
same crystallisation experiment and show this phase change -  the block crystal (1) is 
form 1, with the form 2 plate (2) showing several form 1 block crystals on its surface. 
The form 2 plate (3) is beginning to show signs of the transformation.
Figure 4.11. Photograph of the in situ phase change from form 2 to form 1. 1: form 
1 crystal; 2: form 2 plate covered in form 1 blocks; 3: form 2 block early stage of 
phase transformation
4.3.3 5-Fluorocytosine hydrates
water at room temperature, and further to this, the crystallisation screen yielded a 
second monohydrate crystal structure. This provides an illustration of the inadequacy of 
the term ‘pseudopolymorph’ -  using this term these monohydrates would have to be 
described as ‘polymorphic pseudopolymorphs’. A hemipentahydrate of 5FC was also 
found.
The published monohydrate form of 5FC was easily reproduced by crystallisation from
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5-Fluorocytosine monohydrate form 1(h)
The published monohydrate structure, hereafter form 1(h), was redetermined by SXRD 
at 150 K and this produced a more accurate determination of the structure. The crystals 
were grown by solvent evaporation from a saturated aqueous solution at room 
temperature. 5FC form 1(h) crystallises in the monoclinic space group P2\!c with two 
5FC molecules and two water molecules in the asymmetric unit (figure 4.12 and table 
4.4).
Figure 4.12: Asymmetric unit of 5FC monohydrate form 1(h)
This structure exhibits RM1, with each of the independent 5-fluorocytosine molecules 
from the asymmetric unit alternating in the ribbon. Each molecule participates in two 
R 2 (8) hydrogen bond dimers, with each dimer having the same constituent hydrogen 
bonds: N1-H1-N13 (or N11-H11-N3) and N14-H12- 0 2  (or N4-H2-012). These 
interactions propagate to form the RM1 ribbons. The ribbons stack directly in columns 
parallel to the ab plane, with a ribbon spacing of approximately 3.2 A. One water 
molecule, H21-021-H22, forms four hydrogen bonds: as a donor to a 5-fluorocytosine 
molecule (021-H21—012), as an acceptor to a second 5-fluorocytosine molecule (N4- 
H3—021), as a donor to another water molecule (021-H22—031) and as an acceptor to 
a different water molecule (0 3 1-H31—021). The second independent water molecule 
(H31-031-H32) has a similar hydrogen bonding pattern, acting as a hydrogen bond 
donor to one 5-fluorocytosine molecule (031-H32—02) and as a hydrogen bond 
acceptor to a second 5-fluorocytosine (N14-H13—031) along with participating in the
®F5
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two water--water hydrogen bonds described above. The water molecules form discrete 
cyclic tetramers, denoted R4 in the terminology introduced by Infantes and Motherwell
1 O'?
to classify water patterns in hydrate crystal structures. These water tetramers occupy 
channels in the structure parallel to the b axis and hence the structure is a channel 
hydrate.11 The water tetramers act as bridges between six 5-fluorocytosine ribbons to 
form a three dimensional hydrogen bonded network. Adjacent columns of 5- 
fluorocytosine ribbons have no interactions with each other except via the cyclic water 
tetramers (figure 4.13).
a
Figure 4.13: Crystal packing of 5FC monohydrate form 1(h). W ater tetramers 
mediate all 5FC ribbon***ribbon contacts
DSC and TGA were performed on the sample of 5FC form 1 obtained from 
sublimation, the commercial material, and the form 1(h) monohydrate. The Form 1 
sublimation product and the commercially supplied material decomposed with an onset 
temperature of 301-302° C with no other events prior to decomposition. The form 1(h) 
monohydrate showed a single mass loss event of 11.7% of the initial mass at an onset 
temperature of 99° C. The water in the crystal structure was calculated to comprise 
12.3% of the mass and so this event is the loss of the water from the structure. The 
resulting phase exhibited a sharp decomposition event at an onset of 299° C. XRPD 
before and after dehydration (vacuum dessication, 72 hrs, over sodium pentoxide)
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proved that the form 1 (h) monohydrate underwent a phase transition upon dehydration 
to the form 2  anhydrous structure.
5-Fluorocytosine monohydrate form 2(h)
A new monohydrate structure, hereafter form 2(h), was obtained from a 50% saturated 
solution of tetrahydrofuran by solvent evaporation at room temperature, and with form 
1(h), is a rare example of a pair of polymorphic monohydrates. The crystallisation 
experiment has no water explicitly contained within it, but residual water may have 
been present in the solvent, or was incorporated from the atmosphere -  as only one 
crystal grew in each crystallization vessel, only a trace amount of water would have 
been required to form this monohydrate. This monohydrate crystallises in the triclinic 
space group P 1, with one molecule of 5FC and one water molecule in the asymmetric 
unit (figure 4.14 and table 4.4).
) H8B
7 OH8A
Figure 4.14: Asymmetric unit of 5FC monohydrate form 2(h)
The 5FC molecules adopt the RM2 ribbon, in contrast to all of the other crystal 
structures reported in this chapter, other than the co-crystal. The ribbons stack as the 
0 1 -1 Miller planes. One of the hydrogen atoms in the water molecule is disordered 
over a general site and the inversion centre at (0, 0.5, 0.5). The other hydrogen atom 
(H7) in the water molecule is not disordered. The water molecule forms three hydrogen 
bonds, two to 5-fluorocytosine molecules (03-H7--02 and N4-H3- 02) and one to
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either of two neighbouring water molecules, 03-H8B- 03 or 03-H8A—03, depending 
on the disordered hydrogen occupation (figure 4.15). The structure is a channel 
hydrate, 11 with the channels parallel to the a axis.
Figure 4.15: Two ribbons joined by two water molecules. In both water molecules 
full bonds are shown to the partial hydrogen at the general site and dotted lines 
joins the partial hydrogen on the inversion centre to both water oxygen atoms
5-Fluorocytosine hemipentahydrate (2/5)
A hemipentahydrate of 5FC was originally produced by solvent evaporation from a 
saturated solution of 25% aqueous acetone at 5° C. The structure has also been 
subsequently crystallised from other aqueous solvent mixtures, most commonly 25% or 
50% water mixtures with acetone, THF or ethanol. This compound crystallises in the 
space group P2\lc with two molecules of 5FC and five molecules of water in the 
asymmetric unit (figure 4.16 and table 4.4).
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Figure 4.16: Asymmetric unit of 5FC hemipentahydrate
The two independent 5FC molecules alternate in a RM1 structure, with the ribbon 
propagating by the R.2 (8 )dimer interactions HI 1-N11--N3/N4-H2---012 and N14- 
H12—02/N1-H1—N13. The structure is a planar hydrate11 with the water molecules 
forming sheets parallel to the be plane. Within the sheet, alternating ribbons of hexamer 
and pentamer units occur, with all units sharing edges. In the terminology of Infantes 
and Motherwell, 187 the sheet can be seen as comprised of alternating T5(2)5(3) tapes 
(pentamers) and T6(2) tapes (hexamers), giving an overall layer nomenclature of 
L5(6)6(10) (figure 4.17). In the crystal structure, the hydrogen atoms have been placed 
on the water molecules according to the most significant peaks in the electron density 
map. However there is a degree of disorder in their positions, and consequently figure 
4.17 does not include any hydrogen atoms, but shows the overall water hydrogen 
bonding motif.
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Figure 4.17: Water sheets observed in 5FC hemipentahydrate
The 5FC ribbons stack into columns and the water sheets lie between adjacent columns. 
Adjacent columns do not come into contact with each other, but both hydrogen bond to 
the water sheet separating them (figure 4.18). Four crystallographically independent 
5FC—water hydrogen bonds are present in the structure.
v. X
Figure 4.18: Packing diagram for 5FC hemipentahydrate showing a side view of 
the water sheets packing between 5FC columns
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The 5FC hemipentahydrate was unstable at room temperature and repeated TGA 
experiments showed inconsistent mass loss for the dehydration event, because of water 
loss from the structure prior to the beginning of the experiment.
4.3.4 5-Fluorocytosine solvates
5-Fluorocytosine methanol (2/1)
A 5FC hemimethanolate was crystallised from a saturated solution of methanol by 
solvent evaporation at 5° C. It crystallises in the space group P2\/n with two 5FC 
molecules and one methanol molecule in the asymmetric unit (figure 4.19 and table
4.4).
Figure 4.19: Asymmetric unit of 5FC methanol solvate
There are two crystallographically independent ribbons in the structure with each 
generated using one of the independent 5FC molecules from the asymmetric unit. Both 
of the ribbons propagate are RM1 ribbons containing the single R \ (8) dimer. The 
ribbons stack to form columns parallel to the 0 0 1 Miller planes. In each column both 
independent ribbons are present in an alternating repeat pattern. The methanol hydroxyl 
group acts as a bridging group, forming one donor (021-H24—012) and two acceptor 
(N4-H3—021; N14-H13—021) hydrogen bonds to three different ribbons. Two of the 
ribbons are members of the same column and the third is a member of an adjacent 
column (figure 4.20).
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Figure 4.20: Crystal packing in the 5FC methanol solvate. Ribbons propagate 
parallel to the b axis and are connected via methanol molecules
5-Fluorocytosine 2,2,2-trifluoroethanol (1/1)
A 1:1 5FC 2,2,2-trifluoroethanol solvate was obtained by solvent evaporation at room 
temperature from a saturated solution of 2,2,2-trifluoroethanol. It crystallises in the 
space group P2\/c with one 5FC molecule and one 2,2,2-trifluoroethanol molecule in 
the asymmetric unit (figure 4.21 and table 4.4).
F11
F12
/  C11
011
N4
i  Ft3
Figure 4.21: Asymmetric unit of 5FC 2,2,2-trifluoroethanol solvate
The 5FC molecules again form the RM1 ribbon, and the ribbons stack in columns with 
an ABAB repeat pattern parallel to the 1 0 0 Miller planes. The 2,2,2-trifluoroethanol 
molecules form two hydrogen bonds -  acting as an acceptor (N4-H3- 011) and a donor 
(011-H13 *02) to 5FC molecules from adjacent ribbons in the same column. These 
hydrogen bonds generate a sheet, comprised of an inner layer of 5FC molecules and
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outer layers of 2,2,2-trifluoroethanol molecules. There are no hydrogen bond 
interactions between adjacent sheets but the outer layers of 2,2,2-trifluoroethanol 
molecules from adjacent sheets interlock (figure 4.22).
P a
Figure 4.22: 5FC 2,2,2-trifluoroethanol solvate crystal packing. Two columns of 
5FC ribbons parallel to the be plane, separated by 2,2,2-trifluoroethanol molecules
4.3.5 5-fluorocytosine 5-fluoroisocytosine co-crystal
1885-Fluorocytosine 5-fluoroisocytosine monohydrate (1/1/1)
A co-crystal monohydrate of 5-fluorocytosine with its isomer 5-fluoroisocytosine was 
grown from a 50% aqueous solution of ethanol saturated with 5FC by solvent 
evaporation. Two different crystal forms were obtained from this solution. The major 
crystallisation product exhibited a block morphology and was the form 1(h) 
monohydrate (identified by SXRD unit cell determination). A small number of lath 
shaped crystals were observed as the minor crystallisation product. 5-Fluoroisocytosine 
is assumed to present in the commercial sample as a by-product originating from the 
synthesis. This co-crystal monohydrate crystallises in the space group P I  with one 
molecule of 5FC, one molecule of 5-fluoroisocytosine and a molecule of water in the 
asymmetric unit (figure 4.23 and table 4.4).
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Figure 4.23: Asymmetric unit of 5FC 5-fluoroisocytosine monohydrate
The simplest hydrogen bonded sub-unit observed is a two molecule unit, containing one 
molecule of each isomer, joined by a triplet of hydrogen bonds: N4-H2—014, N13- 
H13 - N3 and N12-H12—02 (figure 4.24). This triplet required complimentary edges to 
be present in the two isomers, and this triplet is analogous to that found in base pairing 
between cytosine and guanine in DNA. R ^ )  hydrogen bonded rings join the triplet 
sub-units together to form a ribbon (figure 4.24). The role of the water molecules in the 
structure is to join together the ribbons into a hydrogen bonded sheet. The water 
hydrogen bonds to two molecules from one ribbon, acting both as donor and acceptor 
(021-H21—N11 and Nl-H 1—021) and as a donor to a third molecule from a different 
ribbon (021-H22—02). The ribbons form stepped sheets, parallel to the 0 1 -1 Miller 
planes. Within the ribbon structure, there is also a close F—F contact, between F5 and 
F I5 of 2.9 A, however this is likely to have arisen as a consequence of the adjacent 
R ^ )  hydrogen bonded ring.
Figure 4.24: Ribbon structure present comprised of 5FC—5-fluoroisocytosine pairs 
joined by the base pairing triplet interaction
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4.4 Discussion
The same RM1 ribbon was found in the two anhydrous polymorphs, the form 1(h) 
monohydrate, the hemipentahydrate, and the methanol and 2,2,2-trifluoroethanol 
solvates. The hydrogen bond interactions within the ribbon structure are strong 
conventional hydrogen bonds, N-H—O and N-H—N. The RM1 ribbon is also found in 
cytosine189 and the other 5-substituted halogenated cytosines: 5-chlorocytosine,190 5- 
bromocytosine190 and 5-iodocytosine.191 The occurrence of the RM1 ribbon in six of the 
experimental crystal structures presented here, many related cytosines and the majority 
of hypothetical structures from the CSP search leads to the conclusion that this is a
robust hydrogen bond motif for 5-fluorocytosine.
1Root mean square deviation overlays, minimising atom atom distances, of 
dimers from the RM1 ribbon for all possible pairings of the six structures show (table 
4.3) that the difference in the conformation of the ribbons between structures is 
minimal, with the RMS deviation values ranging from 0.05 to 0.23 A. The form 2 dimer 
gives the largest RMS values when overlaid with the other structures because of the 
pronounced undulation in the ribbon in this structure.
Methanol 
ribbon 2
Methanol 
ribbon 1
2,2,2-
trifluoro­
ethanol
Hemipenta­
hydrate
Form
1(h) Form 1
Form 2 0 . 2 0 0.15 0.23 0.19 0 . 1 0 0.17
Form 1 0.06 0.05 0.13 0 . 1 0 0.08
Form 1(h) 0 . 1 1 0.07 0.15 0 . 1 2
Hemipentahydrate 0.07 0.09 0.06
2,2,2-
trifluoroethanol 0 . 1 0 0.14
Methanol 0.06ribbon 1
Table 4.3: RMS values (A) for the non-hydrogen atoms for overlaying dimers for 
structures exhibiting RM1 ribbons. Methanol ribbon 1 and ribbon 2 denote the 
two symmetry independent ribbons from the 5FC methanol solvate
In all of these structures an additional hydrogen bond interaction occurs, with solvent in 
the lattice or with adjacent 5FC ribbons (in the case of the anhydrous forms) to satisfy 
the amine hydrogen bond donor on each molecule not used forming the RM1 ribbon. 
These bonds usually transform the two-dimensional ribbon motif into a three-
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dimensional hydrogen bond network. Four solvate structures (monohydrate form 1(h), 
hemipentahydrate, methanolate, 2,2,2-trifluoroethanolate) also showed similarities in 
the three-dimensional hydrogen bond network formed. All of these structures pack RM1 
ribbons into columns with sheets, layers or channels of solvent between the columns 
such that the solvent molecules act as bridging units connecting the adjacent columns.
The crystal structure of the form 2(h) monohydrate is unique in that the 5FC 
molecules propagate using the RM2 motif, which was only present in less stable 
hypothetical structures. This ribbon is related to RM1 by an approximate two-fold 
rotation of every second molecule in the ribbon, with the rotation axis running through 
the centres of the N3-C2 and C5-C6 bonds.
Form 2 crystallises in the space group P2\/n, a space group included in the 
subset of space groups in which MOLPAK generates structures. Comparison of the 
form 2 ExptMinOpt structure with the structures from the ab initio search revealed that 
it corresponded to the third lowest energy structure from the search, and in a similar 
comparison for the planar conformation, the search found the form 2 structure as the 
global energy minimum structure. By the criteria of the CCDC blind tests of crystal 
structure prediction,121123 the prediction of form 2 was a success as in both searches the 
structure would be one of three allowed submissions, if selection was based solely on 
lattice energy. Form 1 could not have been predicted due to the limitations of the search 
algorithm, and would not have been included in such a blind test, as the space group 
P4\2\2 is sufficiently unusual for organic molecules (305 non-ionic, non-polymeric, 
organic crystal structures present in CSD23).
4.5 Conclusion
After 37 years without a published anhydrous structure, the pharmaceutical
5-fluorocytosine has been found to exhibit polymorphism. In addition to the two 
anhydrous crystal structures that have been discovered, two new hydrates, two solvates 
and a co-crystal were obtained. The results of computational crystal structure prediction 
showed that there was a single dominant hydrogen bonded chain, found in the vast 
majority of predicted structures. From this observation it was concluded that any 
anhydrous crystal structures found would exhibit this ribbon motif and would find a 
method of packing to satisfy the extra N-H hydrogen bond donor functionality not used
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in forming the ribbon. This was the case for both of the anhydrous structures and the 
search was also successful in predicting the exact structure of form 2. Four new solvates 
and a redetermination of the known monohydrate structure provided additional evidence 
for the robust nature of the ribbon motif 1, with four of the five exhibiting this motif. It 
is also noteworthy that the form 2(h) monohydrate, the only solvate found not to contain 
the ribbon motif 1, exhibited the alternative ribbon motif 2, which was present in a 
minority of the predicted structures. A co-crystal monohydrate of 5-fluorocytosine with 
its isomer 5-fluoroisocytosine was also found and its structure determined, which 
exhibited the same hydrogen bonding as found in DNA base pairing.
Thus the crystal structure behaviour of 5-fluorocytosine can be rationalised as 
having a strongly preferred two dimensional ribbon structure, which exhibits versatile 
methods of packing, leading to polymorphism and a number of closely related solvate 
structures.
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Crystal Data
Compound name 5-Fluorocytosine 5-Fluorocytosine
form 1 form 2
Empirical formula 129.1 129.1
Formula weight C4 H4 N 3 OF C4 H4 N 3 OF
Crystal system, space group Tetragonal, P4i2i2 Monoclinic, P2\/n
a (A) 6.6387(4) 4.0629(4)
b(A) 6.6387(4) 9.5211(9)
c (A) 23.471(3) 12.7386(12)
a (° ) 90 90
P(°) 90 92.986(2)
Y (°) 90 90
v  (A3) 1034.4(2) 492.10(8)
Z',Z 1 , 8 1,4
D(calc (g cm'3)) 1.658 1.743
Data Collection
Crystal size (mm) 0 .25x0 .23  x0.19 0.70 x 0.25 x 0.09
Temperature (K) 150(2) 150(2)
hkl range (h, k, 1) -8 —>8 , -8 —>8 , -30—>31 -5—>5, -12—>12, -16
Reflections measured, Rint 9022, 0.0208 4186, 0.0132
Independent reflections 820 1177
Reflections I>2o(I) 805 1104
Refinement
Parameters refined 98 98
R(F) (I>2 o(I)) 0.033 0.034
wR(F2) (all reflections) 0.084 0.111
Residual electron density 0.34, -0.18 0.41,-0.24
(min, max (e A'3))
5-Fluorocytosine 
monohydrate form 1 (h) 
147.1
C4H4N3OF, H20  
Monoclinic, Pl \ lc  
7.3871(6)
9.3940(8)
17.5787(15)
90
98.608(2)
90
1206.1(2)
2,8
1.620
0 . 2 1  x 0 .18x0 .12  
150(2)
-9—>9, -12—>-12, -23—>22
10415, 0.0268
2876
2317
229 
0.046 
0.120 
0.38, -0.25
5-Fluorocytosine 
monohydrate form 2 (h) 
147.1
C4H4N3OF, H20  
Triclinic, P  1 
4.1026(5)
8.2731(10)
9.9191(12)
110.036(2)
100.460(2)
96.710(2)
305.14(6)
1,2
1.601
0.41 x 0 .17x0 .13  
150(2)
-5—>5, -10—>10, -13—>12
2672,0.0117
1381
1278
116 
0.037 
0.110 
0.36, -0.23
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Crystal Data
Compound name 5-Fluorocytosine 5-Fluorocytosine 5-Fluorocytosine 5-Fluorocytosine
hemipentahydrate methanol 2 ,2 ,2 -trifluoroethanol 5 -fluoroisocytosine monohydrate
Empirical formula C4 H4 N 3 OF, 2 ,/ 2 (H2 0 ) C4 H4 N 3 OF, 1/2 (CH4 0 ) C4 H4 N 3 OF, C2 H3 OF3 C4 H4 N 3 OF, C4 H4 N 3 OF, H20
Formula weight 174.1 290.3 229.2 276.2
Crystal system, space group Monoclinic, P 2 x/c Monoclinic, P 2 x/n Monoclinic, P2x/c Triclinic, P  1
a (A) 12.2384(8) 8.4486(9) 11.1490(9) 5.412(2)
b (A) 9.4254(6) 9.2898(10) 9.5914(8) 8.447(2)
c (A) 13.8727(9) 16.104(2) 8.5221(7) 12.083(4)
a (°) 90 89.454(5)
P(°) 111.391(1) 97.371(2) 108.139(1) 85.718(5)
r(°) 90 77.096(4)
V (A3) 1490.0(2) 1253.5(2) 8 6 6 .0 2 ( 1 2 ) 536.9(3)
Z',Z 2 , 8 2 , 8 1,4 1 , 2
D(calc (g cm"3)) 1.553 1.538 1.757 1.708
Data Collection
Crystal size (mm) 0.67 x 0.53 x 0.28 0.64x0 .11  x 0.07 0 .4 7 x 0 .2 9 x 0 .1 9 0 .4 4 x 0 .1 4 x 0 .1 1
Temperature (K) 150(2) 150(2) 150(2) 150(2)
hkl range (h, k, 1) -15—>16, -12—>12, -17—>18 -11->11, - 1 2 —>1 2 , -2 1 - ->20 -14—>14, -12—>12, -10—>10 -6 —>6 , -11—>10, -15—>15
Reflections measured, Rint 12658,0.0168 10796,0.0306 7461,0.0170 4532,0.0178
Independent reflections 3539 3000 2072 2405
Reflections I>2a(I) 3311 2138 1932 1884
Refinement
Parameters refined 277 183 164 2 1 2
R(F)(I>2o(I)) 0.044 0.066 0.038 0.044
wR(F2) (all reflections) 0.132 0.162 0.097 0.123
Residual electron density 0.37, -0.30 0.49, -0.26 0.34, -0.24 0.36, -0.24
(min, max (e A"3))
Table 4.4: Crystal structure summary for all 5FC crystal structures included in this chapter
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Chapter 5 -  Coumarin and coumarin derivatives
5.1 Introduction
Coumarin (chromen-2-one) and its substituted derivatives are a naturally occurring class
of compounds found in a wide variety of plants,192 including cinnamon, strawberries
1
and deadly nightshade. 3400 naturally occurring coumarins are known. Substituted 
derivatives of coumarin have found uses as active ingredients in sunscreens because of 
their UV-absorbance properties and as precursors to pharmaceuticals. Coumarin itself is 
responsible for the sweet smell of freshly mown hay. The photoactivity of coumarins 
has led to their use in laser dyes, in which the lasing medium is a solution of the 
coumarin in a solvent. The principal drawback of using coumarins in laser dyes is their 
potential for photodimerisation. Many substituted coumarins, including coumarin itself 
are photoreactive in solution, dimerising under incident UV light (scheme 5.1).
hv
r \-o
syn head-to-head syn head-to-tail
anti head-to-head
0 \  /
anti head-to-tail
Scheme 5.1: Coumarin photodimerisation. Potential products include both head- 
to-head and head-to-tail monomer orientations with syn or anti configurations
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The [2+2] photodimerisation of a coumarin in solution can conceivably yield any of 
four different reaction products, with the two molecules in the dimer orientated either 
head-to-head or head-to-tail in either syn or anti configurations (scheme 5.1). For 
example coumarin is found to give both syn and anti head-to-head dimers depending on 
the chosen solvent.194
In early crystal engineering work by Schmidt195 [2+2] photodimerisation in the 
solid state of /ra«s-cinnamic acids was found to proceed only if the molecular packing 
in the crystal structure allowed the dimerisation. Schmidt defined the ‘topochemical 
principle’196 that for double bonds to undergo photodimerisation they must be parallel 
and separated by less than approximately 4.2 A. Many coumarins have been found to 
undergo photodimerisation in the solid state, but only if the crystal packing brings 
molecules into the correct orientation.197 Indeed it has been noted198 that many 
coumarins known to dimerise in solution are photostable in the solid state, such as 4- 
methoxycoumarin, 7-hydroxycoumarin and 4,7-dimethylcoumarin. In a solid state 
reaction, the orientation of each pair of molecules that react to form the dimer is the 
same and a single product will, in principle, exclusively form with the dimerisation 
product predictable from the crystal structure of the starting compound (figure 5.1). 
‘Diffusionless’199 solid state reactions, based on the molecular orientation within the 
crystal, are an important target for crystal engineering -  not only are these reactions 
solvent free, but because the molecular orientation is well defined in the crystalline state 
the reactions will be highly specific, in some cases providing 100% yields.200 
Photoreactions in the solid state have also been used to generate chiral products in high 
enantiomeric excess.201
Figure 5.1: 7-methoxycoumarin photodimerises in the solid state to give exclusively 
the syn head-to-tail product198
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Work was carried out in collaboration with Katharine Bowes (Cambridge University) to 
predict the possible crystal structures of coumarin and 6-methoxycoumarin as part of a 
study into the photo-crystallography of excited states of molecules induced by laser or 
UV light. This collaborative work lead to further, individual investigations on a range 
of coumarins. 4-Hydroxycoumarin, where only a monohydrate was previously 
known,203;204 was investigated using both crystal structure prediction and a manual 
crystallisation screen to discover anhydrous crystal structures. A limited crystallisation 
screen was carried out on 6-methoxycoumarin in an attempt to elucidate the full crystal 
structure of a second reported polymorph only previously identified by unit cell 
determination.197 Crystal structure prediction was performed on 7-hydroxycoumarin to 
assess whether experimental screening would be likely to yield new polymorphs.
The molecular structures of all coumarins investigated in this work, their CSD 
reference codes and the research completed on them are summarised in table 5.1.
Table 5.1: (next page) Summary table of all work carried out on coumarin systems
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Molecular Structure 
(aromatic hydrogen atoms omitted)
Crystal Structures and 
CSD reference codes Research completed Results
X 5
3 6 ^
S'C8
X 4  
: 1 0  .CN>1^
:3
) 2
^ 0 2
C oum arin  
Form  1
C O U M A R [01 ,0 2 ,1 0 ,1 1 ,1 2 ]
C S P  to  d e term in e  w h eth er  th e  know n  
structure is  th e  th erm o d y n a m ic  form
MOLPAK: 18  s p a c e  g ro u p s, 3 7  
p ack in g  ty p e s , FIT + S C F -d er iv ed  
m u ltip o les
C S P : k now n structu re fou n d  at 
g lob a l e n e r g y  m inim um
03 ,C5
zS
/ (C 8
X 4
39
310
N > ^
33
32
^ 0 2
6 -M eth oxycou m arin
Form  1 
DAX BIN01
Form  2
DAXBIN (unit ce ll on ly)
C S P  to  d e term in e  w h eth er  th e  
DAXBIN unit ce ll c o r r e sp o n d s  to  that 
o f a  poten tia l po lym orph
MOLPAK: 2 2  s p a c e  g r o u p s , 4 7  
p ack in g  ty p e s , FIT + S C F -d er iv ed  
m u ltip o les
E xperim en ta l: 2 0  cry sta llisa tio n s
C S P : D A X BIN 01 fo u n d  2 2 nd 
ran ked . N o  ce ll fou n d  that 
c o r r e sp o n d e d  to  DAXBIN
E xperim enta l: DAXBIN crysta l 
stru cture n ot fou n d
C
H C 
03
X 5
:6 ^
C 8
X 4
9
1 0  JZ
^oS
3
2
^ 0 2
7-H yd roxycou m arin
Form  1 
D E T FO X
C S P  to  d e term in e  w h eth er  th e  know n  
stru cture is  th e  th erm o d y n a m ic  form
MOLPAK: 2 2  s p a c e  g ro u p s, 4 7  
p ack in g  ty p e s , FIT + M P 2-d erived  
m u ltip o les
C S P : know n  structu re fou n d  at 
g lo b a l e n e r g y  m inim um
C
C
X 5
'V  S
C 8
04I/C 4
^  'N
1 0  J
33
32
^ 0 2
4 -H yd roxycou m arin
M on oh yd rate
H O Q H A W [01]
F orm s 1 - 4
(th is w ork, n o  r e fe r e n c e  
c o d e s )
C S P  to  pred ict p o s s ib le  th e  crystal 
stru ctu res o f  a n y  a n h y d ro u s form s
MOLPAK: 2 2  s p a c e  g ro u p s , 4 7  
p ack in g  ty p e s
FIT + M P 2-d erived  m u ltip o les
E xperim en ta l: crysta llisa tion  s c r e e n  to  
find a n h y d ro u s form s
C S P : n o  p red icted  stru ctu res  
c o r r e sp o n d e d  to th e  crysta l 
stru ctu res  o f  form s 2  &3 fou n d  
in th e  ex p er im en ta l s c r e e n
E xperim en ta l: four p o lym orp h s  
d is c o v e r e d , tw o  fully 
ch a r a c te r ise d  b y  S X R D  
(form s 2  & 3 )
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5.2 Energy minimisations
Before crystal structure prediction was carried out on coumarin, 6-methoxycoumarin 
and 7-hydroxycoumarin the known crystal structures were energy minimised to assess 
the performance of the potential in each case, and for comparison purposes to the search 
results. The desired potential, the FIT77,79’84 dispersion-repulsion potential combined
oo
with the electrostatic distributed multipole model derived from the MP2/6-31G(d,p) 
charge density, did not perform well in some cases. Consequently energy minimisations 
for all structures were also performed with the FIT potential and SCF/6-31G(d,p)- 
derived multipoles, to assess whether the poor performance could be rectified by 
altering the electrostatic model. The rationalisation behind trying SCF-derived 
multipoles was that the FIT empirical parameters were originally derived using potential 
derived atomic point charges from SCF level calculations for each of the training set 
molecules. Some of the electron correlation effects explicitly modelled at the MP2 level 
may have been implicitly absorbed into the FIT empirical parameters at the point of 
their derivation. Therefore in some cases MP2-derived multipoles may not give superior 
results to SCF-derived multipoles, despite it being a more realistic representation of the 
isolated molecular charge distribution.
Summary tables for all energy minimisations discussed below are given at the 
end of this section.
Coumarin
The crystal structure of coumarin, determined from neutron data by Katharine Bowes, 
was energy minimised with both the experimental and MP2/6-31G(d,p) ab initio 
optimised conformations using the FIT dispersion-repulsion potential and distributed 
multipoles derived from both the MP2/6-31G(d,p) charge density and the uncorrelated 
SCF/6-31G(d,p) charge density. Neither of the MP2-level minimisations, 
ExptMinExpt(MP2) and ExptMinOpt(MP2), gave satisfactory results yielding F-values 
of 62 and 126 respectively and having errors greater than 5% in the c axial length (table
5.2). An overlay of the unit cells of the experimental crystal structure and the 
ExptMinOpt(MP2) minimised structure shows that the molecular orientations and 
positions did not alter substantially with energy minimisation (figure 5.2). The change
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to SCF-level calculation was both significant and beneficial, with the 
ExptMinExpt(SCF) and ExptMinOpt(SCF) minimisations giving good reproductions of 
the experimental crystal structure and with F-values less than 10.
Figure 5.2: Overlay of the experimental coumarin crystal structure (coloured by 
element) and the ExptMinOpt(MP2) energy minimised structure (coloured blue)
6-Methoxycoumarin
For the purposes of energy minimisation the DAXBIN01 crystal structure was 
manually symmetry reduced from Pnma with Z' = 0.5 to the sub-group Pn2\a with 
2! -  1. This structure was energy minimised using both the experimental and MP2/6- 
31G(d,p) ab initio optimised molecular conformations. The ab initio optimisation 
resulted in a conformation in which the molecular mirror symmetry was retained. 
Distributed multipoles were derived at both the MP2/6-31G(d,p) and SCF/6-31G(d,p) 
levels of theory and again the SCF-derived multipoles gave superior energy 
minimisation results (table 5.3), with the ExptMinOpt(SCF) minimisation returning an 
F-value of 29. The ExptMinExpt(MP2) minimisation required the removal of a 
symmetry operator to find a satisfactory energy minimum, thus reducing the space 
group to P2\/c. The other three energy minimisations retained the Pnma symmetry, 
even though the energy minimisations were performed in Pn2\a.
The ab initio optimised molecular conformation from the DAXBIN crystal 
structure was used as the MOLPAK search input but it is appreciated that there remains 
the possibility that the alternative molecular conformation, with methyl group rotated
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180° with respect to the coumarin skeleton, could also potentially lead to low energy 
CSP crystal structures, but this was not investigated.
7-Hydroxycoumarin
The only known crystal structure, DETFOX,206 was energy minimised with both the 
experimental conformation and the ab initio optimised conformation. Similarly to both 
coumarin and 6-methoxycoumarin, energy minimisations were carried out using 
distributed multipoles derived using both the MP2/6-31G(d,p) and SCF/6-31G(d,p) 
levels of theory (table 5.4). Unlike both coumarin and 6-methoxycoumarin, the SCF 
minimisations were not superior to the MP2 minimisations -  neither the MP2 or SCF 
energy minimisations proved satisfactory, with all four having at least two cell 
parameters reproduced with an error greater than 5%, and all having F-values in excess 
of the usual range for successful reproduction. Qualitatively, overlay of the 
ExptMinOpt(MP2) energy minimised structure with the experimental structure (figure
5.3) showed that the hydrogen bonding had been retained and that the packing of the 
hydrogen bonded ribbons was similar.
Figure 5.3: Overlay of the 7-hydroxycoumarin experimental structure (coloured 
by elements) and ExptMinOpt(MP2) (blue) energy minimised structure
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For coumarin a MOLPAK search utilising 37 packing types covering 18 space groups 
was performed. For 6-methoxycoumarin, 7-hydroxycoumarin and 4-hydroxycoumarin, 
extended MOLPAK searches using 47 packing types spanning 22 space groups were 
carried out. In all of these searches the MP2/6-31G(d,p) ab initio optimised molecular 
conformation was used as the search input. The reproduction of the coumarin and 6- 
methoxycoumarin structures by lattice energy minimisation were substantially superior 
using SCF-derived multipoles and so this electrostatic model was used during the CSP 
searches on both of these molecules. For 7-hydroxycoumarin neither level of theory 
gave superior results, and so MP2-derived multipoles were used during the CSP 
searches because this utilises the higher level of quantum mechanical theory. Based on 
these results, MP2-derived multipoles were also used in the 4-hydroxycoumarin search. 
In all searches generated structures that initially energy minimised to a saddle point 
were symmetry reduced by up to two symmetry operations and if this did not lead to a 
true minimum, the structure was discarded. For all CSP searches a summary table of the 
low energy structures, analysis of their hydrogen bonding motifs and a diagram of the 
atom numbering used during CSP are provided in the supporting information.
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C o u m a rin E x p er im en ta l
M P2
E xp tM in E xp t
%
error
M P2
E xptM in O pt
%
error
SC F
E xp tM in E xp t
%
error
SC F
E xptM in O pt
%
error
a (A) 1 5 .4 7 9 1 5 .2 2 5 -1 .6 4 1 5 .0 7 2 -2 .6 3 1 5 .5 9 3 0 .7 4 1 5 .6 1 9 0 .9 0
b (A) 5 .6 0 9 5 .5 2 8 -1 .4 4 5 .4 6 4 -2 .5 8 5 .6 4 8 0 .7 0 5 .6 4 7 0 .6 9
c ( A ) 7 .7 3 5 8 .241 6 .5 4 8 .441 9 .1 3 7 .8 3 9 1 .34 7 .8 6 8 1.71
V o lu m e  (A 3) 6 7 1 .6 6 9 3 .6 3 3 .2 8 6 9 5 .1 5 3.51 6 9 0 .3 8 2 .8 6 9 4 .0 4 3 .3 5
D e n s ity  (g  c m '3) 1 .4 4 5 1 .3 9 9 -3 .1 8 1 .3 9 6 -3 .3 9 1 .4 0 6 -2 .7 2 1 .3 9 9 -3 .2 4
F inal E n e r g y  (kJ m o l'1) -8 9 .9 5 -88 .41 -1 0 0 .1 9 -9 8 .1 8
F 6 1 .7 7 1 2 5 .7 8 4 .5 2 6 .6 9
Table 5.2: Energy minimisations of the crystal structure of coumarin
DAXBIN01 E x p er im en ta l
M P2
E xptM inE xpt*
%
error
M P2
E xptM in O pt
%
error
SC F
E xp tM in E xp t
%
error
SC F
E xp tM inO p t
%
error
a (A) 6 .771 6 .7 7 -0 .0 2 6 .8 4 2 1 .06 6 .7 3 4 -0 .5 5 6 .7 9 4 0 .3 4
b (A) 6 .4 5 4 6 .4 5 5 0.01 6 .4 5 8 0 .0 7 6 .4 3 7 -0 .2 7 6 .441 -0 .2 0
c(A) 1 8 .7 9 7 1 9 .5 6 5 4 .0 9 1 9 .4 5 9 3 .5 2 1 9 .5 0 3 3 .7 5 1 9 .4 2 8 3 .3 6
a  (°) 90 9 2 .1 8 2 .4 2 90 90 9 0
V o lu m e  (A3) 8 2 1 .4 3 8 5 4 .3 4 4 .01 8 5 9 .9 1 4 .6 9 8 4 5 .2 8 2 .9 0 8 5 0 .2 7 3.51
D e n s ity  (g  c m '3) 1 .4 2 5 1 .3 7 0 -3 .8 5 1.361 -4 .4 8 1 .3 8 4 -2 .8 2 1 .3 7 6 -3 .3 9
F inal E n e r g y  (kJ m o l 1) -1 0 2 .6 2 -9 9 .9 6 -1 1 4 .7 5 -1 1 2 .3 3
F 4 9 .5 7 3 4 .6 2 3 6 .6 2 2 8 .9 8
Table 5.3: Energy minimisations of the crystal structure of 6-methoxycoumarin. * Structure was symmetry reduced from Pnl\a to 
P2ilc in this minimisation
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DETFO X E x p er im en ta l
M P2
E xp tM in E xp t
%
error
M P2
E xptM inO p t
%
error
SC F
E xp tM in E xp t
%
error
S C F
E xp tM in O p t
%
error
a (A) 3.892 4.125 6 . 0 0 4.179 7 .3 7 4.109 5.59 4.170 7.15
b  (A) 1 1 . 0 2 2 10.98 -0 .3 8 11.093 0.65 10.958 -0 .5 8 11.069 0 .4 3
c ( A ) 16.722 15.995 -4 .3 5 15.865 -5 .1 2 15.875 -5 .0 7 15.736 -5.90
P ( ° ) 90.58 8 6 . 0 2 -5 .0 4 84.26 -6 .9 7 85.83 -5 .2 4 84.05 -7.21
V o lu m e  (A 3) 717.30 722.74 0.76 731.78 2 . 0 2 712.97 -0 .6 0 722.5 0.73
D e n s ity  (g  c m '3) 1.501 1.490 -0 .7 5 1.472 -1 .9 8 1.511 0.61 1.491 -0 .7 2
F inal E n e r g y  (kJ m o l'1) -118.66 -113.48 -136.48 -129.52
F 117 190 127 206
Table 5.4: Energy minimisations of the crystal structure of 7-hydroxycoumarin
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5.3 Coumarin
5.3.1 Introduction
Coumarin has only been found to crystallise in one crystal form, although there are 
presently five independent determinations of this structure in the CSD,207'211 along with 
the redetermination of this structure from powder neutron data, by Katharine Bowes, 
that formed the basis of this work. Coumarin crystallises in the orthorhombic space 
group Pca2\ with one molecule in the asymmetric unit. There are no strong hydrogen 
bond donors but a ribbon motif is formed by two weak C-H—O hydrogen bonds, 
bifurcated at 02 (figure 5.4A). Coumarin is known to be photostable in this crystal 
structure as expected from the molecular orientation -  the double bonds in the two 
molecules are situated 3.9-4.0 A apart, but the torsion angle between the double bonds 
in the two molecules is 100° (figure 5.4B).197
100.20
A B
Figure 5.4: The crystal structure of coumarin. A: Weak C-H*”0  hydrogen bonding 
present in the crystal structure of coumarin; B: Orientation of the two molecules 
closest in orientation to a photodimerising pair
5.3.2 Crystal structure prediction
The CSP search yielded a large number of structures (260) within 10 kJ mol'1 of the 
global energy minimum and 53 structures within 5 kJ mol'1 (figure 5.5). All structures 
within 5 kJ mol'1 were examined after the search for their true space group using the 
ADDSYM algorithm contained in PLATON.139
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Figure 5.5: Scatter plot of all CSP generated structures for coumarin within 
5 kJ mol'1 of the global energy minimum
The global energy minimum structure was found to correspond exactly to the 
ExptMinOpt(SCF) structure. The global energy minimum structure was only 
0.5 kJ m ol1 more stable than the second lowest energy structure, but it was the most 
dense structure predicted. An analysis of the 10 lowest energy structures by Katharine 
Bowes showed that none of the predicted structures showed a similar motif to the 
experimental structure, apart from the global energy minimum structure. The other nine 
predicted structures all contained C-H --0 weak hydrogen bonds, but in a variety of 
motifs, including sheets and ribbons that utilised the oxygen atom in the heterocyclic 
ring as a hydrogen bond acceptor as well as the carbonyl oxygen (figure 5.6).
Of the 10 lowest energy predicted structures the second, third and fourth lowest 
energy structures had the molecules orientated correctly for potential [2+2] 
photodimerisation, though the distances between the molecules in all three structures 
were between 4.125 and 4.469 A. These distances are at Schmidt’s upper limit for 
photodimerisation, though it has been noted that photodimerisation of 7-chlorocoumarin 
occurs at a molecular separation of 4.454 A .197
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Figure 5.6: Sheet motif present in the 2nd lowest energy predicted structure. All 
C-H—O contacts have D***A < 3.6 A
5.3.3 Discussion
The crystal structure prediction of coumarin was successful, generating the known 
crystal structure at the global energy minimum with the highest density of any predicted 
structure. The presence of five determinations in the CSD, plus the neutron diffraction 
redetermination used for this work, suggests that this crystal structure is the only easily 
obtainable crystal structure for coumarin, consistent with the CSP results.
The known coumarin crystal structure does not contain the constituent 
molecules in the correct orientation for photodimerisation. However, if a metastable 
crystal structure could be kinetically trapped that corresponded to one of the second, 
third or fourth lowest energy structures then photodimerisation to give the syn head-to- 
head dimer could be possible.
5.4 6-Methoxycoumarin
5.4.1 Introduction
Relatively little is known about the chemical and physical properties of
6-methoxycoumarin. It is known to photodimerise in solution, to produce the anti head- 
to-head photodimer.212 A unit cell was reported for 6-methoxycoumarin in the course of 
a photodimerisation study of a range of coumarins in the solid state197 (DAXBIN, table
5.5), though the full structure was not determined. This crystal structure was found to be 
photoreactive, producing syn head-to-head dimers. More recently an SXRD structure
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determination has produced a crystal structure with a different unit cell to that 
reported in the earlier work (DAXBIN01, table 5.5).
CSD 
reference code
Space
Group T (K) a (A) b (A) c (A) V (A3)
DAXBIN197 P c a 2 i 2 9 8 6 .7 3 7 .1 7 2 1 .2 6 1 0 2 6
DAXBIN01205 Pnma 2 0 3 6 .7 7 1 (2 ) 6 .4 5 4 (2 ) 1 8 .7 9 7 (5 ) 8 2 1 .4 (4 )
Table 5.5: Summary of the unit cells reported for 6-methoxycoumarin
Each molecule in the DAXBIN01 crystal structure occupies 205 A3 compared to 256 A3 
for the DAXBIN unit cell. The extra volume in the latter unit cell could correspond to a 
solvate, but the solvent would have to be small, such as a dihydrate or a methanolate, or 
be a hemi-solvate with a larger solvent. Unfortunately no information is given in the 
original paper about the crystallisation that yielded the DAXBIN unit cell.
The DAXBIN01 crystal structure adopts the orthorhombic space group Pnma 
with the molecule in the asymmetric unit located on the mirror plane (Z' = 0.5, four 
molecules in the unit cell). Like coumarin, 6-methoxycoumarin cannot form strong 
hydrogen bonds, but again weak C-H -O hydrogen bonds are present in the structure. 
The two long edges of the 6-methoxycoumarin molecule are complimentary for forming 
C-H -O interactions205 with one edge presenting groups in the order donor-acceptor- 
acceptor and the other acceptor-donor-donor. This allows molecules to form triplets of 
approximately parallel C-H—O interactions. Two adjacent ribbons propagated by this 
triplet interaction form the sides of a ladder, with the rungs of the ladder consisting of a 
further C-H--O weak hydrogen bond (figure 5.7).
169
Figure 5.7: Ladder motif present in the 6-methoxycoumarin DAXBIN01 crystal 
structure. The ladder runs from left to right. All C-H***0 hydrogen bonds have 
D -A  < 3.5 A
5.4.2 Crystal structu re prediction
The CSP search produced 88 structures within 10 kJ mol'1 of the global energy 
minimum and 26 structures within 7 kJ mol*1 (figure 5.8). All structures within 7 kJ 
mol*1 were examined after the search for extra symmetry using the ADDSYM algorithm 
contained in PLATON.139
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Figure 5.8: Scatter plot of all CSP generated structures for 6-methoxycoumarin 
within 7 kJ mol'1 of the global energy minimum
The CSP search generated a structure that corresponded exactly to the 
ExptMinOpt(SCF) minimised experimental crystal structure. However, this structure 
was only 22nd lowest in energy, 6.7 kJ mol’1 higher in energy than the global energy 
minimum. The structure was generated in the space group P2i2i2i, and the symmetry 
corresponding to the space group Pnma was found after energy minimisation during the 
PLATON analysis.
All 26 structures within 7 kJ m of1 were analysed for their C-H—O hydrogen 
bonding motifs, and for the presence of molecular orientations that could potentially 
photodimerise. Of the 26 structures no less than 20 contained the same triplet 
interaction as that observed in the experimental structure, and in all cases the triplet 
interaction propagated the same ribbon. In 18 of the 20 structures that contained this 
ribbon, adjacent ribbons formed C-H- O contacts via the methyl group, producing 
sheets in 15 instances (figure 5.9) and a 3D motif in the other 3 instances. The other two 
structures that contained triplet ribbons, but did not include methyl--carbonyl 
interactions, were the structure that corresponded to the experimental structure and a 
structure closely related in energy and motif.
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1Figure 5.9: Sheet motif found in 15/26 of the low energy structures in the 6- 
methoxycoumarin search
Of the 26 low energy structures, 10 had the required parallel molecular orientation and 
molecular separation (less than 4.2 A) in the crystal structure for potential 
photodimerisation, all of which would give the syn head-to-head dimer geometry. 
Interestingly there is no correspondence between the hydrogen bond motif present in the 
structure and the presence of molecules in the correct orientation for photodimerisation. 
The DAXBIN01 crystal structure does not have molecules in the correct orientation for 
photodimerisation, in contrast to DAXBIN, whose crystal structure is unknown, but 
which was reported to photodimerise.197
5.4.3 Experimental crystallisation screen
6-Methoxycoumarin was purchased from APIN Chemicals (Abingdon, 98% purity). 
The XRPD diffraction pattern of the commercial material was measured and compared 
to the simulated XRPD pattern from the DAXBIN01 single crystal structure, which it 
matched closely. A series of solvent evaporation crystallisations were carried out at 
room temperature using 20 common solvents chosen because any of them could have 
potentially been the solvent used for the crystallisation that yielded the DAXBIN 
crystals. In each crystallisation 10 mg of 6-methoxycoumarin was dissolved in 5 ml of 
each solvent. From each solution the solvent was allowed to evaporate slowly to give 
the 6-methoxycoumarin crystallisation product. A flat needle morphology was observed 
14 times. In six of these cases the crystals were suitable for unit cell determination by
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SXRD and all gave the reported DAXBIN01 unit cell. In one instance, from tert- 
butylmethylether, very large block crystals were formed, but further investigation again 
proved this to be the DAXBIN01 form. In three instances a plate morphology was 
observed, but this was a modification of the flat needle morphology, which again 
proved to be the DAXBIN01 crystal structure. In no cases were crystals grown that 
showed desolvation on removal from the mother liquor, and none of the nine samples 
for which a unit cell was determined proved to be the DAXBIN crystal structure. A 
summary of the crystallisation experiments is provided in the supporting information.
5.4.4 Discussion
The results of crystal structure prediction on 6-methoxycoumarin show that none of the 
predicted structures have a calculated volume per molecule close to that of the 
DAXBIN unit cell -  the range from the predicted structures is 206-217 A3 compared to 
256 A3 calculated for DAXBIN. This result lends weight to the assertion that DAXBIN 
corresponds to a solvate. The DAXBIN01 crystal structure was found in the search 6.7 
kJ mol'1 higher in energy than the global energy minimum structure. However the 
majority of the predicted structures did contain the same ribbon hydrogen bond motif, 
comprised of the same triplet of interactions between adjacent molecules, although the 
ribbon was usually part of a hydrogen bonded sheet rather than the ladder observed in 
the DAXBIN01 structure.
The limited series of crystallisations carried out on 6-methoxycoumarin did not 
yield a crystal structure with a unit cell corresponding to that reported for DAXBIN, 
making it impossible to confirm the inference from the molecular volume comparison 
that it is a solvate. It is interesting to note the large difference in morphology with 
solvent. The flat needle or plate morphology found in the majority of 6- 
methoxcoumarin crystallisations would not be advantageous in pharmaceutical 
manufacturing processes such as filtration steps. However, if tert-butylmethylether was 
used as the crystallisation solvent of choice, it would produce block shaped crystals -  
the optimal crystal morphology.
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5.5 7-Hydroxycoumarin
5.5.1 Introduction
7-hydroxycoumarin (umbelliferone) is found in a wide variety of plants and has found 
application as a fine chemical used in sunscreens to absorb ultraviolet radiation. One 
crystal structure has been determined for 7-hydroxycoumarin, found in the space 
group Fl\!c with one molecule in the asymmetric unit (CSD reference code DETFOX). 
The DETFOX crystal structure is made up of chains with a V-shaped profile, in which 
the constituent molecules form O-H—O hydrogen bonds. Comparing the C-0 and C=0 
bonds directions across the hydrogen bond, adjacent molecules have an anti orientation 
(figure 5.10). The chains stack directly upon one another when viewed parallel to the a 
axis.
Figure 5.10: Hydrogen bonding motif present in 7-hydroxycoumarin. Adjacent 
molecules in the chain have an anti orientation
It has been reported that 7-hydroxycoumarin does not to photodimerise.197 In the 
DETFOX crystal structure the length of the a axis (3.892(1) A) is the separation 
between directly stacked parallel molecules (figure 5.11), well within Schmidt’s upper 
limit.195 The stacking of the molecules is offset to produce attractive 7i-stacking,213 but 
this offset stacking could possibly cause the /?-orbitals comprising the double bond 
between atoms C3=C4 to overlap insufficiently for [2+2] photodimerisation to occur. 
However the initial report of photostability does not identify the specific crystal 
structure tested, so it is conceivable that it was a different crystal structure to that of 
DETFOX. Consequently, the DETFOX 7-hydroxycoumarin crystal structure should not 
be discounted as incapable of photodimerisation, and the possibility that the photostable 
structure is a different polymorph should be considered.
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Figure 5.11: A pair of molecules in the 7-hydroxycoumarin structure. The C3=C4 
double bonds are parallel and close enough for photodimerisation but the 
inclination of the molecules may not allow it. The intermolecular distance is shown
5.5.2 Crystal structu re  prediction
The CSP search yielded 173 structures within 10 kJ mol'1 of the global energy 
minimum and 29 structures within 5 kJ mol'1 (figure 5.12). All structures within 5 kJ 
mol'1 were examined after the search for their true space group using the ADDSYM 
algorithm contained in PLATON.139
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Figure 5.12: Scatter plot of all CSP generated structures for 7-hydroxycoumarin 
within 5 kJ mol'1 of the global energy minimum
The global energy minimum structure from the CSP search was found to correspond 
exactly to the ExptMinOpt(MP2) minimisation of DETFOX, 0.8 kJ mol"1 lower in 
energy than the next structure and over 2 kJ mol'1 lower in energy than the third lowest 
energy structure. It was also the most dense structure generated.
All 29 structures showed the same 0-H --0 hydrogen bond as observed in the 
experimental structure (figure 5.10). The majority of structures (15) exhibited ribbons in 
which the hydrogen bond angle H—0=C was almost linear (figure 5.13). Almost all of 
these structures were in the low symmetry space groups P I, P I  or P2\. The higher 
symmetry space groups such as P2\/c and Pna2\ almost always formed chains with 
either anti (7) or syn (7) configurations. The global energy minimum structure was the 
only anti structure in the lowest 4.7 kJ mol'1. Figure 5.14 shows a flat syn chain that 
takes advantage of the possibility of forming a C - H - 0  interaction as well as the strong 
hydrogen bond. However, only two syn structures form this flat chain, with the other 
five exhibiting rippled syn chains that preclude formation of the C - H - 0  hydrogen 
bond. Five of the six lowest energy predicted structures have offset 7c-stacking though 
there is no correlation within the set of low energy predicted structures between chain 
configuration and the presence or absence of offset jc-stacking.
X oc X qc Xxx
U U It
Figure 5.13: Linear hydrogen bonded motif present in 15/29 7-hydroxycoumarin 
predicted structures. The angle C=0**H is almost linear
4 4 6 7
Figure 5.14: syn hydrogen bonded motif present in 7/29 7-hydroxycoumarin 
predicted structures. The C-H***0 contact (3.467 A) is shown once (red dotted line)
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A total of 12 of the 29 low energy structures have molecules correctly orientated for 
potential photodimerisation, with nine producing the syn head-to-head product, two the 
anti head-to-tail product and one the syn head-to-tail product.
5.5.3 Discussion
The crystal structure prediction search on 7-hydroxycoumarin was successful with the 
known experimental structure found at the global energy minimum with highest density. 
Crystal structure prediction was carried out to assess whether 7-hydroxycoumarin was a 
molecule that could potentially exhibit polymorphism, and from the results of the search 
it can be concluded that the known form is probably the thermodynamically most stable 
structure, and that any other polymorphs that could be discovered would be metastable. 
Analysis of the predicted structures shows that the expected O-H—O chain hydrogen 
bonded motif is present in all structures, but with three different chain configurations 
possible, syn/antHlinear, with the linear disposition found twice as often as either syn or 
anti.
5.6 4-Hydroxycoumarin
5.6.1 Introduction
Several derivatives of 4-hydroxycoumarin including warfarin, acenocoumarol and 
phenprocoumon (figure 5.15), comprise one of the most important classes of 
pharmaceutical anti-coagulants.
n o 2
o h
.CH-
OH OH
c h 3 c h 3
Acenocoumarol Warfarin
Figure 5.15: Chemical structure of 4-hydroxycoumarin derived anti-coagulants
The only known 4-hydroyxcoumarin crystal structure is a monohydrate that has been 
determined twice,203’204 (CSD reference codes HOXCUM and HOXCUMOl) but no
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anhydrous crystal structure has been reported. The synthesis of 4-hydroxycoumarin was 
reported by Anschutz214 in 1909 with a melting point of 204-206° C, while an 
alternative synthesis in 1943 by Stahmann et al.215 reported a melting point of 214-216° 
C, perhaps indicating that these different syntheses yielded different crystal forms.
The monohydrate crystal structure has been reported to be photostable.197 It 
crystallises in the orthorhombic space group P2\2\2\, with a single 4-hydroxycoumarin 
molecule and a water molecule in the asymmetric unit. Water mediates all hydrogen 
bond contacts in the crystal structure, so there are no 4-hydroxycoumarin* • *4- 
hydroxycoumarin contacts (figure 5.16), and the hydrogen bonds produce a three 
dimensional motif. The 4-hydroxycoumarin hydroxyl group participates in one 
hydrogen bond and the carbonyl group acts as a hydrogen bond acceptor to two 
different water molecules.
Figure 5.16: Hydrogen bonding present in 4-hydroxycoumarin monohydrate
Crystal structure prediction was undertaken alongside an experimental crystallisation 
screen to predict and discover anhydrous forms of 4-hydroxycoumarin. Four anhydrous 
forms were experimentally identified, with the crystal structures of two of them, forms 2 
and 3, fully determined by SXRD. After determination of their crystal structures, both 
were energy minimised for comparison with the CSP results. Forms 1 and 4 were 
identified using XRPD, with form 4 successfully indexed.
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5.6.2 Energy minimisation of forms 2 and 3
Forms 2 and 3 of 4-hydroxycoumarin were energy minimised with both their 
experimental molecular conformations and the MP2/6-31G(d,p) ab initio optimised 
molecular conformation (tables 5.6 and 5.7), and using the same potential as that used 
for the CSP search (FIT dispersion-repulsion potential plus MP2/6-31G(d,p) derived 
distributed multipoles). To enable the same comparison of electrostatic models as made 
in section 5.2, energy minimisations were also carried out with SCF/6-31G(d,p)-derived 
multipoles.
The energy minimisations of form 2 were not successful with either electrostatic 
model, with all minimisations having F-values greater than 75 and with errors greater 
than 5% in the a and b axes in all cases. In contrast the energy minimisations of form 3 
were successful with both electrostatic models, with a largest F-value of 55 and largest 
cell parameter error of 3.32%, both for the ExptMinOpt(MP2) minimisation. These 
minimisations justified the choice of the MP2/6-31G(d,p)-derived multipoles with the 
SCF-derived multipoles not providing substantially superior minimisations in either 
case.
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4 -h y d r o x y c o u m a r in  
F orm  2 E x p e r im e n ta l
M P2
E xp tM in E xp t
%
error
M P2
E xp tM in O p t
%
error
SC F
E xp tM in E xp t
%
error
S C F
E xp tM in O p t
%
error
a (A) 9 .3 5 5 8 .7 9 5 -5 .9 8 8 .7 5 4 -6 .4 3 8 .9 1 5 -4 .7 0 8 .8 7 2 -5 .1 6
b (A ) 1 0 .9 7 5 1 1 .8 0 8 7 .6 9 1 1 .9 7 9 9 .1 4 1 1 .5 9 9 5 .6 8 1 1 .7 6 4 7 .1 8
c  (A) 1 4 .8 1 7 1 4 .9 0 8 0 .6 2 1 5 .0 0 7 1 .2 8 1 4 .8 6 8 0 .3 5 1 4 .9 8 5 1 .1 4
P(°) 1 0 5 .6 9 1 0 6 .0 6 0 .3 5 1 0 6 .2 8 0 .5 6 1 0 6 .0 9 0 .3 8 1 0 6 .3 2 0 .6 0
V o lu m e  (A 3) 1 4 6 4 .5 5 1 487 .91 1 .5 9 1 5 1 0 .4 5 3 .1 3 1 4 7 7 .2 9 0 .8 7 1 5 0 0 .9 7 2 .4 9
D e n s ity  (g  c m '3) 1 .471 1 .4 4 8 -1 .5 7 1 .4 2 6 -3 .0 4 1 .4 5 8 -0 .8 6 1 .4 3 5 -2 .4 3
F inal E n e r g y  (kJ m o l'1) -1 1 2 .5 -1 0 6 .8 5 -1 2 7 .0 8 -1 2 0 .1 7
F 1 3 1 .2 1 7 8 .2 7 6 .7 1 1 2 .6 4
Table 5.6: Energy minimisations of the crystal structure of 4-hydroxycoumarin form 2
4 -h y d r o x y c o u m a r in  
F orm  3 E x p e r im e n ta l
M P2
E xp tM in E xp t
%
error
M P2
E xp tM in O p t
%
error
SC F
E xp tM in E xp t
%
error
SC F
E xp tM in O p t
%
error
a (A) 2 1 .2 0 1 2 1 .6 8 7 -2 .2 9 2 1 .9 0 4 3 .3 2 2 1 .5 1 8 1 .49 2 1 .7 2 6 2 .4 8
b (A) 3 .7 8 5 3 .8 1 2 0 .7 2 2 3 .8 1 2 0 .7 3 3 .8 7 2 2.31 3 .8 7 6 2.41
c (A) 2 0 .0 4 5 2 0 .5 4 8 2.51 2 0 .6 5 4 3 .0 4 2 0 .2 9 8 1 .2 6 2 0 .3 9 6 1 .7 5
m 1 1 5 .6 8 1 1 7 .7 3 1 .77 117 .71 1 .7 6 1 1 7 .6 8 1 .73 1 1 7 .6 8 1 .7 3
V o lu m e  (A3) 1 4 4 9 .6 4 1 5 0 3 .7 4 3 .7 3 1 5 2 6 .9 3 5 .3 3 1 4 9 7 .7 6 3 .3 2 1 5 2 1 .0 6 4 .9 3
D e n s ity  (g  c m '3) 1 .4 8 6 1 .4 3 2 -3 .6 0 1.41 -5 .0 6 1 .4 3 8 -3 .21 1 .4 1 6 -4 .7 0
F in al E n e r g y  (kJ m o l'1) -1 1 0 .2 4 -1 0 5 .9 8 -1 2 1 .9 4 -1 1 7 .5 1
F 3 7 .5 6 5 4 .8 0 3 2 .9 5 4 6 .2 2
Table 5.7: Energy minimisations of the crystal structure of 4-hydroxycoumarin form 3
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5.6.3 Crystal structure prediction
The MP2/6-31G(d,p) ab initio optimised molecular conformation was the search input 
for the MOLPAK search which used 47 packing types covering 22 space groups. 
Distributed multipoles derived from the MP2/6-31G(d,p) charge density were used 
along with the FIT dispersion-repulsion potential. The search generated 147 structures 
within 10 kJ mol'1 of the global energy minimum and 50 structures within 5 kJ mol'1 
(figure 5.17). All structures within 10 kJ mol'1 were examined after the search for their 
true space group using the ADDSYM algorithm contained in PLATON,139 and all 
structures within 5 kJ mol'1 were analysed for their hydrogen bonding motifs. Predicted 
structures were not found that corresponded to the energy minimised structures of either 
form 2 or form 3 because in both structures the asymmetric unit contained two 
independent molecules. The energy minimised experimental structures of forms 2 and 3 
were respectively 6.6 and 7.5 kJ mol'1 higher in energy than the global minimum.
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Figure 5.17: Scatter plot of all CSP generated structures for 4-hydroxycoumarin 
within 10 kJ mol'1 of the global energy minimum
In all predicted structures the hydrogen bond 04-H2 ”02 was present giving a chain 
motif, with C|(6) graph set. The two lowest energy structures both exhibited the space 
group Cite and the crystal packing in both was found to be almost identical. The third
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lowest energy structure was 1.8 kJ mol'1 higher in energy than the global minimum 
structure, with a substantially different chain conformation.
34 predicted structures had the molecules in a syn configuration across the 
hydrogen bond (figure 5.18), and none of these structures contained flat chains which 
would utilise the C3-H1—01 and C8-H6—02 weak hydrogen bonds. In 17 of these syn 
structures the chains had a rippled profile and the other 17 contained V-shaped chains 
(figure 5.19). In all structures containing V-shaped chains and all but one of the 
structures containing rippled chains, the chains stacked directly, with adjacent stacked 
chains have an offset 7t-7r stacked geometry rather than having their aromatic rings in 
direct face-to-face contact. The almost exclusive observation of offset 7i-stacking in the 
syn structures follows the Hunter-Sanders rules for tl-k interactions that state that the 
face-to-face 7i-stacked geometry is repulsive whereas the offset 7i-stacked geometry has 
attractive n-o interactions between the aromatic ring in one molecule and the aromatic 
hydrogen atoms of the next molecule.216 This offset molecular stacking also lead to 
almost all syn structures having the potential for syn head-to-head photodimerisation.
Figure 5.18: Chain conformation found in 34 4-hydroxycoumarin predicted 
structures with syn configuration across the 0-H"*0 hydrogen bond
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A B
Figure 5.19: 4-Hydroxycoumarin syn chain profiles. A: V-shaped profile; B: 
Rippled chain profile. Both views almost parallel to chain axes
In 15 of the 50 lowest energy structures, including the two lowest energy predicted 
structures, the molecules are orientated anti across the hydrogen bond. In the two lowest 
energy structures the chain was in a stepped conformation (figure 5.20). In only the 
three lowest energy anti chain structures and one other structure were the molecules 
packed with the attractive offset 7c-stacking. The rest of the anti chain structures had 
molecules packing with repulsive face-to-face 7c-stacking or no overlap of the aromatic 
rings. Only two of the anti chain structures had molecules orientated correctly for 
potential photodimerisation.
Figure 5.20: Chain conformation found in the two lowest 4-hydroxycoumarin 
predicted structures. A: the molecules have an anti configuration across the O- 
H***0 hydrogen bond; B: the chain has a stepped profile
a
A B
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From this analysis of the CSP results it was concluded that anhydrous experimental 
structures could potentially contain chains in either anti or syn configurations across the 
ubiquitous 04-H 2-02 hydrogen bond. Offset 7r-stacking was almost certain to be 
present in any structure with syn chains and possible with anti chains. Syn chains were 
likely to lead to structures that could potentially photodimerise. Weak C-H -0  hydrogen 
bonds, as could be expected from the molecular structure which contains complimentary 
hydrogen bonding edges, were not expected as they were not present in any of the 
predicted structures.
5.6.4 Experim ental crystallisation screen
4-Hydroxycoumarin was purchased from Sigma-Aldrich (Poole, 98% purity). The 
material was supplied as an anhydrous microcrystalline powder and its XRPD pattern 
was recorded. As no anhydrous crystal structure had previously been reported for 4- 
hydroxycoumarin this crystal form was designated form 1 (figure 5.21).
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Figure 5.21: XRPD pattern of commercially supplied 4-hydroxycoumarin
All of the peaks were broad suggesting either a poor quality crystalline sample or 
possible disorder. The region of severe peak overlap between 24-28° in 20 precluded 
indexing the structure.
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The solubility of 4-hydroxycoumarin in 46 solvents at room temperature was crudely 
measured by adding measured quantities of 4-hydroxycoumarin to a specified volume 
of each solvent until the solid was in excess. The solvents were then grouped into four
categories (table 5.8).
Insoluble < 1 mg/ml 1-10 mg/ml >10 mg/ml
1 -o c te n e 1 ,2 -d ich lo ro eth a n e 1 ,4 -d io x a n e 1-butanol
butyl v inylether 1-b rom ob u tan e aceton itrile 1-propan ol
c y c lo h e x a n e benzonitrile d ieth y leth er 2 ,2 ,2 -tr iflu oroeth an ol
n -h e x a n e b ro m o eth a n e e th y la c e ta te 2 ,4 -p e n ta d io n e
n -o c ta n e chloroform m e th y lb en zo a te 2-b u tan o l
tetrach loroeth y len e d i-n -butylether n itrom eth an e 2 -b u to x y eth a n o l
d ib rom om eth an e t-b uty lm ethylether 2 -ch lo ro e th a n o l
d ich lo ro m eth a n e 2-p rop an o l
iso p ren e 2 -m eth o x y e th a n o l
isop rop y leth er 2 -m eth y la m in o eth a n o l
o -x y len e a c e t ic  acid
to lu en e a c e to n e
w ater DMF
DMSO
eth a n o l
m eth an o l
m eth y le th y lk eto n e
n -octan o l
tetrahydrofuran
trifluoroacetic an h yd rid e
Table 5.8: Solubility groupings for 4-hydroxycoumarin. Measured in mass of 4- 
hydroxycoumarin per millilitre of solvent
A single solvent evaporation at room temperature was carried out for all solvents with 
solubilities less than 1 mg/ml of 4-hydroxycoumarin. For solvents of higher solubility 
which were classified as toxic only one solvent evaporation crystallisation was set up 
(2,4-pentadione, 2-chloroethanol, 2-methoxyethanol, 2-methylaminoethanol, DMF, 
DMSO, n-octanol, trifluoroacetic anhydride). For each of the remaining 21 solvents 5 
crystallisations were set up (table 5.9): solvent evaporation of a 100% saturated solution 
at room temperature; solvent evaporation of a 50% saturated solution at room 
temperature; solvent evaporation of a 100% saturated solution at 5° C in a domestic 
refrigerator; vapour diffusions with both chloroform and toluene anti-solvents.
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Solvent EV 100 
(RT)
EV 50 
(RT)
EV 100
(5° C)
VD
CHCIa
VD
TOL
1 ,4 -D io x a n e X X X X X
1-B utanol X X X X X
1-P ropanol X X X X X
2 ,2 ,2 -T  rifluoroethanol X X X X X
2-B utanol X X X X X
2 -B u toxyeth an ol X X X X X
2-P ropanol X X X X X
A cetic  Acid X X X X X
A ceto n e X X X X X
A cetonitrile X X X X X
B utylvinylether X X X X X
D iethylether X X X X X
Ethanol X X X X X
E th y laceta te X X X X X
Isopropylether X X X X X
M ethanol X X X X X
M eth y lb en zo a te X X X X X
M eth ylethylketone X X X X X
N itrom ethane X X X X X
t-B utylm ethylether X X X X X
T etrahydrofuran X X X X X
1 ,2 -D ich lo ro eth a n e X
1-B rom ob u tan e X
2 ,4 -p e n ta d io n e X
2-C h loroeth an o l X
2-M eth oxyeth an o l X
2-M eth y lam in oeth an o l X
B enzonitrile X
B ro m o eth a n e X
Chloroform X
D ib rom om eth an e X
D ich lorom eth an e X
D i-n-butylether X
DMF X
DM SO X
Isop ren e X
n-O ctanol X
o -X y len e X
T e trach loroeth y len e X
T o lu en e X
Trifluoroacetic anhydride X
W ater X
Table 5.9: Summary of all crystallisations of 4-hydroxycoumarin. x denotes that 
this crystallisation was set up; EV = evaporation of 100%, 50% saturated 
solutions; VD = vapour diffusion with chloroform or toluene
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In 44 crystallisations the crystal morphology was evident, with fine needles observed 40 
times which were usually too small for single crystal X-ray diffraction. In some of these 
crystallisations the needles formed ferns on the base and walls of the crystallising 
vessel. In the crystallisations in which a clear crystal morphology was not observed the 
product was a white microcrystalline precipitate.
Only six samples yielded crystals suitable for checking by SXRD, and five 
further samples were chosen for XRPD based on the quantity of precipitate and the 
crystal morphology.
Block crystals and a white precipitate were grown from dibromomethane and the 
blocks were found to be a new polymorph (form 2). This polymorph was also 
crystallised from toluene. The crystal structure (form 3) found in the common needle 
morphology was characterised by SXRD from crystals grown from a sub-saturated 
solution of 4-hydroxycoumarin in tert-butylmethylether. XRPD on samples with fern 
morphology found these to be form 3. A solvate was isolated by solvent evaporation 
from trifluoroacetic anhydride, identified by XRPD, and the desolvation of this sample 
led to the observation of the new unsolvated form 4, which was indexed from its XRPD 
pattern. 4-hydroxycoumarin was not particularly soluble in water at room temperature 
but the known monohydrate was grown from the hygroscopic solvents nitromethane and 
acetonitrile, and grew as long flat needles.
A crystallisation database, summarising all crystallisations and results, is 
provided on the supporting information CD (in Chapter_5_Coumarins) and a summary 
spreadsheet detailing crystallisation conditions for all of the forms of 4- 
hydroxycoumarin is also given (Crystallisation_Summary.xls).
5.6.5 4-Hydroxycoumarin form 2
Slow crystallisation from dibromomethane gave two products, a white microcrystalline 
material and several block crystals (figure 5.22). The two were manually separated and 
XRPD was used to determine that the white material was form 1, the same form as the 
commercially supplied material. The block crystals were of sufficient quality for single 
crystal X-ray diffraction and a full data set was collected and the structure determined. 
The simulated powder pattern of this new polymorph, form 2, was different to that of 
form 1. Repeating this crystallisation led to the observation that faster solvent
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evaporation of dibromomethane gave no block crystals, and it was confirmed by XRPD 
that form 2 was completely absent.
Figure 5.22: 4-Hydroxycoumarin grown from dibromomethane. Blocks are form 2 
while the white microcrystalline material is form 1
4-Hydroxycoumarin form 2 crystallises in the space group P2\!c with two molecules in 
the asymmetric unit (figure 5.23, table 5.10).
o  C16
Figure 5.23: Asymmetric unit of 4-hydroxycoumarin form 2
In this crystal structure the molecules are not orientated correctly for photodimerisation 
and the aromatic rings are not stacked in the crystal structure. The hydrogen bond 
04-H2—012 is present with the two independent molecules forming an almost flat
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dimer in an anti configuration across the hydrogen bond. These dimers then comprise 
the basic unit that form a stepped chain (figure 5.24) and adjacent chains intercalate 
(figure 5.25). The lowest energy predicted structure is made up of stepped chains that 
intercalate in a similar manner, but each unit in the stepped chain is a single molecule.
Figure 5.24: Three dimers forming part of one stepped chain in
4-hydroxycoumarin form 2
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Figure 5.25: Two intercalated chains in 4-hydroxycoumarin form 2. One chain is 
coloured red and the other is coloured blue
5.6.6 4-Hydroxycoumarin form 3
Large crystals of the common needle morphology were grown from a sub-saturated 
solution of 4-hydroxycoumarin in tert-butylmethylether (figure 5.26). The crystals were 
found to be non-merohedrally twinned, and a SXRD data set was collected on a good 
quality twinned crystal.
The twin resolution program GEMINI217 was used to index the two separate 
parts of the twin. The data set collected was integrated using the orientation matrix of 
both components separately and the TWINHKL component of GEMINI217 was used to 
write two data files: one containing only the non-overlapping data for the major 
component and a second containing all data. This second data file was an hkl file in 
which each reflection was assigned as belonging to component 1 or component 2 or 
having contributions from both. The structure was solved on just the major component 
and subsequently the data file containing data from both components was used to refine 
against. The twin components were related by the twin law (-1 0 0, 0 -1 0, 0 -0.92 1) 
and were in the ratio 83:27.
Figure 5.26: Cluster of needle crystals of 4-hydroxycoumarin form 3
4-hydroxycoumarin form 3 crystallises in the space group F2\!c with two independent 
molecules in the asymmetric unit (figure 5.27, table 5.10). The crystal structure solution 
was not straight forward, with the final solution having an R-factor of 13.6%. Each of 
the atoms C6, C7, C8 and CIO in the first independent molecule have ratios of 
maximum to minimum atomic displacement parameters greater than four -  such strong 
anisotropy usually indicates that there is disorder present in the crystal structure. 
Attempts to model disorder did not however lead to a superior structure solution and 
consequently the best ordered solution is presented here.
C16
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Figure 5.27: Asymmetric unit of 4-hydroxycoumarin form 3
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In contrast to form 2, the independent molecules in this polymorph are syn orientated 
across the 04-H2- 012 hydrogen bond, forming a rippled chain. The chains stack 
directly in the crystal structure parallel to the ac plane, with the distance between the 
chains the b axial length, 3.785(2) A (figure 5.28). The aromatic rings in the 
4-hydroxycoumarin molecules have the attractive offset Ti-stacking as observed in 
almost all of the sy«-chain based predicted structures and the molecular orientation, 
along with the short stacking separation, leads to this structure being potentially 
photoreactive.
Figure 5.28: Chain stacking in 4-hydroxycoumarin form 3. The lower chain is 
shown in wireframe and the separation between the chains is 3.785(2) A
5.6.7 4-Hydroxycoumarin trifluoroacetic anhydride solvate and form  4
Solvent evaporation from a saturated solution of 4-hydroxycoumarin in trifluoroacetic 
anhydride produced a microcrystalline material that was identified as a solvate by 
thermogravimetric analysis, with a 42% weight loss recorded at an onset temperature of 
77° C. This compares with the calculated 56% weight loss that a 1:1 
4-hydroxycoumarin : trifluoroacetic anhydride solvate would undergo upon desolvation. 
The solvate proved very unstable upon removal from the mother liquor and appreciable 
desolvation could be expected to have occurred prior to the weight loss measurement. 
XRPD of the solvate produced a novel diffraction pattern, but it was likely that there
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was a mix of phases present, including both the solvate and one or more desolvated 
phases, and indexing was not possible. Upon rapid desolvation by mild heating an 
XRPD measurement run immediately showed that the initial desolvation product was 
predominantly amorphous. Within 12 hours the amorphous phase crystallised, usually 
to a mix of two phases: form 1 and a new form 4. In one particular slow desolvation 
experiment form 4 was successfully isolated and an accurate XRPD pattern measured 
between 2-40° in 20, with a 0.05° step size and 80 seconds of exposure at each step.
^ 1  o
This was analysed by Martin Vickers (University College London) using CrysFire to 
index the data, Checkcell to assign a unit cell and Rietica219 for Le Bail refinement 
(figure 5.29).
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Figure 5.29: XRPD pattern of 4-hydroxycoumarin form 4. Shown in red is the 
recorded powder pattern; blue tick marks indicate the position of the peaks 
according to the determined unit cell; green line shows the agreement between the 
two
The unit cell was determined to belong to the orthorhombic space group Fddl, and from 
the volume of the unit cell and multiplicity of the space group, this requires the 
asymmetric unit to contain one molecule (table 5.10). Proton NMR of the desolvation 
product of the trifluoroacetic anhydride solvate was unchanged from that of the 
commercially supplied material, discounting the possibility that this crystal structure is 
a reaction product or that solvent was still present.
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5.6.8 Discussion
Crystal structure prediction carried out on 4-hydroxycoumarin gave a large number of 
low energy structures all based on the only strong hydrogen bond possible, 04-H2—02. 
Two chain configurations were observed in the low energy predicted structures: 15 
structures including the two lowest energy structures contained the anti chain 
configuration and 34 had a syn chain motif. Offset 7c-stacking was present in the 
majority of the syn structures, and the lowest energy anti structures. Within the 50 
structures examined there was no preference among the lowest energy structures for 
either the anti or syn chain configuration.
The experimental search for anhydrous forms of 4-hydroxycoumarin was a success, 
with four polymorphs identified during the crystallisation screen. Form 1 was only 
identified by X-ray powder diffraction, forms 2 and 3 were fully determined by single 
crystal X-ray diffraction and form 4 was indexed from the powder pattern. Both chain 
configurations found in the predicted structures were found in the experimental crystal 
structures: form 2 was based on an anti chain motif with intercalated chains and bore 
some resemblance to the lowest energy predicted structure; form 3 was based on a syn 
motif, with both the offset rc-stacking and correct molecular orientation for 
photodimerisation as found in almost all sy«-based predicted structures.
A predicted structure corresponding to the unit cell of form 4 was not found 
because structures were not generated by MOLPAK in the space group Fddl. Forms 2 
and 3 were not predicted because they both contain two molecules in the asymmetric 
unit but the structures were energy minimised for comparison to the predicted 
structures. The global energy minimum structure was found to be over 6.6 kJ mol'1 
lower in energy than forms 2 and 3, superficially suggesting that thermodynamically 
more stable polymorphs could be found. However the errors in the reproduction of 
forms 2 and 3 give little confidence in the energies of these structures relative to the 
predicted structures, and therefore no comment can be made on the plausibility of 
finding a thermodynamically more stable form.
The melting points of forms 1 and 3 were recorded and both were found to melt 
between 217-218° C, not providing any information on their relative stability. The 
production of form 2 concomitantly only under slow thermodynamically controlled 
crystallisation conditions, and its absence under faster kinetic crystallisation conditions,
194
indicates that it is more stable than form 1. The formation of form 4 was usually 
concomitant with form 1 and the phase change of the exclusively form 4 sample to a 
mix of forms 1 and 4 upon standing suggests that form 1 is more stable than form 4.
5.7 Conclusion
The crystal structure prediction of both coumarin and 7-hydroxycoumarin found the 
known structure in both searches as the global energy minimum structure suggesting 
that the known crystal structure of both molecules is the thermodynamically most stable 
form. These studies exemplify one of the key envisaged utilities of crystal structure 
prediction -  namely the confirmation of a known polymorph as the thermodynamically 
most stable form. This information would be of considerable use during the physical 
characterisation stage of pharmaceutical development: further experimental
investigation to confirm that the known crystal structure is the thermodynamically most 
stable form could be curtailed, and possibly refocused toward generating metastable 
forms.
The known structure of 6-methoxycoumarin was found during crystal structure 
prediction ranked 22nd. All of the predicted structures in this search exhibited the same 
fundamental triplet of C-H - 0  hydrogen bonds and differed only by the interactions 
between ribbons propagated by these triplet interactions. No predicted structure was 
found that corresponded to a second unit cell reported for 6-methoxycoumarin. From 
the range of cell volumes of the predicted structures is concluded that this unit cell must 
correspond to that of a solvate. A limited crystallisation screen did not produce a crystal 
structure with this unit cell.
The crystal structures of two anhydrous forms of 4-hydroxycoumarin were fully 
determined during the experimental investigation and two further polymorphs were 
identified by X-ray powder diffraction. The predicted structures of 
4-hydroxycoumarin were found to exhibit chains in which the molecules were either syn 
or anti orientated across the hydrogen bond. In the syn chains offset 7E-stacking was 
observed which led to classification of almost all of these structures as potentially 
photoreactive. The anti chain based structures were found to be less likely to have offset 
7r-stacking and consequently less likely to have the molecules orientated correctly for 
photodimerisation. While neither of the fully characterised crystal structures was
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predicted in the search because of the limitations of the search method, they did confirm 
that the features identified in the predicted structures were realistic: form 2 was found to 
be based on an anti-chains and indeed showed neither offset 7c-stacking or molecular 
orientation correct for photodimerisation; form 3 contained syn configured chains and 
confirmed the prediction results by having both offset rc-stacking and being potentially 
photoreactive.
The crystal structure prediction for all four molecules investigated in this chapter 
resulted in some hypothetical structures that could potentially photodimerise and some 
that could not. This observation was borne out by the experimental discovery of two 4- 
hydroxycoumarin polymorphs, one of which fell into each of these categories. This 
highlights the role crystal structure prediction could play, in combination with 
experiment, in identifying candidates for photodimerisation reactions and the potential 
for polymorphism to be exploited as a facet of crystal engineering towards the ultimate 
goal of solid state ‘diffusionless’ reactions. MacGillivray states that “Approaches to 
align olefins in molecular solids for a [2+2] photoreaction may be classified into two 
general categories: methods that employ (1) intramolecular substitution, or (2) auxiliary
99 0components” -  the work presented here suggests that the exploitation of 
polymorphism may provide a third pathway to photoreactive crystal structures.
5.8 Further work
The experimental study on 4-hydroxycoumarin remains incomplete: further
investigation of the transiently stable form 4 could yield a structure determined by 
X-ray powder diffraction, either using the method of production detailed here, 
desolvation of the trifluoroacetic anhydride solvate, or potentially by an alternative 
method. Upon production of a pure sample of form 4, kinetic stabilisation by cooling to 
low temperature would be required to prevent the phase change to a mixed phase with 
form 1. Further analysis to determine the relative thermodynamic stabilities of the four 
polymorphs and their inter-relationships would be beneficial to understanding the 
crystallisation behaviour of 4-hydroxycoumarin.
Investigations into the photoreactivity of the polymorphs of 4-hydroxycoumarin 
could confirm the hypothesis that form 3 would photodimerise while form 2 would not. 
This, along with investigations of the DAXBIN01 form of 6-methoxycoumarin to
196
confirm the assertion that it is photostable, and of the DETFOX 7-hydroxycoumarin 
form to determine its photoreactivity, would add to our understanding of the crystal 
packing required for coumarins to photodimerise and how we can use crystal structure 
prediction to assess the likelihood that a coumarin will pack to give a photodimerising 
crystal structure.
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Crystal Data
Compound name 4 -hydroxycoumarin 4-hydroxycoumarin 4-hydroxycoumarin
form 2 form 3 form 4*
Empirical formula C9 H6 0 3 C9 H6 O3 C9 H6 O3
Formula weight 162.1 162.1 162.1
Crystal system, space group Monoclinic, P 2 x/c Monoclinic, P 2 x/c Orthorhombic, F ddl
a (A) 9.3547(17) 2 1 .2 0 ( 1 ) 11.354(2)
b (A) 10.975(2) 3.785(2) 32.12(4)
c (A) 14.817(3) 20.05(1) 8.088(5)
a (°) 90 90 90
P(°) 105.688(3) 115.56(1) 90
Y(°) 90 90 90
V (A3) 1464.6(5) 1451.5(1.4) 2950(4)
Z',Z 2 , 8 2 , 8 1 , 16
D(calc (g cm'3)) 1.471 1.484 1.460(2)
Data Collection
Crystal size (mm) 0.45 x 0 .27x0 .13 0 . 57 x 0 .1 2 x 0 .1 0 0.3mm recessed flat plate
Temperature (K) 150(2) 150(2) 298(2)
hkl range (h, k, 1) -12—>12, -14—>14, -19-->19 -28—>23, -5—>5, -26->26 -
Reflections measured, Rint 12284, 0.0404 12339, - -
Independent reflections 3480 7938 -
Reflections I>2o(I) 2699 4391 -
Refinement
Parameters refined 265 225 -
R(F) (I>2o(I)) 0.050 0.136 -
wR(F2) (all reflections) 0.137 0.353 3.61 (Rwp)
Residual electron density 0.39, -0.19 0.69, -0.64 -
(min, max (e A'3))
Table 5.10: Crystal structure summary for 4-hydroxycoumarin structures included in this chapter. * indexed from XRPD data, 
Cu Ka radiation, X = 1.54056 A
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Chapter 6 -  3-Azabicyclo[3.3.1]nonane-2,4-dione
6.1 Introduction
3-Azabicyclo[3.3.1]nonane-2,4-dione (BQT, figure 6.1) is a small, rigid organic 
molecule that was one of the three test molecules used for the second CCDC 
international blind test of computational crystal structure prediction methods 
(CSP2001).122
C2
C 40 1 = C 1 C8.
:C7
H1 C6
02
Figure 6.1: 3-AzabicycIo[3.3.11nonane-2,4-dione (BQT) with numbering scheme
Computational crystal structure prediction progressed rapidly from its inception in the 
early 1960s117 and has reached a stage where comparative testing of the different 
techniques in use today could give insights into the weaknesses of different 
methodologies. Three international blind tests of crystal structure prediction have been 
organised by the CCDC in 1999 (CSP1999),121 2001122 and 2004 (CSP2004).123 Each 
blind test comprised three test molecules of increasing complexity, with only the 
molecular diagrams released to the participating groups. Each group was limited to 
proposing three hypothetical crystal structures for each test molecule and the choice of 
which structures to submit from the total set of predicted structures was usually based 
on lattice energy, sometimes aided by crystallographic experience. One academic group 
also made predictions using a method exploiting the supramolecular synthons present in 
the crystal structures of structurally similar molecules,221 which has the added advantage 
that the frequency of supramolecular synthons in the CSD222 is influenced by kinetic 
factors as well as thermodynamics. Upon submission of all predicted hypothetical 
structures, comparisons were made with the experimental crystal structures, which until 
this point were held in secret. A predicted structure that corresponded closely to the
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experimental structure within a tight tolerance limit based on nearest neighbour 
distances and orientation, was viewed as a successful prediction.124
6.2 2001 blind test results
BQT was the simplest molecule used for CSP2001, by virtue of being rigid, containing 
fewer than 25 atoms and comprising only C H N and O atoms. Participants were 
informed that the experimental crystal structure contained only one molecule in the 
asymmetric unit and that the space group was one of the ten most common space groups 
for organic molecules found in the CSD.223 In spite of the relative simplicity of this 
molecule and its conventional crystallographic properties only 2 submissions from the 
total of 45 from the 15 participants correctly predicted the experimental structure (form 
l224) within the allowed tolerance, though many participants subsequently found it 
within their expanded list of hypothetical structures. The two successful predictions 
were ranked second and third by their submitting participants. Analysis of the 45 
submitted structures showed that there were two common recurring hydrogen bond 
motifs. 34 structures exhibited a hydrogen bonded dimer motif (figure 6.2A) and 8 
exhibited hydrogen bonded chain motifs (figure 6.2B). The dimer-based structures were 
produced by a range of CSP methods using a variety of intermolecular potentials for 
energy minimisation of the crystal structures, leading to the conclusion that dimer-based 
structures are energetically competitive with the chain-based structures.
Figure 6.2: Common hydrogen bonded motifs found in BQT predicted structures. 
A: Dimer; B: Chain
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Of the eight structures that exhibit a chain motif, only in the two successful predictions 
was the chain propagated by a glide plane; in the other six the chain was propagated by 
a 21 screw axis giving a different shape to the chain (figure 6.3).
Figure 6.3: Hydrogen bonded chains viewed parallel to the chain axis. A: 
Experimental chain motif propagated by a glide plane; B: Predicted chain motif 
propagated by a 2i screw axis
Investigation of the extent of polymorphism in the test molecules was not explicitly 
addressed in any of the blind tests. Estimates that approximately one third of organic 
molecules exhibit polymorphism under normal temperature and pressure conditions, 
makes potential for polymorphism in the blind test molecules a significant factor given 
the impact it would have on the outcome of the blind tests. For each of the blind test 
molecules a single crystal structure was determined and used for comparison with the 
hypothetical structures. Within the total test set of nine molecules used in the three blind 
tests, so far two have been found to exhibit polymorphism. The most simple test 
molecule used in CSP1999, 3-oxabicyclo(3.2.0)hepta-l,4-diene, was found to be 
polymorphic during the initial crystal structure determination. It initially crystallised in 
space group Pbca but subsequently could only be obtained in an alternative crystal 
packing in P2\!c. Both experimental structures were considered during comparison with 
the predicted structures and all of the four ‘correct’ predictions for this molecule were of 
the metastable Pbca form. Had the metastable form not been observed, no correct 
predictions would have been made. 6-Amino-2-phenylsulfonylimino-l,2- 
dihydropyridine, the flexible test molecule from CSP2001, was found two years later to 
have a second polymorph226 after one of the participants became convinced that there 
was a new polymorph with a different hydrogen bonding motif to be found. This new 
structure contained two molecules in the asymmetric unit, placing this outside the limits 
set by the CCDC on the predicted structures, and consequently did not lead to any 
further ‘correct’ predictions in retrospect.
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The prevalence of hydrogen bonded dimer-based structures for BQT in the predicted 
structures submitted during CSP2001, which were found to be energetically competitive 
with the experimental chain-based crystal structure, and the lack of any previous 
experimental investigation into its polymorphism provided the inspiration for an 
automated crystallisation screen on BQT to attempt to discover dimer based polymorphs 
of this molecule.
6.3 Synthesis
BQT is not commercially available, and consequently it was synthesised during this 
study, specifically to facilitate the crystallisation screen. The synthesis was performed 
under the supervision of Dr. Colin Bedford (UCL Chemistry).
The procedure of Goodwin & Perkin227 was used to convert the starting material, 
a mixture of cis/trans 1,3-cyclohexane dicarboxylic acid (Sigma-Adrich, Poole, UK), to 
the pure cis isomer. 75g of mixed cis/trans 1,3-cyclohexane dicarboxylic acid, was 
refluxed with 120ml of acetyl chloride for 1 hour at 80° C. Acetyl chloride and acetic 
acid were distilled off at 160° C, leaving a residue of pure 3-oxabicyclo[3,3,l]nonane- 
2,4-dione. Residual traces of acetic acid were removed by mild heating under strong 
vacuum (~1 mmHg). This anhydride was then dissolved in 150ml of hot distilled water 
to convert it to cis-1,3-cyclohexanedicarboxylic acid. The volume was reduced by 
approximately 20ml by heating and the mixture was cooled to room temperature, with 
constant stirring. The product was filtered off to leave pure cis- 1,3-cyclohexane 
dicarboxylic acid. From 75g of the starting mixture of geometric isomers, 70.92g of 
pure cis acid was recovered, 94.6% yield.
The cis- 1,3-cyclohexane dicarboxylic acid was converted to the final product 
after the method of Hall. 40ml of 30% aqueous ammonium hydroxide was added to 
25g of cis- 1,3-cyclohexane dicarboxylic acid, with ammonia released by the reaction. 
The water was distilled off and the residual imide was distilled using a free flame under 
~15 mmHg vacuum into an air condenser. The distilled product was a wet white solid, 
which was washed with water and mechanically recovered into a beaker. The water was 
strongly acidic due to the presence of cis- 1,3-cyclohexane dicarboxylic acid from the 
hydrolysis of the minor by-product 3-oxabicyclo[3,3,l]nonane-2,4-dione. The acid 
solution was neutralised using 10% sodium hydroxide and the product was taken up in
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50 ml of chloroform. The water layer was washed with 2x50ml portions of chloroform. 
9.4lg of BQT was recovered upon evaporation of the chloroform solution to dryness, 
42% yield. 37.7g was made using this method.
6.4 Automated crystallisation screen
The Chemspeed Accelerator SLT100 (Augst, Switzerland) automated parallel 
crystallisation platform located at Strathclyde Institute of Biomedical Science was used 
in preference to manual crystallisation methods as it allowed a large number of 
crystallisations to be carried out in a short period of time along with giving a high
99Qdegree of control over the exact crystallisation conditions. This work was carried out 
under the guidance of Dr. Andrea Johnston (Strathclyde University). A solvent library 
containing 67 solvents with a wide range of physico-chemical properties59 formed the 
principal basis of variation in the crystallisation screen and three different crystallisation 
methods were employed.
A schematic diagram of the crystallisation apparatus is shown in figure 6.4. Up 
to 32 crystallisations, incorporating different solvents, but the same crystallisation 
conditions could be performed in parallel. To allow for the possibility of a novel crystal 
structure based on a dimer motif, crystalline seeds of the starting form of BQT were 
rigorously excluded from all crystallisation vessels by a specifically designed filtration 
step between the dissolution and crystallisation stages. All solutions were filtered 
through a 10 pm filter at the same temperature as the dissolution stage. As soon as the 
solution had been filtered into the crystallisation vessel, it was subjected to a rapid 
heating cycle to dissolve any seeds smaller than 10 pm, before entering the 
crystallisation regime. This method, as far as it is possible, removed all crystalline 
seeds, forcing the solution to crystallise via primary nucleation or secondary nucleation 
only on the surface of the crystallisation vessel.
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Scheme 6.1: Schematic representation of the automated crystallisation process. 
This apparatus is duplicated within the automated crystallisation platform
To facilitate high temperature dissolution in the range of solvents available, the 67 
available solvents were divided into eight groups of eight and a group of three 
according to descending boiling point. For each group a temperature Tmax was chosen 
just below the boiling point of the lowest boiling member of the group, at which the 
dissolution step could be carried out without significant solvent vaporisation. The 
solvent groups and associated Tmax temperatures are given in the supporting 
information.
The first crystallisation method involved saturation of 2 ml quantities of each 
solvent with BQT at its Tmax, followed by filtration of the solutions at Tmax and 
controlled cooling to 15° C at >20 °C min'1, while subject to a 1000 rpm vortex. The 
second crystallisation method involved dissolution of 100 mg of BQT in 2 ml of solvent 
at Tmax to produce sub-saturated solutions, which were filtered at Tmax, and subsequently 
cooled to 15 °C at >20 °C m in1 under an 850 rpm vortex. The third crystallisation 
method involved dissolution of 100 mg of BQT in 2 ml of solvent at 75 °C, followed by 
filtration and transferral of each solution to a crystallisation vial on a hot plate at 75 °C.
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The solvent was then evaporated while under a 500 rpm vortex. In total 181 
crystallisation experiments were carried out.
The products of all crystallisations were initially analysed by X-ray powder 
diffraction using a multi-sample Bruker-AXS D8-Advance X-ray powder diffractometer
io n
in a transmission configuration. This provided rapid and detailed evaluation of the 
crystallisation products. Novel forms were identified by XRPD pattern matching using 
the computer software EVA, along with all crystallisations that yielded form 1.
A crystallisation database, summarising all crystallisations and results, is 
provided on the supporting information CD (in Chapter_6_3Azabicyclononane-2,4- 
dione) and a summary spreadsheet detailing crystallisation conditions for all of the 
forms of BQT is also given (Crystallisation_Summary.xls).
6.5 Results
The synthesis of BQT gave a crystalline product which was identified as form 1 by 
XRPD. BQT was soluble in all 67 solvents at each solvent’s Tmax and the product of the 
vast majority of crystallisations in the screen was form 1. The crystallisation screen 
produced two solvates, containing acetic acid and 1 -methylnaphthalene and a new 
metastable polymorph (form 2). Thermal analysis of the synthesised material also 
yielded form 2 and a high temperature plastic crystalline phase (form 3). A spreadsheet 
detailing all crystallisations and the identity of the products is provided in the 
supporting information.
9^ 93-Azabicyclo[3.3.1]nonane-2,4-dione acetic acid (1/1)
The acetic acid solvate precipitated from a controlled cooling crystallisation as block 
crystals of sufficient size for SXRD and its crystal structure was fully determined. It 
crystallised in the triclinic space group P I  with one molecule of BQT and one 
molecule of acetic acid in the asymmetric unit (figure 6.4 and table 6.2).
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Figure 6.4: Asymmetric unit of BQT-acetic acid solvate
The crystal structure is comprised of hydrogen bonded chains of alternating BQT and 
acetic acid molecules. The hydrogen bonded back-bone of the chain (figure 6.5) is very 
similar to that found in BQT form 1 and both polymorphs of acetic acid.233 234 The 
BQT-acetic acid chain is a modification of the BQT form 1 chain with the carboxylic 
acid group of the acetic acid mimicking the role of the BQT amide functionality in the 
hydrogen bonded chain.
Figure 6.5: Hydrogen bonded chain present in the BQT acetic acid solvate
The chains propagate parallel to the b crystallographic axis and stack parallel to the a 
axis in an ABAB repeating pattern. This allows the bulky cyclohexane ring present in
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the BQT molecules to alternate from side to side in the stack, allowing efficient packing 
of the chains (figure 6.6).
Figure 6.6: ABAB stacking of the BQT acetic acid chains
3-Azabicyclo[3.3.1Jnonane-2,4-dione 1 -methylnaphthalene (2/l)235 
The 1-methylnaphthalene solvate crystallised with a fine needle morphology proving 
unsuitable for single crystal X-ray diffraction, and consequently an XRPD data set on a 
capillary transmission diffractometer was collected and from this data set the structure 
was determined and refined by Dr. Philippe Fernandes and Dr. Alastair Florence 
(Strathclyde University). The solvate was found to crystallise in the monoclinic space 
group P2\lc with two molecules of BQT and one molecule of 1-methylnaphthalene in 
the asymmetric unit (figure 6.7 and table 6.2). All atoms were refined with fixed 
isotropic temperature factors (UiS0 = 0.032 for C, O, N; Uiso = 0.076 for all H). The 
molecule was constructed for the simulated annealing structure solution process using 
standard bond lengths, angles and torsions and restraints were added in the refinement 
process that did not allow any bond to deviate by more than 0.1 A or angles by more 
than 0.8°. Atoms C4, C5, 02, N l, HI, Cl, 01, C2 (and the analogous group in the 
second BQT molecule) were restrained to be planar. The 1 -methylnapthalene molecule 
was also restrained to be planar.
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Figure 6.7: Asymmetric unit of BQT l-methylnaphthalene. All temperature factors 
are fixed and isotropic (see text)
The two symmetry independent BQT molecules form a hydrogen bonded chain very 
similar to that of forms 1 and 2, and, similarly to form 2, the chain exhibits a pseudo­
glide plane parallel to the b axis. The l-methylnaphthalene molecules occupy channels 
with each channel surrounded by four BQT chains (figure 6.8). The plane of the 1- 
methylnapthalene molecules, parallel to the ac plane, is perpendicular to the direction of 
the channels, parallel to the b axis.
Figure 6.8: BQT l-methylnaphthalene solvate. A: view parallel to the b axis 
showing the channels containing 1-methylanphthalene molecules; B: hydrogen 
bonded BQT ribbons shown coloured by element with l-methylnaphthalene 
molecules coloured grey
3-Azabicyclo[3.3.1]nonane-2,4-dione form 3
Combined DSC and TGA were carried out on BQT form 1, as synthesised. The 
instrument used was a Netzsch STA449C, with a liquid nitrogen attachment to allow
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control of cooling phases. Samples were heated to 200° C at 10° C min*1 and cooled 
back to room temperature at the same rate. A phase change was observed with an onset 
temperature of 137° C prior to melting at 190° C. The phase change from form 1 to this 
new form 3 was reversible on cooling, occurring at 106° C (figure 6.9). A second 
sample exhibited a form 3 to form 1 transition temperature of 124° C and the variation 
in transition temperature between samples can be attributed to an undercooling effect - 
the persistence of the metastable phase into the temperature domain of the stable form.
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Figure 6.9: DSC data for a heat-cool cycle starting from BQT form 1. The sample 
was heated to 200° C then cooled to 30° C before heating to 220° C
Hot stage microscopy showed that upon heating form 1 to 145° C the crystallites lost 
their optical activity, with the birefringence present under partially crossed polarising 
sheets disappearing at the phase change. No initial loss of shape or translucency of the 
crystallites was evident, but with increased temperature the sharp definition of the 
separate crystallites was lost as the new phase began to slowly ‘flow’. This plastic flow 
continued until the only features present in the sample were the boundaries between 
what were originally separate crystallites. At 195° C the plastic phase melted and 
droplets of liquid were formed. With cooling the liquid condensed into the plastic phase, 
which then crystallised sharply at 108° C (figure 6.10). On this evidence it was 
concluded that form 3 is a plastic crystalline phase.236
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Figure 6.10: Hot stage microscopy showing the phase changes to and from the 
plastic form 3. (a) crystals of form 1 at room temperature (b) phase change to form 
3 at 145° C (c) plastic flow (d) phase change from form 3 to liquid at 195° C (e) 
liquid droplets condense to form 3 below 190° C (f) form 3 converts to form 1 at 
108° C
XRPD data were collected by Dr. Alastair Florence on form 3  above 1 4 5 °  C .  The 
XRPD pattern contains seven distinct peaks ( 2 0  ( ° )  =  1 6 . 5 1 1 ( 3 ) ,  2 3 . 4 2 4 ( 3 ) ,  2 8 . 8 0 3 ( 4 ) ,  
3 3 . 3 8 5 ( 1 ) ,  3 7 . 4 5 5 ( 3 ) ,  4 1 . 2 0 0 ( 3 ) ,  4 4 . 6 6 2 ( 3 ) ,  figure 6 . 1 1 )  which are present at all 
temperatures below the melting point of the plastic phase.
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Figure 6.11: X-ray powder diffraction pattern of the form 3 plastic crystalline 
phase (12-46°). Insert shows high angle region (31-46°)
2 3 73-Azabicyclo[3.3.1]nonane-2,4-dione form 2
Fast cooling of the plastic form 3 to -28° C produced a metastable polymorph, which 
was kinetically trapped for long enough to collect a XRPD data set. From this data set 
the structure was determined and refined by Dr. Philippe Fernandes and Dr. Alastair 
Florence. All atoms were refined with fixed isotropic temperature factors (UiSO = 0.038 
for C, O, N; UiS0 = 0.076 for all H). The molecule was constructed for the simulated 
annealing structure solution process using standard bond lengths, angles and torsions 
and restraints were added in the refinement process that did not allow any bond to 
deviate by more than 0.1 A or angles by more than 1°. Atoms C4, C5, 02, N l, HI, C l, 
01, C2 (and the analogous group in the second BQT molecule) were restrained to be 
planar. The unit cell dimensions of form 2 are closely related to those of form 1 (table 
6.1), with the crystallographic c axis of the unit cell doubled with respect to the form 1 
structure, with the cell now containing two molecules in the asymmetric unit (table 6.2 
and figure 6.12).
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S . G. a (A) b (A) c  (A) P (° )
F orm  1 P 2 1/a 7 .7 0 4 6 (5 ) 1 0 .6 0 6 2 (6 ) 9 .3 3 8 4 (2 ) 9 5 .0 3 3 (2 )
F orm  2 P2:lc 7 .6 7 1 0 (2 ) 1 0 .5 4 8 3 (2 ) 1 8 .8 8 6 7 (4 ) 9 5 .5 8 0 (1 )
Table 6.1: Comparison of the unit cell dimensions of forms 1 and 2
012
C15
N11
C12 ,C11C16
C17 C
011
Figure 6.12: Asymmetric unit of BQT form 2. All temperature factors are fixed 
and isotropic (see text)
The powder pattern of form 2 is closely related to that of form 1, with a number of extra
peaks (figure 6.13).
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Figure 6.13: Overlay of experimental XRPD patterns for form 2 (red) and form 1 
(blue)
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Form 2 was also observed twice during the crystallisation screen, crystallising from 
chloroform and carbon tetrachloride, both by fast cooling of solutions saturated at 40° C 
and 70° C respectively. This highly metastable, kinetically stabilised form is an example
'V J O
of a trapped Ostwald phase, a metastable phase initially formed on crystallisation that 
subsequently transforms to a more stable form.
In form 1 the hydrogen bonded chain is propagated, by the a glide plane, parallel 
to the a axis. In form 2, there are two independent molecules forming the same 
hydrogen bonded chain, again parallel to the a axis, but here the chain propagates by a 
pseudo-glide plane, with the space group now P2\/c rather than P2\/a (figure 6.14).
Figure 6.14: Pseudo-glide plane parallel to the a axis in form 2. Molecules are 
coloured by symmetry equivalence
In the crystal structure form 2 packs the chains in a manner similar to form 1, with the 
chains lying side by side to form layers parallel to the ab plane. In both cases the layers 
are related by the 2\ screw axis parallel to the b axis, but the stacking of the layers 
differs between the two forms, with form 1 showing an AB repeat and form 2 an ABCD 
repeat (figure 6.15). The stacking in form 2 can be envisaged as related to that of form 1 
by a translation of approximately half a unit cell parallel to the b axis for the C and D 
layers. The lack of strong interactions between the layers would account for the rapid 
conversion of form 2 to form 1 in under one hour at room temperature.
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4Figure 6.15: Overlay of the layer stacking of form 1 (blue) and form 2 (red). The 
top layer and two bottom layers match closely, whilst the intermediate layers do 
not
6.6 Discussion
The predicted plausible low energy hydrogen bond dimer-based hypothetical structures 
for BQT, produced by a range of CSP methods and intermolecular potentials during 
CSP2001, has not been realised by experimental research. Rather a new metastable 
chain-based polymorph has been discovered.
The crystallisation methods employed in this study provided for a range of 
conditions under which a new polymorph could have the opportunity to form. The 
filtration step removed, in so far as it is possible, all pre-existing crystalline seeds from 
the crystallisation process. The high temperature dissolution and the heat pulse after 
filtration removed the possibility of ‘crystal memory’ -  small clusters of undissolved 
BQT molecules which retained the form 1 crystal structure. The wide range of physico­
chemical properties exhibited by the solvent range used provided the opportunity for 
different self-assembled units at the pre-nucleation stage, possibly leading to different 
crystallisation outcomes. In sub-saturated non-polar solvents it could be envisaged that 
the first association between BQT molecules would be the formation of hydrogen 
bonded dimers. However, even from non-polar solvents in a sub-saturated regime, the 
form 1 crystal structure was produced. The formation of chain based crystal structures 
from all solvents using the different crystallisation methods requires an explanation.
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The production of form 1 as the result of the majority of crystallisations in this screen 
leads to the conclusion that it is the thermodynamically most stable phase below 
approximately 140° C at ambient pressure. Above 140° C the plastic form 3 is the most 
stable phase. Of the three new crystal structures that were found by the crystallisation 
screen, none contained BQT in a hydrogen bonded dimer motif. Form 2 has a close 
structural similarity to form 1 and exhibits the same chain hydrogen bond motif. It can 
be considered a metastable species due to its rapid transformation to form 1 at room 
temperature, and the requirement to kinetically trap it at low temperature for 
characterisation. The acetic acid solvate incorporates the solvent into the chain motif, 
with acetic acid molecules alternating with BQT molecules. This result is not surprising 
given that the supramolecular synthons present in BQT form 1 and in both of the 
polymorphs of acetic acid are very similar and the hydrogen bonded chain found in this 
solvate can be envisaged as an ‘average’ of the two parent supramolecular synthons. 
The 1-methylnapthalene solvate contains the same hydrogen bonded chains of BQT as 
found in forms 1 and 2.
Plastic crystalline phases such as form 3 are well known for globular molecules, 
and they commonly express cubic symmetry.236 The most well known molecules that 
form plastic crystalline phases are adamantane and camphor and plastic phases have 
been found in molecules structurally similar to BQT such as bicyclo[3.3.1]nonane, 
bicyclo[3.3.1]nonan-9-one240 and 3-oxabicyclo[3.3.1]nonane-2.4-dione. The plastic 
phase has been contrasted with liquid crystals by Timmermans.236 He envisaged the 
melting process as consisting of two parts both of which are a result of thermal motion: 
the free rotation of the molecule and the loss of coherence of the crystal (the 
translational repeat order that forms the lattice). In liquid crystals the coherence of the 
crystal is lost before isotropic rotation of the molecules can occur, due to the strongly 
anisotropic shape of the molecules. In plastic crystals the free rotation is facilitated first, 
due to the globular conformation of the molecules, with the breaking of the crystalline 
lattice occurring at higher temperature as a separate event. The large librational motion 
of the molecules in a plastic crystal accounts for the rapid decrease in the intensity of X- 
ray scattering with angle. The Debye factor relating the observed intensity to the 
intensity for non-vibrating atoms is
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where p (bar) is the mean square amplitude of vibration normal to the reflection 
plane.241 At higher angles of diffraction the intensity decreases rapidly, leading to a 
small number of observed Bragg peaks, consistent with the observation of only seven 
peaks in the XRPD pattern of form 3. The seven peaks in the XRPD pattern are 
consistent with a cubic cell, space group I2i, a = 7.5856(1) A, Rw  = 0.016). The unit 
cell has a volume of 436.49(1) A3 and when compared to the volume of 190 A3 per 
molecule for BQT form 1, it can be assumed that the unit cell contains two molecules, 
with the approximate 15% increase in volume per molecule consistent with the 
introduced disorder. Two molecules in the unit cell would be consistent with body 
centring.
Two models for the disorder in plastic crystals have been proposed.242 In the 
Pauling model243 the molecules are free rotors with no well defined energy minima. In 
the Frenkel model244 the crystal is considered disordered, with the molecules distributed 
over a number of discrete energy minima. The molecules show significant libration at 
each energy minimum and can step between the discrete minima. It has been noted that 
X-ray diffraction would not be able to distinguish between free rotation and a range of 
discrete orientations.245 The largest diameter that can be swept out by a BQT molecule 
rotating around its centre of mass is approximately 8.6 A (calculated from the distance 
from the centre of mass to H9 = 3.10 A and the van der Waals radius for hydrogen =1.2 
A). Comparison of the diameter of a BQT molecule to the unit cell size suggests that 
each molecule does not have sufficient space to freely rotate and the Frenkel model is 
appropriate in this case.241 Guthrie and McCullough245 have attempted to relate the 
entropy of transition to the number of discrete molecular orientations based on the 
Frenkel model. In this model it is assumed that the entropy of transition is caused solely 
by the disordering of the molecules across the discrete orientations and that the lattice 
modes and molecular vibrational modes do not contribute significantly to the entropy of 
transition. The relation is:
plastic
NV  ordered J
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where Np ia s tic  is the number of discrete orientations in the plastic phase and No r d e r e d  is the 
number of discrete orientations in the low temperature fully crystalline phase, in this 
case 1. Seven DSC heating measurements of the form 1 to plastic phase transition and 
plastic melting events were recorded. The averages of these data gave an onset 
temperature for the form 1 to plastic transition of 135.6 ± 0.4° C, with AHtrs = 16.3 ±
0.7 kJ mol'1, leading to AStrs = 39.9 ± 1.9 J K-l mol'1. For the plastic melting event,
the average onset temperature from six measurements was 190 .6±0 .3°C  with AHtrs =
3.27 ± 0.2 kJ moLi and AStrs = 7.05 ± 0.43 J K-l mol'1. The entropy of the form 1 to
plastic transition therefore suggests that there are 120 discrete orientations in the plastic 
phase, but this is very much an approximation as some of the entropy of transition 
should be apportioned to the librational motion and consideration of the errors suggests 
a range of 100 to 150 orientations. This figure is similar to that calculated for 
heptacyclotetradecane, using a modified version of the above method, of 114 discrete 
orientations.246 BQT is a rare example of an organic compound that has a high 
temperature plastic phase and also has hydrogen bond donors and acceptors that can
'JA'lform conventional hydrogen bonds. Calculation of the solvent-accessible electrostatic 
surface of BQT by Gareth Welch (University College London) has shown the N-H 
group to be a weak hydrogen bond donor, with the electrostatic potential around this 
hydrogen not particularly more positive than around the hydrogen atoms on the 
cyclohexane ring. This weakness of the hydrogen bonds is consistent with the formation 
of the plastic phase, in which these hydrogen bonds must be broken. The related 
compound, 3-oxabicyclo[3,3,l]nonane-2,4-dione also shows a plastic transition, but at 
lower temperature, onset 74° C, consistent with the absence of even the weak hydrogen 
bonds seen in BQT.
6.7 Conclusion
A metastable polymorph, two solvates and a high temperature plastic phase have been 
discovered for the molecule 3-azabicyclo[3.3.1]nonane-2,4-dione, all based on 
hydrogen bonded chains. This is an example where our understanding of polymorphism 
has been complicated by the experience of applying CSP methods -  the proposal of 
nearly equi-energetic hypothetical structures built from hydrogen bonded dimers
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contrasts with the experimental situation where only crystal structures based on 
hydrogen bonded chains have been observed.
A greater knowledge of the processes of crystal growth -  specifically the 
assembly of molecules in solution prior to nucleation and the competition between 
nuclei of different crystal structures early in the pre-critical nucleus stage -  could 
provide the crucial reasoning as to why hydrogen bond dimer based structures have not 
been discovered. The weakness of the N-H - 0  hydrogen bond, as implied by the 
formation of the plastic phase and the calculations of the electrostatic potential around 
the molecule, and the globular shape of the molecule provides the basis for a hypothesis 
why dimer-based structures are not observed: both of these factors would allow the 
molecules in crystal nuclei to reorientate easily, allowing rearrangement into the more 
thermodynamically stable chain-based structure that is observed (form 1, and form 2 as 
a modification of form 1). The ease of this conversion would make the trapping of a 
dimer-based form very unlikely. This selectivity of the crystallisation pathway is not 
considered in the computational crystal structure prediction method. Those structures 
that are thermodynamically plausible but are selected against by the crystallisation 
process will remain in the set of hypothetical structures generated by CSP for as long as 
lattice energy is the only factor used to discriminate between hypothetical structures.
Further polymorphs may be waiting to be discovered, possibly by using novel 
crystallisation conditions such as growth on polymer substrates25 or templating,53 
though it should be noted that high pressure crystallisation techniques66 which can yield 
novel structures, did not produce a new polymorph in this instance.248
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Crystal Data
Compound name BQT BQT BQT
acetic acid 1  -methylnaphthalene* form 2 *
Empirical formula C8 HuN 0 2, C2 H4 O2 C8 H „N 02, ^(CnH.o) c 8 h „ n o 2
Formula weight 213.2 224.28 153.2
Crystal system, space group Triclinic, P  1 Monoclinic, P2.Jc Monoclinic, P2\/c
a (A) 6.6224(7) 15.0236(2) 7.6710(2)
b (A) 7.3580(8) 7.3230(1) 10.5483(2)
c(A) 10.7995(12) 22.5164(3) 18.8867(4)
ot(°) 103.598(2) 90 90
PC) 93.378(2) 106.0201(6) 95.580(1)
Y(°) 97.272(2) 90 90
v  (A3) 505.2(1) 2380.99(6) 1521.00(6)
z \ z 1 , 2 2 , 8 2 , 8
D(calc (g cm'3)) 1.402 1.251 1.338
Data Collection
Crystal size (mm) 0.35 x 0 .29x0 .17 XRPD capillary XRPD capillary
Temperature (K) 150(2) 295(2) 250(2)
hkl range (h, k, 1) - 8 —>8 , -9—>9, -14—>13 0->10, -4—>4, -14—>14 0—>5, -6 —>-6 , -12—>12
Reflections measured, Rmt 4424, 0.0126 736,- 448 ,-
Independent reflections 2313 - -
Reflections I>2o(I) 2 1 2 1 - -
Refinement
Parameters refined 196 2 1 1 142
R(F) (I>2o(I)) 0.039 0.044 (Rp) 0.054 (Rp)
wR(F2) (all reflections) 0.098 0.053 (R^) 0.070 (Rwp)
Residual electron density 0.35,-0.18 - -
(min, max (e A'3))
Table 6.2: Crystal structure summary of all BQT crystal structures included in this chapter. * Crystal structures determined by 
XRPD by Dr. Philippe Fernandes and Dr. Alastair Florence (Strathclyde University), 235;23 Cu Ka radiation, X = 1.54056 A
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Chapter 7 -  Crystal structure prediction of monohydrates
7.1 Introduction
7.1.1 The significance of hydrates
The potential of a compound to form crystalline hydrates is of particular significance in 
fine chemical development because water is commonly used in many chemical 
manufacturing processes and the water molecule is a versatile hydrogen bond donor and 
acceptor which can often lead to the formation of a hydrate. It has been reported that 
approximately one third of organic molecules are capable of forming hydrates,19 and 
figures as high as 75% have been suggested for pharmaceutical compounds.187
No conceptual difference exists between hydrates and other solvates -  all 
solvates incorporate the solvent into the crystal structure in addition to the parent 
molecule. Some molecules can form hydrates in different hydration states, each with 
different stoichiometric ratios of water to the parent molecule, including hemihydrates 
(1:2), monohydrates (1:1) and dihydrates (2:1). Each different hydration state is 
classified as a different solvate of the parent molecule, and where two hydrates have the 
same stoichiometric ratio, but different crystal structures, the two forms can be 
classified as polymorphic hydrates.
In fine chemical development, the likelihood and potential implications of 
producing hydrates must be thoroughly understood. Factors that can affect the state of 
hydration of a drug substance include manufacturing processes, changes in 
environmental humidity and time.11 Many manufacturing processes such as aqueous 
granulation, spray drying, crystallisation and aqueous film-coating may bring the drug 
substance into contact with water, providing the opportunity for a hydrate to form.11 
Even after the drug substance has been formulated into a drug product, there may exist 
the opportunity for a phase change to a hydrate by incorporating water from hydrated 
excipients by water redistribution within the dosage form or by incorporating water 
from the air in humid environments.249
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Bym2 has summarised why solvates require investigation:
• They are commonly the penultimate form of a drug, prior to desolvation to the 
drug form used in manufacture, and consequently control over the formation of 
the solvate is required.
• They may be chosen for recovery or purification processes.
• They may exhibit physical properties, such as morphology, that are important 
during particular manufacturing steps.
• They may be the only form of a drug substance that is crystalline in the solid 
state, allowing determination of the drug substance structure by X-ray 
diffraction.
• The desolvated form may be used in the drug product because of attractive 
physical properties such as dissolution rate and bioavailability.
• They may be a route to increased patent protection of the drug substance.
The different chemical composition and crystal packing in a hydrate compared to an 
anhydrous form of the same molecule will cause them to have different physical and 
chemical properties. The internal energy of the hydrate versus the anhydrate is altered 
by the different intermolecular interactions, and the entropy can be altered significantly 
if the water is disordered. These changes alter the free energy of the crystal structure 
which can ultimately affect the solubility and dissolution rate of the hydrate.249 A 
hydrate will always be less soluble in water than the corresponding anhydrate: in the 
hydrate crystal structure the parent molecule already has water contacts and the 
dissolution process yields fewer new parent molecule--water contacts, leading to a 
lower free energy of dissolution.249
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7.1.2 The formation of hydrates
Water is a common solvate-forming solvent because of its versatile hydrogen bonding 
capability, enabling improved intermolecular interactions in the hydrate crystal structure 
compared to the anhydrate, commonly by addressing hydrogen bond donor/acceptor 
imbalances. Its size allows water to fill small voids in crystal structures and its ability to 
form up to two donor hydrogen bonds and two acceptor hydrogen bonds allows it to 
simultaneously hydrogen bond to several groups from the parent molecule or other 
water molecules. Water commonly forms a tetrahedron of hydrogen bonds with the 
oxygen lone pairs acting as hydrogen bond acceptors and the two hydrogen atoms 
acting as hydrogen bond donors (figure 7.1). The charge density of the oxygen atom is 
more accurately represented as a single diffuse lobe of electron density250 and the 
tetrahedral geometry, as found in all polymorphs of ice, is an artefact of donor/acceptor 
balancing to give two donors and two acceptors.
j i
Figure 7.1: Tetrahedral water hydrogen bond geometry. The water molecule forms 
four hydrogen bonds, acting as a hydrogen bond donor twice (green) and as a 
hydrogen bond acceptor twice (blue)
Water does not have to exhibit this tetrahedral hydrogen bond geometry in hydrate 
crystal structures. A recent study251 has identified a range of water hydrogen bonding 
geometries found in hydrate structures present in the CSD, from a single hydrogen bond 
up to the maximum of four. 2-, 3-, and 4- co-ordinated geometries were all present in 
significant numbers of the organic hydrate structures investigated. It has been noted252 
that hydrate crystal structures are more prevalent for organic molecules in which there is
2 2 2
a donor/acceptor imbalance particularly when there are fewer donors than acceptors and 
the inclusion of the water addresses this imbalance.
In solution the activity of the water is critical in determining whether a hydrate 
or anhydrate forms and if a hydrate is favoured, which level of hydrate is formed. The 
equilibrium between the hydrate and anhydrate is given by the equation:11
Kh
A(soiici) + tw-H20<=> A.wH20 (solid) 
with the equilibrium constant defined as:
= 4A-mH2o(s„lidj
h 4A ,soJ4H 20]m
The equilibrium constant depends on the activity of the water in the solution, which can 
be expressed as the ratio of the partial vapour pressure of water in the hydrate to the 
vapour pressure of pure water at a given temperature.
7.1.3 Terminology for the prediction of hydrate crystal structures
The reliable computational prediction of hydrate crystal structures would be a powerful 
tool in understanding the solid state of a compound. For cases where one or more 
hydrates were predicted to be stable and liable to be found experimentally, the 
manufacturing process could be designed to avoid water as a solvent so negating the 
possibility of forming the hydrate. Alternatively, the prior knowledge of the possible 
hydrates that could form could be exploited to help control the formation of the hydrate 
and aid in its identification.
The crystal structure prediction of hydrates is not technically distinct from the 
crystal structure prediction of other solvates, co-crystals or single molecule systems 
with Z' > 1. In all cases the prediction requires generation of hypothetical structures 
with more than one molecule (identical or non-identical) in the asymmetric unit. Van 
Eijck and Kroon253 have provided several definitions for the formulation of this 
problem:
• Z' = Z/M where Z is the number of residues (e.g. the unit [A.H2 O] for a 
monohydrate) in the unit cell and M is the multiplicity of the space group.
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• Z" = the number of crystallographically inequivalent molecules. An asymmetric 
unit containing two half molecules at special positions (eg: mirror plane or 
inversion centre) will have Z' = 1 but Z" = 2.
• G = the number of independent molecules used for the CSP search. For a system 
where two symmetry independent chemically identical molecules are used as the 
basis for the search (G = 2), a sub-set of the generated structures may gain extra 
symmetry, and can be expressed in a space group incorporating the extra 
symmetry with Z' = 1. These structures have G = 2, but Z' = Z" = 1.
A CSP search for a 1:1 molecular adduct will require G = 2 (one molecule of species 1 
plus one molecule of species 2), and will commonly generate Z' = 1 structures, where 
one unit is defined as containing one molecule of each species. Even assuming that the 
molecules are rigid, the dimensionality of the crystal structure prediction of systems 
with G > 1 is significantly higher than for the case where G = 1. For each additional G, 
six extra variables are added to define the position and orientation of the extra molecule. 
For the prediction of hydrates, with no prior information about the stoichiometric ratio, 
several different values of G would have to be investigated and for some values of G 
different ratios would have to be considered. A search with G = 2 (1 parent molecule : 1 
water molecule) would only generate monohydrates. G = 3 (1 parent molecule : 2 water 
molecules) would generate dihydrates but G = 3 (2 parent molecules : 1 water molecule) 
would commonly generate hemihydrates with Z' = 2 (where Z = A.V2H2 O).
In the only published work on the prediction of hydrate crystal structures, Van 
Eijck and Kroon253 used a random search method to generate possible crystal structures 
for polyalcohols and carbohydrates. Seven of these molecules were chiral, limiting the 
search procedure to the four most common enantiomorphic space groups and in five of 
these searches the experimental structure was found. For two non-chiral molecules 
searches were carried out in the experimental space group plus the four most common 
enantiomorphic space groups, but neither search found the experimental structure. The 
presence of the experimental structure in the list of generated structures is the primary 
requirement for CSP, with the structure ranking and energy difference with the global 
minimum indicators of the performance of the intermolecular potential and the impact
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of neglect of thermal effects. This work highlighted the requirement for the search 
procedure to thoroughly explore the crystal packing landscape in light of the extra 
complexity introduced by including more than one molecule in the search procedure.
This present study is the first use of the MOLPAK/DMAREL method to attempt 
to predict the crystal structure of a monohydrate system. Predicted monohydrate 
structures were generated for 5-azauracil, which has a single known monohydrate 
crystal structure. This search required prior testing of the FIT dispersion-repulsion 
potential to assess its ability to reliably reproduce intermolecular interactions involving 
water. It was tested, in conjunction with a MP2/6-31G(d,p)-derived distributed 
multipole electrostatic model, for its ability to reproduce four of the six ordered 
structures of ice and a range of 22 experimental hydrate crystal structures.
7.2 Validation of the intermolecular potential using the polymorphs of 
ice
7.2.1 The polymorphs of ice
The phase diagram of ice presently contains 14 distinct crystalline phases. In the 
majority of the phases the hydrogen atoms are disordered, with partial hydrogen 
occupancy along each of the four tetrahedrally arranged hydrogen bonds around each 
water molecule. Disordered phases include ices Ih (common ice), III, IV, V, VI, VII and 
XII. Ices II254;255 and VIII256 are high pressure ordered phases with no disordered 
analogues. Ice IX is a nearly ordered modification of ice III. Ice XI ’ is a low
temperature, ambient pressure modification of ice Ih that is proton ordered. Very
260recently low temperature ordered versions of ices V and XII have been reported.
The ability of the FIT dispersion-respulsion potential to reproduce water' water 
interactions was a pre-requisite for its application to the energy minimisation of hydrate 
structures. Successful reproductions of the crystal structures of ice would satisfy this 
condition. The disordered polymorphs of ice were discounted from the set of ice 
structures chosen for this potential validation because DMAREL cannot energy 
minimise disordered structures. Four of the ordered structures of ice were chosen: ices 
II, VIII, IX and XI. The reproduction of ice XI was of most interest, as its stability 
domain (stable under 73 K at ambient pressure) most closely matched the conditions of 
the DMAREL energy minimisation process. Ices II and VIII were chosen because their
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structures were known to be unique phases and fully ordered. Ice IX was considered 
using the fully ordered major component while ignoring the minor (ca. 4%) disordered
257component.
7.2.2 The crystal structures of ices II, VIII, IX and XI
The crystal structure of ice II has been determined by neutron single crystal 
diffraction255 using D2 O, crystallising in the trigonal space group R 3 with two complete 
independent molecules in the asymmetric unit. Each of the water molecules is 
tetrahedrally hydrogen bonded with the crystal structure primarily comprised of 
hydrogen bonded six-member water rings (of which ice Ih is exclusively comprised) but 
also contains smaller rings caused by collapsing of the six-fold rings at higher
250pressure.
The crystal structure of D2 O in the ice VIII structure has been determined by 
Kuhs et al.,256 and was found to crystallise in the tetragonal space group I4\/amd, with 
the oxygen atom located on the mirror plane (Z' = 0.5). The high pressure required to 
generate this phase causes Ice VIII to exhibit interpenetrating sub-lattices of the six- 
member rings, with each water molecule tetrahedrally co-ordinated by four identical 
hydrogen bonds.250
The ice IX structure was determined using D2 O and single crystal neutron 
diffraction.257 It crystallises in the space group P4\2\2, with one water molecule on a 
general position and a second molecule present on the twofold axis. This structure has 
Z' = 1.5 but Z" = 2.
The structure of D2 O in the Ice XI modification has been determined by neutron 
powder diffraction.259 Ice XI crystallises in the orthorhombic space group Cmc2\ with 
two independent half molecules in the asymmetric unit. For one of the independent 
molecules each atom has half occupancy because the molecule lies on the mirror plane. 
For the second independent molecule, the oxygen lies on the mirror plane and has half 
occupancy but the single hydrogen it is bonded to in the asymmetric unit is located on a 
general position with the second hydrogen generated by the mirror plane. This leads to a 
structure with Z' = 1, but Z" = 2. Both independent molecules are tetrahedrally 
hydrogen bonded, and the structure is comprised exclusively of six-member hydrogen 
bonded rings.
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The bond lengths, H-O-H angles and the hydrogen bonding parameters for these 
structures of ice are given in table 7.1. For comparison, the average water geometry of 
an isolated molecule is also given. Deviations of water molecules in ice crystal 
structures from the average water geometry occur because the water molecules distort 
upon incorporation into the crystal structure to optimise the hydrogen bonding 
geometries. An ab initio energy scan varying the H-O-H angle and using the high 
quality MP2/AUG-cc-pVTZ basis set, showed that deformations up to 104±10° incurred 
a maximum 6.7 kJ mol'1 energy penalty. The O-H bonds are longer in ice structures 
than in the average water geometry value because of their participation in hydrogen 
bonding.
Structure Intramolecular Hydrogen bonds
O-H lengths H-O-H angle 0 — 0  length O-H—O angle
Ice II 0.958 103 2.805 166
0.972 107 2.767 167
0.942 - 2.779 178
1.014 - 2.845 168
Ice VIII 0.968 106 2.879 178
Ice IX 0.977 106 2.75 167
0.971 105 2.797 175
0.979 - 2.763 165
Ice XI 0.976 108 2.74 177
1.054 114 2.803 178
0.947 - 2.737 176
Average Water 
Geometry 0.9572 104.52 n/a n/a
Table 7.1: Summary of water geometries and hydrogen bond values for ice II, 
VIII, IX and XI. The average water geometry250 is given for comparison
Three of the ice structures detailed above contain half molecules in the asymmetric unit 
and required symmetry reduction to lower symmetry settings containing full molecules 
prior to energy minimisation. The ice XI structure was symmetry lowered to the sub­
group C 1 1 2i (unconventional setting of P2\) by removal of the mirror and glide 
symmetry operators. The asymmetric unit of this symmetry lowered structure contains 
two fully occupied water molecules (Z' = 2, Z" = 2). The ice IX structure was symmetry 
lowered to P2\ (with consequent change in setting), with six molecules in the 
asymmetric unit, four of which are identical and the remaining two are identical to each 
other (Z' = 6, Z" = 2). The ice VIII structure was symmetry lowered to space group P 1
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with four identical molecules in the asymmetric unit (Z' = 4, Z" =1) .  After energy 
minimisation, the retention of the higher experimental symmetry by the energy
1 3Qminimised structures was confirmed by the PLATON ADDSYM algorithm.
7.2.3 Intermolecular potentials optimised for water
A range of potentials have been developed over many years to model the physical 
properties of water, dating back to the work of Bernal and Fowler in 1933261 which used 
a negative point charge located on the H-O-H angle bisector, positive charges on the 
hydrogen atoms and dispersion-repulsion terms only on the oxygen. The majority of 
water potentials developed since this first work are empirically based, with point 
charges either located on the atomic nuclei, or on slightly off-nuclear positions and the 
dispersion-repulsion terms commonly represented by a Lennard-Jones 12-6 potential76 
only on the oxygen atom. The potentials that take this form, e.g. BF,261 SPC,262 
TIP3P,263 differ in the dispersion-repulsion parameterisation and the magnitude of the 
partial charges placed on the atomic sites, or at off-nuclear positions. In an attempt to 
gain further accuracy more complex potentials have been developed with water 
modelled as flexible rather than rigid (SPC/F), or with empirically based polarisability 
added to the water molecule (SPCP, PTIP4P, SPC/FQ), or a combination of these 
variables (SPC/FP).264 Much more complex force fields with more accurate treatment of 
the electrostatic, dispersion and repulsion parts of the intermolecular potential and with 
explicit calculation of polarisability and charge transfer terms based on the results from 
ab initio calculations have recently been developed.265 Such further advancements 
beyond the earlier rigid body/point charges/Lennard-Jones model are too complex for 
consideration here, but clearly indicate the upper limit of the type of models that are 
required to model water accurately.
It is worth appreciating the physical properties against which the more simple 
water potentials were parameterised, and therefore aim to reproduce. Guillot264 has 
summarised the most common physical properties used, which include the density of 
liquid under ambient conditions, the heat of vaporisation, the self-diffusion coefficient, 
the atom-atom pair distribution functions in liquid water, the temperature of maximum 
density and the critical temperature. Properties of ice are not usually incorporated into 
the parameterisations of these simple potentials, though an explicit attempt to modify a
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water potential for use with ice is available, which reparameterises the TIP4P 
potential to reproduce the density of several forms of ice.
7.2.4 Ice energy minimisation method
All four of the experimental ice crystal structures were determined by neutron 
diffraction. Neutron diffraction produces accurate hydrogen (or deuteron) locations, 
leading to true O-D distances, as opposed to the foreshortened O-H lengths reported by 
X-ray diffraction. Consequently the water molecular conformations as found in the 
crystal structures were used in the energy minimisations, with no optimisation of their 
geometries. Consequently all of the results are ExptMinExpt minimisations.
DMAREL can use dispersion-repulsion potentials based on both Lennard-Jones 
and Buckingham forms, and a range of water potentials were tested alongside with the 
FIT potential for their ability to reproduce the four chosen structures of ice. In the FIT 
potential the Hp polar hydrogen parameters were employed for the water hydrogen
7 ^ 7  7A7atoms. The Lennard-Jones based potentials included SPC, its derivatives SPC/E 
and MSPC/E,268 and the two related potentials TIP3P263 and TIP4P.263 The NSPC/E269 
potential was also included as it is a Buckingham form potential. All of these potentials 
have point charges on the three atomic sites (with TIP4P having an off-site charge near 
the oxygen, rather than on the atomic site) and a dispersion-repulsion potential placed 
only on the oxygen atom. A derivative of the FIT potential was also included, 
FIT(COOH), which used the Hp dispersion-repulsion terms derived from the hydrogen 
in carboxylic acid groups during a CSP study270 of small organic molecules containing 
carboxylic acid groups. The repulsion term for the carboxylic acid hydrogen was 
reduced compared to the standard value for Hp in the FIT potential, achieved by an 
approximate halving of the pre-exponential factor. Oxygen dispersion-repulsion 
potential parameters were unaltered from the FIT values. The potentials used are 
summarised in table 7.2.
The FIT/FIT(COOH) oxygen potential has a much shallower form compared to 
all of the Lennard-Jones based potentials because it uses explicit dispersion-repulsion 
terms sited on the hydrogen atoms as well as the oxygen, whereas the Lennard-Jones 
based potentials incorporate the hydrogen dispersion-repulsion into a single term on the 
oxygen atom (figure 7.2). The NSPCE potential has a single Buckingham form potential
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sited on the oxygen and has a markedly deeper well situated at greater intermolecular 
separation than the other potentials perhaps because it was optimised for vapour-liquid 
coexistence properties over a wide temperature range, a quite specific task different 
from the properties against which the Lennard-Jones potentials were parameterised.
Lennard-Jones
Oxygen
Potential
r(OH)
(A)
<H-0-H
n
q(O)
(e)
q(H)
(e)
A
(eV mol'1)
C
(eV mol'1)
SPC 1.0 109.47 -0.82 0.41 27293 27.12
SPC/E 1.0 109.47 -0.8476 0.4238 27446 27.20
MSPC/E 0.9839 109.47 -0.8216 0.4108 21568 23.56
TIP4P 0.9572 104.52 -1.04* 0.52 26018 26.45
TIP3P 0.9572 104.52 -0.834 0.417 25237 25.80
Buckingham
Oxygen
Potential
r(OH)
(A)
<H-0-H
n
q(O)
(e)
q(H)
(e) o
< 
E 
>3*
B
(A) o
o 
E 
>3L
NSPCE 1.0668 109.5 -0.7374 0.3687 2240.97 3.29 64.78
FIT /
FIT(COOH) - - - - 2384.47 3.96 11.65
Hydrogen
Potential
A
(eV mol-1)
B
(A)
C
(eV mol-1)
FIT 2240.97 3.96 11.65
FIT(COOH) 1072.98 3.96 11.65
Table 7.2: Summary of water potentials used in testing. * Oxygen charge located 
0.15 A off nuclear site
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Figure 7.2: 0 —0  intermolecular dispersion-repulsion potential for a range of 
common water potentials. The FIT oxygen homoatomic potential is plotted for 
comparison
For all potentials minimisations were carried out with the electrostatic intermolecular 
potential modelled using both MP2/6-31G(d,p)-derived distributed multipoles and 
electrostatic potential derived charges (CHELPG charges,271 denoted ESP). For each of 
the potentials that included nuclear site charges in their definition, an additional energy 
minimisation was carried out using their published potential charges (only for SPC 
derivatives and TIP3P, denoted Potential Charges).
7.2.5 Results and discussion
The results of the energy minimisations of all four ice structures with all of the 
dispersion-repulsion/electrostatic model combinations are summarised in tables 7.3-7.6. 
For each individual structure wide variations in the quality of reproduction with 
different potential combinations were observed. For some combinations the success of 
reproduction varied substantially between the ice polymorphs -  for example the 
TIP4P/multipoles combination reproduced the structure of ice VIII with an F-value of 
1.23 whereas it reproduced the structure of ice XI with an F-value of 161 and with a 
10% error in the b lattice length and an over-estimation of the density by 16%.
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D is p e r s io n /
R e p u ls io n E le c tr o s ta t ic
a
(A)
%
error
b
(A)
%
error
c
(A)
%
error
V ol.
(A3)
%
error
D e n s ity
(g /c m 3)
%
error
F in al E 
(k J /m o l) F
E xperim ental 1 2 .9 8 3 1 2 .9 8 3 6 .2 5 4 9 1 2 .8 2 1 .18
FIT M ultipoles 1 2 .7 7 3 -1 .61 1 2 .7 7 3 -1.61 6 .1 9 0 -1 .0 2 8 7 4 .5 9 -4 .1 8 1 .23 4 .3 7 -53 .61 13.51
E S P 1 3 .3 4 3 2 .7 8 1 3 .3 4 3 2 .7 8 6 .4 4 3 3 .0 3 9 9 3 .4 7 8 .8 4 1 .08 -8 .1 2 -4 0 .1 3 3 2 .7 6
FIT(COOH) M ultipoles 1 2 .0 2 5 -7 .3 8 1 2 .0 2 5 -7 .3 8 5 .8 0 2 -7 .2 2 7 2 6 .5 3 -20 .41 1 .48 2 5 .6 4 -6 6 .0 4 1 8 2 .7 7
E S P 1 2 .7 3 4 -1 .9 2 1 2 .7 3 4 -1 .9 2 6 .1 0 4 -2 .3 9 8 5 7 .1 2 -6 .1 0 1 .26 6 .5 0 -47 .21 1 9 .4 5
N S P C E M ultipoles 1 2 .6 1 2 -2 .8 5 1 2 .6 1 2 -2 .8 5 5 .9 8 4 -4 .3 2 8 2 4 .3 2 -9 .7 0 1.31 10 .7 4 -6 0 .8 2 4 6 .4 3
E S P 1 3 .2 7 5 2 .2 5 1 3 .2 7 5 2 .2 5 6 .2 4 6 -0 .1 2 9 5 3 .2 5 4 .4 3 1 .13 -4 .2 4 -4 6 .4 6 2 0 .1 8
Potential 1 3 .3 8 2 3 .0 7 1 3 .3 8 2 3 .0 7 6 .2 6 4 0 .1 6 9 71 .41 6 .4 2 1.11 -6 .0 3 -4 3 .8 2 2 9 .9 3
S P C M ultipoles 1 2 .6 2 2 -2 .7 8 1 2 .6 2 2 -2 .7 8 5 .9 8 4 -4.31 8 2 5 .5 7 -9 .5 6 1 .30 1 0 .5 7 -6 0 .7 3 4 5 .0 8
E S P 13 .021 0 .2 9 13 .021 0 .2 9 6 .2 0 7 -0 .7 5 9 1 1 .3 2 -0 .1 6 1 .18 0 .1 6 -4 5 .7 4 7 .6 4
P otential 1 2 .8 4 7 -1 .0 5 1 2 .8 4 7 -1 .0 5 6 .1 1 8 -2 .1 7 8 7 4 .3 8 -4.21 1 .23 4 .4 0 -5 4 .9 2 14.31
S P C E M ultipoles 12 .631 -2 .71 12 .631 -2 .71 5 .9 8 8 -4 .2 5 8 2 7 .2 7 9 .3 7 1 .30 1 0 .3 4 -6 0 .5 8 4 3 .6 7
E S P 1 3 .0 2 9 0 .3 6 1 3 .0 2 9 0 .3 6 6 .211 -0 .6 9 9 1 3 .0 2 0 .0 2 1 .18 -0 .0 2 -4 5 .6 5 7 .6 4
P otential 1 2 .7 7 7 -1 .5 9 1 2 .7 7 7 L ~1 -59 6 .0 8 7 -2 .6 7 860 .51 -5 .7 3 1 .25 6 .0 8 -5 9 .2 8 1 9 .9 9
M SPC E M ultipoles 12 .261 -5 .5 6 12.261 -5 .5 6 5 .8 2 3 -6 .8 9 7 5 8 .1 3 -1 6 .9 5 1 .42 2 0 .4 0 -6 6 .9 5 127 .01
E S P 1 2 .6 9 0 -2 .2 5 1 2 .6 9 0 -2 .2 5 6 .0 5 8 -3 .1 3 8 4 4 .8 9 -7 .4 4 1 .28 8 .0 4 -4 9 .2 8 2 8 .4 8
Potential 1 2 .5 1 2 -3 .6 3 1 2 .5 1 2 -3 .6 3 5 .9 6 6 -4 .6 0 8 0 8 .8 1 -1 1 .3 9 1 .33 1 2 .8 6 -5 9 .6 5 5 8 .4 6
T IP3P M ultipoles 1 2 .5 0 3 -3 .6 9 1 2 .5 0 3 -3 .6 9 5 .931 -5 .1 5 8 0 3 .0 2 -1 2 .0 3 1 .34 1 3 .6 7 -6 2 .6 2 6 6 .6 3
E S P 1 2 .9 1 2 -0 .5 4 1 2 .9 1 2 -0 .5 4 6 .1 5 8 -1 .5 2 8 8 9 .1 9 -2 .5 9 1.21 2 .6 6 -46 .81 9 .9 7
Potential 1 2 .6 9 8 -2 .1 9 1 2 .6 9 8 -2 .1 9 6 .051 -3 .2 4 8 4 4 .9 6 -7 .4 3 1 .27 8 .0 3 -5 8 .5 9 2 8 .6 3
T IP4P M ultipoles 1 2 .5 4 7 -3 .3 6 1 2 .5 4 7 -3 .3 6 5 .9 5 0 -4 .8 5 8 1 1 .1 7 -1 1 .1 4 1 .33 1 2 .5 3 -6 1 .9 9 5 8 .2 3
E S P 12.951 -0 .2 4 12 .951 -0 .2 4 6 .1 7 5 -1 .2 5 8 9 7 .0 0 -1 .7 3 1 .20 1 .76 -4 6 .4 9 8 .6 4
Table 7.3: Results of energy minimisations of Ice II using different combinations of dispersion-repulsion and electrostatic models
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D is p e r s io n
R e p u ls io n E le c tr o s ta t ic
a
(A)
%
error
b
(A)
%
error
c
(A)
%
error
V ol.
(A3)
%
error
D e n s ity
(g /c m 3)
%
error
F inal E 
(k J /m o l) F
E xperim ental 4 .6 5 6 4 .6 5 6 6 .7 7 5 1 4 6 .8 7 1 .6 3
FIT M ultipoles 4 .5 8 3 -1 .5 6 4 .5 8 3 -1 .5 6 6 .6 3 5 -2 .0 6 1 3 9 .3 9 -5 .0 9 1 .72 5 .3 6 -5 5 .5 3 1 0 .4 5
E S P 4 .3 7 3 -6 .0 7 4 .3 7 3 -6 .0 7 8 .0 1 3 1 8 .2 7 1 5 3 .2 6 4 .3 5 1 .5 6 -4 .1 7 -4 0 .6 5 4 6 4 .6 8
FIT cooh M ultipoles 4 .3 9 4 -5 .6 3 4 .3 9 4 -5 .6 3 6 .2 4 0 -7 .8 9 1 2 0 .4 8 -1 7 .9 7 1 .9 9 2 1 .9 0 -6 6 .0 0 1 3 8 .6 6
E S P 4 .2 5 5 -8 .61 4 .2 5 5 -8 .61 7 .571 1 1 .7 4 1 3 7 .0 6 -6 .6 8 1 .7 5 7 .1 6 -4 6 .5 5 3 1 6 .6 6
N S P C E M ultipoles 4 .8 2 0 3.51 4 .8 2 0 3.51 7 .1 0 7 4 .9 0 1 6 5 .0 8 1 2 .4 0 1 .4 5 -1 1 .0 3 -52 .41 5 4 .5 0
E S P 4 .7 3 2 1 .62 4 .7 3 2 1 .62 8 .161 2 0 .4 6 1 8 2 .7 0 2 4 .4 0 1.31 -19 .61 -4 0 .7 0 4 8 9 .2 5
P otential 4 .7 5 1 2 .0 4 4 .7 5 1 2 .0 4 8 .2 1 6 2 1 .2 6 1 8 5 .4 3 2 6 .2 5 1 .2 9 -2 0 .7 9 -3 8 .6 0 5 3 0 .9 7
S P C M ultipoles 4 .6 6 9 0 .2 9 4 .6 6 9 0 .2 9 6 .8 3 5 0 .8 9 1 4 9 .0 3 1 .4 7 1.61 -1 .4 5 -5 3 .0 5 2 .1 7
E S P 4 .5 5 5 -2 .1 8 4 .5 5 5 -2 .1 8 7 .8 3 7 1 5 .6 7 1 6 2 .5 7 1 0 .6 9 1 .4 7 -9 .6 5 -3 9 .0 3 2 9 4 .4 0
Potential 4 .5 1 1 -3 .1 2 4 .5 1 1 -3 .1 2 7 .7 2 4 1 4 .0 0 1 5 7 .1 6 7.01 1 .52 -6 .5 5 -4 5 .6 7 2 4 7 .8 1
S P C E M ultipoles 4 .6 7 2 0 .3 4 4 .6 7 2 0 .3 4 6 .841 0 .9 7 1 4 9 .3 2 1 .67 1 .6 0 -1 .6 4 -5 2 .9 3 2 .4 2
E S P 4 .5 5 7 -2 .1 3 4 .5 7 0 -2 .1 3 7 .8 4 2 1 5 .7 5 1 6 2 .8 6 1 0 .8 8 1 .4 7 -9 .8 2 -3 8 .9 6 2 9 6 .9 4
Potential 4 .4 9 3 -3 .4 9 4 .4 9 3 -3 .4 9 7 .6 7 8 1 3 .3 3 1 5 5 .0 2 5 .5 5 1 .54 -5 .2 6 -4 8 .9 5 2 3 1 .9 8
M SP C E M ultipoles 4 .5 5 9 -2 .0 7 4 .5 5 9 -2 .0 7 6 .6 1 3 -2 .3 9 1 3 7 .4 8 -6 .3 9 1 .7 4 6 .8 3 -5 7 .8 7 1 6 .6 4
E S P 4 .4 5 9 -4 .2 2 4 .4 5 9 -4 .2 2 7 .6 1 2 1 2 .3 5 1 5 1 .3 7 3 .0 6 1 .5 8 -2 .9 7 -4 1 .6 4 2 1 4 .7 9
Potential 4 .4 1 4 -5 .2 0 4 .4 1 4 -5 .2 0 7 .4 9 6 1 0 .6 4 1 4 6 .0 2 -0 .5 8 1 .6 4 0 .5 8 -4 9 .1 2 1 8 8 .7 6
T IP3P M ultipoles 4 .6 3 3 -0 .4 9 4 .6 3 3 -0 .4 9 6 .7 6 3 -0 .1 7 1 4 5 .1 9 -1 .1 4 1 .6 5 1 .1 6 -5 4 .4 9 1.61
E S P 4 .5 2 4 -2 .8 4 4 .5 2 4 -2 .8 4 7 .7 6 3 1 4 .5 9 1 5 8 .8 7 8 .1 7 1.51 -7 .5 5 -3 9 .8 0 2 6 3 .6 3
P otential 4 .4 6 9 -4 .01 4 .4 6 9 -4 .01 7 .6 2 4 1 2 .5 3 1 5 2 .2 9 3 .6 9 1 .5 7 -3 .5 6 -4 8 .3 7 2 1 6 .1 2
T IP 4P M ultipoles 4 .6 4 6 -0 .21 4 .6 4 6 -0 .21 6 .7 8 9 0 .2 0 1 4 6 .5 4 -0 .2 2 1 .6 3 0 .2 2 -5 4 .0 6 1 .23
E S P 4 .5 3 4 -2 .6 2 4 .5 3 4 -2 .6 2 7 .7 8 9 1 4 .9 7 1 6 0 .1 2 9 .0 2 1 .50 -8 .2 8 -3 9 .6 2 2 7 3 .9 8
Table 7.4: Results of energy minimisations of Ice VIII using different combinations of dispersion-repulsion and electrostatic models
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D is p e r s io n
R e p u ls io n E le c tr o s ta t ic
a
(A)
%
error
b
(A)
%
error
c
(A)
%
error
V ol.
(A3)
%
error
D e n s ity
(g /c m 3)
%
error
F in a l E 
(k J /m o l) F
E xperim ental 6 .7 3 6 .8 3 6 .7 3 3 0 9 .3 5 1 .1 6
FIT M ultipoles 6 .6 3 9 -1 .3 5 6 .701 -1 .8 9 6 .6 3 9 -1 .3 5 2 9 5 .4 0 -4 .51 1 .22 4 .7 2 -5 3 .2 7 16.01
E S P 7 .3 1 2 8 .6 4 6 .1 1 2 -10 .51 7 .3 1 2 8 .6 4 3 2 6 .7 4 5 .6 2 1.1 -5 .3 2 -3 9 .2 0 3 1 1 .6 3
FIT cooh M ultipoles 6 .1 6 9 -8 .3 3 6 .6 7 2 -2 .3 2 6 .1 6 9 -8 .3 3 2 5 3 .9 2 -1 7 .9 2 1.41 2 1 .8 3 -6 6 .4 2 1 7 0 .0 4
E S P 6 .9 1 6 2 .7 6 5 .9 6 4 -1 2 .6 8 6 .9 1 6 2 .7 6 2 8 5 .2 7 -7 .7 8 1 .2 6 8 .4 4 -4 6 .1 9 2 09 .1
N S P C E M ultipoles 6 .3 5 2 -5 .6 2 6 .7 7 4 -0 .8 2 6 .3 5 2 -5 .6 2 2 7 3 .3 -1 1 .6 5 1.31 1 3 .1 9 -6 3 .1 9 7 5 .3 4
E S P 7 .0 5 8 4 .8 8 6 .4 0 6 -6 .2 0 7 .0 5 8 4 .8 8 3 1 9 .1 7 3 .1 7 1 .12 -3 .0 8 -4 5 .8 0 100 .41
P otentia l 7 .1 1 4 5 .7 0 6 .4 1 3 -6 .1 0 7 .1 1 4 5 .7 0 3 2 4 .5 2 4 .9 1.11 -4 .6 7 -4 3 .2 8 1 1 9 .1 5
S P C M ultipoles 6 .4 8 5 -3 .6 3 6 .9 8 5 2 .2 6 6 .4 8 5 -3 .6 3 2 9 3 .7 7 -5 .0 4 1 .2 2 5 .3 -6 1 .8 0 3 9 .2 7
E S P 6 .9 9 9 4 .0 0 6 .3 8 7 -6 .4 8 6 .9 9 9 4 .0 0 3 1 2 .9 1 1 .1 5 1 .1 5 -1 .1 4 -4 4 .9 8 86 .11
P otentia l 6 .8 8 0 2 .2 2 6 .3 7 9 -6 .6 0 6 .8 8 0 2 .2 2 3 0 1 .9 1 -2 .41 1 .19 2 .4 6 -5 4 .4 7 6 2 .2 8
S P C E M ultipoles 6 .4 9 0 -3 .5 6 6 .9 8 7 2 .2 9 6 .4 9 0 -3 .5 6 2 9 4 .3 2 -4 .8 6 1 .22 5.11 -6 1 .6 4 3 8 .1 4
E S P 7 .0 0 4 4 .0 7 6 .3 9 -6 .4 4 7 .0 0 4 4 .0 7 3 1 3 .4 8 1 .3 3 1 .1 5 -1 .3 2 -4 4 .8 9 8 6 .9
P otentia l 6 .8 3 6 1 .5 7 6 .3 7 7 -6 .6 4 6 .8 3 6 1 .5 7 2 9 7 .9 5 -3 .6 8 1.2 3 .8 2 -5 8 .8 8 57 .01
M SP C E M ultipoles 6 .2 7 7 -6 .7 4 6 .9 1 9 1.31 6 .2 7 7 -6 .7 4 2 7 2 .5 8 -1 1 .8 9 1 .32 1 3 .4 9 -6 8 .6 8 1 1 1 .4 3
E S P 6 .8 0 2 1 .0 7 6 .2 9 6 -7 .81 6 .8 0 2 1 .07 2 9 1 .3 3 -5 .8 3 1 .2 3 6 .1 9 -4 8 .6 3 7 3 .2
Potential 6 .681 -0 .7 3 6 .2 8 7 -7 .9 5 6 .681 -0 .7 3 2 8 0 .6 -9 .2 9 1 .28 1 0 .2 5 -5 9 .3 8 74 .11
T IP3P M ultipoles 6 .4 1 6 -4 .6 7 6 .9 7 2 .0 4 6 .4 1 6 -4 .6 7 2 8 6 .9 -7 .2 6 1 .25 7 .8 2 -6 3 .9 0 58 .61
E S P 6 .9 3 4 3 .0 3 6 .3 6 0 -6 .8 9 6 .9 3 4 3 .0 3 3 0 5 .7 9 -1 .1 5 1 .17 1 .1 6 -4 6 .0 9 7 6 .4 9
Potential 6 .7 9 0 0 .8 9 6 .3 4 8 -7 .0 5 6 .7 9 0 0 .8 9 2 9 2 .6 8 -5 .3 9 1 .2 3 5 .7 -5 8 .2 3 5 9 .5 4
T IP 4P M ultipoles 6 .4 4 2 -4 .2 8 6 .9 6 9 2 .0 4 6 .4 4 2 -4 .2 8 2 8 9 .2 3 6.51 1 .24 6 .9 6 -6 3 .1 9 5 0 .2 2
E S P 6 .9 5 8 3 .3 9 6 .3 6 6 -6 .7 9 6 .9 5 8 3 .3 9 3 0 8 .2 -0 .3 7 1 .16 0 .3 7 -4 5 .7 5 8 0 .2 9
Table 7.5: Results of energy minimisations of Ice IX using different combinations of dispersion-repulsion and electrostatic models
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D is p e r s io n
R e p u ls io n E le c tr o s ta t ic
a
(A)
%
error
b
(A)
%
error
c
(A)
%
error
V ol.
(A3)
%
error
D e n s ity
(g /c m 3)
%
error
F in al E 
(k J /m o l) F
E xperim ental 4 .5 0 1 9 7 .7 9 7 9 7 .3 2 8 2 5 7 .2 5 0 .9 3
FIT M ultipoles 4 .6 9 6 4 .3 2 7 .4 8 4 -4 .0 2 7 .1 9 4 -1 .8 2 2 5 2 .8 7 -1 .7 0 0 .9 5 1 .73 -5 5 .4 7 4 3 .9 5
E S P 4 .3 2 3 -3 .9 7 8 .9 9 7 1 5 .3 7 7 .4 6 5 1 .8 7 2 9 0 .3 2 1 2 .8 6 0 .8 2 -1 1 .3 9 -3 7 .8 8 3 3 1 .8 7
FIT cooh M ultipoles 4 .4 1 2 -2 .0 0 6 .8 2 9 -1 2 .4 2 6 .7 0 4 -8 .5 2 2 0 1 .9 8 -2 1 .4 9 1 .19 2 7 .3 7 -7 1 .0 2 2 7 4 .7 7
E S P 4 .2 0 2 -6 .6 6 8 .4 1 6 7 .9 3 7 .1 0 9 -2 .9 8 2 5 1 .4 2 -2 .2 7 0 .9 5 2 .3 2 -4 4 .9 2 1 5 3 .1 4
N S P C E M ultipoles 4 .4 4 1 -1 .3 4 6 .2 9 9 -1 9 .2 3 6 .7 6 3 -7 .71 1 8 9 .1 9 -2 6 .4 6 1 .27 3 5 .9 7 -7 1 .1 6 5 1 5 .1 7
E S P 4 .4 2 5 -1 .7 2 8 .531 9 .4 0 6 .8 9 7 -5 .8 8 2 6 0 .3 4 1 .2 0 0 .9 2 -1 .1 8 -4 3 .8 0 2 0 5 .4 1
Potentia l 4 .4 4 4 -1 .3 0 8 .7 3 5 1 2 .0 2 6 .921 -5 .5 6 2 6 8 .6 3 4 .4 2 0 .8 9 -4 .2 4 -3 9 .2 0 2 7 9 .5 9
S P C M ultipoles 4 .5 8 1 1 .7 6 7 .0 3 6 -9 .7 7 7 .0 0 9 -4 .3 5 2 2 5 .9 2 -1 2 .1 8 1 .0 6 1 3 .8 7 -6 8 .4 6 1 4 0 .3 5
E S P 4 .4 2 1 -1 .8 0 8 .2 7 6 6 .1 3 7 .1 5 3 -2 .3 8 26 1 .7 1 1 .7 3 0.91 -1 .7 0 -4 5 .0 2 7 9 .0 5
Potentia l 4 .3 6 7 -2 .9 9 8 .1 6 7 4 .7 3 7 .0 9 7 -3 .1 6 2 5 3 .1 2 -1 .61 0 .9 5 1 .63 -5 2 .2 9 7 2 .1 7
S P C E M ultipoles 4 .5 8 4 1 .83 7 .0 4 2 -9 .6 9 7 .0 1 4 -4 .2 8 2 2 6 .4 3 -1 1 .9 8 1 .06 13.61 -6 8 .2 7 1 3 8 .0 8
E S P 4 .4 2 3 -1 .7 6 8 .2 8 2 6.21 7 .1 5 8 -2 .3 2 2 6 2 .2 0 1 .92 0.91 -1 .8 9 -4 4 .9 2 7 9 .9 3
Potentia l 4 .3 4 9 -3 .41 8 .1 0 3 3.91 7 .0 6 2 -3 .6 2 2 4 8 .8 4 -3 .2 7 0 .9 6 3 .3 8 -56 .71 6 9 .0 6
M SP C E M ultipoles 4 .4 5 4 -1 .0 7 6 .7 8 6 -1 2 .9 8 6 .8 0 5 -7 .1 3 2 0 5 .6 8 -2 0 .0 5 1 .1 6 2 5 .0 7 -7 7 .1 7 2 6 3 .0 6
E S P 4 .3 3 3 -3 .7 5 8 .0 0 2 2 .6 2 6 .9 8 4 -4 .6 9 2 4 2 .1 9 -5 .8 5 0 .9 9 6 .2 2 -4 9 .1 2 6 8 .8 8
Potential 4 .2 7 8 -4 .9 7 7 .8 9 3 1 .22 6 .9 2 3 -5 .5 3 2 3 3 .7 6 -9 .1 3 1 .02 1 0 .0 5 -5 7 .4 6 8 3 .8 8
T IP 3P M ultipoles 4 .5 3 9 0 .8 3 6 .9 5 3 -1 0 .8 4 6 .9 4 2 -5 .2 6 2 1 9 .1 0 -1 4 .8 3 1 .09 17.41 -7 1 .1 4 1 7 4 .4 5
E S P 4 .3 9 2 -2 .4 4 8 .1 8 5 4 .9 6 7 .0 9 8 -3 .1 3 2 5 5 .1 8 -0 .8 0 0 .9 4 0.81 -4 6 .2 8 6 9 .8 9
P otential 4 .3 2 8 -3 .8 7 8 .041 3 .1 2 7 .021 -4 .1 9 2 4 4 .3 2 -5 .0 3 0 .9 8 5 .2 9 -5 6 .1 5 7 0 .2 6
T IP4P M ultipoles 4 .5 5 5 1 .18 6 .9 8 4 -1 0 .4 4 6 .9 6 7 -4 .9 2 2 2 1 .6 2 -1 3 .8 5 1 .0 8 1 6 .0 8 -7 0 .1 9 1 6 1 .0 5
E S P 4 .4 0 3 -2 .21 8 .2 1 9 5 .4 0 7 .1 1 7 -2 .8 7 2 5 7 .5 3 0.11 0 .9 3 -0.11 -4 5 .8 6 72 .91
Table 7.6: Results of energy minimisations of Ice XI using different combinations of dispersion-repulsion and electrostatic models
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The average F-values summed over all four structures for each potential combination 
are summarised in table 7.7, ranked by the average F-value.
Dispersion- 
repulsion potential
Electrostatic
potential
Average
F-value
FIT M ultipoles 2 0 .9 8
S P C /E M ultipoles 5 5 .5 8
S P C M ultipoles 5 6 .7 2
T IP4P M ultipoles 6 7 .6 8
T IP3P M ultipoles 7 5 .3 3
T IP3P P oten tia l 9 3 .6 4
S P C /E P oten tia l 9 4 .5 1
M SPC /E E S P 9 6 .3 4
S P C P otentia l 9 9 .1 4
M SPC /E P oten tia l 1 0 1 .3 0
T IP3P E S P 1 0 5 .0 0
T IP4P E S P 1 0 8 .9 6
S P C E S P 1 1 6 .8 0
S P C /E E S P 1 1 7 .8 5
M SPC /E M ultipoles 1 2 9 .5 4
N SP C /E M ultipoles 1 7 2 .8 6
FIT(COOH) E S P 1 7 4 .5 9
FIT(COOH) M ultipoles 1 9 1 .5 6
N S P C /E E S P 2 0 3 .8 1
N S P C /E P oten tia l 2 3 9 .9 1
FIT E S P 2 8 5 .2 4
Table 7.7: Summary of the average F-value for each dispersion-
repulsion/electrostatic combination averaged over all four structures
A given dispersion-repulsion potential in combination with the multipole electrostatic 
model potential generally proved superior to the corresponding combination with ESP 
or potential charge electrostatic models, and the five most successful potential 
combinations used the multipole electrostatic model. Of the five potentials which were 
tested with their published potential charges three (TIP3P, SPC/E and SPC) gave 
slightly superior results compared to the ESP derived charges. The NSPC/E and 
FIT(COOH) dispersion-repulsion potentials proved inadequate for reproducing these ice 
structures, in combination with both the point charge and multipole electrostatic models. 
The NSPC/E potential was derived to reproduce vapour-liquid co-existence properties, 
and so was an inappropriate choice to use for ice. The FIT(COOH) potential only 
differed from the FIT potential by a reduction in the repulsion at the hydrogen atoms, 
but this change proved critical. It appears that the Hp parameters82 derived by fitting to a
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range of predominantly N-H containing molecules (FIT) approximates the hydrogen in
9 7  fiwater better than the Hp parameters derived from carboxylic acids (FIT(COOH)). The 
most successful potential was the FIT/multipoles combination, which was expected as 
the potential was more sophisticated than the others tested, containing hydrogen 
dispersion-repulsion terms as well as those located on oxygen. The FIT potential was 
also the only potential derived from properties of the crystalline solid state, rather than 
the liquid state of water. Interestingly the sensitivity of the FIT potential to the 
combined electrostatic potential was very large, with the FIT/ESP charges proving the 
least successful potential combination of any, only reproducing the structure of ice II 
adequately and introducing large errors in the reproductions of the other three 
polymorphs. The range of final lattice energies varied considerably depending on the 
dispersion-repulsion/electrostatic model combination, but the FIT/multipoles calculated 
energies for the four polymorphs fell into a small range, -55.53 to -53.27 kJ mol'1, 
realistic of the typical relative energy differences between polymorphs, and compares 
with the sublimation enthalpy of ice Ih at 0 K, calculated to be -47.34(2) kJ mol'1.272
This work has proved that within the limitations of the simple potential forms 
considered here, the FIT dispersion-repulsion potential in combination with the 
distributed multipoles electrostatic potential can successfully model water-water 
interactions in the solid state, giving good reproductions of all four of the structures of 
ice considered. The accuracy with which this combination modelled the four structures 
of ice suggests that attempts to optimise the FIT Hp dispersion-repulsion potential 
further specifically for ice would not lead to a significantly improved potential.
7.3 Validation of the intermolecular potential using hydrate crystal 
structures
7.3.1 Hydrate crystal structures test set and method
The FIT empirical dispersion-repulsion parameters for oxygen were originally derived 
from a series of oxohydrocarbons and the Hp parameters from molecules containing 
hydrogen atoms in N-H functional groups. It was not certain that the combining rules 
would produce heteroatomic parameters to model the interactions between the atoms in 
water and the atoms in the parent molecule that would be adequate to successfully 
reproduce hydrate crystal structures. To assess the performance of the cross-terms,
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testing against a range of hydrate structures was undertaken. MP2/6-31G(d,p)-derived 
distributed multipoles were used to model the electrostatic terms, both for the organic 
molecule and the water molecule in the hydrate structures in all cases.
The CSD23 (May 2004) was searched for suitable hydrate crystal structures. The 
search was limited to structures containing only the atomic species C, H, N, O, and F. 
Filters were applied to remove structures containing ions, polymers, disordered 
structures, structures without three dimensional co-ordinates and structures determined 
from XRPD. Each structure in the subsequent set was examined manually and those 
with undetermined water hydrogen positions were discounted along with those in which 
the parent molecule was too flexible. The most flexible groups included were methyl, 
nitro and amino substituents.
Seven of the monohydrate compounds were found to have one or more 
corresponding anhydrous crystal structures reported on the CSD. Thymine, cytosine, 3- 
amino-5-nitro-l,2,4-triazole, 5-azauracil have one reported anhydrous structure, 5- 
fluorocytosine (chapter 4) and 4-hydroxycoumarin (chapter 5) have two anhydrous 
structures each and 5-nitrouracil has three. An anhydrous structure was also found for a 
close structural analogue of 6-nitro-2,3-dihydroxyquinoxaline, with a second nitro 
group at the 7 position, and was also included in testing. These eight hydrate/anhydrous 
pairs were specifically identified to allow further analysis of the performance of the FIT 
dispersion-repulsion potential. The performance of the potential in energy minimising 
each anhydrous crystal structure can be compared to the results of energy minimising 
the corresponding hydrated structure to assess the degradation in potential performance 
with addition of water molecules.
For all structures both ExptMinExpt (with neutron standardised bond lengths to 
hydrogen) and ExptMinOpt minimisations were carried out. For the ExptMinOpt 
minimisations the water molecule was optimised at the MP2/6-31G(d,p) level and then 
O-H bond lengths fixed to 1.0 A to address the bond lengthening that occurs when 
water is hydrogen bonded. For several of the structures which contain flexible torsion 
angles these torsions were fixed to the experimental values during the molecular 
optimisation, with all other bond lengths and angles allowed to fully optimise. These 
structures were the 5-nitrouracil monohydrate and the three anhydrous 5-nitrouracil
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structures (torsion to the NO2 group fixed), dialuric acid monohydrate (one hydroxyl 
group) and anhydrous 5-fluorocytosine form 1 (ring atom positions fixed).
This gave a final set of 22 hydrate crystal structures and eight anhydrous 
structures that were energy minimised, as summarised in table 7.8.
Compound Name CSD code Molecular Structure F-value*
2,4-D iam inopterid ine
m onoh yd rate
NH,
A M PT R A 10
H,N N N
5 6 .3 9
5-A m inotetrazo le
m onoh ydrate AM TETZ01
.NH,
1 1 4 .7 0
8 -A za g u a n in e
m onoh ydrate AZG UAN
HN
H,N N
\
- /
H
2 9 5 .6 6
6-N itro-2 ,3-
d ihydroxyquinoxaline
m onoh ydrate
6,7-D in itro-2 ,3-
dihydroxyquinoxaline
BAK GO J01
HIHZUT
5 6 .7 9
56 .5 1
5-F lu orocy tosin e  
m onoh ydrate  
anhydrate form  1 
anhydrate form  2
BIRMEU
M EBQ EQ 01
M EBQ EQ
6 0 .0 5
6.88t
1 0 .7 7
1-M ethyl-isoguan in e
dihydrate
H,N
CIMMEQ ,C H , 1 3 6 6 .3
C ytosin e
m onoh ydrate
anhydrate
CYTO SM
CYTSIN
AN NH
H,N
8 1 1 .5 4
1 0 .1 6
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Dialuric acid  
m on oh yd rate DIALA C02
oX
2 3 6 .3 6 *
2 ,4 -
D iam inoqu inazoline
m onohydrate
D U PY IW
NJL
h2ist
nh2
N
4 2 .9 2
A d en in e
trihydrate F U SV A Q 01
nh2
"6c>
" H
106 .11
5-A zauracil
m onohydrate
anhydrate
HOQHAW
X E R B E B
0x
HN NAJ
H
9 9 .4 2
7 1 .9 7
4-H ydroxycoum arin  
m onohyd rate  
anhydrate form  2  
an hyd rate form 3
HOXCUM 01
OH
8 9 .3 6
17 8 .2 1
5 4 .7 6
3-H ydroxyxanth ine
dihydrate HX A NTH 10 Y'
H N ^
DH
rD
Z
^
Z
X
 
\ / 8 3 .9 0
3-A m ino-5-nitro-
1 ,2 ,4 -triazo le
m onohydrate
anhydrate
JIYW ET
JOW W IB
h2n^ ^ N\ ^ ^ no2
N----- N
H
1 0 9 .2 8
5 1 .2 0
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4 ,6 -D im eth y l-
is o x a z o lo -(3 ,4 -
b )pyrid in-3-one
m on oh yd rate
M IOZPO >-A
° \  '
H
2 0 8 .2 6
5-Nitrouracil
m onoh ydrate
an hydrate form 1 
anhydrate form 2  
anhydrate form 3
NURAM H
NIM FOE
NIM FOE01
N IM FO E 02
0x
HN NHX j
n h 2
7 1 .8 8 f
5 0 .5 2 t
9 8 .4 2 t
2 0 .0 2 *
2 ,6 -D iam in o-4 -
pyrim idinone
m onoh ydrate SEYD IJ
N H,r
N < ^  NH
1 8 4 .0 5
5-M ethyl pyridazin-3- 
o n e
m onoh ydrate TEKVIO
H,C
XN ^ 0  
H
4 3 .5 3
T hym ine
m onoh ydrate
anhydrate
THYMMH
THYMIN01
0x
HN NHx
c h 3
1 6 3 2 .6
1 5 .6 0
T etrazo lo (5 ,1 )-p u rin e
m onoh ydrate
T R Z PU R
M  N>_rvx ^N H ^ / /  \ -------N\=/ 1 1 7 .8 1
7-H ydroxy-4-m ethyl-
c h ro m en -2 -o n e
m onohydrate WIKDAV
c h 3
3 5 .5 0
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X a n th a zo le
9 4 .9 6m on oh yd rate XANAZH01
NH
HN.
Table 7.8: Hydrate structures used for potential validation. Compound name, CSD 
reference code and molecular structure are given. * ExptMinOpt F-value, 
t ExptMinConOpt
7.3.2 Results and discussion
The final column in table 7.8 includes the corresponding ExptMinOpt F-values for all 
structures in the test set. Table 7.9 summarises the cell parameter variations and F- 
values for all 22 hydrate minimisations ranked by F-value. Table 7.10 summarises the 
most changed hydrogen bond donor acceptor distance between experimental and 
ExptMinOpt structures to assess the reproduction of the hydrogen bonding. To identify 
the hydrogen bond patterns, the hydrogen bonds for all experimental and minimised 
structures were identified using the standard PLUTO141 hydrogen-bond criteria: 0---0 
MAXD (maximum distance) < 2.52 A, O—N MAXD < 2.55 A, N—O MAXD < 2.52 A, 
N—N MAXD < 2.55 A with hydrogen bonds slightly above this range manually 
identified only in minimised structures if a corresponding experimental hydrogen bond 
occurred. Summary tables detailing both the ExptMinExpt and ExptMinOpt 
reproductions of all 22 hydrate structures and the hydrate/anhydrate pairs are given on 
the supporting information CD (Chapter_7_5Azauracil_Monohydrate).
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R E FC O D E F a (A)
%
error
b (A) % error c  (A)
%
error a ( ° )
%
error P (°)
%
error y n
%
error
V o lu m e
(A3)
%
error
WIKDAV 3 5 .5 6 .9 3 2 -2 .4 5 1 1 .5 3 6 1 .77 12 .001 1 .56 9 0 - 1 0 4 .9 5 -0 .3 4 90 - 9 2 7 .1 5 0 .9 9
DUPYIW 4 2 .9 2 2 1 .2 1 9 -1 .7 2 1 .2 1 9 -1 .7 7 .7 3 8 1 .53 9 0 - 90 - 90 - 3 4 8 4 .2 7 -1 .9
TEKVIO 4 3 .5 3 6 .7 0 5 -2 .8 6 6 .4 0 4 1.61 14 .9 3 .4 3 9 0 - 9 3 .8 7 1.9 90 - 63 8 .3 1 1 .92
A M PT R A 10 5 6 .3 9 6 .7 7 8 0 .2 5 7 .3 7 3 0 .7 8 8 .4 5 9 -0 .9 7 9 6 .8 2 -2 .01 101 .21 2 .4 6 1 1 2 .6 6 2 .6 4 3 7 3 .8 1 -2 .4 9
BAKGOJ01 5 6 .7 9 7 .6 9 5 2 .9 5 1 1 .7 2 4 -1 .7 10 .831 3 .2 4 9 0 - 9 6 .9 9 -0 .5 3 9 0 - 9 6 9 .8 1 4 .6
BIRMEU 6 0 .0 5 7 .511 1 .6 8 9 .6 3 2 .5 2 1 7 .8 9 1 .76 9 0 - 9 9 .8 3 1 .23 9 0 - 1 2 7 4 .9 3 5 .7 0
HXANTH 10 8 3 .9 7 .7 1 7 -1 .5 4 7 .9 6 3 -5 .2 6 7 .631 2 .5 6 1 1 1 .7 -2 .21 1 0 6 .0 4 -2 .5 4 6 7 .4 2 .3 6 3 9 7 .3 2 -0 .8 8
HOXCUM 01 8 9 .3 6 6 .8 7 0 -0 .7 5 9 .6 2 8 -4 .1 5 1 2 .9 0 2 6 .2 4 9 0 - 9 0 - 9 0 - 8 5 3 .2 9 1 .06
XANAZH01 9 4 .9 6 9 .6 3 5 -0 .3 6 1 0 .7 3 3 0 .2 2 5 .4 1 7 3 .3 8 9 8 .0 5 -2 .7 9 1 4 5 .0 8 2 .2 4 8 7 .8 9 1 .00 3 1 4 .5 1 -3 .1 3
NURAMH 7 1 .8 8 5 .3 1 7 3 .5 2 2 .6 3 9 3.11 9 .5 9 5 0 .0 8 9 0 1 4 6 .2 9 1 .95 9 0 6 4 0 .8 4 -0 .3 6
HOQHAW 9 9 .4 2 6 .5 8 4 2 .3 7 5 .7 7 5 -7 .01 7 .0 6 5 3 .5 9 9 0 - 1 0 1 .8 2 .0 8 90 - 2 6 2 .9 8 -2 .0 7
FU SV A Q 01 106 .11 6 .841 4 .9 7 7 .6 7 5 -3 .2 3 8 .5 1 5 -1 .71 9 4 .4 4 -2 .4 2 9 8 .2 7 6 .2 8 9 9 .6 5 0 .3 0 4 3 3 .8 -0 .9 2
JIYW ET 1 0 9 .2 8 1 0 .3 9 7 -6 .5 8 1 4 .9 4 2 -1 .8 7 7 .3 8 9 3 .6 4 9 0 - 9 8 .3 5 -2 .9 0 9 0 - 1 1 3 5 .7 6 -4 .1 5
AM TETZ01 1 1 4 .7 6 .301 -1 .4 2 6 .891 -5 .3 9 .7 2 2 -0 .8 3 9 0 - 8 6 .5 5 -4 .0 9 9 0 - 4 2 1 .3 7 -7 .5 9
T R Z PU R 117 .81 1 1 .6 8 8 -0 .3 5 1 7 .1 3 0 .7 3 .8 0 .5 3 9 0 - 9 0 - 9 0 - 7 6 0 .8 3 0 .8 8
SEYDIJ 1 8 4 .0 5 16 .321 -2 .3 9 3 .8 9 8 -8 .11 1 9 .0 8 2 4.31 9 0 - 9 0 - 9 0 - 1 2 1 3 .9 2 -6 .4 4
MIOZPO 2 0 8 .2 6 8 .0 7 7 -4 .1 9 9 .321 7.51 6 .9 4 3 2.1 7 1 .4 4 -8 .3 2 76.1 -1 .2 5 62 .51 -3 .1 2 4 3 6 .8 5 0 .7 4
DIALAC02 2 3 6 .3 6 1 3 .2 0 5 3 .8 6 3 .9 6 7 7 .9 2 1 2 .2 6 2 -5 .31 9 0 - 9 1 .5 4 -3 .0 3 9 0 _ 6 4 2 .1 3 6 .4 2
AZGUAN 2 9 5 .6 6 3 .671 2 .8 3 11 .2 -1 .8 4 1 6 .1 9 6 -2 .0 2 9 0 - 9 5 .3 3 0 .0 3 90 - 6 6 3 .0 3 -1 .11
CYTOSM 8 1 1 .5 4 8 .8 3 2 1 3 .2 2 9 .3 1 7 -5 .3 6 7 .2 6 0 -5 .51 9 0 - 8 6 .5 8 -1 3 .1 6 90 _ 5 9 6 .3 4 2 .5 4
CIMMEQ 1 3 6 6 .2 7 4 .5 1 3 9 .8 2 8 .7 5 5 -7 .3 9 1 3 .2 5 4 7 .7 3 6 2 .9 7 -15 .01 6 9 .7 5 -1 7 .4 7 7 8 .5 3 -1 .7 9 4 3 7 .1 6 -3 .31
THYMMH 1 6 3 2 .6 4 .9 5 6 -1 8 .4 5 2 6 .2 8 2 -5 .6 7 4 .9 4 1 2 9 .4 8 9 0 - 8 9 .9 3 -4 .6 5 90 - 6 4 3 .5 5 -0 .11
Table 7.9: Summary of the energy minimisations of all 22 hydrate structures
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R EFC O D E M o st p o o r ly  r e p r o d u c e d  h y d r o g e n  b o n d
E x p er im en ta l (A) M in im ised  (A) % error
WIKDAV 2 .7 9 0 2 .8 7 5 3 .0 5
DUPYIW 3.051 2 .8 9 0 -5 .2 8
TEKVIO 2 .7 5 9 2 .8 7 7 4 .2 8
A M PTR A10 3 .0 6 6 2 .9 2 6 -4 .5 7
BAKGOJ01 2 .7 6 8 2 .8 6 3 3 .4 3
BIRMEU 2 .7 5 5 2 .9 9 4 8 .6 8
HXANTH10 2 .8 1 7 2 .9 4 8 4 .6 5
HOXCUM01 2 .7 8 3 2 .9 3 5 .2 8
XANAZH01 2 .8 8 3 2 .8 1 4 -2 .3 9
NURAMH 2 .9 2 4 2 .8 4 5 -2 .7 0
HOQHAW 2 .7 3 3 2 .8 1 9 3 .1 5
FUSVAQ 01 2 .9 9 3 2 .8 4 3 -5 .01
JIYWET N o lon ger within h yd rogen  bond criteria
AMTETZ01 2 .9 7 8 2 .9 1 7 -2 .0 5
TRZPUR 3 .0 1 7 2 .8 5 7 -5 .3 0
SEYDIJ 2 .7 8 9 3 .081 1 0 .4 7
MIOZPO 2 .7 2 2 2 .8 5 2 4 .7 8
DIALAC02 No lon ger  within hydrogen  bond criteria
AZGUAN No lon ger within hydrogen  bond criteria
CYTOSM No longer within hydrogen  bond criteria
CIMMEQ No lon ger within hydrogen  bond criteria
THYMMH 2.551 2 .8 6 4 1 2 .2 7
Table 7.10: Most poorly reproduced hydrogen bonds between experimental and 
minimised structures. In five structures the hydrogen bonding pattern had been 
substantially altered by the energy minimisation procedure
Energy minimised structures that had a low F-value and retained the hydrogen bonding 
present in the corresponding experimental structure with minimal discrepancy in the 
most poorly reproduced hydrogen bond length were classified as successful. This was 
the case for all but one (JIYWET) of the 15/22 ExptMinOpt minimisations with an F- 
value of less than 120. Of the four ExptMinOpt structures within the F-value range 180- 
300 range, two retained the corresponding experimental hydrogen bond set (MIOZPO 
and SEYDIJ) and in the other two the hydrogen bonding was altered (DIALAC02 and 
AZGUAN). Three ExptMinOpt structures had F-values greater than 300, with two 
having altered hydrogen bonding patterns (CYTOSM and CIMMEQ). All but one of the 
structures with F greater than 180 had at least one cell parameter that had altered by 
more than 7.5%. In only five of the 22 minimisations was the hydrogen bonding altered 
in the minimised structure: cytosine monohydrate (CYTOSM), thymine monohydrate 
(THYMMH), 8-azaguanine monohydrate (AZGUAN), 1-methyl-isoguanine dihydrate 
(CIMMEQ) and dialuric acid (DIALAC02), while the remaining 17 structures
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successfully retained the original hydrogen bonding pattern on minimisation. From 
these results it can be concluded that an upper F-value limit of 120 can be taken to be 
indicative of a successful energy minimisation of a monohydrate crystal structure.
For the eight hydrate/anhydrous pairs studied, in four cases the hydrate structure 
was reproduced with approximately equivalent accuracy to that of the corresponding 
anhydrate structures (for hydrates NURAMH, HOQHAW and BAKGOJOl, 
HOXCUMOl). For BIRMEU the hydrate structure was adequately reproduced, but 
appreciably less accurately than the corresponding anhydrate crystal structure. For the 
remaining three pairs, JIYWET, CYTOSM and THYMMH, energy minimisation of the 
anhydrate structures gave very good reproductions, while the hydrate structures were 
significantly altered, with significant changes in both unit cell parameters and molecule 
placement in the unit cell. Figure 7.3 shows the least successful hydrate reproduction, 
overlaying the experimental thymine monohydrate structure with the ExptMinOpt 
structure, matched on the thymine molecules. It is clear that the thymine hydrogen 
bonded chains remain intact, but the positions of the water molecules are very different 
and are the main contributory factor.
From the successful reproduction of the majority of hydrates structures tested it 
can be concluded that the FIT potential is adequate for use in a CSP search for 
monohydrates of a small organic molecule.
Figure 7.3: Overlay of crystal structure of thymine monohydrate (coloured by 
element) with that of the ExptMinOpt energy minimised structure (coloured blue)
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7.4 Crystal structure prediction of 5-azauracil monohydrate
7.4.1 Modification of the CSP method
5-Azauracil monohydrate was chosen from the 22 hydrates used in the hydrate potential 
testing to be used as the monohydrate CSP test subject. It was reasonably well 
reproduced by the FIT potential, with an F-value of 99. The known structure was found 
to crystallise in the space group P2\/m with both the 5-azauracil and water molecules 
lying on the mirror plane, giving Z' = 0.5. For the energy minimisation process, the 
space group was reduced to P2\ with Z' = 1. MOLPAK does not generate structures in 
the space group P2\/m but it was expected that this structure would be generated in the 
sub-groups of P2\/m, such as P2\ or possibly P 1.
When generating hypothetical crystal structures for a single molecule MOLPAK 
requires a rigid conformation of the molecule to be used as the basic unit which it packs 
into different packing types with different orientations to generate crystal structures. For 
monohydrates the MOLPAK search required modification to include a water molecule 
along with the parent molecule to produce a cluster which MOLPAK can then use to 
generate possible crystal structures. The orientation of the two molecules in this cluster 
remains fixed during the MOLPAK structure generation procedure, but once the most 
densely packed structures are passed to DMAREL the parent molecule and water 
molecule are treated as independent and can re-orientate with respect to one another 
during DMAREL energy minimisation. The orientation of the molecules in a cluster 
input to MOLPAK has a significant influence on the range of structures generated -  a 
single input cluster could not be expected to explore all of the crystal packing 
landscape. A possible structure with a markedly different water-parent molecule 
orientation to the input cluster may not be generated because the required reorientation 
in DMAREL is impossible because the structure is already too dense to accommodate 
it. Consequently a range of clusters with the constituent molecules in different 
orientations must be used as the input to separate MOLPAK searches to produce the 
fullest possible total search. Each different cluster requires a separate MOLPAK search 
with the sum of all of these individual searches producing the total search, making the 
crystal structure prediction of monohydrates a computationally expensive undertaking.
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For 5-azauracil (scheme 7.1) clusters were not be generated in a random way, but by 
exploiting crystallographic knowledge of the hydrogen bond directionality and 
intermolecular separation that could be expected in hydrate crystal structures. In 
different clusters water molecules were placed at sites to hydrogen bond to one of the 
three 5-azauracil hydrogen bond acceptors. The three acceptor groups were denoted Al, 
A2 and A3 (scheme 7.1). The CSD was searched to provide common values for some 
the orientational variables between the water and 5-azauracil molecules, to limit the 
total number of clusters required. Clusters were not considered in which water hydrogen 
bonded to the two amino hydrogen bond donors on 5-azauracil because it was expected 
that this cluster space would be automatically sampled by the generation of full crystal 
structures from the acceptor clusters and for practical considerations to limit the number 
of individual MOLPAK searches required. It should be noted that the methodology 
described here to define the set of clusters is specific to 5-azauracil, though the general 
method is applicable to any other molecule.
the acceptor labelling also shown
7.4.2 CSD analysis
Water molecules in predicted monohydrate crystal structures of 5-azauracil were 
expected to be hydrogen bonded and the directionality of hydrogen bonds, combined 
with typical hydrogen bond length and angle statistics derived from the CSD, were 
exploited to define common values for some orientational parameters between water 
and 5-azauracil to limit the total number of clusters. The orientation between water and
A1
02
A3 A2
Scheme 7.1: Definition of the numbering scheme for 5-azauracil used for CSP with
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another molecule across a hydrogen bond can be defined completely in terms of one 
distance (b l—a3), two angles (a2-a3—bl, a3—bl-b2) and three torsions (al-a2-a3—bl,
1T\a2-a3—bl-b2, a3—bl-b2-b3), as shown in scheme 7.2, with the water atoms H-O-H 
defined as a3-a2-al.
b3 ,b1
b2
a3
a2
\ a1
Scheme 7.2: Definition of the orientation of two fragments. Distance b l—a3, angles 
a2-a3—bl, a3—bl-b2 and torsions al-a2-a3—b l, a2-a3—bl-b2 and a3—bl-b2-b3
1 ^The CSD (May 2005) was searched for close contacts between water and the two 
types of hydrogen bond acceptor present in 5-azauracil (figure 7.4). Statistics were 
determined for the distance, angles and torsions defined above, between the water 
molecule and hydrogen bond acceptor fragments. The CSD searches were limited to 
returning fully determined structures with R factors < 0.075, no disorder, no errors, no 
polymers, no ions, no XRPD structures, and only organic molecules. All bonds to 
hydrogen were normalised to neutron values during the CSD search. For both A and B 
(figure 7.4) the results from the searches were sorted into 0.1 A bins for the distances 
and 10° bins for the angles and torsion angles (tables 7.11 and 7.12).
H,
H.
(M)
o
H 
N.
(b2) c  C
B
Figure 7.4: Interactions used to search the CSD. A: hydrogen bond to carbonyl 
group; B: hydrogen bond to aza group
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For A (figure 7.4A) 205 matches were returned. The distance Hw—O (a3—bl) showed a 
maximum frequency in the range 1.8-1.9 A (63/205 matches) with the range 1.9-2.0 A 
almost as populated (59). Both of the angles showed single maxima, with the angle Ow- 
Hw—O (a2-a3- bl) range 160-170° having maximum frequency (74). For the angle Hw- 
0=C (a3 -bl-b2) the range 130-140° proved most common (61). None of the three 
torsion angles showed any trend.
1.7-1.8 1.8-1.9 1.9-2.0 2.0-2.1 2.1-2.2 2.2-2 3 2.3-2 4  2.4-2 5 2.5-2 6 2.6-2 7 2.7-2.8
Distance Hw- 0  (A)
90-100 100-110 110-120 120-130 130-140 140-150 150-160 160-170 170-180
Angle Ow-Hw- 0  (°)
70-80 80-90 90-100 100-110 110-120 120-130 130-140 140-150 150-160 160-170
Angle H „-0=C  (°)
a
2  2  
o  o  o  op
o  o  o  o
Torsion Ow-Hw-0 = C  (°)
O O O O is a  a
Torsion Hw-Ow-HW ”0  (°)
8 8 o o  o o  o  o  o o  oh- o co in h-
o o o o o O Oo o  o  o  oo  Cp (ip Tf 04
o o o o o
o  o  o  o o o o oCM Tt (O 00 O  O  O
Torsion Hw-0=C -N  (°)
Table 7.11: Histograms of CSD search results for the interaction shown in figure 
7.4A. Vertical scale in all cases is frequency. Subscript w refers to water atoms
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For B (figure 7.4B) 253 matches were returned (table 7.12). It should be noted that three 
sequentially bonded atoms are required in each fragment for definition of all six 
parameters defined according to scheme 7.2. Initially the CSD was searched for water 
interacting with the fragment N(-C)-C(=0)-[any atom], the aza group with adjacent 
carbonyl as found in 5-azauracil, but only 5 matches were found. The more generic N(- 
C)-C fragment as shown in figure 7.4B gave a larger number of matches for five of the 
six parameters, but without information on the torsion a3—bl-b2-b3. Again single 
maxima were found for the Hw - N distance (range 1.9-2.0 A = 95 matches) and the two 
angles, Ow-Hw*"N (range 170-180° = 93 matches) and Hw-N-C (range 110-120° = 85 
matches). Neither of the torsions showed any trend.
'JIAFrom the experimental crystal structure of 5-azauracil monohydrate, the 
parameters for the hydrogen bonds formed between water molecules and the acceptors 
A1 and A3 were measured. The hydrogen bond distances and angles were found to lie 
in the common ranges identified by the CSD analyses above. The hydrogen bond to A1 
had the following parameters: distance O—Hw = 1.90 A, angle C=0 -Hw = 162°, angle 
0-"Hw-Ow = 124°; and for A3: distance N—Hw = 1.87 A, angle N -Hw-Ow = 178°, and 
angle C-N-Hw = 110°.
It is appreciated that a conic correction factor should have been applied to the 
results for the hydrogen bond angles in both CSD analyses but this was not done. 
This would have increased the relative population of the 170-180° bins for the hydrogen 
bond angles Ow-Hw- 0  and Ow-Hw—N in the CSD searches.
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Table 7.12: Histograms of CSD search results for the interaction shown in figure 
7.4B. Vertical scale in all cases is frequency. Subscript w refers to water atoms
7.4.3 Definition of clusters used in the search
For clusters around the acceptors A1 and A2, the a3 -b l distance was fixed to 1.9 A, 
because from the CSD analysis the bins 1.8-1.9 A and 1.9-2.0 A contained the majority 
of structures and 1.9 A was the mid-value of this range. Similarly the angle a3--bl-b2 
was fixed to 135° because the bin with greatest frequency was 130-140°. The angle a2- 
a3—bl had greatest frequency in the range 160-170° but was fixed at 180° as this
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produced a linear hydrogen bond and also fixed the torsion a2-a3- -bl-b2 to be zero. 
This left only two torsions that required systematic variation. With four of the six 
variables now fixed, the torsion a3--bl-b2-b3 now defined the position of the water 
molecule with respect to the plane of the 5-azauracil molecule and the torsion al-a2- 
a3- -bl defined the orientation of the non-hydrogen bonded hydrogen. Due to both 5- 
azauracil and water being non-chiral, only 0-180° of the a3 --bl-b2-b3 torsion was 
included, with the other hemisphere duplicated by the mirror plane through the plane of 
the 5-azauracil molecule. Consequently clusters were generated with this torsion set at 
0°, 60°, 120° and 180°. At each of these water positions, the torsion al-a2-a3--bl was 
varied in 60° steps between 0-360°. This led to 24 clusters at each of the acceptors A1 
and A2. Figures 7.5 shows an overlay of all of the water positions in the clusters at A1 
and A2 -  for each there are four water sites, and at each site there are six orientations of 
the free hydrogen of the water molecule.
A1 A2
Figure 7.5: Overlay of all clusters generated around acceptors A1 and A2
A similar process was used to define the clusters around A3, but in this case the choice 
of b2 and b3 determined the placement of the water sites. The atoms C2 and N2 were 
chosen as b2 and b3 as this led to clusters occupying space closer to C3-H5 rather than 
C2=03 around which clusters had already been generated. From the CSD analysis and 
defining the hydrogen bond as linear led to the fixed variables: a3—bl = 1.9 A, angle 
a2-a3—bl = 180°, angle a3-bl-b2 = 120° and torsion al-a2-a3—bl = 0°. Again the 
torsion a3—bl-b2-b3 was varied in 60° steps between 0-180° and the torsion al-a2- 
a3--bl was varied in 60° steps between 0-360°. Setting torsion a3* -bl-b2-b3 = 0° lead
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to overlap of the water molecule with C3-H5 and so this water position was not used. 
This gave a total of 18 clusters at acceptor site A3 (figure 7.7).
Figure 7.6: Overlay of all clusters generated around acceptor A3
For the purposes of comparison a cluster was considered with the parameters as found 
in the experimental crystal structure, with the water molecule hydrogen bonded to 02 
(scheme 7.3). This cluster was expected to generate a predicted structure corresponding 
to the experimental within the low energy predicted structures. This cluster had the 
following parameters as defined from the crystal structure:274 distance a3 -bl = 1.947 
A, angle a2-a3—bl = 161.75°, angle a3~-bl-b2 = 123.80°, torsion al-a2-a3---bl = 180°, 
torsion a2-a3 - bl-b2 = 0° and torsion a3 —bl-b2-b3 = 0°, all within the common ranges 
identified in the CSD analysis.
Scheme 7.3: Experimental cluster
The MP2/6-31G(d,p) ab initio optimised conformation of 5-azauracil and water were 
used, with the water O-H lengths 0.96 A and a H-O-H angle of 104°. For each search
O H
a2 a1
H a3
b1 O
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37 MOLPAK packing types covering 18 space groups were used. 5000 structures were 
generated in each packing type of which the top 125 from each packing type were 
passed to DMAREL for energy minimisation. All structures that minimised to saddle 
points were discarded. In total 67 clusters were subjected to an individual MOLPAK 
search. Definitions of all clusters considered are given in the supporting information.
7.4.4 Results
Each cluster was uniquely labelled in the form A[l-3]_[l-4]_[a-f] with the first term 
denoting the acceptor, the second term the a3---bl-b2-b3 torsion number, where 0° = 1 
and 180° = 4 and the third term the al-a2-a3---bl torsion with the six positions denoted 
from a to f. The low energy structures from all 67 individual searches were collated and 
the lowest energy example of each unique structure was retained. 24 structures were 
found lower in energy than the ExptMinOpt structure. A predicted structure was found 
in 51 of the searches that corresponded exactly to the ExptMinOpt structure and this 
structure was included in the low energy structure list, leading to a final set of 25 low 
energy structures, within an energy window of 4.3 kJ mol'1 (table 7.13).
The number of individual searches in which each structure is found gives an 
indication of the completeness of the total search -  if all structures were found 
repeatedly the search procedure could be considered close to complete, with only a 
small possibility of new low energy structures being found by considering further 
clusters. The clusters defined above included the water molecule placed at 11 distinct 
sites relative to the 5-azauracil molecule and at each site six different water orientations 
were sampled. For each of the 11 water sites the frequency with which the six searches 
at each site discovered each of the 25 low energy structures have been collated in table 
7.14. Except for the experimental column (which includes only one search), all other 
entries can have a maximum of six, which would mean that at this site all six searches 
found that particular low energy structure. The total at the end of each row shows the 
total number of searches, from a maximum of 67, which found each structure. The total 
at the bottom of each column shows the completeness of the searches at each of the 11 
water placement sites, with a maximum of 25 meaning that the six searches at this site 
found all 25 of the low energy structures.
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Structure
Rank
Lowest energy 
example *
Final Energy 
(kJ mol'1)
Space
Group a (A) b (A) c (A) a(°) P(°) Y(°)
Volume
(A3)
Hydrogen 
Bond Motif
1 A1 3  c a d /3 2 -1 6 5 .0 1 P c 5 .0 6 4 7 .0 8 4 7 .2 7 5 9 0 9 0 .6 1 9 0 261 S h e e t  2
2 A 2 3  b a d /1 -1 6 4 .2 0 7 Pc 5 .4 9 9 6 .9 7 2 6 .8 4 4 9 0 9 3 .7 1 9 0 2 6 2 S h e e t  2
3 A1 2  d d a /9 2 -1 6 4 .0 6 5 Cc 7 .3 3 7 7 .0 3 9 1 0 .0 4 9 0 9 0 .3 1 9 0 5 1 8 S h e e t  2
4 A 3 1 c  a d /9 -1 6 2 .4 7 4 Pc 3 .6 8 3 5 .7 0 6 1 2 .6 4 6 9 0 1 0 0 .2 2 9 0 2 6 2 N ot S h e e t
5 A 3 3  b a a /9 3 -1 6 2 .4 1 9 P1 3 .7 0 1 5 .7 6 2 6 .1 7 2 1 0 2 .4 3 9 4 .7 9 1 .3 5 1 2 8 S h e e t  1
6 A 2 2  e  d a /1 10 -1 6 2 .3 4 4 C c 1 1 .9 3 4 7 .4 0 3 1 0 .1 8 3 9 0 1 4 4 .4 9 7 9 0 5 2 3 S h e e t  1
7 A 3 1 f a d /1 7 -1 6 2 .2 5 Pc 5 .0 4 7 .4 1 3 7 .0 0 7 9 0 9 3 .3 8 9 0 261 S h e e t  1
8 A 3 1 d a a /9 3 -1 6 2 .2 0 9 P1 4 .8 9 5 4 .9 9 5 5 .3 6 1 9 2 .4 4 9 2 .0 1 9 0 .7 8 131 S h e e t  1
9 A1 2  b a h /6 5 -1 6 2 .1 1 2 P 2 i 3 .6 2 5 1 2 .1 4 9 5 .8 0 2 9 0 9 1 .1 1 9 0 2 5 5 N ot S h e e t
10 A 3 1 fa d /3 1 -1 6 2 .0 3 9 P 2 i 4 .7 1 6 5 .2 6 1 1 0 .6 2 3 9 0 9 6 .6 5 9 0 2 6 2 N ot S h e e t
11 A 3 1 c  d a /6 6 -1 6 1 .8 8 2 Cc 6 .9 9 8 7 .4 0 6 1 0 .1 1 3 9 0 9 3 .0 9 9 0 5 2 3 S h e e t  1
12 A 2 4  b d a /7 5 -1 6 1 .8 5 7 Cc 1 2 .8 5 8 6 .9 0 6 6 .7 8 9 9 0 1 1 9 .1 3 9 0 5 2 7 S h e e t  1
13 A 2 2  d d a /9 7 -1 6 1 .3 7 1 Cc 7 .1 8 6 7 .0 1 2 1 0 .3 4 9 9 0 9 0 .8 8 9 0 521 S h e e t  2
14 A 2 2  b d a /8 4 -1 6 1 .3 1 8 Cc 1 2 .6 6 6 .7 9 6 7 .1 9 4 9 0 1 2 3 .6 7 9 0 5 1 5 S h e e t  1
15 A 2 2  b a b /1 2 3 -1 6 1 .0 5 6 P-1 6 .9 2 6 .8 7 1 6 .9 1 1 1 0 4 .0 6 1 0 9 .3 2 1 1 3 .4 9 2 5 6 S h e e t  1
16 A 2 4  d ad/1 -1 6 1 .0 5 6 Pc 3 .8 1 1 7 .4 7 5 9 .0 6 6 9 0 9 1 .1 1 9 0 2 5 8 S h e e t  1
17 A 2 3  e  d e /8 -1 6 0 .9 4 4 C 2 /c 1 1 .5 3 5 7 .5 7 1 5 .7 4 7 9 0 13 1 .8 1 9 0 1 0 2 4 S h e e t  1
18 A1 3  a  d e /4 4 -1 6 0 .9 3 9 C 2 /c 1 1 .5 3 5 7 .5 7 1 1 .7 8 2 9 0 9 5 .0 4 4 9 0 1 0 2 5 S h e e t  1
19 A 2 4  b a i/7 -1 6 0 .8 3 4 P2i/c 7 .2 2 7 6 .9 4 6 1 0 .1 2 5 9 0 9 2 .2 5 9 0 5 0 8 N ot S h e e t
2 0 A1 3  d d c /1 3 -1 6 0 .8 3 1 C2lc 1 1 .5 9 8 7 .5 5 1 1 .7 8 6 9 0 9 3 .9 4 9 0 1 0 3 0 S h e e t  1
21 A 2 4  a  fa /7 8 -1 6 0 .8 2 8 P 2-|/c 6 .7 0 5 1 1 .7 0 6 9 .2 8 1 9 0 1 3 0 .7 9 0 5 5 2 N ot S h e e t
2 2 A 3 1 e  d a /5 7 -1 6 0 .7 7 4 C c 1 1 .6 7 6 7 .4 8 2 1 7 .4 3 7 9 0 1 6 0 .2 0 8 9 0 5 1 6 S h e e t  1
2 3 A 3 1 a d a /2 8 -1 6 0 .7 6 7 C c 1 2 .0 1 4 7 .4 8 2 7 .5 6 6 9 0 1 3 0 .6 8 9 0 5 1 6 S h e e t  1
2 4 A 2 2  c a m /8 6 -1 6 0 .7 2 P 2-|/c 6 .9 3 5 1 2 .4 6 8 6 .9 6 6 9 0 1 2 0 .1 3 9 0 521 S h e e t  2
2 5 A1 1 a  a b / 1 9 t -1 6 0 .6 9 6 P2-|/m 6 .5 8 4 5 .7 7 5 7 .0 6 5 9 0 1 0 1 .8 9 0 2 6 3 S h e e t  Expt
Table 7.13: Summary of the 25 lowest energy 5-azauracil monohydrate predicted structures. * This structure is the lowest energy 
example of each unique structure; * corresponds to the ExptMinOpt structure
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Structure
Rank Exptl A1_1 A1_2 A1_3 A1_4 A2_1 A2_2 A2_3 A2_4 A3_1 A3_2 A3_3
Total
Occurrence
1 1 4 6 6 5 3 0 1 0 2 6 5 3 9
2 0 1 1 2 0 3 6 6 6 5 1 0 31
3 0 0 4 5 2 1 3 4 0 4 2 4 2 9
4 0 0 0 0 0 0 0 0 0 1 0 0 1
5 1 6 6 6 6 6 6 5 6 6 6 6 6 6
6 0 0 4 3 4 4 6 6 6 6 5 4 4 8
7 0 0 2 5 1 1 1 1 0 6 5 3 2 5
8 1 6 6 6 6 6 6 6 6 6 6 6 6 7
9 0 6 6 6 4 6 6 6 6 6 6 6 6 4
10 0 0 0 0 0 0 0 0 0 1 0 0 1
11 0 0 1 3 2 0 1 2 0 6 0 2 17
12 0 1 4 4 5 6 5 5 6 6 5 4 51
13 0 0 1 4 0 3 5 5 4 2 2 3 2 9
14 0 5 2 2 4 3 6 4 6 4 5 0 41
15 1 4 6 6 6 6 6 6 6 5 6 6 6 4
16 0 0 1 0 0 2 0 2 3 2 0 1 11
17 1 3 2 3 3 3 2 1 1 2 1 0 2 2
18 0 1 4 2 2 0 4 1 1 3 5 4 2 7
19 0 2 1 0 2 0 0 2 4 2 2 0 15
2 0 0 2 2 3 5 3 4 4 3 5 5 4 4 0
21 0 4 6 6 0 1 1 1 2 5 5 3 3 4
2 2 0 0 1 0 0 2 3 1 1 1 2 1 12
2 3 0 0 2 2 1 1 2 0 0 1 1 2 12
2 4 0 0 1 0 0 0 1 0 0 2 1 0 5
2 5 1 6 6 6 2 6 6 5 1 3 6 3 51
Completness 6 /2 5 1 4 /2 5 2 3 /2 5 1 9 /2 5 1 7 /2 5 1 9 /2 5 2 0 /2 5 2 1 /2 5 1 7 /2 5 2 5 /2 5 2 1 /2 5 1 8 /2 5
Table 7.14: 5-azauracil monohydrate CSP summary. Last column - frequency with which each structure was found in the total 
search; last row - completeness for each set of six searches at a single water site
7.4.5 Discussion
The set of six searches at 5/11 water sites found 20 or more of the low energy structures 
but only the A3_l set of searches found all 25. It was not be expected that a single water 
site would be capable of finding all of the low energy structures, even with the use of 
six different water orientations at each site, and these results confirm the decision to use 
a range of water sites as well as water orientations. The eighth ranked structure was 
found by all 67 individual searches, and four predicted structures were found more than 
60 times. 11 of the 25 low energy predicted crystal structures were found by more than 
half of the individual searches, including the structure that corresponds exactly to the
tViExptMinOpt structure (the 25 ranked structure in table 7.14). Of concern was that two 
structures were found only once, the fourth and tenth ranked structures, both by the 
same A3_l set of searches. Both structures were structurally reasonable and not 
artefacts of this particular set of searches. The conclusion that must be drawn is that the 
total search is not close to completeness and other hypothetical structures could be 
found that are energetically competitive with the low energy structures reported above.
All of the structures were examined to identify recurring hydrogen bond motifs, 
to assess the qualitative similarities between the crystallographically distinct structures. 
The ExptMinOpt structure was examined to provide a basis for comparison with the 
predicted structures. It is comprised of hydrogen bonded sheets that lie on the mirror 
plane perpendicular to the b axis. Each 5-azauracil molecule hydrogen bonds to two 
other 5-azauracil molecules and three different water molecules. The water molecule 
hydrogen bonds to three different 5-azauracil molecules -  once as an acceptor and twice 
as a donor. 5-Azauracil acts as a hydrogen bond donor twice, once to a water molecule 
and once to another 5-azauracil molecule, and a hydrogen bond acceptor three times, 
twice to water molecules and once to a 5-azauracil molecule. This balances the 
acceptor/donor ratio in the structure. There are no strong hydrogen bonds between 
adjacent sheets. Two hydrogen bonded rings are present in the sheet, a R^IO) ring and
a larger 1^(16) ring (figure 7.7).
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Figure 7.7: The hydrogen bond scheme found in the experimental structure of 5- 
azauracil monohydrate
Upon examination of the other predicted structures, none showed the same hydrogen 
bonded motif as ExptMinOpt structure. However, two recurring hydrogen bonded 
sheets were identified, with sheet 1 (figure 7.8) found in 14 structures and sheet 2 
(figure 7.9) in 5 predicted structures, including the three lowest energy structures. The 
remaining 5 structures all exhibited extended three dimensional hydrogen bonded arrays 
that do not show strong similarities to one another.
Sheet 1 is comprised of one hydrogen bonded ring, R4(l8) (figure 7.8). Within 
the sheet the 5-azauracil molecules only form three hydrogen bonds, one each from the 
two amino groups and one to the aza nitrogen. The water molecule forms three 
hydrogen bonds within the sheet -  the oxygen atom acts as acceptor to two hydrogen 
bonds from 5-azauracil molecules and one of the hydrogen atoms is donated to a third 
5-azauracil molecule. The second water hydrogen atom is orientated out of the plane of 
the sheet and forms a bifurcated interaction with two 5-azauracil carbonyl groups in the 
adjacent sheet.
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Figure 7.8: Sheet 1 hydrogen bonding. Orange dashed lines show hydrogen bonds 
out of the plane of the sheet to molecules that are not shown
Sheet 2 is similar to sheet 1, being comprised of the same Rg(l8) hydrogen bonded 
rings and in both sheets the water molecule and the 5-azauracil form the same hydrogen 
bonds. Sheet 1 contains 5-azauracil molecules in only one orientation, leading to all of 
the constituent rings being orientated in the same direction. In comparison, sheet 2 has 
5-azauracil molecules in two different orientations, with every second molecule rotated 
by 120°, leading to two different orientations of the 1^(18) rings, with adjacent rings
offset by 120° (figure 7.9). In sheet 2, similarly to sheet 1, one of the water hydrogen 
atoms points out of the plane of the sheet forming a bifurcated hydrogen bond 
interaction with two carbonyl oxygen atoms in the adjacent sheet.
y
Figure 7.9: Sheet 2 hydrogen bonding. Orange dashed lines show hydrogen bonds 
out of the plane of the sheet to molecules that are not shown
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The primary qualitative difference between the structures based on sheets 1 and 2 and 
the experimental crystal structure is that the experimental crystal structure contains 
5-azauracil--5-azauracil hydrogen bonds while the predicted structures based on sheets 
1 and 2 do not -  all 5-azauracil contacts are mediated by water molecules. The 
experimental crystal structure contains four unique hydrogen bonds -  each 5-azauracil 
molecule participates in five hydrogen bonds and the water participates in three. In the 
predicted structures based on sheets 1 and 2, there are five unique hydrogen bonds, with 
each 5-azauracil molecule and each water molecule participating in five hydrogen 
bonds. The predicted structures based on sheets 1 and 2 have two fewer strong hydrogen 
bonds within the sheet than the experimental structure, but in compensation a water 
hydrogen atom is orientated out of the plane of the sheet and forms a bifurcated 
interaction with two carbonyl groups in the adjacent sheet. This bifurcated interaction 
provides the extra hydrogen bonds and is an advantage compared to the experimental 
crystal structure where there is no hydrogen bonding between sheets.
In both sheets 1 and 2 this molecular arrangement brings the carbonyl groups 
into close head-to-head contact with one another. The carbonyl O—O distance is less 
than 3 A in all structures, compared to the van der Waal’s radius of oxygen which is 
1.52 A. While carbonyl—carbonyl interactions are well established,276 the carbonyl 
groups are positioned so the partially positively charged carbon atom interacts with the 
partially negatively charged oxygen atom, in contrast to the head-to-head interaction 
observed here.
The energy ranking of the predicted structures based on sheets 1 and 2 compared 
to the experimental ExptMinOpt structure principally depends on the balance of the 
repulsive carbonyl contact against the extra hydrogen bonding introduced by the 
bifurcated interaction. This would be a subtle effect, very dependent on the performance 
of the potential, and a small over-estimation of the strength of the inter-sheet bifurcated 
interaction, or under-estimation of the carbonyl group repulsion could lead to the more 
favourable ranking of the sheet 1 and 2 structures over the experimental structure.
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7.5 Conclusion
The successful reproduction of four ordered structures of ice using the FIT dispersion- 
repulsion potential in conjunction with the distributed multipole electrostatic model, 
proved it capable of reproducing water--water contacts. This potential was also 
successful in energy minimising 17 out of the 22 hydrate structures tested, returning 
acceptably small errors in the cell parameters and retaining the hydrogen bonding 
present in the experimental structures. This proved it capable of adequately modelling 
contacts between water and organic molecules in hydrate structures. An upper F-value 
limit for a successful reproduction of a monohydrate of approximately 120 was 
determined. The energy minimisation of corresponding anhydrous structures for eight 
of the 22 hydrates showed the inclusion of water in the crystal structure did not 
significantly degrade the accuracy of the energy minimisation in five of the eight cases.
5-Azauracil was chosen from the set of hydrates used in the potential validation 
to be the initial test candidate for the crystal structure prediction of a monohydrate 
system. Modification of the MOLPAK structure generation method was required with a 
range of clusters, each containing a 5-azauracil molecule and a water molecule, used as 
separate MOLPAK inputs. Crystallographic knowledge that hydrogen bonds have 
preferred contact distance and angles was exploited in the definition of the range of 
clusters. CSD analyses gave common length and angle statistics for hydrogen bonds to 
each of the acceptor functional groups found in 5-azauracil, and so the hydrogen bond 
length and angles could be fixed in the clusters to the values found. For each 5-azauracil 
acceptor the placement of the water molecule on the circle around each acceptor defined 
by fixing hydrogen bond length and angles to their typical values, and the orientation of 
the water molecule were varied systematically. This approach limited the number of 
clusters considered in the total search to 67, upon each of which a MOLPAK search was 
carried out to produce the final set of predicted monohydrate structures.
The principal requisite of any crystal structure prediction was satisfied by the 
search results -  the search successfully generated a hypothetical structure that 
corresponded exactly to the energy minimised experimental structure. Many of the 
individual searches found this structure and it proved energetically competitive with the 
other predicted structures, only 4.3 kJ mol'1 higher in energy than the global energy
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minimum. The majority of the low energy predicted structures were based on one of 
two closely related hydrogen bonded sheet motifs. These sheets were fundamentally 
different from the experimental structure because they contained no 5-azauracil—5- 
azauracil hydrogen bonds, with all interactions mediated by water molecules. In contrast 
to the experimental structure these predicted structures had interactions between 
adjacent sheets, with a bifurcated interaction between water and the two 5-azauracil 
carbonyl acceptors. These structures also had unconventional repulsive carbonyl head- 
to-head interactions which could possibly lead to them being classified as unrealistic. 
Discounting these structures on the basis of these carbonyl contacts would rank the 
ExptMinOpt structure sixth, 2.1 kJ mol'1 above the new energy minimum.
Analysis of the results suggest that the search may not be satisfactorily close to 
completeness because two of the 25 lowest energy structures were only generated by a 
single individual search, suggesting that further individual searches starting from 
clusters with molecular orientations not considered in this search could potentially yield 
additional low energy predicted structures.
The search strategy employed here was specific to 5-azauracil, an isolated site 
hydrate, and may not perform as well on other types of hydrates such as channel or 
sheet hydrates. For example the crystal structures of thymine and cytosine hydrates 
were poorly reproduced during the potential testing and CSP searches for these 
structures could be expected to be less successful. It should also be noted that for the 
truly blind prediction of the hydrates of a candidate molecule, the search would have to 
address the potential for higher hydrates, such as di- and tri- hydrates, as well as 
fractional hydrates such as hemihydrates and sesquihydrates. With this would come 
proportional increases in computational expenditure. However the general methodology 
is applicable to any system where more than one molecule must be considered, such as 
other hydrates, solvates, co-crystals and Z' > 1 systems.
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Chapter 8 -  Conclusion
8.1 Overview
The work presented in chapters 3-7 includes the results of experimental polymorph 
screening carried out on four small organic molecules: 5-fluorouracil, 5-fluorocytosine,
3-azabicyclo[3.3.1]nonane-2,4-dione and 4-hydroxycoumarin. All four molecules are 
small, rigid organic molecules containing both hydrogen bond acceptor and donor 
groups and these highly functionalised molecules proved versatile in crystallising both 
on their own and with solvent. In the course of this work eight new polymorphs were 
discovered, with the structures of six of them fully determined by single crystal X-ray 
diffraction. The crystal structures of 12 solvates and two co-crystals were also fully 
characterised.
Computational crystal structure prediction was used to generate low energy 
potential polymorphs for six molecules: 5-fluorouracil, 5-fluorocytosine,
4-hydroxycoumarin, coumarin, 6-methoxycoumarin and 7-hydroxycoumarin. After the 
experimental polymorph screens described above, nine fully determined crystal 
structures were available for these six molecules. Using the criteria of the CCDC 
international blind tests of crystal structure prediction,121'123 in which a structure ranked 
within the top three predictions is viewed as a successful prediction, the predictions of
5-fluorouracil form 2, 5-fluorocytosine form 2, coumarin and 7-hydroxycoumarin, were 
successful, with all four of these structures found at the global energy minimum. The
6-methoxycoumarin computational search fulfilled the principal requirement of crystal 
structure prediction in that it found the experimental structure within the commonly 
accepted energy range for polymorphism, but was only ranked 22nd in the search results.
4-Hydroxycoumarin was the only molecule for which the computational search method 
failed to successfully predict at least one polymorph. This was principally because both 
of the fully determined polymorphs fell outside of the limitations of the computational 
search procedure as both contained two molecules in the asymmetric unit. The 
limitations of the computational search method also led to neither 5-fluorouracil form 1 
(Zf = 4) nor 5-fluorocytosine form 1 (high symmetry space group) being predicted. Such 
limitations are an artefact of the method used in this work and more thorough search
253*277methods, incorporating more space groups are now available. ’
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In all cases crystal structure prediction generated a range of structures within the energy 
range for potential polymorphism. For each molecule analysis of the hydrogen bonding 
present in the low energy predicted structures revealed that only two or three hydrogen 
bonded motifs recurred repeatedly. For 5-fluorouracil three recurring motifs were 
discovered, with the motif present in the lowest energy structures found in the newly 
discovered form 2, and with the most common recurring motif present in two solvates, 
though the form 1 polymorph contained a unique hydrogen bond pattern.
5-Fluorocytosine provided an even more unequivocal example with only two identified 
motifs from the low energy predicted structures -  the vastly more common motif was 
found in both newly discovered polymorphs and all but one of the solvates, with the 
remaining solvate containing the alternative motif. The predicted structures of
4-hydroxycoumarin were all found to contain the same hydrogen bonded ribbon, but 
with two distinct configurations of molecules around the hydrogen bond. Each 
configuration was observed in one of the polymorphs of 4-hydroxycoumarin found 
experimentally.
The study on 3-azabicyclo[3.3.1]nonane-2,4-dione provided an exception to the 
assertion that a crystal structure will be forthcoming with the most common motif found 
in the crystal structure prediction search results. Extensive crystal structure prediction 
during the CCDC blind test of crystal structure prediction122 produced two distinct 
motifs -  hydrogen bonded dimer-based and chain-based structures -  but only the less 
common chain motif was observed experimentally, albeit in all of its discovered crystal 
structures. The hydrogen bonding in this system was found to be unusually weak, as 
evidenced by the formation of a high temperature plastic phase, and confirmed by 
calculation of the electrostatic potential on the van der Waals surface of the molecule 
which showed the imide N-H to be a weak hydrogen bond donor.
While crystal structure prediction is principally aimed at the prediction of 
polymorphism, the prevalence of solvates, and especially hydrates, for organic 
molecules makes the prediction of solvates desirable. The ultimate aim of such an 
extension of the crystal structure prediction method would be the ability to 
computationally characterise all of the solid state forms of an organic molecule rather 
than just its polymorphs.273 The work presented in chapter 7 describes the application 
of crystal structure prediction to a monohydrate test subject, 5-azauracil, and shows that
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the generation of hypothetical monohydrate structures is possible using existing 
methods. The intermolecular potential used was found to be capable of reproducing 
intermolecular interactions between water and organic molecules. The search method 
proved successful, generating the known 5-azauracil monohydrate structure within 
5 kJ m ol1 of the global energy minimum, making it energetically feasible. Two 
principal recurring hydrogen bonded motifs were identified from the hypothetical 
structures and while neither of these motifs was that oberved in the experimental 
structure, they provided different realistic hydrogen bond patterns for this system. The 
most significant factor used to limit the scope of the structure generation was the fore­
knowledge that the experimental structure was a monohydrate, and the search was 
consequently limited to monohydrate structures. Even so the increase in computational 
expense was commensurate with the increased dimensionality of including a second 
molecule in the search procedure -  the building of a range of hydrogen bonded
5-azauracil-water clusters resulted in 67 individual searches compared to the one 
commonly required to generate potential polymorphs of a rigid candidate molecule. The 
search strategy employed was specific to 5-azauracil, but the general method is 
applicable to other isolated site hydrates and could be used in a similar manner for 
solvates and co-crystals.
8.2 Further aims
In none of the studies reported here was there an energy gap between any experimental 
structure and the predicted structures, which would imply that the discovery of further 
polymorphs could be discounted. For all molecules studied in this work a significantly 
larger range of predicted polymorphs was generated than were already known, or 
subsequently found experimentally. This is a general feature of computational crystal 
structure prediction and a greater understanding of the causes of polymorphism is 
required to reliably discount many of the predicted structures that would never be found 
experimentally. Lattice energy can only be used as a structural discriminant to discount 
structures outside of the commonly accepted range for polymorphism (approximately 
8-10 kJ mol'1).1 The remaining predicted structures have realistic intermolecular 
interactions, look crystallographically plausible278 and are calculated to be, at the very 
least, energetically competitive with the known polymorphs. Some limitations of the
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method can account for generation of excess structures, with the lack of treatment of 
lattice vibrations and the zero-point energy leading to structures being classified as 
distinct that would in reality have a sufficiently low energy barrier between them that 
could be overcome by thermal energy, leading to only one of the structures being 
observed at room temperature.
The most significant criteria for selection of which of the low energy predictions 
will correspond to experimentally achievable structures must come with the further 
understanding of nucleation processes. It is at the nucleation stage, between molecular 
self-assembly in solution and the post-critical-nucleus stage that the vast majority of 
potential polymorphs are selected against. Different crystallisation conditions can only 
influence the crystallisation pathway to a certain extent, and many of the potential 
polymorphs predicted will remain unobserved in the macroscopic crystalline state, even 
after thorough polymorph screening. Computational methods generate the end result of 
a ‘crystallisation’ -  the crystal structure -  without any incorporation of the selection 
process that the pathway from solution to crystal structure exerts on the outcome of 
experimental crystallisations. Only upon understanding the crystallisation pathways 
available to molecules, can this knowledge be used to discriminate between hypothetical 
structures, reducing the sub-set of plausible hypothetical structures.
8.3 Conclusion
This thesis contributes to a larger inter-institutional project to control and predict the 
organic solid state and, as part of this project, a substantial number of compounds will 
be screened for polymorphism to add to our knowledge about polymorphic and non- 
polymorphic systems. In the studies reported in this work four molecules were 
experimentally screened for polymorphism and in all cases the molecule was found to 
exhibit polymorphism and show a propensity for solvate formation leading to more 
solid state forms than initially expected at the outset. This clearly shows that crystal 
structure prediction methods cannot be accurately evaluated without complimentary 
experimental polymorph screening of the molecules under study. The experimental 
crystallisation screens documented in this work also include details of the crystallisation 
conditions that not only yielded new polymorphs, but those that gave known 
polymorphs and those where the solvent ‘interrupted’ the common crystallisation
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pathway to produce solvate crystal structures. Such knowledge of crystallisation 
conditions will play an important role in developing an understanding of how kinetic 
factors influence crystallisation, leading to the incorporation of a kinetic aspect into the 
computational model for the prediction of polymorphism. Two of the studies presented 
in this thesis included some investigation of the influence that nucleation processes can
have on polymorphic outcome. Molecular dynamics simulations of supersaturated
• 1805-fluorouracil solutions revealed different self-assemblies in solution that led directly 
to different polymorphs containing these units. In the case of 
3-azabicyclo[3.3.1]nonane-2,4-dione the absence of an alternative predicted motif in the 
crystalline state was attributed to the weakness of the hydrogen bonds, rationalised from 
the formation of a plastic phase and calculation of the electrostatic surface of the 
molecule, which along with the globular shape of the molecule would be conducive to 
facile molecular rearrangement in the fluxional pre-critical nucleation stage. This would 
enable the molecules to reorientate into the observed, more stable motif, rather than 
produce the alternative predicted motif.
While such advances will be important in the future, this work shows that 
current crystal structure prediction methods often generate known polymorphs as the 
most stable predicted structure. In those cases where known structures were not found 
in the search, usually because of limitations inherent to the method, the hypothetical 
structures that were generated could still be used to rationalise the solid state forms 
found experimentally. The crystal structure prediction results were used to identify the 
most reliable, robust hydrogen bonded motifs for each molecule with these predicted 
motifs proving realistic: those predicted for several of the molecules studied were then 
found experimentally, not only in polymorphs of the molecule in question, but also in 
many solvates where the role of the solvent was ancillary to the formation of the motif 
identified from the predicted structures.
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